Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
SLC22A8	OAT3	ENSG00000149452	"Solute carrier family 22 member 8"	Q8TCC7	11	62989154-63015839	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	341	"brain: 33.7;kidney: 127.3;retina: 93.5"	"Cell line enriched"	"Detected in single"	13	"EFO-21: 1.2"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.6"	"Region enriched"	"Detected in some"	25	"pons and medulla: 33.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044174	Enhanced									"HPA044174: AB_10963058"							"unprognostic (5.35e-4)"					"unprognostic (4.66e-1)"	"unprognostic (6.88e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.20e-1)"			0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	1.0	0.1	0.1	3.8	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.1	127.3	0.1	0.1	0.1	0.1	1.3	0.1	0.1	0.1	0.2	0.1	33.7	0.1	0.1	93.5	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	1.0	0.7	0.1	0.1	1.3	33.7	0.0
RHO	"CSNBAD1, OPN2, RP4"	ENSG00000163914	Rhodopsin	P08100	3	129528640-129535169	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	151	"retina: 415.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"cerebellum: 1.6;cerebral cortex: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA013440, CAB022486, CAB034887, CAB034888"	Enhanced									"CAB022486: , CAB034887: AB_785511, CAB034888: AB_785512, HPA013440: AB_2668844"	"unprognostic (4.32e-2)"			"unprognostic (1.21e-1)"	"unprognostic (1.68e-1)"		"unprognostic (1.83e-1)"	"unprognostic (2.87e-1)"		"unprognostic (1.94e-1)"			"unprognostic (9.19e-11)"	"unprognostic (4.24e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.91e-1)"		0.2	0.0	0.0	0.0	0.3	0.0	0.1	1.6	2.7	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.5	0.0	0.0	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.4	0.2	0.0	0.0	0.1	415.0	0.3	0.2	0.0	1.8	0.0	0.3	0.0	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	2.7	0.2	0.2	0.0	0.0	0.0	0.0
OPTC		ENSG00000188770	Opticin	Q9UBM4	1	203494143-203508864	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	92	"retina: 245.8"	"Cell line enhanced"	"Detected in some"		"BJ: 1.0;HeLa: 1.5;NTERA-2: 2.5;RT4: 1.6;SCLC-21H: 1.2;U-2 OS: 1.0"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA034951, HPA034952"	Enhanced				"Secreted in other tissues"					"HPA034951: AB_10669852, HPA034952: AB_2674379"				"unprognostic (3.29e-1)"	"unprognostic (1.56e-1)"					"unprognostic (7.69e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.70e-3)"		"unprognostic (8.24e-2)"	"unprognostic (3.65e-2)"			0.3	0.0	0.2	0.1	0.2	0.0	0.2	0.4	1.0	0.4	1.3	0.1	0.1	0.4	1.3	2.2	0.8	0.8	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	1.1	0.3	0.0	0.1	0.4	0.1	0.7	0.3	245.8	0.1	0.6	0.1	1.1	0.2	1.1	0.1	0.1	0.1	2.6	0.1	0.1	0.2	0.1	0.1	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.2	1.0	0.3	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.7	0.0	0.1	0.0	0.0	1.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.1	0.1	0.2	0.2	0.1	0.1	0.1
RCVRN	RCV1	ENSG00000109047	Recoverin	P35243	17	9896320-9905621	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	75	"retina: 208.6"	"Cell line enriched"	"Detected in some"	6	"WM-115: 7.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015783, CAB022363"	Enhanced									"CAB022363: , HPA015783: AB_2669298"	"unprognostic (1.65e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.95e-3)"		"unprognostic (4.82e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.94e-4)"	"unprognostic (1.62e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.41e-2)"	"unprognostic (9.23e-2)"	1.4	0.0	1.1	0.8	1.4	0.9	0.2	1.5	2.7	0.5	0.3	0.2	0.1	0.7	0.5	0.2	0.1	0.3	0.5	0.8	1.0	0.7	0.1	0.1	0.4	0.2	0.3	0.1	0.3	0.1	0.0	0.1	0.1	0.7	0.1	0.1	208.6	0.1	0.3	0.1	0.7	0.4	0.6	0.2	0.8	0.6	0.3	0.1	0.2	0.2	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.4	1.5	2.7	1.0	0.7	0.3	0.1	0.7	0.1
TYR	"OCA1, OCA1A, OCAIA"	ENSG00000077498	Tyrosinase	P14679	11	89177452-89295759	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	70	"retina: 82.0;skin 1: 25.2"	"Cell line enriched"	"Detected in single"	844	"SK-MEL-30: 84.3"	"Cancer enriched"	"Detected in single"	1755	"melanoma: 351.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000079, HPA043241, HPA050889, HPA064583"	Enhanced		Enhanced	Vesicles				Vesicles	Vesicles	"CAB000079: AB_564045, HPA043241: AB_2678383, HPA050889: , HPA064583: "	"unprognostic (1.16e-1)"								"unprognostic (1.01e-1)"		"unprognostic (1.85e-3)"		"unprognostic (9.75e-3)"					0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	82.0	0.7	0.0	0.0	25.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	84.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0
LRIT1	"DKFZP434K091, FIGLER9, LRRC21, PAL"	ENSG00000148602	"Leucine rich repeat, Ig-like and transmembrane domains 1"	Q9P2V4	10	84231593-84241461	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	67	"retina: 20.7;testis: 10.1"	"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"																												"unprognostic (2.13e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0
DCT	TYRP2	ENSG00000080166	"Dopachrome tautomerase"	P40126	13	94436808-94479682	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	58	"retina: 151.5;skin 1: 54.2"	"Cell line enriched"	"Detected in single"	259	"SK-MEL-30: 75.0"	"Cancer enriched"	"Detected in some"	215	"melanoma: 155.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA010742, HPA010743, HPA010800, CAB017634"	Enhanced		Supported	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"	"Vesicles, Plasma membrane"	"CAB017634: AB_1130818, HPA010742: , HPA010743: AB_1847519, HPA010800: AB_1847520"	"unprognostic (5.99e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.06e-2)"	"unprognostic (6.18e-5)"	"unprognostic (6.97e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.42e-1)"	0.2	0.2	0.5	0.1	1.5	0.1	1.7	0.2	0.6	0.2	0.1	0.3	0.1	0.0	0.2	0.5	0.1	0.8	0.1	0.1	0.4	0.5	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.1	1.4	0.1	0.3	0.2	0.0	151.5	1.4	0.2	0.2	54.2	0.2	0.1	0.8	0.1	0.0	0.3	0.4	0.1	0.1	0.3	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	75.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	1.5	0.2	0.6	0.4	0.5	0.3	0.1	0.3	0.4
RBP3	"D10S64, D10S65, D10S66, RP66"	ENSG00000265203	"Retinol binding protein 3"	P10745	10	47348371-47357875	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	45	"retina: 135.2"	"Group enriched"	"Detected in some"	8	"HaCaT: 2.6;HDLM-2: 2.4;SH-SY5Y: 2.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041301, HPA044239"	Enhanced				"Secreted in other tissues"					"HPA041301: AB_2677398, HPA044239: AB_2678868"	"unprognostic (3.48e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.36e-2)"		"unprognostic (4.02e-2)"	"unprognostic (1.40e-1)"		"unprognostic (1.58e-2)"		"unprognostic (5.09e-2)"	"unprognostic (5.14e-3)"			"unprognostic (7.44e-2)"	"unprognostic (1.23e-1)"		"unprognostic (4.68e-3)"	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	135.2	0.0	0.0	0.0	0.5	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	2.6	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CRX	"CORD2, CRD, LCA7, OTX3"	ENSG00000105392	"Cone-rod homeobox"	O43186	19	47819779-47843330	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	42	"retina: 125.2"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036762, HPA036763"	Enhanced									"HPA036762: AB_10673663, HPA036763: AB_10670922"	"unprognostic (1.09e-2)"	"unprognostic (1.25e-2)"		"unprognostic (1.58e-1)"	"unprognostic (2.56e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.71e-1)"	"unprognostic (3.82e-2)"		"unprognostic (1.33e-2)"	"unprognostic (1.95e-10)"	"unprognostic (9.27e-2)"	"unprognostic (1.82e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.78e-3)"	0.1	0.1	0.1	0.3	0.1	1.0	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.2	0.2	0.4	0.1	0.5	0.3	0.3	0.2	0.1	1.8	0.1	0.2	0.2	0.0	0.4	0.7	0.0	0.1	0.0	0.9	0.1	0.0	125.2	0.4	0.0	2.9	0.9	0.3	0.0	0.1	0.1	0.2	1.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	1.3	1.0	2.9	0.6	0.9	0.6	0.3	0.2	0.6	0.3	0.2	0.1	0.0	0.7	0.5	0.0	0.1	0.0	0.3	0.5	0.4	0.3	0.0	0.5	0.2	0.0	0.1	0.2	0.3	0.6	0.7	0.6	0.0	0.7	0.4	0.0	0.0	0.1	0.1	0.0	0.2	0.9	0.0	0.4	0.2	0.8	3.1	0.0	0.4	0.3	0.0	0.0	0.7	0.4	0.3	0.6	0.7	0.0	0.3	0.5	0.0	1.1	0.3	0.3	0.9	0.6	0.2	0.4	0.1	0.3	0.3	2.1	0.6	0.5	0.4	0.3	0.5	0.6	0.4	0.4	0.2	1.3	0.6	0.5	2.9	0.9	0.4	1.0	0.3	0.3	0.1	0.1	0.1	0.1	0.3	0.2	0.2	0.0	0.9	0.0
MFRP	"C1QTNF5, FLJ30570, NNO2, rd6"	ENSG00000235718	"Membrane frizzled-related protein"	Q9BY79	11	119338942-119346673	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	40	"brain: 54.9;retina: 112.9"	"Cell line enhanced"	"Detected in single"		"NB-4: 2.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	10	"pons and medulla: 54.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basal ganglia: 3.5;hippocampal formation: 13.2;pons and medulla: 10.8;thalamus: 8.9"	"Low region specificity"	"Detected in some"																															0.9	0.3	0.6	0.0	0.4	0.1	0.1	0.2	2.8	0.2	0.1	14.6	0.0	0.2	0.3	0.0	0.1	0.2	0.1	0.2	5.5	0.5	0.2	0.1	0.3	0.2	0.8	0.0	0.1	0.1	2.0	0.5	0.6	54.9	0.1	0.0	112.9	0.1	0.1	0.5	0.1	0.2	0.4	0.4	0.3	0.2	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.4	0.2	2.8	5.5	0.5	0.8	0.0	54.9	0.0
GNAT1	CSNBAD3	ENSG00000114349	"G protein subunit alpha transducin 1"	P11488	3	50191612-50196516	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	39	"retina: 171.9"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.4;MCF7: 2.3;RT4: 2.5;SCLC-21H: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA045393	Enhanced									"HPA045393: AB_2679310"	"unprognostic (3.08e-1)"	"unprognostic (1.81e-1)"		"unprognostic (8.56e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.82e-3)"		"unprognostic (6.10e-2)"				"unprognostic (1.07e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.02e-1)"	"unprognostic (9.48e-3)"	0.3	0.5	0.3	0.0	0.3	0.1	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.1	0.2	0.0	0.3	0.3	0.1	0.7	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	171.9	0.0	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	1.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.3	0.3	0.3	0.2	0.0	0.0	0.0
AIPL1	LCA4	ENSG00000129221	"Aryl hydrocarbon receptor interacting protein like 1"	Q9NZN9	17	6393693-6435199	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	37	"retina: 123.7"	"Cell line enhanced"	"Detected in some"		"HaCaT: 5.4;HeLa: 2.2"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 0.5"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA026578	Enhanced		Uncertain	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA026578: AB_2671905"		"unprognostic (2.42e-2)"		"unprognostic (1.17e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.68e-3)"		"unprognostic (3.24e-1)"		"unprognostic (1.13e-3)"				"unprognostic (3.76e-1)"	"unprognostic (5.35e-2)"			0.1	0.1	1.4	0.4	0.3	2.9	0.1	0.5	0.8	0.2	0.1	0.1	0.1	0.0	0.1	0.3	1.1	0.0	0.3	0.1	0.6	0.5	0.1	0.1	0.2	0.1	0.5	0.1	0.2	0.1	0.0	0.8	0.1	0.1	0.1	0.0	123.7	2.3	0.1	0.1	2.4	0.1	0.1	0.1	1.0	0.2	3.3	0.1	0.2	0.4	0.1	0.2	0.1	0.1	1.0	1.1	2.2	0.7	1.1	0.6	0.0	0.2	2.0	0.6	0.2	0.1	0.1	0.5	0.0	0.4	0.1	0.7	0.1	0.2	0.4	0.2	0.0	5.4	0.2	0.2	0.3	0.3	0.4	0.6	2.2	0.6	0.0	0.2	0.4	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.5	0.3	0.1	1.1	1.7	0.2	0.0	0.0	0.1	1.4	0.2	0.3	1.1	0.4	0.0	0.3	0.0	0.0	0.4	0.3	0.6	0.4	0.4	0.2	0.1	0.9	0.6	0.2	0.9	0.7	0.6	0.6	0.3	0.3	0.6	0.3	0.1	0.3	1.0	0.3	0.4	2.2	1.1	0.5	1.1	0.4	0.0	1.4	0.3	0.5	0.5	0.6	0.5	0.5	0.1	0.1	0.1
GSG1L2		ENSG00000214978	"GSG1 like 2"	A8MUP6	17	9802386-9822071	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	36	"brain: 4.8;retina: 3.3;testis: 2.6"	"Cell line enhanced"	"Detected in single"		"HeLa: 2.7"	"Cancer enriched"	"Detected in single"	95	"renal cancer: 4.7"	"Group enriched"	"Detected in some"	4	"cerebral cortex: 1.7;olfactory region: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																			0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	4.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	1.7	0.3	0.0	0.0	2.6	0.0	0.0
G6PC2	IGRP	ENSG00000152254	"Glucose-6-phosphatase catalytic subunit 2"	Q9NQR9	2	168901240-168910000	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	35	"pancreas: 28.8;retina: 12.1"	"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.1"	"Cancer enriched"	"Detected in single"	92	"pancreatic cancer: 9.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"														"unprognostic (6.42e-2)"				"unprognostic (2.39e-2)"		"unprognostic (6.04e-2)"		"unprognostic (9.05e-2)"		"unprognostic (2.97e-1)"		"unprognostic (3.10e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.87e-1)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.8	0.0	0.0	0.0	0.1	0.0	0.0	12.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0
AC010319.2		ENSG00000269035			19	17436611-17460804	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	32	"retina: 41.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.2;HHSteC: 1.0;THP-1: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA041580	Approved		Uncertain	"Nuclear membrane"				"Nuclear membrane"	"Nuclear membrane"	"HPA041580: AB_10795700"																		0.9	0.2	0.4	0.1	0.5	0.1	0.3	0.1	0.5	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.5	0.1	0.3	0.5	0.4	0.1	0.1	0.3	0.1	0.2	0.0	0.7	0.1	0.1	0.3	0.1	1.2	0.1	0.1	41.6	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.1	0.5	0.5	0.4	0.2	0.0	1.2	0.0
NPVF	"C7orf9, RFRP"	ENSG00000105954	"Neuropeptide VF precursor"	Q9HCQ7	7	25224570-25228486	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"brain: 9.5;lymphoid tissue: 2.9;retina: 7.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	95	"hypothalamus: 9.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	17	"hypothalamus: 7.2"	"Region enriched"	"Detected in some"	4	"hypothalamus: 3.8"	HPA041733	Enhanced				"Secreted in other tissues"					"HPA041733: AB_10794524"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0
TSPAN10	OCSP	ENSG00000182612	"Tetraspanin 10"		17	81637171-81648749	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	29	"retina: 117.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 6.0;SK-MEL-30: 17.7;U-138 MG: 6.4;U-87 MG: 8.1"	"Cancer enriched"	"Detected in many"	15	"melanoma: 32.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	12	"olfactory region: 1.6"	"Low region specificity"	"Detected in many"														"unprognostic (1.81e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.74e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.59e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.31e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.58e-1)"	1.0	0.1	0.1	1.3	0.1	0.0	0.4	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.9	1.1	0.5	0.3	0.7	0.1	0.1		0.1	0.2	0.5	2.2	0.1	0.1	0.2	0.9	0.0	0.1	1.4	0.2	1.1	0.0	117.4	0.3	1.0	0.1	4.0	0.1	0.1	0.1	0.2	0.2	0.5	0.1	0.4	0.1	0.5	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.8	1.8	0.2	0.2	0.6	0.7	0.2	1.9	6.0	2.9	1.6	0.6	3.1	0.7	0.7	1.7	0.1	0.1	0.4	0.3	0.6	3.5	0.0	0.4	0.4	0.4	0.0	1.1	0.7	0.8	3.3	0.1	0.0	0.0	0.2	2.8	0.2	0.1	0.4	0.2	2.9	1.3	0.0	0.0	0.2	0.5	0.0	1.3	3.2	0.4	17.7	3.5	0.4	0.1	6.4	2.0	0.5	1.7	0.0	0.0	0.0	8.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NR2E3	"PNR, rd7, RP37"	ENSG00000278570	"Nuclear receptor subfamily 2 group E member 3"	Q9Y5X4	15	71792638-71818259	"Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"retina: 50.2"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.1;MCF7: 3.2;T-47d: 3.0"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (9.90e-2)"	"unprognostic (2.50e-1)"	"unprognostic (8.25e-3)"	"unprognostic (2.63e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.85e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.75e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.82e-1)"	0.1	0.4	0.1	0.1	0.1	0.2	1.5	0.1	0.1	1.9	0.2	0.1	0.1	0.0	0.2	1.3	0.1	0.7	0.3	0.1	0.1		0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	1.8	0.2	50.2	0.9	0.1	0.1	0.7	0.5	0.1	0.1	0.1	0.9	1.3	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.2	0.7	0.0	0.3	1.9	0.0	3.1	0.1	0.9	0.0	0.7	0.4	0.1	0.1	0.3	0.3	1.3	1.2	0.0	2.2	1.0	0.7	0.2	0.0	0.9	0.0	0.5	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.5	0.3	0.0	0.0	0.1	3.2	0.0	0.8	0.2	1.4	0.1	1.0	0.0	1.6	0.2	0.3	0.2	0.3	0.4	0.5	3.0	0.3	1.7	0.4	0.2	1.1	0.2	0.4	0.5	0.2	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.7	0.0										
SAG	"ARRESTIN, RP47"	ENSG00000130561	"S-antigen visual arrestin"	P10523	2	233307816-233347055	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"retina: 215.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	39	"basal ganglia: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004946	Enhanced									"HPA004946: AB_2667304"	"unprognostic (4.76e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.52e-3)"	"unprognostic (3.95e-1)"	"unprognostic (8.54e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.54e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.12e-9)"	"unprognostic (2.56e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.03e-5)"	0.0	0.0	0.2	0.0	8.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	215.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
RPE65	"BCO3, LCA2, rd12, RP20"	ENSG00000116745	"RPE65, retinoid isomerohydrolase"	Q16518	1	68428822-68449959	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"retina: 268.3"	"Cell line enhanced"	"Detected in some"		"A-431: 6.0;PC-3: 10.4;U-2 OS: 2.5"	"Group enriched"	"Detected in some"	10	"glioma: 5.8;head and neck cancer: 1.5"	"Group enriched"	"Detected in many"	5	"hypothalamus: 6.0;midbrain: 8.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"														"unprognostic (1.59e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.15e-1)"		"prognostic favourable (9.75e-4)"	"unprognostic (4.55e-2)"		"unprognostic (5.91e-2)"	"unprognostic (6.59e-4)"	"unprognostic (2.98e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.24e-2)"	"unprognostic (3.21e-4)"	"unprognostic (2.11e-1)"	"unprognostic (2.05e-1)"	"unprognostic (3.48e-2)"	"unprognostic (8.40e-3)"	0.0	0.0	0.9	0.1	0.7	0.0	1.0	0.1	3.8	0.2	0.1	1.3	1.4	0.4	1.4	0.7	0.8	0.6	0.2	0.0	1.5	6.0	0.0	0.0	0.0	0.1	8.8	0.1	0.1	0.0	0.0	0.0	0.0	1.2	4.2	0.2	268.3	0.2	10.5	0.0	0.0	0.1	0.5	1.4	0.2	0.6	0.2	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.1	0.6	1.5	6.0	8.8	0.1	1.2	0.6
PDC	MEKA	ENSG00000116703	Phosducin	P20941	1	186443566-186461122	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"retina: 56.6"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.9;BJ: 1.8;BJ hTERT+: 3.5;hTERT-HME1: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062235	Enhanced									"HPA062235: AB_2684720"	"unprognostic (2.06e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.90e-4)"	"unprognostic (2.18e-1)"	"unprognostic (7.53e-2)"		"unprognostic (2.43e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.39e-2)"	"unprognostic (8.28e-3)"	"unprognostic (4.07e-7)"	"unprognostic (3.48e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.67e-2)"	0.5	0.0	0.3	0.2	0.5	0.2	0.2	2.0	1.5	0.3	0.2	0.2	0.2	0.0	0.3	0.2	0.4	0.1	0.4	0.4	0.5	0.3	0.2	0.2	0.2	0.6	0.4	0.2	0.5	0.5	0.0	0.2	0.2	0.2	0.7	0.0	56.6	0.6	1.2	2.3	0.7	0.2	0.2	0.4	0.2	0.2	1.3	0.2	0.2	0.5	0.2	0.2	0.2	0.2	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.4	0.5	0.2	0.0	1.9	0.0	1.8	3.5	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.2	0.0	0.3	0.6	0.1	0.0	0.0	0.7	0.3	0.0	0.7	0.1	0.0	0.0	0.2	1.9	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.1	0.7	0.0	0.4	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.4	0.0	1.1	0.2	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.5	2.0	0.5	0.5	0.3	0.4	0.2	0.2	0.2
PPEF2	PPP7CB	ENSG00000156194	"Protein phosphatase with EF-hand domain 2"	O14830	4	75859864-75902571	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"retina: 75.7"	"Cell line enhanced"	"Detected in single"		"hTCEpi: 1.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"cerebellum: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (3.19e-2)"	"unprognostic (2.92e-1)"		"unprognostic (2.50e-1)"	"unprognostic (4.73e-2)"			"unprognostic (1.53e-1)"		"unprognostic (9.02e-2)"	"unprognostic (3.32e-4)"	"unprognostic (2.74e-2)"	"unprognostic (4.54e-8)"	"unprognostic (2.89e-1)"	"unprognostic (5.98e-2)"	"unprognostic (5.16e-1)"	"unprognostic (3.66e-3)"	0.1	0.0	0.0	0.2	0.4	0.2	0.3	3.1	0.2	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	75.7	0.0	0.0	0.3	0.4	0.1	0.1	0.1	0.3	0.1	2.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	3.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0
SAMD7	DKFZp686E1583	ENSG00000187033	"Sterile alpha motif domain containing 7"	Q7Z3H4	3	169911572-169939175	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"retina: 34.7"	"Group enriched"	"Detected in some"	7	"Daudi: 2.3;U-698: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																		"unprognostic (1.27e-3)"									"unprognostic (5.46e-2)"				0.0	0.3	0.1	0.0	0.2	0.6	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	34.7	0.1	0.0	0.1	0.2	0.3	0.0	0.0	0.5	0.1	1.2	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.5	0.0	0.8	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	4.1	0.0	0.1	0.0	0.4	0.1	0.4	0.2	0.0	0.2	0.4	0.1	0.2	0.0	0.5	0.2	0.1	0.8	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0
TULP1	"LCA15, RP14, TUBL1"	ENSG00000112041	"Tubby like protein 1"	O00294	6	35497874-35512938	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"retina: 56.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.3;MCF7: 4.0"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in single"	4	"hippocampal formation: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"						"unprognostic (7.98e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.38e-2)"	"unprognostic (4.60e-5)"	"unprognostic (2.28e-2)"	"unprognostic (3.12e-3)"		"unprognostic (3.30e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.66e-6)"	"unprognostic (1.72e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.11e-2)"	0.3	0.2	0.3	0.6	0.5	0.0	0.3	0.3	0.3	1.0	0.3	0.3	0.3	0.0	1.2	2.3	0.7	1.4	0.3	0.3	2.4	0.0	0.3	0.3	0.3	0.3	0.3	0.3	1.3	0.3	0.0	0.6	0.8	0.4	2.7	0.0	56.1	1.1	1.9	0.3	2.5	0.3	0.3	0.3	0.3	0.2	0.9	0.3	0.3	0.3	0.3	0.3	0.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	7.3	0.1	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.4	0.1	0.2	0.0	1.1	0.0	0.0	0.4	0.3	0.0	0.1	0.4	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.3	2.4	0.0	0.3	0.3	0.4	0.3
RRH	peropsin	ENSG00000180245	"Retinal pigment epithelium-derived rhodopsin homolog"	O14718	4	109827994-109844604	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"retina: 66.3"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 4.0;U-266/84: 4.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.3"	"Lineage enriched"	"Detected in single"	7	"T-cells: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (1.59e-1)"	"unprognostic (2.47e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.25e-2)"	"unprognostic (7.56e-2)"	"unprognostic (8.47e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.62e-3)"	"unprognostic (4.65e-1)"	"unprognostic (4.38e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.18e-2)"	0.4	1.4	1.3	0.5	1.2	0.3	2.1	3.7	1.8	0.8	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.9	0.4	0.4	1.2	1.2	1.9	1.0	0.4	0.5	1.2	0.6	0.6	0.5	0.7	0.5	0.4	0.4	0.9	0.8	66.3	0.5	0.7	0.7	2.3	0.4	0.4	0.8	0.5	0.4	0.7	0.4	0.4	0.9	0.4	0.4	0.4	0.4	0.1	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.2	0.8	0.7	0.0	0.1	0.0	0.2	0.7	0.1	0.1	0.2	0.3	0.8	0.7	0.3	0.0	2.2	0.1	0.2	1.0	0.9	0.1	0.0	0.3	0.1	1.5	0.0	0.0	4.0	0.0	0.3	0.2	1.0	0.3	0.7	0.1	1.2	1.5	0.5	0.2	1.0	0.2	0.6	2.0	0.2	1.1	0.3	0.0	0.4	0.1	0.8	0.5	0.3	0.0	0.2	0.4	0.1	0.6	4.6	0.0	0.2	0.5	1.1	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.3	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.1	1.3	1.2	3.7	1.4	1.2	1.2	1.2	0.6	0.4	0.4
OTX2		ENSG00000165588	"Orthodenticle homeobox 2"	P32243	14	56799905-56810479	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"brain: 27.7;retina: 78.2"	"Group enriched"	"Detected in some"	545	"HAP1: 62.7;NTERA-2: 52.5"	"Cancer enriched"	"Detected in single"	27	"testis cancer: 11.6"	"Group enriched"	"Detected in many"	5	"cerebellum: 20.4;pons and medulla: 27.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"HPA000633, HPA001123"	Uncertain		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA000633: AB_1079538, HPA001123: "					"unprognostic (3.82e-1)"			"unprognostic (2.56e-2)"							"unprognostic (9.28e-2)"			0.2	0.2	0.0	0.2	0.3	0.2	0.2	20.4	0.3	0.2	0.2	3.7	0.0	0.2	0.2	1.0	0.2	0.2	0.2	0.2	1.8	2.7	0.2	0.2	0.2	0.5	4.7	0.0	0.5	0.2	0.2	2.8	0.2	27.7	0.3	0.2	78.2	0.2	1.3	0.2	0.5	0.2	0.2	0.2	0.4	0.2	3.1	2.3	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	20.4	0.3	1.8	2.7	4.7	0.0	27.7	2.3
MPP4	DLG6	ENSG00000082126	"Membrane palmitoylated protein 4"	Q96JB8	2	201644870-201698694	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"retina: 78.2"	"Cell line enhanced"	"Detected in some"		"HBF TERT88: 11.0;hTEC/SVTERT24-B: 10.2;LHCN-M2: 41.4;TIME: 8.2;U-87 MG: 10.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"cerebellum: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA057393			Supported	"Actin filaments,Cytosol"				Cytosol	Cytosol	"HPA057393: AB_2732612"	"unprognostic (1.42e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.22e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.09e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.33e-16)"	"unprognostic (1.82e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-2)"	0.4	1.7	0.3	0.5	0.6	0.0	0.3	4.9	1.1	1.2	0.2	0.2	0.2	0.0	0.8	0.4	0.3	0.1	0.4	0.2	0.5	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.8	0.2	0.0	0.7	0.7	0.3	0.3	0.3	78.2	0.2	0.5	0.6	4.1	0.2	0.3	0.2	3.8	0.1	2.2	0.2	0.2	0.6	0.6	0.2	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	5.3	1.3	3.3	3.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.4	11.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.3	0.0	10.2	0.0	6.0	0.0	0.0	41.4	0.0	0.0	0.0	0.3	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	4.2	1.2	0.9	3.7	0.0	0.0	0.0	10.8	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	4.9	0.6	0.5	0.4	0.2	0.2	0.3	0.2
NRL	"D14S46E, NRL-MAF, RP27"	ENSG00000129535	"Neural retina leucine zipper"	P54845	14	24080107-24115014	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	16	"retina: 124.5"	"Cell line enhanced"	"Detected in many"		"U-266/70: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB026066, HPA064599"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"CAB026066: , HPA064599: AB_2685295"	"unprognostic (2.71e-2)"	"unprognostic (8.17e-4)"	"unprognostic (4.60e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.88e-5)"	"unprognostic (3.59e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.75e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.38e-5)"	"unprognostic (2.56e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.35e-3)"	1.5	2.7	4.4	2.3	4.1	1.0	1.8	2.1	2.8	1.9	1.3	1.7	1.7	3.2	1.4	7.9	1.3	1.4	1.2	2.7	3.8	3.1	3.5	3.9	1.7	1.9	3.9	1.4	1.8	3.4	5.4	2.8	1.8	2.1	1.8	1.0	124.5	1.6	2.4	4.1	0.9	1.9	1.0	4.4	2.6	1.3	4.3	1.2	3.3	4.3	1.8	1.6	1.5	2.2	3.8	1.4	4.1	1.3	2.0	2.7	1.2	0.8	1.7	0.5	1.8	0.5	0.5	1.6	0.4	0.4	2.2	1.0	1.1	0.8	2.5	0.8	1.0	1.0	1.0	1.2	0.3	1.8	1.5	0.7	0.5	3.7	1.2	1.9	3.3	0.7	1.0	0.6	1.2	1.1	1.6	3.0	0.8	2.6	2.2	1.8	0.6	1.8	2.2	2.1	0.7	1.2	1.7	2.0	2.0	1.3	1.5	1.6	1.1	2.6	0.4	1.4	0.8	0.6	1.2	7.6	3.2	2.7	0.2	1.6	1.5	0.0	1.1	4.1	1.1	1.2	0.7	3.8	1.1	1.6	1.3	2.4	2.7	2.3	0.2	2.0	1.3	1.4	1.0	1.2	4.4	4.1	2.1	2.8	3.8	3.1	3.9	1.4	2.1	1.2
RP1L1	DCDC4B	ENSG00000183638	"RP1 like 1"		8	10606349-10712187	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	16	"retina: 34.0"	"Cell line enhanced"	"Detected in some"		"A-431: 1.4;TIME: 1.9;U-2 OS: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA024686, HPA024744"	Enhanced									"HPA024686: AB_2671650, HPA024744: AB_2671668"	"unprognostic (3.27e-1)"	"unprognostic (9.97e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.98e-5)"	"unprognostic (3.57e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.08e-4)"	"unprognostic (8.52e-2)"	"unprognostic (5.77e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.82e-1)"	0.5	0.5	0.1	0.1	0.1	1.6	0.5	0.1	0.1	0.7	0.1	0.1	0.1	0.0	0.4	0.1	0.6	0.2	0.3	0.4	0.1	0.0	0.3	0.1	0.7	0.1	0.1	0.1	0.2	0.2	0.0	1.7	0.7	0.1	0.2	0.1	34.0	0.5	0.1	0.3	2.0	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.3	0.1	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.1	0.1	0.5	0.0	0.9	0.8	0.7	0.2	0.0	0.1	0.2	0.6	0.8	0.4	0.4	0.0	0.0	0.0	0.1	0.6	0.4	0.0	0.3	0.0	0.0	0.0	1.9	0.0	1.4	0.1	0.3	0.7	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
VSX2	"CHX10, HOX10, RET1"	ENSG00000119614	"Visual system homeobox 2"	P58304	14	74239472-74262738	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"retina: 29.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.2;HAP1: 1.0;SK-BR-3: 1.2;U-698: 1.4"	"Cancer enriched"	"Detected in single"	34	"testis cancer: 2.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003436	Enhanced									"HPA003436: AB_1078523"	"unprognostic (2.87e-1)"	"unprognostic (1.22e-1)"			"unprognostic (2.79e-1)"	"unprognostic (3.29e-1)"		"unprognostic (3.21e-4)"		"unprognostic (7.77e-2)"				"unprognostic (8.39e-4)"	"unprognostic (3.13e-1)"			0.3	0.1	0.3	0.4	1.0	0.2	0.1	0.3	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.1	1.7	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	29.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	1.6	0.0	0.2	0.2	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.1	0.0	0.8	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.3	0.2	0.5	0.4	0.5	0.0	0.2	0.0
ANKRD33	"C12orf7, DKFZp686O1689, PANKY"	ENSG00000167612	"Ankyrin repeat domain 33"	Q7Z3H0	12	51887960-51891664	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	14	"placenta: 21.9;retina: 19.5"	"Cell line enhanced"	"Detected in single"		"BEWO: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA058753	Enhanced									"HPA058753: AB_2683808"			"unprognostic (4.42e-2)"	"unprognostic (2.13e-5)"	"unprognostic (8.25e-4)"	"unprognostic (2.37e-1)"	"unprognostic (3.25e-5)"	"unprognostic (2.42e-1)"		"unprognostic (4.07e-1)"	"unprognostic (6.21e-2)"		"unprognostic (5.51e-10)"	"unprognostic (4.41e-3)"	"unprognostic (5.56e-2)"		"unprognostic (2.18e-1)"	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.2	1.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.8	21.9	0.0	0.0	0.0	19.5	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.2	0.0	0.0	0.0
RAX	RX	ENSG00000134438	"Retina and anterior neural fold homeobox"	Q9Y2V3	18	59267035-59274086	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"pituitary gland: 12.9;retina: 45.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.4;HEK 293: 1.3;HMC-1: 6.0;SH-SY5Y: 3.1;THP-1: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"															"unprognostic (4.14e-2)"				"unprognostic (1.79e-1)"		"unprognostic (3.76e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.22e-1)"				"unprognostic (1.33e-1)"	"unprognostic (3.46e-1)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.1	2.1	0.0	45.2	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.4	0.2	0.0	0.0	0.1	0.1
RLBP1	CRALBP	ENSG00000140522	"Retinaldehyde binding protein 1"	P12271	15	89209869-89221751	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"retina: 164.1"	"Cell line enriched"	"Detected in single"	48	"SK-MEL-30: 21.4"	"Group enriched"	"Detected in some"	30	"glioma: 3.7;melanoma: 7.4"	"Group enriched"	"Detected in many"	4	"amygdala: 6.9;basal ganglia: 10.6;cerebral cortex: 7.0;hippocampal formation: 3.7"	"Group enriched"	"Detected in some"	7	"basophil: 3.3;neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042051, HPA044083"	Enhanced	Approved	Supported	Nucleoplasm,Centrosome,Cytosol				Cytosol	Cytosol	"HPA042051: AB_2732495, HPA044083: AB_2678802"	"unprognostic (3.19e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.76e-1)"		"unprognostic (8.24e-3)"	"unprognostic (5.21e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.76e-1)"		"unprognostic (2.78e-1)"	"unprognostic (1.13e-1)"		"unprognostic (8.42e-2)"	0.2	0.7	6.9	0.6	10.6	0.6	0.2	0.6	11.5	0.2	0.8	0.3	0.1	0.9	0.2	1.0	0.3	0.2	0.3	0.2	3.7	1.3	0.2	0.2	0.3	0.3	1.6	0.6	0.2	0.2	0.2	1.7	0.3	0.4	0.2	0.8	164.1	0.2	0.2	0.5	0.3	0.6	0.5	0.5	0.3	0.2	1.1	0.1	0.1	0.2	0.1	0.2	0.2	0.1	0.0	0.0	3.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	6.9	10.6	0.6	7.0	3.7	1.3	1.6	0.6	0.4	0.1
CLEC19A		ENSG00000261210	"C-type lectin domain containing 19A"	Q6UXS0	16	19285739-19322145	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	13	"brain: 7.2;retina: 24.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.2;EFO-21: 1.3;MCF7: 1.8;NTERA-2: 1.1;RPMI-8226: 2.0;U-2 OS: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted - unknown location"									"unprognostic (3.19e-1)"				"unprognostic (3.72e-1)"		"unprognostic (1.11e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.20e-1)"		"unprognostic (1.53e-1)"				0.1	0.0	2.6	0.0	0.2	0.0	0.0	0.8	7.2	0.1	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	4.5	1.3	0.0	0.1	0.5	0.3	0.3	0.2	0.0	0.1	0.0	0.3	0.1	1.2	0.8	0.1	24.4	0.4	0.0	0.3	1.2	0.1	0.0	0.1	0.0	0.8	0.5	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.1	0.0	0.0	0.0	2.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	2.6	0.2	0.8	5.0	4.5	1.3	0.3	0.2	1.2	0.0
GNGT1	GNG1	ENSG00000127928	"G protein subunit gamma transducin 1"	P63211	7	93591573-93911265	"Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"retina: 107.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 12.5;HeLa: 4.2;SK-BR-3: 4.0;T-47d: 6.8;U-266/70: 3.9;U-266/84: 5.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA042721	Enhanced									"HPA042721: AB_10806370"		"unprognostic (1.30e-1)"	"unprognostic (2.55e-4)"	"unprognostic (3.32e-4)"		"unprognostic (5.01e-2)"		"unprognostic (2.54e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.55e-1)"		"unprognostic (2.23e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.69e-1)"		"unprognostic (1.35e-1)"	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.5	0.3	0.1	1.9	0.0	0.0	0.0	0.4	0.0	2.6	0.1	0.1	0.1	7.9	0.3	0.0	0.0	107.2	1.0	0.0	0.0	0.4	0.0	0.1	0.3	0.1	0.4	0.7	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.5	0.5	1.6	0.2	0.1	1.2	0.6	1.4	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.1	12.5	0.0	0.1	0.2	0.0	0.0	0.1	0.4	0.0	4.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.6	0.1	1.9	0.1	0.0	2.0	0.1	0.0	0.0	0.6	0.3	1.5	3.6	1.3	0.2	4.0	0.1	6.8	0.2	0.2	0.0	3.7	0.2	0.0	3.9	5.2	0.0	0.2	0.0	0.0	1.6	0.0	0.1	0.7	0.1	0.9	0.5	1.0	0.9	0.3	0.4	0.8	0.8	1.3	0.1	0.2	0.5	1.2	0.6	0.0	0.0	0.0	0.0	0.3	0.1	0.4	0.0	0.3	0.0
GUCA1B	"GCAP2, RP48"	ENSG00000112599	"Guanylate cyclase activator 1B"	Q9UMX6	6	42184401-42194916	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"retina: 88.4"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 8.4;U-698: 8.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055479	Enhanced									"HPA055479: AB_2732598"	"unprognostic (1.61e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.14e-6)"	"unprognostic (5.39e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.87e-3)"	"unprognostic (6.06e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.57e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.28e-7)"	"unprognostic (4.50e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.59e-3)"	1.8	0.9	1.9	1.4	2.5	2.7	2.9	6.6	2.5	1.8	1.4	1.4	1.4	0.7	2.8	2.8	1.4	2.6	1.4	1.4	1.8	1.6	1.4	1.9	1.4	1.4	2.0	1.4	3.5	1.4	0.7	1.4	1.4	1.4	1.4	1.1	88.4	1.4	1.7	6.0	7.0	1.4	2.8	1.9	2.3	0.6	2.7	1.4	1.4	1.4	1.4	2.2	1.4	1.4	0.7	0.7	0.5	0.1	0.0	1.2	0.0	0.2	1.6	3.5	1.0	2.3	2.4	0.8	1.4	1.8	2.3	1.7	3.6	0.9	3.7	1.7	0.3	1.1	3.5	0.7	2.2	2.9	1.2	0.8	0.0	0.5	0.7	2.8	1.1	0.9	8.4	1.7	2.8	0.2	2.1	2.7	0.3	2.0	1.4	2.0	0.1	0.6	0.3	1.5	0.0	1.0	1.2	1.2	2.4	0.0	0.4	0.2	0.3	2.4	0.0	0.5	3.5	0.8	1.2	5.4	2.3	8.3	0.5	1.1	0.5	0.0	0.1	0.0	0.1	0.0	0.7	0.6	0.2	0.0	0.0	0.7	0.0	1.2	0.5	0.0	0.0	0.7	0.1	0.0	1.9	2.5	6.6	1.7	1.8	1.6	2.0	1.4	1.4	1.4
RGR	RP44	ENSG00000148604	"Retinal G protein coupled receptor"	P47804	10	84245053-84259960	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"retina: 228.3"	"Cell line enhanced"	"Detected in many"		"TIME: 4.0"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"midbrain: 30.1;olfactory region: 95.6;thalamus: 30.2"												"unprognostic (9.28e-2)"		"unprognostic (1.05e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.53e-2)"				"unprognostic (4.57e-2)"	"unprognostic (1.57e-1)"				"unprognostic (1.59e-1)"	"unprognostic (1.97e-1)"			0.4	0.4	6.6	0.5	6.1	1.3	0.6	0.4	18.1	0.5	0.4	0.6	0.0	0.3	0.5	1.1	0.6	0.3	0.3	0.3	3.0	2.2	0.4	0.4	0.4	0.6	3.2	1.3	0.5	0.3	0.2	0.4	0.4	1.1	0.5	0.6	228.3	0.6	0.4	0.6	1.1	0.5	0.2	0.2	0.5	0.4	1.2	0.7	0.0	0.4	0.0	0.3	0.3	0.0	0.9	0.9	2.2	0.8	1.0	0.7	0.1	0.6	0.7	0.8	1.6	0.6	0.5	0.4	0.4	0.4	1.0	0.4	1.5	0.2	0.8	0.7	1.2	1.2	0.3	0.7	0.2	0.5	0.2	0.3	3.0	1.0	0.2	1.4	1.7	0.3	0.7	0.5	1.2	0.3	0.6	1.4	0.0	1.2	0.5	0.9	1.5	0.2	0.5	0.6	1.5	0.0	1.5	0.3	0.4	1.0	0.7	1.4	0.2	0.1	4.0	1.6	2.1	0.8	0.3	1.2	0.3	1.2	0.3	1.3	1.0	1.0	0.8	0.8	0.6	0.8	0.4	0.8	0.7	0.5	0.3	0.9	0.6	0.6	2.2	1.0	0.4	0.9	0.2	0.1	6.6	6.1	0.4	7.3	3.0	2.2	3.2	1.3	1.1	0.7
SLC39A12	FLJ30499	ENSG00000148482	"Solute carrier family 39 member 12"	Q504Y0	10	17951839-18043292	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"brain: 42.3;retina: 19.2"	"Cell line enhanced"	"Detected in single"		"U-2 OS: 1.2"	"Cancer enriched"	"Detected in single"	8	"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.43e-2)"				"unprognostic (2.67e-1)"	"unprognostic (3.30e-1)"		"unprognostic (8.70e-2)"	"unprognostic (1.02e-1)"		"unprognostic (8.35e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.40e-6)"	"unprognostic (1.94e-1)"	"unprognostic (8.11e-2)"	"unprognostic (3.76e-2)"		1.2	1.0	13.7	1.0	14.6	0.9	2.3	2.2	31.2	0.9	1.0	14.8	0.0	0.9	0.9	0.9	0.9	0.9	0.9	1.0	21.4	5.5	0.9	0.9	1.0	0.9	9.9	5.6	0.9	1.2	0.9	1.5	1.1	42.3	1.0	1.1	19.2	1.0	0.9	0.9	0.9	0.9	1.0	1.5	1.0	0.9	1.4	8.7	0.0	0.9	0.0	0.9	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.4	0.3	0.1	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	14.6	2.2	17.5	21.4	5.5	9.9	5.6	42.3	8.7
AC021072.1		ENSG00000283536			12	53241889-53245134	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	12	"retina: 24.8"	"Cell line enhanced"	"Detected in some"		"MCF7: 1.3;NTERA-2: 2.8"									"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"																																			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0		0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.8	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0										
GABRR2		ENSG00000111886	"Gamma-aminobutyric acid type A receptor rho2 subunit"	P28476	6	89257208-89315299	"FDA approved drug targets, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	12	"retina: 18.8"	"Cell line enhanced"	"Detected in some"		"U-266/70: 4.3;U-266/84: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"														"unprognostic (2.05e-2)"	"unprognostic (1.47e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.88e-4)"	"unprognostic (4.19e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.24e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.54e-6)"	"unprognostic (3.69e-2)"	"unprognostic (7.81e-2)"	"unprognostic (5.79e-2)"	"unprognostic (7.15e-3)"	0.2	0.6	0.2	0.5	0.4	0.3	0.1	0.3	0.4	0.1	0.1	0.1	0.1	0.0	0.7	0.5	0.2	0.1	0.4	0.2	0.3	0.2	0.3	0.4	0.1	0.9	0.3	0.1	0.1	0.8	0.0	0.2	0.1	0.1	0.3	0.0	18.8	0.6	0.2	1.5	0.5	0.1	0.1	0.2	0.4	0.1	0.6	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.3	1.0	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.4	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.6	0.3	0.2	0.1	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.1	0.2	0.0	0.0	0.2	0.9	0.4	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	1.0	0.0	0.4	0.0	0.0	0.0	4.3	1.5	0.0	0.4	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.2	0.4	0.3	0.3	0.3	0.2	0.3	0.1	0.1	0.1
GRK1	"GPRK1, RHOK, RK"	ENSG00000185974	"G protein-coupled receptor kinase 1"	Q15835	13	113667155-113737735	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"retina: 51.5"	"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.2"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035200, HPA059376"	Enhanced									"HPA035200: AB_2674515, HPA059376: AB_2683996"	"unprognostic (7.93e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.24e-5)"	"unprognostic (1.76e-3)"	"unprognostic (1.53e-1)"		"unprognostic (3.59e-2)"		"unprognostic (2.21e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.00e-2)"	"unprognostic (4.02e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.18e-2)"	"unprognostic (6.11e-2)"		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	51.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0
AOC2	"DAO2, RAO"	ENSG00000131480	"Amine oxidase, copper containing 2"	O75106	17	42844600-42850707	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"retina: 133.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 14.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 4.0"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA057779	Uncertain				"Intracellular and membrane"					"HPA057779: "	"unprognostic (3.79e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.10e-4)"	"unprognostic (1.90e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.16e-2)"	"unprognostic (8.27e-3)"	"unprognostic (4.55e-5)"	"unprognostic (3.55e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.63e-2)"	"prognostic favourable (2.47e-4)"	11.6	1.2	0.9	1.3	3.2	1.8	3.1	3.2	1.6	1.5	1.1	0.9	0.9	0.6	1.5	1.2	1.0	1.5	1.5	1.3	1.2	1.8	0.9	3.6	2.2	1.0	0.9	0.9	1.0	1.2	0.8	2.1	0.9	0.9	1.3	0.5	133.5	1.2	1.2	1.4	1.2	1.0	1.3	1.0	1.7	0.7	6.5	0.9	1.0	1.0	0.9	1.2	1.6	0.9	0.1	0.0	4.0	0.0	0.0	0.6	0.0	0.2	2.8	0.6	3.1	14.3	1.4	7.4	0.9	0.9	2.0	2.8	2.2	0.3	1.1	1.4	0.3	1.2	2.7	0.7	4.1	2.3	7.3	0.4	1.3	2.2	0.9	0.4	2.8	2.2	2.5	1.9	2.9	0.5	0.7	2.6	0.6	0.3	0.6	1.1	1.1	0.9	1.4	2.8	2.2	0.4	4.4	1.0	0.6	0.1	1.0	4.0	0.5	0.2	0.5	1.9	4.0	2.5	1.2	5.7	5.5	1.1	0.5	2.6	1.0	0.0	0.0	0.8	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.2	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.9	3.2	3.2	1.6	1.2	1.8	0.9	0.9	0.9	0.9
ARR3	ARRX	ENSG00000120500	"Arrestin 3"	P36575	X	70268305-70281840	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"retina: 62.9"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA063129	Enhanced									"HPA063129: AB_2732696"	"unprognostic (1.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.70e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.02e-3)"	"unprognostic (2.77e-7)"	"unprognostic (8.64e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.43e-1)"	0.3	0.5	0.3	1.0	0.3	0.7	0.3	0.3	0.3	0.3	1.2	0.3	0.3	1.4	0.7	0.3	0.3	0.4	0.7	0.7	0.3	0.2	0.4	0.3	0.3	1.9	0.3	0.3	0.6	0.7	0.0	0.4	0.4	0.3	0.4	0.2	62.9	0.4	0.3	0.5	5.6	3.6	0.3	0.3	0.9	0.8	0.4	0.3	0.3	0.9	0.3	0.3	0.8	0.3	1.3	0.7	0.5	0.4	0.0	1.6	0.3	0.4	0.7	3.2	2.1	0.0	0.0	1.8	1.8	0.0	0.0	0.0	0.6	1.1	1.3	0.4	0.0	0.7	0.0	0.0	0.0	1.4	3.3	0.4	1.1	0.0	0.0	0.7	1.6	0.1	0.0	0.0	0.0	0.0	0.4	5.9	0.0	0.5	1.2	0.6	0.9	0.7	1.1	0.6	0.1	0.0	1.5	0.4	1.0	0.6	0.2	0.1	0.1	0.4	2.5	1.5	2.0	1.4	0.1	1.4	0.8	0.8	1.4	2.0	1.4	0.0	0.4	0.5	0.9	0.2	0.0	1.3	0.4	0.0	0.5	0.4	1.6	0.1	0.1	0.0	0.0	0.7	0.2	0.3	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.3	0.3
EYS	"bA166P24.2, bA307F22.3, bA74E24.1, C6orf178, C6orf179, C6orf180, dJ1018A4.2, dJ303F19.1, EGFL10, EGFL11, RP25, SPAM"	ENSG00000188107	"Eyes shut homolog (Drosophila)"	Q5T1H1	6	63719980-65707225	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	11	"retina: 40.7"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.4;SCLC-21H: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"basophil: 3.7;neutrophil: 3.2"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.7"														"Secreted in other tissues"						"unprognostic (2.92e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.38e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.61e-4)"	"unprognostic (1.89e-1)"	"unprognostic (8.41e-2)"	"unprognostic (6.38e-3)"	"unprognostic (1.11e-1)"	2.8	0.4	0.4	0.6	0.2	1.1	1.1	1.2	0.8	0.2	0.7	0.2	0.2	0.4	0.3	0.2	0.2	0.3	0.4	0.4	0.4	0.2	0.2	1.7	0.3	0.6	0.2	0.5	0.4	0.6	0.0	2.2	0.3	0.5	0.6	2.6	40.7	0.5	0.2	0.6	1.3	0.6	0.2	0.3	0.3	0.3	2.9	0.2	0.6	0.5	0.2	0.2	0.4	0.3	0.3	0.3	3.7	0.8	0.3	0.4	0.9	0.4	0.3	0.7	0.5	0.0	0.6	0.2	0.4	0.3	0.0	0.0	0.3	0.3	0.8	0.5	0.1	0.2	0.8	0.4	0.0	0.5	0.7	0.5	1.2	1.1	0.1	0.8	0.3	0.3	0.9	0.3	0.1	0.0	0.6	5.4	0.5	0.0	0.3	0.3	0.2	0.6	0.3	0.1	0.4	1.2	0.2	3.8	0.3	0.2	0.1	0.2	0.0	0.8	0.3	0.5	0.6	0.3	0.5	1.5	0.8	0.4	0.6	1.0	0.2	3.7	0.8	0.2	0.3	0.2	0.2	0.2	0.1	0.1	0.3	0.3	0.3	0.4	3.2	0.3	0.3	0.2	0.1	0.9	0.4	0.2	1.2	0.7	0.4	0.2	0.2	0.5	0.5	0.2
IMPG1	"GP147, IPM150, SPACR"	ENSG00000112706	"Interphotoreceptor matrix proteoglycan 1"	Q17R60	6	75921115-76072678	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"retina: 110.5"	"Cell line enhanced"	"Detected in some"		"A-431: 2.0;AF22: 2.9;HaCaT: 4.0;TIME: 2.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"basal ganglia: 10.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027142, HPA030332, HPA030333"	Enhanced				"Secreted in other tissues"					"HPA027142: AB_2672132, HPA030332: AB_2673432, HPA030333: AB_2673433"	"unprognostic (6.65e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.69e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.49e-3)"	"unprognostic (5.97e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.89e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.09e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.96e-2)"	0.6	0.0	0.4	0.4	10.3	0.0	0.4	1.0	2.8	0.4	0.4	0.4	0.4	2.8	0.4	0.4	0.4	0.1	1.1	0.5	0.5	0.4	0.8	0.4	0.5	0.4	0.5	0.4	0.4	5.4	0.0	0.4	0.6	0.4	0.7	0.0	110.5	0.6	0.4	0.6	4.0	2.3	0.4	0.4	0.5	0.7	0.9	0.4	0.4	0.8	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.0	0.1	2.9	0.0	0.0	0.6	1.5	0.8	0.0	0.0	0.0	1.7	0.6	0.0	0.3	0.0	4.0	0.0	0.0	0.0	0.1	1.5	0.7	0.1	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.6	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.7	0.7	1.2	0.0	1.8	0.3	0.0	0.3	2.4	0.4	0.0	0.0	0.2	0.7	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	10.3	1.0	1.9	0.5	0.4	0.5	0.4	0.4	0.4
OPN1LW	"CBBM, CBP, COD5, RCP"	ENSG00000102076	"Opsin 1, long wave sensitive"	P04000	X	154144224-154159032	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	11	"retina: 14.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																															"unprognostic (6.05e-2)"								0.3	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.1	0.0	1.2	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RS1	"RS, XLRS1"	ENSG00000102104	"Retinoschisin 1"	O15537	X	18639910-18672109	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"retina: 54.9"	"Cell line enhanced"	"Detected in single"		"HeLa: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059546	Enhanced				"Secreted in other tissues"					"HPA059546: AB_2684058"	"unprognostic (8.31e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.80e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.14e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.04e-4)"	0.1	0.0	1.0	0.1	2.3	0.0	0.1	0.6	3.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	1.0	0.4	0.4	0.1	5.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	54.9	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.5	0.1	0.2	0.1	0.1	0.5	0.1	0.5	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.2	0.1	0.1	0.1	0.0	1.0	2.3	0.6	2.4	1.0	0.4	0.1	0.1	0.1	0.1
TTR	"CTS, CTS1, HsT2651, PALB"	ENSG00000118271	Transthyretin	P02766	18	31591726-31599021	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 1008.0;liver: 680.8;retina: 332.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 30.7;EFO-21: 10.8;Hep G2: 47.1;U-2 OS: 14.2"	"Group enriched"	"Detected in many"	28	"liver cancer: 928.2;pancreatic cancer: 666.0"	"Region enriched"	"Detected in many"	9	"pons and medulla: 1008.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 1513.1;hippocampal formation: 5269.0;pons and medulla: 5831.5;thalamus: 3501.9"	"Region enhanced"	"Detected in many"		"pons and medulla: 1006.9"	"CAB002517, HPA002550, CAB062567, CAB073406"	Supported		Approved	"Golgi apparatus"	"Secreted to blood"	180000000000	180000000000	"Golgi apparatus"	"Golgi apparatus"	"CAB002517: AB_563965, CAB062567: AB_2665620, CAB073406: , HPA002550: AB_1080419"	"unprognostic (6.79e-3)"		"unprognostic (3.38e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.74e-1)"		"unprognostic (1.84e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.74e-2)"		"unprognostic (9.66e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.35e-3)"	"unprognostic (5.26e-1)"		"unprognostic (3.52e-2)"	0.5	0.4	3.6	0.4	3.0	0.6	0.4	5.8	60.8	0.4	0.6	361.3	0.0	0.9	0.4	0.4	0.4	0.4	3.3	0.4	115.6	4.4	1.0	680.8	0.4	0.4	7.1	0.0	0.4	62.3	1.6	0.5	0.4	1008.0	0.4	0.5	332.4	0.4	0.4	0.4	1.0	0.6	0.4	4.9	0.5	2.0	0.4	0.6	0.0	0.4	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	30.7	0.0	0.6	10.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.1	0.0	47.1	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.3	0.0	14.2	0.0	1.0	0.0	0.6	4.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.0	5.8	60.8	115.6	4.4	7.1	0.0	1008.0	0.6
AL662820.1		ENSG00000285064			6	33321386-33329286	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	10	"retina: 26.6"	"Group enriched"	"Detected in some"	6	"U-266/84: 1.5;U-698: 3.2;U-937: 1.6"									"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.5;neutrophil: 2.4"	"Group enriched"	"Detected in many"	4	"B-cells: 2.5;granulocytes: 2.4;T-cells: 1.6"																																					0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	2.5	0.0	2.4	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	3.2	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	2.5	0.3	1.6	2.4	0.5	0.0	0.0	0.3	0.0										
CACNA1F	"AIED, Cav1.4, CORDX3, CSNB2, CSNB2A, CSNBX2, JM8, JMC8, OA2"	ENSG00000102001	"Calcium voltage-gated channel subunit alpha1 F"	O60840	X	49205063-49233371	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"retina: 55.8"	"Cell line enhanced"	"Detected in some"		"A549: 2.5;BEWO: 2.5;MCF7: 2.8;U-266/70: 4.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA068379	Enhanced									"HPA068379: AB_2732782"	"unprognostic (1.20e-3)"	"unprognostic (8.62e-2)"	"unprognostic (4.25e-3)"	"unprognostic (1.56e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.04e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.08e-7)"	"unprognostic (8.03e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.77e-3)"	0.7	0.8	1.8	0.7	1.5	4.0	1.8	5.3	2.0	0.7	1.0	0.7	0.7	1.9	0.7	2.7	0.7	1.0	0.7	0.7	0.8	0.6	0.7	0.7	1.4	2.7	0.7	0.7	0.7	1.4	0.0	0.7	0.7	0.7	0.7	1.5	55.8	1.2	0.9	0.7	2.4	3.7	0.7	0.7	1.8	1.0	0.7	0.7	0.7	1.2	0.7	0.9	0.7	0.7	1.4	4.6	2.0	0.9	0.5	1.0	0.2	0.2	2.5	0.2	0.0	0.6	0.0	2.5	0.4	0.2	0.0	0.0	0.1	0.9	1.4	0.5	0.5	0.1	0.4	0.0	0.0	0.1	0.0	0.7	0.0	0.5	0.5	0.1	0.8	0.6	0.0	0.4	0.0	0.7	1.0	0.3	0.0	2.8	1.3	1.5	1.1	0.0	0.1	0.0	0.5	0.4	1.5	0.6	0.0	0.0	0.1	0.0	0.9	1.5	1.0	0.2	0.3	0.2	0.1	4.6	1.6	0.0	0.8	0.4	0.0	0.9	0.7	0.6	0.6	0.5	0.5	0.7	0.8	0.4	0.8	1.4	0.5	1.0	2.0	0.5	0.9	4.6	0.7	0.2	1.8	1.5	5.3	2.0	0.8	0.6	0.7	0.7	0.7	0.7
CPLX4	CPX-IV	ENSG00000166569	"Complexin 4"	Q7Z7G2	18	59275156-59318649	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"retina: 61.9"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"cerebellum: 6.3"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.7"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047627	Enhanced									"HPA047627: "					"unprognostic (1.85e-1)"		"unprognostic (4.46e-1)"			"unprognostic (4.20e-2)"		"unprognostic (4.05e-2)"		"unprognostic (9.90e-3)"				0.1	0.3	0.2	0.0	0.1	2.8	0.1	6.3	0.2	0.1	0.1	0.1	0.0	0.2	0.1	0.8	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.2	0.3	0.2	0.3	0.0	0.1	0.2	0.0	0.2	0.0	0.4	0.1	0.0	61.9	0.3	0.0	0.3	1.9	0.1	0.0	0.2	0.3	0.1	1.2	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.6	0.7	1.7	0.3	0.8	0.7	0.1	0.1	0.8	0.4	0.8	0.7	0.2	0.8	0.8	0.0	0.1	0.0	0.3	0.6	0.5	0.1	0.2	1.1	0.2	0.0	1.2	0.3	0.0	0.2	1.5	0.8	0.0	0.0	0.3	0.3	0.6	0.0	0.0	0.0	0.1	0.7	0.6	0.4	0.3	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.4	0.2	0.0	0.9	0.0	0.1	0.3	0.6	0.6	0.2	0.9	0.0	0.8	0.4	0.4	0.1	0.2	0.6	0.4	0.3	0.1	0.3	0.0	0.3	0.1	0.4	0.3	0.0	0.6	0.2	0.7	1.7	0.8	0.1	0.7	0.2	0.1	0.2	0.1	6.3	0.1	0.1	0.1	0.3	0.0	0.4	0.0
GUCY2F	"CYGF, GC-F, GUC2DL, RetGC-2, ROS-GC2"	ENSG00000101890	"Guanylate cyclase 2F, retinal"	P51841	X	109372906-109482072	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"retina: 23.1"	"Group enriched"	"Detected in some"	5	"THP-1: 4.4;U-266/70: 1.6;U-937: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	"unprognostic (1.91e-1)"	"unprognostic (4.45e-2)"									"unprognostic (2.96e-1)"	"unprognostic (2.23e-1)"			0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.1	0.0	1.5	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0
CLDN19		ENSG00000164007	"Claudin 19"	Q8N6F1	1	42733093-42740254	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"brain: 13.8;kidney: 22.5;placenta: 20.9;retina: 37.0"	"Group enriched"	"Detected in some"	6	"CACO-2: 5.3;Hep G2: 11.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.6"	"Group enriched"	"Detected in some"	54	"midbrain: 13.8;pons and medulla: 9.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"olfactory region: 6.7"	"Low region specificity"	"Detected in all"														"unprognostic (6.23e-4)"	"unprognostic (1.80e-1)"		"unprognostic (1.85e-6)"	"unprognostic (5.30e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.22e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.12e-1)"		"unprognostic (3.29e-3)"	1.0	0.2	0.1	0.1	0.2	0.2	1.6	0.2	0.1	0.2	0.1	0.2	0.0	0.2	0.2	0.9	0.6	0.3	0.1	0.4	0.2	0.1	22.5	0.2	0.2	0.1	13.8	0.0	0.2	0.2	0.1	0.2	20.9	9.5	0.4	0.1	37.0	1.2	2.7	0.4	0.8	0.3	1.0	6.2	0.1	0.5	0.2	0.0	1.3	0.1	2.6	0.1	0.8	1.0	0.5	0.4	1.4	0.3	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.3	0.3	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.5	0.5	0.5	1.4	0.2	0.2	0.4	0.3	0.1	0.1	0.2	0.2	0.1	0.2	0.1	13.8	0.0	9.5	0.0
CNGB3	"ACHM1, ACHM3, RMCH"	ENSG00000170289	"Cyclic nucleotide gated channel beta 3"	Q9NQW8	8	86553977-86743675	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"retina: 68.9"	"Cell line enriched"	"Detected in some"	13	"SCLC-21H: 21.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA057244	Enhanced									"HPA057244: AB_2683380"	"unprognostic (5.35e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.82e-1)"	"unprognostic (9.28e-2)"	"unprognostic (2.77e-4)"	"unprognostic (1.40e-4)"	"unprognostic (1.66e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.84e-1)"	0.2	0.1	0.4	0.4	0.2	7.9	0.2	0.2	1.0	0.9	0.1	0.1	0.1	0.9	0.7	0.4	0.2	2.8	0.1	0.3	0.2	0.2	0.2	0.1	0.1	0.3	0.6	0.1	1.0	1.5	0.0	0.6	0.1	1.8	0.1	0.0	68.9	0.3	0.1	0.1	2.4	0.4	0.1	0.8	0.1	0.6	5.4	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	1.3	0.1	0.0	0.0	0.3	0.0	0.0	0.4	0.0	1.6	21.2	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.5	0.2	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.2	0.2	1.0	0.2	0.2	0.6	0.1	1.8	0.1
GNG13	"G(gamma)13, h2-35"	ENSG00000127588	"G protein subunit gamma 13"	Q9P2W3	16	798041-800733	"Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 78.6;retina: 22.9"	"Cell line enhanced"	"Detected in many"		"CACO-2: 11.0;HEK 293: 9.7;HeLa: 5.8;MCF7: 13.6"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	7	"cerebellum: 78.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"cerebellum: 1054.1"	"Group enriched"	"Detected in many"	6	"cerebellum: 43.5;olfactory region: 18.2"	HPA046272	Enhanced									"HPA046272: AB_10960062"	"unprognostic (1.84e-1)"	"unprognostic (2.75e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.57e-2)"	"unprognostic (5.41e-2)"		"unprognostic (8.47e-2)"	"unprognostic (9.16e-3)"	"unprognostic (4.04e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.77e-2)"		"unprognostic (7.12e-2)"	"unprognostic (1.55e-1)"		"unprognostic (3.38e-1)"	0.2	0.2	1.8	0.7	3.3	0.9	0.3	78.6	11.3	0.2	2.9	3.4	0.0	5.4	0.2	0.7	0.2	0.2	0.3	0.2	1.1	1.6	0.2	0.2	0.3	0.6	1.3	2.7	0.3	0.2	0.2	0.3	0.4	2.7	0.4	0.6	22.9	0.2	0.2	0.2	0.5	5.1	0.4	1.9	0.4	0.8	1.5	0.2	0.2	0.3	0.0	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.9	0.5	1.1	0.0	0.0	0.9	1.0	0.0	0.0	0.0	11.0	0.3	1.2	0.3	0.0	1.7	0.0	0.0	0.0	1.3	9.7	1.4	5.8	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.0	0.0	1.9	0.9	0.0	13.6	1.3	0.8	1.3	1.1	3.0	3.1	0.7	0.0	1.6	1.0	0.9	1.0	0.4	0.2	0.8	0.1	0.0	1.4	1.4	1.9	0.3	0.5	2.4	4.4	0.0	2.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	3.3	78.6	11.3	1.1	1.6	1.3	2.7	2.7	0.2
NXNL1	"RDCVF, TXNL6"	ENSG00000171773	"Nucleoredoxin like 1"	Q96CM4	19	17455425-17460954	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"retina: 48.8"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (2.62e-1)"				"unprognostic (5.49e-1)"				"unprognostic (1.81e-1)"	"unprognostic (3.63e-1)"						"unprognostic (1.13e-1)"		5.6	4.3	1.2	0.3	1.8	0.5	2.2	0.4	1.0	0.3	0.3	0.5	0.3	0.3	0.3	0.3	0.6	0.3	0.3	0.9	1.2	0.6	0.3	0.3	0.4	0.4	1.6	0.3	0.8	0.3	0.0	0.3	0.3	1.8	0.5	0.1	48.8	1.2	0.3	1.9	1.9	0.3	0.3	0.8	0.3	0.2	0.7	0.3	0.3	0.9	0.3	0.3	0.3	0.3	1.8	1.8	1.8	1.0	0.7	1.3	0.2	0.9	2.2	1.2	1.7	2.4	1.6	0.9	0.7	0.2	2.1	0.4	1.0	0.4	0.2	0.9	1.8	1.0	1.0	1.1	0.2	0.8	1.5	1.1	0.5	1.7	1.8	0.8	1.6	0.4	0.5	0.9	1.1	0.0	0.8	2.2	0.0	2.5	0.3	1.1	0.7	1.4	1.1	2.3	0.5	0.6	0.3	1.7	0.6	0.3	0.0	1.7	0.6	0.4	0.1	0.3	0.9	1.4	0.3	1.4	1.4	2.0	0.1	1.2	0.0	0.2	1.0	1.2	0.8	0.9	0.2	0.7	0.7	0.4	0.2	1.8	1.1	0.7	1.8	0.7	0.6	1.8	1.3	0.2	1.2	1.8	0.4	1.0	1.2	0.6	1.6	0.3	1.8	0.3
RAX2	"ARMD6, CORD11, MGC15631, RAXL1"	ENSG00000173976	"Retina and anterior neural fold homeobox 2"	Q96IS3	19	3769089-3772221	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"retina: 51.7"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			HPA052533	Uncertain									"HPA052533: AB_2681862"										"unprognostic (5.53e-2)"				"unprognostic (1.39e-2)"	"unprognostic (4.48e-1)"			0.2	0.0	0.1	0.2	0.3	1.4	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.2	1.0	0.1	0.1	2.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.2	3.7	5.9	0.1	0.2	0.1	0.1	51.7	0.1	0.1	0.2	0.9	0.1	0.3	0.1	0.3	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.9	0.5	1.8	0.7	1.0	0.8	0.2	0.1	0.0	0.1	0.3	0.0	0.0	0.3	0.2	0.1	0.0	0.1	0.7	0.2	0.1	0.0	0.2	0.1	0.0	0.5	0.1	0.0	0.8	0.0	1.0	0.2	0.0	0.2	0.4	0.0	0.0	0.1	0.2	0.0	0.5	1.8	0.4	0.9	0.3	0.9	0.1	0.2	0.1	0.2	0.1	0.1	0.6	0.6	0.6	0.4	0.5	0.0	0.5	0.0	1.1	0.2	0.8	0.2	0.0	0.7	0.2	0.4	0.1	1.2	0.3	1.1	0.7	0.3	0.3	0.4	0.6	0.2	0.4	0.3	0.2	0.9	0.6	0.8	1.8	1.0	0.3	0.5	0.4	0.2	0.1	0.3	0.2	0.4	0.2	0.1	0.1	0.1	0.2	0.1
SERPINE3		ENSG00000253309	"Serpin family E member 3"	A8MV23	13	51335773-51364735	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"retina: 49.3"	"Cell line enhanced"	"Detected in some"		"HeLa: 2.7;TIME: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA051904, HPA055804"	Uncertain				"Secreted in other tissues"					"HPA051904: AB_2681659, HPA055804: AB_2682928"	"unprognostic (1.60e-1)"	"unprognostic (6.17e-2)"	"unprognostic (9.66e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.52e-2)"	"unprognostic (8.54e-3)"	"unprognostic (2.67e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.94e-6)"	"unprognostic (1.29e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.31e-2)"	2.6	0.9	0.6	1.2	0.8	0.2	0.6	1.9	1.7	0.6	0.8	0.6	0.6	0.8	1.1	2.0	1.1	0.9	1.4	1.9	0.7	0.5	0.8	1.2	0.6	1.4	0.6	0.6	1.0	5.7	0.1	0.6	0.6	1.2	0.6	0.1	49.3	0.9	0.6	0.6	4.0	3.2	0.6	1.1	0.8	0.8	1.0	0.6	0.6	1.1	0.6	0.6	0.9	0.9	1.6	0.0	0.1	0.9	0.0	0.8	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.1	0.2	0.8	0.3	0.0	0.7	0.0	0.0	0.0	0.9	0.1	0.9	2.7	0.2	0.0	1.9	0.9	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.4	0.3	0.8	2.3	0.0	0.3	0.0	0.0	1.3	1.1	0.3	2.1	0.1	0.2	1.0	2.1	2.9	0.7	1.9	0.2	1.3	0.4	0.7	0.2	1.5	0.2	1.4	0.0	0.2	0.0	0.3	0.9	0.0	0.0	0.8	0.1	0.0	1.6	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.8	1.9	0.6	0.7	0.5	0.6	0.6	1.2	0.6
SIX3	HPE2	ENSG00000138083	"SIX homeobox 3"	O95343	2	44941898-44946077	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 40.2;parathyroid gland: 32.1;pituitary gland: 30.9;retina: 66.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 6.8;SCLC-21H: 36.7;SH-SY5Y: 14.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"basal ganglia: 40.2"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 38.7"	HPA067988			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA067988: AB_2685939"	"unprognostic (1.19e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.76e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.76e-2)"		"unprognostic (1.31e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.49e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.76e-1)"		"unprognostic (2.73e-2)"	0.4	0.4	3.7	0.5	40.2	0.5	0.5	0.7	0.7	1.5	0.4	1.5	0.0	0.5	0.4	0.4	0.5	0.4	0.5	0.4	1.6	7.2	0.4	0.4	0.5	0.5	1.1	2.7	0.4	1.0	32.1	30.9	0.4	0.1	0.4	0.4	66.5	0.4	0.4	1.1	0.5	0.4	0.4	0.0	0.4	0.5	0.8	6.5	0.0	0.4	0.0	0.4	0.4	0.0	1.1	1.1	4.5	2.2	1.9	1.7	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	6.8	0.0	0.0	0.3	3.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.2	0.1	0.0	0.2	0.0	0.0	0.0	36.7	14.7	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.6	1.2	1.0	1.1	1.7	1.1	1.1	0.8	0.8	1.1	1.3	1.4	1.7	1.9	2.2	1.1	1.3	0.7	3.7	40.2	0.7	0.7	1.6	7.2	1.1	2.7	0.1	6.5
SLC13A4	"SUT-1, SUT1"	ENSG00000164707	"Solute carrier family 13 member 4"	Q9UKG4	7	135681237-135729258	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	9	"brain: 85.4;placenta: 44.8;retina: 23.5"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 25.1"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	7	"pons and medulla: 85.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA048582	Approved									"HPA048582: AB_2680450"	"unprognostic (2.40e-1)"	"unprognostic (2.51e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.78e-1)"	"unprognostic (7.69e-2)"	"unprognostic (3.96e-6)"	"unprognostic (3.33e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.56e-3)"	"unprognostic (9.23e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.30e-6)"	"unprognostic (1.53e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.73e-2)"	0.3	0.4	0.7	0.3	1.4	0.3	0.4	4.0	8.9	1.2	0.3	34.0	0.0	0.3	0.4	0.3	4.1	0.8	0.4	0.4	12.3	0.8	0.3	0.4	0.4	0.3	1.4	5.4	0.4	0.5	0.4	1.4	44.8	85.4	0.3	0.3	23.5	1.0	0.4	0.3	0.4	0.3	0.4	5.1	0.3	0.3	5.4	0.5	0.0	0.3	0.0	1.9	0.3	1.8	0.0	0.2	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.4	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	25.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.1	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	1.4	4.0	8.9	12.3	0.8	1.4	5.4	85.4	0.5
SLC45A2	"AIM-1, MATP, OCA4"	ENSG00000164175	"Solute carrier family 45 member 2"	Q9UMX9	5	33944616-33984730	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"retina: 39.9"	"Cell line enriched"	"Detected in single"	40	"SK-MEL-30: 36.7"	"Cancer enriched"	"Detected in some"	18	"melanoma: 47.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (2.97e-1)"	"unprognostic (3.99e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.34e-3)"	"unprognostic (4.06e-2)"	"unprognostic (8.45e-2)"	"unprognostic (7.39e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.50e-3)"	"unprognostic (2.48e-2)"	"unprognostic (3.39e-1)"	0.2	0.0	0.3	0.2	0.4	0.0	0.2	0.7	0.4	0.2	1.1	0.2	0.2	0.0	0.5	0.2	0.2	0.4	0.3	1.5	0.4	0.6	0.8	3.1	0.2	0.2	0.3	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.8	1.2	39.9	0.2	0.2	0.4	4.5	0.2	0.3	0.4	0.2	0.6	2.8	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	36.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.7	0.4	0.4	0.6	0.3	0.2	0.2	0.2
TRPM1	"CSNB1C, LTRPC1, MLSN1"	ENSG00000134160	"Transient receptor potential cation channel subfamily M member 1"	Q7Z4N2	15	31001061-31161273	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"retina: 99.0"	"Cell line enriched"	"Detected in single"	122	"SK-MEL-30: 15.9"	"Cancer enriched"	"Detected in single"	179	"melanoma: 14.6"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014779, HPA071139"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane,Centriolar satellite"				"Centriolar satellite"	"Centriolar satellite"	"HPA014779: AB_2669090, HPA071139: "	"unprognostic (5.28e-2)"	"unprognostic (1.35e-1)"		"unprognostic (9.89e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.29e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.58e-1)"	"unprognostic (7.84e-2)"	"unprognostic (6.20e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.63e-2)"	0.1	0.0	0.4	0.0	0.6	0.0	0.1	0.1	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.2	0.3	0.1	0.1	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	99.0	0.4	0.0	0.2	10.4	0.0	0.1	1.9	0.0	0.0	2.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.4	0.6	0.1	0.3	0.7	0.2	1.6	0.0	0.3	0.1
ADAMTS20	GON-1	ENSG00000173157	"ADAM metallopeptidase with thrombospondin type 1 motif 20"	P59510	12	43353866-43551921	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	8	"brain: 5.1;placenta: 3.6;retina: 1.5;testis: 2.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.4;Karpas-707: 6.6;NB-4: 2.9;NTERA-2: 5.2;U-266/70: 7.5;U-266/84: 3.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons and medulla: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027608, HPA027609"	Uncertain				"Secreted to extracellular matrix"					"HPA027608: AB_10600098, HPA027609: AB_10599024"	"unprognostic (3.18e-2)"			"unprognostic (1.19e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.04e-1)"		"unprognostic (9.61e-2)"	"unprognostic (3.29e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.26e-1)"		"unprognostic (1.05e-4)"	"unprognostic (7.42e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.81e-3)"	"unprognostic (2.57e-1)"	0.2	0.0	0.7	0.1	1.4	0.1	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.1	0.0	0.6	0.0	0.3	0.0	0.2	0.0	3.6	5.1	0.0	0.0	1.5	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	2.3	1.1	0.0	0.1	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.6	0.2	0.0	0.0	2.9	5.2	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.7	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.7	0.0	0.0	7.5	3.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.4	0.0	1.2	0.3	0.7	0.6	0.0	5.1	1.1
BCO1	"BCDO, BCDO1, BCMO, BCMO1, FLJ10730"	ENSG00000135697	"Beta-carotene oxygenase 1"	Q9HAY6	16	81238448-81291142	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 28.1;retina: 62.0"	"Cell line enhanced"	"Detected in some"		"A549: 12.5;EFO-21: 9.5;HAP1: 3.6;NTERA-2: 5.1;RPTEC TERT1: 9.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA043811			Uncertain	"Actin filaments,Centriolar satellite"				"Actin filaments, Centriolar satellite"	"Actin filaments, Centriolar satellite"	"HPA043811: "	"unprognostic (2.78e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.61e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.05e-2)"	"unprognostic (8.01e-4)"	"unprognostic (1.65e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.58e-3)"	"unprognostic (7.26e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.09e-1)"	0.1	0.0	1.3	0.2	1.4	0.0	0.2	0.2	1.6	0.3	28.1	0.3	1.4	11.0	0.7	0.5	0.7	0.6	1.4	0.1	1.7	1.9	4.2	2.5	0.3	0.1	0.8	0.1	2.0	0.4	0.0	1.9	0.1	5.9	1.3	3.6	62.0	1.3	2.8	0.6	0.3	16.9	0.4	0.4	0.1	2.3	0.2	0.3	0.3	0.2	0.5	0.1	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.4	2.5	0.0	9.5	0.0	0.1	3.6	0.0	0.0	0.1	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	5.1	0.0	0.0	0.0	0.0	9.6	0.3	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.4	0.2	1.6	1.7	1.9	0.8	0.1	5.9	0.3
BEST1	"BEST, BMD, RP50, VMD2"	ENSG00000167995	"Bestrophin 1"	O76090	11	61949821-61965515	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"retina: 218.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 9.2;SK-MEL-30: 32.8;U-266/70: 8.8"	"Group enriched"	"Detected in some"	6	"glioma: 2.0;melanoma: 6.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"neutrophil: 23.3"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 23.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA057464	Enhanced									"HPA057464: AB_2683444"	"unprognostic (2.41e-3)"	"unprognostic (3.67e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.06e-1)"	"unprognostic (4.27e-10)"	"unprognostic (1.38e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.72e-3)"	5.2	2.9	7.4	9.5	11.8	26.4	2.3	1.6	12.6	2.0	1.4	16.0	0.7	2.1	2.6	9.6	3.0	2.6	6.2	2.5	9.2	5.3	1.4	1.1	4.7	2.5	14.8	6.0	3.7	2.2	0.5	1.4	2.8	9.4	1.6	1.3	218.0	1.2	1.9	0.7	3.0	2.0	2.1	16.9	5.4	1.3	3.9	13.3	0.3	2.3	0.4	0.6	3.9	2.3	0.3	1.6	23.3	2.8	0.1	0.1	0.9	0.5	0.5	0.2	0.4	9.2	1.9	0.9	0.6	1.1	0.2	0.7	0.2	0.3	0.1	1.3	0.6	0.7	0.0	0.0	0.1	0.1	0.1	0.0	3.5	0.5	2.8	0.1	0.3	2.6	1.1	1.2	2.5	0.0	0.4	5.1	1.1	0.3	0.1	0.4	0.0	1.3	0.0	0.1	0.2	0.0	1.2	0.6	0.5	1.0	0.1	32.8	0.5	1.3	0.1	0.5	0.3	0.5	0.2	8.8	0.5	0.5	3.4	0.3	1.0	1.5	2.3	2.1	0.1	2.7	0.1	0.3	0.1	0.1	1.6	0.1	0.1	0.0	23.3	0.1	2.8	0.3	0.1	0.9	7.4	11.8	1.6	5.9	9.2	5.3	14.8	6.0	9.4	13.3
C2orf71	"FLJ34931, RP54"	ENSG00000179270	"Chromosome 2 open reading frame 71"	A6NGG8	2	29060976-29074261	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	8	"retina: 28.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (2.28e-3)"	"unprognostic (1.23e-1)"		"unprognostic (1.13e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.88e-1)"		"unprognostic (5.88e-3)"	"unprognostic (6.68e-3)"	"unprognostic (1.21e-1)"	"unprognostic (6.61e-2)"	"unprognostic (3.81e-2)"		"unprognostic (2.37e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.28e-4)"	0.2	0.1	0.4	0.1	0.9	0.0	0.2	0.1	0.7	0.4	0.1	0.1	0.1	0.1	0.1	0.1	1.0	0.4	0.1	3.6	0.7	0.3	1.3	0.1	1.1	0.1	0.5	0.4	2.0	0.1	0.0	0.3	0.1	0.1	0.5	0.0	28.6	0.4	0.1	0.7	0.7	0.1	0.1	0.5	0.1	0.2	1.1	0.1	0.1	0.5	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.1	0.7	0.7	0.3	0.5	0.4	0.1	0.1
CABP2	DFNB93	ENSG00000167791	"Calcium binding protein 2"	Q9NPB3	11	67518912-67524517	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	8	"retina: 10.7"	"Cell line enhanced"	"Detected in single"		"AF22: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	22	"cerebellum: 5.2"	"Not detected"	"Not detected"																															0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CYP26A1	"CP26, CYP26, P450RAI, P450RAI1"	ENSG00000095596	"Cytochrome P450 family 26 subfamily A member 1"	O43174	10	93073475-93077890	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"liver: 23.2;retina: 7.3"	"Cell line enriched"	"Detected in some"	7	"AF22: 36.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebral cortex: 6.8"												"unprognostic (2.80e-1)"	"unprognostic (4.21e-3)"	"unprognostic (5.65e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.90e-1)"	"unprognostic (4.17e-2)"	"unprognostic (6.22e-2)"	"unprognostic (3.35e-1)"	"unprognostic (4.89e-1)"	"unprognostic (1.11e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.04e-11)"	"unprognostic (1.84e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.11e-1)"	0.1	0.3	0.3	0.0	0.6	0.1	0.3	0.4	1.8	0.3	0.1	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.6	0.3	0.0	23.2	0.1	0.0	0.2	1.4	0.1	0.0	0.0	0.2	0.8	0.3	0.1	0.0	7.3	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.2	0.2	1.2	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	36.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.4	1.8	0.6	0.3	0.2	1.4	0.3	0.2
DRD4		ENSG00000069696	"Dopamine receptor D4"	P21917	11	637293-640706	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"retina: 86.1"	"Cell line enhanced"	"Detected in some"		"HaCaT: 2.6;Hep G2: 2.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	14	"plasmacytoid DC: 3.2"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (8.83e-2)"	"unprognostic (2.99e-2)"	"unprognostic (4.98e-4)"	"unprognostic (3.81e-2)"	"unprognostic (7.52e-2)"	"unprognostic (7.89e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.96e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.07e-2)"	"unprognostic (3.28e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.05e-4)"	"unprognostic (1.26e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.85e-1)"	0.9	0.6	1.8	0.5	1.9	1.2	0.7	3.5	1.6	1.2	1.4	4.3	0.5	1.5	1.5	0.5	0.5	1.5	0.6	0.7	2.3	2.0	1.0	0.7	1.1	1.4	1.0	1.1	3.4	1.4	0.5	4.2	1.1	7.3	1.6	0.5	86.1	1.6	0.5	10.2	3.5	2.8	0.8	1.2	1.0	0.6	1.8	0.7	0.7	1.3	0.5	1.0	0.5	1.2	0.0	3.2	0.2	0.0	0.0	0.0	0.0	1.2	0.6	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	2.6	0.0	0.1	0.0	0.3	1.3	0.2	0.3	2.6	0.0	0.6	0.3	0.0	0.3	0.0	0.3	0.0	1.0	0.0	0.0	0.8	0.6	0.1	0.6	0.0	0.2	0.3	0.0	0.0	0.3	0.0	1.0	0.5	0.3	0.1	0.3	0.9	0.0	0.6	0.6	0.1	0.9	1.0	0.9	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.2	0.0	0.0	1.8	1.9	3.5	1.6	2.3	2.0	1.0	1.1	7.3	0.7
GNB3		ENSG00000111664	"G protein subunit beta 3"	P16520	12	6839954-6847393	"Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"pituitary gland: 27.0;retina: 79.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 8.4;NTERA-2: 10.1;U-698: 25.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.5"	"Lineage enriched"	"Detected in single"	9	"B-cells: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA040736	Uncertain		Approved	"Golgi apparatus,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA040736: AB_2677106"	"unprognostic (3.86e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.96e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.53e-2)"	"unprognostic (5.74e-3)"	"unprognostic (5.98e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.25e-5)"	"unprognostic (3.21e-2)"	"unprognostic (4.77e-11)"	"unprognostic (2.43e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.07e-2)"	0.8	1.6	0.9	1.4	2.0	0.5	0.8	6.9	1.6	1.1	1.0	0.8	0.8	2.3	2.7	0.8	0.8	1.0	1.1	5.4	1.0	1.3	0.8	0.8	0.8	1.4	1.1	0.8	3.5	0.8	3.2	27.0	0.8	1.6	1.6	0.4	79.9	2.6	1.8	1.5	0.6	1.6	4.1	0.9	0.9	0.9	0.8	0.8	0.8	1.2	1.0	1.8	2.1	0.8	1.5	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.4	4.9	0.8	0.6	0.8	0.5	2.9	0.6	1.6	1.1	1.0	0.2	8.4	0.0	3.1	0.3	4.8	0.2	1.5	0.7	1.1	2.1	2.6	0.7	0.5	0.6	1.4	1.2	0.2	1.5	2.1	1.3	0.8	0.7	0.4	0.4	0.4	0.4	10.1	0.3	0.3	1.7	0.5	0.3	0.2	0.8	1.2	0.2	0.0	0.6	0.0	0.5	2.6	1.3	2.0	2.4	3.8	0.7	0.5	25.4	0.6	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	2.0	6.9	1.5	1.0	1.3	1.1	0.8	1.6	0.8
GRM6	"CSNB1B, GPRC1F, mGlu6, MGLUR6"	ENSG00000113262	"Glutamate metabotropic receptor 6"	O15303	5	178978327-178996206	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"retina: 22.0"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014511	Enhanced									"HPA014511: AB_2669025"	"unprognostic (1.85e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.25e-3)"	"unprognostic (7.72e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.12e-3)"	"unprognostic (6.27e-2)"	"unprognostic (3.34e-4)"	"unprognostic (2.58e-1)"	"unprognostic (3.36e-4)"	"unprognostic (1.23e-1)"	"unprognostic (6.45e-2)"	"unprognostic (7.59e-3)"	"unprognostic (1.97e-1)"	0.3	0.5	0.6	0.4	0.6	1.6	0.3	1.9	1.6	0.4	0.4	0.3	0.3	0.3	0.6	0.5	0.3	0.5	0.7	0.4	0.5	1.2	0.4	0.4	0.4	0.5	0.8	0.3	0.7	0.9	0.1	2.9	0.3	1.2	1.1	0.1	22.0	0.6	0.3	1.3	1.8	0.3	0.3	0.3	0.5	0.3	2.2	0.3	0.3	0.9	0.3	0.3	0.3	0.3	0.9	1.1	2.4	0.4	0.6	0.6	0.1	0.5	0.3	0.7	1.3	0.3	0.1	0.7	0.2	0.0	0.1	0.0	0.5	0.9	0.8	0.6	0.0	0.7	0.0	0.1	0.0	0.2	0.7	0.5	0.7	1.0	0.2	0.8	0.9	0.1	0.3	0.1	0.5	0.0	0.9	1.7	0.0	1.0	0.2	0.7	0.6	0.6	0.6	0.3	0.8	0.1	0.6	0.9	1.2	0.5	0.7	0.5	0.9	1.1	0.9	0.5	0.5	0.4	0.5	0.7	0.6	0.4	0.4	0.7	0.3	1.9	0.4	0.5	0.6	0.3	0.4	0.4	0.4	0.3	0.2	0.9	0.4	0.4	2.4	0.6	0.2	1.1	0.2	0.1	0.6	0.6	1.9	0.5	0.5	1.2	0.8	0.3	1.2	0.3
GUCA1A	"C6orf131, COD3, CORD14, dJ139D8.6, GCAP, GCAP1, GUCA, GUCA1"	ENSG00000048545	"Guanylate cyclase activator 1A"	P43080	6	42155406-42180056	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"retina: 91.2;testis: 62.2"	"Group enriched"	"Detected in some"	8	"NTERA-2: 7.0;SH-SY5Y: 8.8"	"Cancer enriched"	"Detected in single"	9	"testis cancer: 3.5"	"Region enhanced"	"Detected in many"		"basal ganglia: 10.0"	"Cell type enriched"	"Detected in single"	84	"plasmacytoid DC: 8.4"	"Lineage enriched"	"Detected in single"	84	"dendritic cells: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA005561	Enhanced		Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA005561: AB_2667361"	"unprognostic (1.91e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.49e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.04e-4)"	"unprognostic (9.70e-2)"		"unprognostic (6.71e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.79e-1)"		"unprognostic (1.51e-1)"	"unprognostic (1.54e-1)"		"unprognostic (1.16e-1)"	0.2	0.2	2.7	0.3	10.0	0.2	0.2	0.1	1.6	0.2	0.2	0.1	0.1	0.1	0.1	0.4	0.2	0.1	0.2	0.1	1.5	5.4	0.1	0.1	0.2	0.3	1.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.2	0.2	91.2	0.2	0.1	0.1	0.2	0.2	0.3	0.2	0.1	0.1	62.2	0.1	0.1	0.1	0.1	0.5	0.3	0.1	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	2.7	10.0	0.1	0.8	1.5	5.4	1.1	0.1	0.3	0.1
KCNV2	Kv8.2	ENSG00000168263	"Potassium voltage-gated channel modifier subfamily V member 2"	Q8TDN2	9	2717502-2730037	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"retina: 82.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.6;HDLM-2: 2.8;HeLa: 2.3"	"Cancer enriched"	"Detected in single"	78	"testis cancer: 6.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031131	Enhanced									"HPA031131: AB_10609996"	"unprognostic (5.06e-2)"	"unprognostic (1.47e-3)"	"unprognostic (3.45e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.12e-3)"	"unprognostic (5.38e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.35e-1)"	"unprognostic (7.96e-8)"	"unprognostic (3.01e-1)"	"unprognostic (4.90e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.06e-2)"	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	82.3	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.1	0.0	0.6	0.0	0.2	0.7	0.2	0.4	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.9	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	2.8	1.3	0.8	2.3	0.3	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.5	0.6	0.1	0.2	0.0	0.3	0.0	0.0	0.4	0.3	0.0	0.1	0.2	0.1	0.6	0.0	0.0	0.7	0.3	0.5	0.3	0.3	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.8	0.2	0.1	0.0	0.0	0.0	0.0	0.0
PDE6A	"PDEA, RP43"	ENSG00000132915	"Phosphodiesterase 6A"	P16499	5	149857955-149944793	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"retina: 153.4"	"Cell line enriched"	"Detected in some"	4	"CACO-2: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016970, HPA074677"	Enhanced									"HPA016970: AB_1855125, HPA074677: AB_2732264"	"unprognostic (6.85e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.72e-2)"	"unprognostic (4.39e-3)"	"unprognostic (8.83e-2)"	"unprognostic (6.54e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.77e-2)"	"unprognostic (9.21e-2)"	"unprognostic (7.57e-5)"	"unprognostic (9.93e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.26e-2)"	0.2	2.3	0.2	0.2	0.2	0.9	0.2	0.3	0.2	0.2	1.8	0.2	0.3	0.2	0.2	20.1	2.4	0.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	4.6	0.2	0.2	0.2	1.0	153.4	1.4	0.2	0.2	1.6	0.2	0.2	0.2	0.2	0.1	3.1	0.2	0.2	0.4	0.3	0.5	0.2	0.2	1.5	0.8	3.3	0.8	1.2	0.8	0.1	0.4	0.7	0.6	0.5	0.3	0.3	0.6	0.3	0.1	0.4	0.1	7.4	0.8	0.9	1.3	0.2	0.7	0.2	0.4	0.5	0.6	0.3	1.0	1.1	0.6	0.2	0.7	0.6	0.3	1.1	0.9	0.6	0.2	0.3	1.4	1.4	0.3	0.4	0.9	0.5	0.5	0.3	0.8	0.7	0.5	0.9	0.8	1.1	0.0	0.7	0.2	1.0	0.5	1.4	0.8	1.6	0.8	0.5	0.6	0.3	0.5	0.8	0.8	0.6	3.3	0.8	0.5	0.6	0.4	0.5	0.7	0.6	0.5	0.2	1.5	0.7	0.8	2.8	1.2	0.5	0.8	0.4	0.1	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.2	0.2	0.2
PRPH2	"CACD2, rd2, RDS, RP7, TSPAN22"	ENSG00000112619	"Peripherin 2"	P23942	6	42696600-42722574	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"retina: 117.8"	"Cell line enhanced"	"Detected in some"		"ASC diff: 4.2;ASC TERT1: 4.8;fHDF/TERT166: 6.9;HHSteC: 10.8;HSkMC: 8.4;LHCN-M2: 4.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029458	Enhanced									"HPA029458: AB_10602193"	"unprognostic (2.37e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.67e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.87e-3)"	"unprognostic (4.73e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.18e-2)"	"unprognostic (7.07e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.59e-1)"	"unprognostic (8.42e-2)"	"unprognostic (8.96e-3)"	1.0	0.8	1.5	1.0	1.0	0.0	1.0	1.0	4.8	1.7	2.0	1.0	1.0	0.3	2.3	2.3	1.0	0.9	1.2	1.4	1.1	3.0	1.0	1.0	1.2	1.0	1.1	1.0	3.4	2.0	6.9	2.7	1.0	1.0	1.4	0.8	117.8	1.0	1.3	14.4	0.0	1.1	2.3	1.0	1.0	1.0	3.5	1.0	1.0	5.2	1.0	1.0	1.0	1.0	0.6	0.3	3.4	0.6	0.2	0.8	0.0	0.0	0.0	0.0	0.0	4.2	4.8	1.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	10.8	0.0	0.0	8.4	0.0	0.0	0.0	1.2	0.0	0.0	4.7	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.3	0.0	0.4	0.2	0.8	0.2	0.3	0.0	0.3	0.6	0.4	0.2	2.5	0.2	0.6	0.0	0.3	0.0	1.5	1.0	1.0	3.0	1.1	3.0	1.1	1.0	1.0	1.0
RP1	"DCDC4A, ORP1"	ENSG00000104237	"RP1, axonemal microtubule associated"	P56715	8	54509422-54871720	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"fallopian tube: 15.4;lung: 28.7;retina: 49.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.2;HDLM-2: 6.9;RPTEC TERT1: 14.2;U-2197: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA042257	Enhanced									"HPA042257: AB_10797385"	"unprognostic (3.19e-3)"	"unprognostic (2.63e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.16e-3)"		"unprognostic (6.24e-2)"		"unprognostic (4.56e-2)"	"unprognostic (4.13e-5)"	"unprognostic (2.48e-1)"	"unprognostic (2.16e-5)"	"unprognostic (8.92e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.96e-2)"	0.2	0.1	0.1	0.0	0.1	0.0	0.9	0.1	0.1	0.6	0.1	0.0	0.0	0.0	0.4	0.3	0.1	15.4	0.0	0.1	0.1	0.1	3.6	0.1	28.7	0.0	0.1	0.0	3.9	0.1	0.0	0.6	0.3	0.1	0.1	0.0	49.2	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.3	0.6	1.7	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	2.2	0.0	0.0	1.0	0.0	0.0	6.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
TRPM3	"GON-2, KIAA1616, LTRPC3"	ENSG00000083067	"Transient receptor potential cation channel subfamily M member 3"	Q9HCF6	9	70529063-71446904	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 36.6;kidney: 28.0;retina: 105.2"	"Cell line enriched"	"Detected in some"	4	"HAP1: 19.0"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	16	"NK-cell: 2.1"	"Lineage enriched"	"Detected in single"	16	"NK-cells: 2.1"	"Low region specificity"	"Detected in all"							"HPA072650, HPA074393"	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"HPA072650: , HPA074393: "	"unprognostic (3.74e-1)"	"unprognostic (6.30e-2)"	"unprognostic (4.79e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.82e-7)"	"unprognostic (3.51e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.50e-2)"	0.9	1.7	6.0	0.7	4.5	1.1	0.8	36.6	5.1	0.8	0.7	9.6	2.1	1.8	2.4	3.0	0.7	1.3	1.3	1.4	9.4	6.0	28.0	0.9	0.8	0.7	8.3	3.5	5.3	1.5	0.7	6.8	0.8	34.8	1.4	0.7	105.2	0.8	5.0	1.1	0.8	0.7	1.0	8.1	1.1	1.6	5.3	5.9	0.0	2.1	0.0	0.6	0.8	0.5	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	1.0	0.1	1.2	2.9	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	19.0	0.0	0.1	0.0	0.1	0.1	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	1.1	4.4	0.0	0.0	0.0	1.3	0.1	0.0	0.2	0.0	0.9	0.0	1.3	0.0	0.2	0.0	0.3	0.0	0.0	3.5	0.0	0.1	3.4	0.0	0.0	0.0	0.0	0.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	6.0	4.5	36.6	3.8	9.4	6.0	8.3	3.5	34.8	5.9
UBAP1L		ENSG00000246922	"Ubiquitin associated protein 1 like"	F5GYI3	15	65092770-65115197	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	8	"retina: 91.1"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 6.8;U-266/70: 3.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	10	"cerebellum: 49.0;pons and medulla: 8.6"	HPA065334			Uncertain	"Nuclear bodies"				"Nuclear bodies"	"Nuclear bodies"	"HPA065334: AB_2685472"	"unprognostic (6.89e-3)"	"unprognostic (2.62e-1)"	"unprognostic (2.66e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.98e-3)"	"unprognostic (6.59e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.62e-5)"	"unprognostic (6.40e-3)"	"unprognostic (3.11e-6)"	"unprognostic (5.03e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.70e-1)"	"unprognostic (6.11e-3)"	1.4	1.5	2.4	0.9	2.4	1.1	1.3	11.5	3.6	1.5	0.9	0.9	0.9	0.4	2.7	1.1	1.2	1.5	0.9	0.9	2.8	3.2	0.9	1.1	1.0	1.1	2.6	0.9	3.2	1.0	0.5	0.9	0.9	3.6	1.1	0.2	91.1	2.0	1.8	6.2	1.5	1.1	1.2	3.1	2.0	0.9	1.5	0.9	0.9	1.2	0.9	2.2	0.9	0.9	0.1	1.3	0.0	0.1	0.4	0.3	0.0	0.1	0.0	0.8	2.0	0.6	0.2	1.8	1.3	0.1	0.6	0.6	1.1	0.3	0.9	1.6	0.2	1.4	1.1	0.1	0.0	1.7	1.1	0.1	1.1	0.2	0.8	1.0	0.9	0.6	0.9	0.3	0.4	0.2	0.5	0.7	0.2	0.2	0.3	1.2	0.7	0.7	1.5	0.5	1.1	0.0	0.3	1.0	0.6	0.6	0.2	6.8	0.4	1.0	0.0	0.6	0.3	0.6	0.6	3.6	0.6	0.4	0.4	0.7	0.5	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.4	0.0	1.3	0.0	0.0	2.4	2.4	11.5	3.1	2.8	3.2	2.6	0.9	3.6	0.9
AC005551.1		ENSG00000284638			19	3482804-3483446	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	7	"intestine: 15.0;retina: 22.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 1.7;CAPAN-2: 1.2;HEL: 1.1;PC-3: 1.7;U-937: 2.9"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"																																			0.0	0.0	0.0	0.8	0.0	2.6	0.0	0.0	0.0	0.3	6.0	0.0	1.3	15.0	0.0	1.9	0.0	0.0	0.6	0.0	0.1		1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	22.4	0.0	0.6	0.0	0.0	8.9	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CACNA2D4		ENSG00000151062	"Calcium voltage-gated channel auxiliary subunit alpha2delta 4"	Q7Z3S7	12	1791957-1918836	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"retina: 47.0"	"Cell line enhanced"	"Detected in some"		"Hep G2: 5.3;HL-60: 3.1;HMC-1: 16.6;NB-4: 7.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"dendritic cells: 4.5;monocytes: 6.6;T-cells: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031952	Uncertain									"HPA031952: AB_10600798"	"unprognostic (5.04e-2)"	"unprognostic (2.82e-2)"	"unprognostic (5.32e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.18e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.62e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.13e-1)"	1.8	0.7	0.6	2.2	0.9	2.2	0.8	0.1	1.1	1.4	0.8	0.6	0.2	2.3	1.1	0.5	0.8	0.3	1.6	1.6	0.8	0.5	1.5	0.3	1.4	2.2	1.2	0.2	0.4	1.5	0.1	3.9	2.1	1.0	0.7	0.3	47.0	0.7	0.5	0.2	0.2	1.4	1.5	1.3	2.2	0.6	1.7	0.7	1.2	0.5	0.9	1.4	2.3	0.5	0.0	4.5	0.2	6.6	0.6	6.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	5.3	0.3	3.1	16.6	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.4	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.5	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.0	6.6	0.0	3.5	2.4	6.7	0.0	1.6	2.5	4.5	0.0	0.9	0.5	0.2	0.6	0.7	0.2	0.9	2.3	0.6	0.9	0.1	1.1	0.8	0.5	1.2	0.2	1.0	0.7
CHRNA3		ENSG00000080644	"Cholinergic receptor nicotinic alpha 3 subunit"	P32297	15	78593052-78621295	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 33.6;lymphoid tissue: 57.2;retina: 74.1"	"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 84.4"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"cerebellum: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029430	Approved									"HPA029430: AB_10603785"	"unprognostic (2.28e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.16e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.86e-4)"	"unprognostic (2.65e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.48e-1)"	0.4	33.6	0.8	4.0	2.4	0.1	0.3	6.0	0.4	0.5	8.2	0.7	0.2	1.2	0.5	0.1	0.5	0.1	0.8	0.4	0.2	0.8	0.1	0.1	0.3	2.8	0.4	0.0	0.1	0.2	0.1	1.5	0.2	1.2	0.6	3.4	74.1	0.2	0.6	0.1	0.6	2.9	2.8	0.2	0.2	3.6	0.9	0.5	57.2	0.2	0.2	0.7	0.8	0.6	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	16.0	84.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.4	6.0	0.4	0.2	0.8	0.4	0.0	1.2	0.5
CRYBB2	"CCA2, CRYB2, CRYB2A"	ENSG00000244752	"Crystallin beta B2"	P43320	22	25219522-25231869	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"retina: 26.9"	"Cell line enhanced"	"Detected in some"		"HeLa: 5.1;THP-1: 1.7;U-138 MG: 2.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043749	Supported		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA043749: AB_2678652"	"unprognostic (1.28e-1)"	"unprognostic (2.71e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.57e-3)"	"unprognostic (9.51e-3)"	"unprognostic (8.55e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.73e-5)"	"unprognostic (1.44e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.28e-1)"	"unprognostic (9.89e-3)"	0.8	0.7	2.0	0.5	3.7	0.1	1.7	0.5	1.8	1.0	1.3	0.5	0.5	0.8	0.5	1.8	1.1	0.4	0.5	0.6	2.9	1.5	0.5	0.5	1.4	0.5	0.8	0.5	0.5	0.5	0.0	2.6	0.5	0.9	0.9	1.5	26.9	1.2	0.5	0.6	0.4	1.0	1.0	0.5	0.5	0.2	4.0	0.5	0.5	1.7	0.5	0.5	0.5	0.5	1.4	1.3	0.5	1.1	1.7	1.4	0.7	0.2	0.5	0.1	0.7	0.0	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.5	0.0	0.6	0.0	0.8	0.0	0.0	0.2	0.0	1.1	0.6	5.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.3	1.2	0.3	0.6	0.0	0.2	0.1	0.6	0.0	0.2	0.0	0.8	1.7	0.0	2.9	0.7	0.4	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.5	0.8	0.4	1.4	0.6	0.6	1.4	1.2	0.7	1.1	1.0	1.1	1.2	0.1	1.7	1.1	1.3	0.4	0.7	2.0	3.7	0.5	1.8	2.9	1.5	0.8	0.5	0.9	0.5
DCST1	FLJ32785	ENSG00000163357	"DC-STAMP domain containing 1"	Q5T197	1	155033824-155050930	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"retina: 18.2;skin 1: 6.8;testis: 10.7"	"Cell line enhanced"	"Detected in some"		"HaCaT: 4.8;HeLa: 4.0;RPMI-8226: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060314	Uncertain									"HPA060314: AB_2684250"	"unprognostic (1.44e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.05e-4)"	"unprognostic (3.58e-2)"	"unprognostic (8.75e-4)"	"unprognostic (1.46e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.01e-3)"	"unprognostic (2.22e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.33e-15)"	"unprognostic (7.77e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.23e-1)"	0.2	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.2	0.1	0.1	0.1	1.7	0.1	0.1	0.4	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.0	18.2	0.7	0.1	0.1	6.8	1.6	0.1	0.1	0.2	0.4	10.7	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.8	0.8	0.9	1.2	0.0	1.0	0.1	1.5	0.7	2.7	1.5	0.1	0.0	1.0	0.5	0.0	0.0	0.0	0.7	3.2	1.5	0.5	0.0	4.8	0.0	0.0	0.0	1.2	0.4	0.4	4.0	0.3	0.0	1.1	0.6	0.0	0.2	0.0	0.0	0.0	1.1	2.3	0.0	1.0	0.0	0.3	0.2	2.2	0.0	1.1	5.4	0.0	0.8	0.9	1.8	0.6	1.8	0.2	3.4	0.1	0.0	0.3	0.2	0.8	0.4	0.9	0.8	0.3	0.7	1.6	0.0	0.0	0.2	0.9	0.1	0.0	0.0	0.8	0.4	0.2	0.3	0.0	1.0	0.2	0.2	0.0	1.2	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
FOXI3		ENSG00000214336	"Forkhead box I3"	A8MTJ6	2	88446787-88452656	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"placenta: 11.6;retina: 15.7"	"Group enriched"	"Detected in some"	5	"BEWO: 30.7;NTERA-2: 7.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 10.5"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (2.72e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.92e-1)"	"unprognostic (6.72e-4)"		"unprognostic (8.11e-3)"		"unprognostic (1.36e-1)"		"unprognostic (6.58e-2)"				"unprognostic (5.29e-2)"	"unprognostic (1.15e-1)"			0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	11.6	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	1.9	0.5	0.9	0.6	0.3	0.0	0.0	0.1	0.0	0.0	0.0	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.5	0.2	0.4	0.2	0.3	0.4	0.4	0.3	0.2	0.7	0.4	0.6	1.5	0.9	0.5	0.5	0.2	0.3										
GABRR3		ENSG00000183185	"Gamma-aminobutyric acid type A receptor rho3 subunit (gene/pseudogene)"	A8MPY1	3	97986673-98035304	"FDA approved drug targets, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in some"	7	"retina: 18.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.1;U-266/70: 2.0;U-698: 4.6"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	25	"plasmacytoid DC: 2.4"	"Lineage enriched"	"Detected in single"	25	"dendritic cells: 2.4"	"Not detected"	"Not detected"																						"unprognostic (3.22e-2)"		"unprognostic (2.06e-3)"							"unprognostic (5.65e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.43e-4)"	"unprognostic (2.84e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	18.2	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0										
LRAT	LCA14	ENSG00000121207	"Lecithin retinol acyltransferase"	O95237	4	154626945-154753118	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"retina: 82.4"	"Cell line enriched"	"Detected in some"	8	"NTERA-2: 16.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 4.5"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA070726			Uncertain	"Endoplasmic reticulum,Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA070726: "	"unprognostic (3.64e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.75e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.15e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.65e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.03e-4)"	"unprognostic (4.49e-6)"	"unprognostic (6.11e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.98e-1)"	0.9	0.8	2.2	0.8	3.2	1.8	1.4	0.7	1.1	0.9	4.2	3.0	0.8	3.7	0.5	1.2	0.5	0.9	2.3	0.6	3.1	4.2	0.6	3.3	1.0	0.5	2.9	2.4	1.0	2.9	0.3	1.0	0.3	8.9	1.6	0.4	82.4	0.5	1.6	2.3	1.4	11.1	0.3	7.0	0.7	0.9	2.9	3.1	0.0	4.9	0.2	0.6	0.5	0.7	0.9	3.7	2.0	4.5	0.6	0.3	3.9	0.6	0.5	0.4	0.2	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.1	0.8	0.6	0.1	0.1	0.2	0.5	0.3	0.3	0.1	0.1	0.0	0.1	0.2	0.1	0.2	0.1	0.3	16.1	0.0	0.1	0.0	0.1	1.9	0.5	0.1	0.0	0.2	0.1	0.2	0.1	0.0	0.0	0.4	0.2	0.6	0.1	0.1	0.0	0.0	0.0	0.2	0.5	1.0	4.5	0.4	0.3	1.6	0.3	0.5	0.3	0.3	3.7	0.9	0.3	0.3	2.0	0.6	0.5	0.5	0.2	3.9	2.2	3.2	0.7	1.1	3.1	4.2	2.9	2.4	8.9	3.1
PDE6H		ENSG00000139053	"Phosphodiesterase 6H"	Q13956	12	14973022-14981865	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"retina: 67.4"	"Group enriched"	"Detected in some"	4	"AN3-CA: 4.2;MOLT-4: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045118	Supported		Uncertain	Vesicles				Vesicles	Vesicles	"HPA045118: AB_2732517"					"unprognostic (1.47e-3)"										"unprognostic (1.07e-2)"			0.1	1.3	1.2	0.2	1.5	9.4	0.1	0.1	4.2	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	1.0	2.1	0.1	0.1	0.2	0.2	2.2	0.1	0.1	0.1	0.0	0.1	2.5	0.7	0.1	0.1	67.4	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.8	0.0	0.1	0.1	0.2	0.1	0.1	0.2	0.3	0.1	0.0	0.0	0.6	0.7	0.0	0.0	1.4	0.2	0.0	0.8	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4	1.2	1.5	0.1	4.2	1.0	2.1	2.2	0.1	0.7	0.1
PNPLA3	"adiponutrin, ADPN, C22orf20, dJ796I17.1, FLJ22012, iPLA2epsilon"	ENSG00000100344	"Patatin like phospholipase domain containing 3"	Q9NST1	22	43923739-43964488	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"liver: 31.1;retina: 39.3"	"Cell line enhanced"	"Detected in many"		"AF22: 13.3;LHCN-M2: 15.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA058058	Approved		Approved	Nucleoli,Mitochondria,Cytosol				Nucleoli	Nucleoli	"HPA058058: AB_2683590"	"unprognostic (4.74e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.52e-3)"	"unprognostic (5.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.01e-1)"	2.8	0.4	0.5	0.7	1.0	0.3	4.0	0.3	2.4	0.8	1.3	0.4	0.0	1.0	0.5	1.9	0.4	1.1	0.5	0.9	0.8	0.6	4.6	31.1	1.4	0.4	0.3	1.8	0.5	0.2	0.6	0.2	0.4	2.2	0.2	0.2	39.3	0.9	0.2	2.2	5.3	0.6	0.2	0.5	0.6	0.3	0.5	0.3	0.0	0.2	0.0	0.3	0.2	0.4	1.2	0.7	1.8	0.6	0.9	0.8	0.0	3.9	1.2	13.3	5.4	3.8	4.2	0.4	2.4	1.4	3.3	7.1	3.8	7.0	0.0	2.0	4.0	3.3	8.3	3.9	2.7	0.0	0.7	0.2	3.1	7.1	6.1	0.0	0.2	4.8	3.0	10.4	0.5	0.4	0.0	0.0	15.0	0.6	0.2	0.0	9.1	0.0	0.0	7.2	0.1	1.4	0.2	1.2	0.1	2.7	1.0	3.7	4.2	4.5	0.4	1.3	4.0	0.1	0.1	0.0	0.0	0.0	11.4	0.0	4.7	1.5	0.6	0.4	0.5	0.4	0.3	0.7	0.4	0.3	0.2	1.2	0.6	0.8	1.8	0.9	0.3	0.7	0.2	0.0	0.5	1.0	0.3	2.4	0.8	0.6	0.3	1.8	2.2	0.3
SLC16A8	"MCT3, REMP"	ENSG00000100156	"Solute carrier family 16 member 8"	O95907	22	38078134-38084093	"Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"retina: 70.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.9;SiHa: 6.4;T-47d: 7.7;U-266/70: 11.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA075017	Enhanced		Approved	"Intermediate filaments,Focal adhesion sites"				"Focal adhesion sites"	"Focal adhesion sites"	"HPA075017: AB_2732276"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-2)"	"unprognostic (5.07e-6)"	"unprognostic (2.99e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.34e-4)"	"unprognostic (7.69e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (9.71e-5)"	1.6	2.6	1.9	0.8	5.1	1.2	0.8	0.8	3.3	0.8	0.8	0.8	0.8	0.5	1.3	0.8	1.1	1.2	2.7	2.9	2.7	2.9	0.8	0.8	0.8	0.9	2.8	0.8	0.8	2.1	0.0	2.6	0.8	1.3	4.0	0.0	70.9	10.0	0.8	1.9	4.2	0.8	0.8	3.7	1.8	2.3	2.0	0.8	0.8	0.9	0.8	0.8	1.6	0.8	0.0	0.0	0.0	0.0	0.5	0.6	0.0	1.3	0.7	1.1	0.2	0.0	0.0	5.9	0.5	0.0	0.0	0.0	1.2	3.5	0.4	1.7	0.0	0.8	0.0	0.0	0.0	0.0	1.8	0.3	1.0	0.1	0.2	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	3.9	0.0	0.0	1.4	0.1	2.0	0.0	0.0	0.0	4.4	1.9	0.3	6.4	0.3	0.9	7.7	0.2	0.0	0.0	3.5	0.3	0.0	11.3	1.6	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.9	5.1	0.8	1.2	2.7	2.9	2.8	0.8	1.3	0.8
SLC1A7	EAAT5	ENSG00000162383	"Solute carrier family 1 member 7"	O00341	1	53087179-53142632	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	7	"retina: 70.1"	"Cell line enriched"	"Detected in some"	9	"HHSteC: 23.8"	"Cancer enhanced"	"Detected in many"		"lung cancer: 3.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"gdTCR: 5.7;memory CD8 T-cell: 2.2;naive CD8 T-cell: 2.6"	"Lineage enriched"	"Detected in single"	58	"T-cells: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049124	Enhanced									"HPA049124: AB_2680643"	"unprognostic (2.33e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.48e-4)"	"unprognostic (2.31e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.26e-3)"	"unprognostic (4.35e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.58e-3)"	"unprognostic (5.43e-2)"	"unprognostic (8.12e-2)"	"unprognostic (4.70e-3)"	2.0	0.2	1.1	0.6	0.6	0.0	1.2	0.6	0.7	0.9	1.0	0.7	0.6	4.1	1.3	1.2	2.1	2.2	9.6	2.9	1.7	1.1	0.7	2.8	0.9	0.6	1.2	0.6	3.8	0.6	0.0	0.6	0.6	1.1	0.9	0.0	70.1	0.6	0.6	2.1	1.2	5.3	0.6	1.3	0.6	1.1	0.9	0.6	0.6	0.6	0.6	0.6	2.5	0.9	0.0	0.0	0.0	0.0	0.0	5.7	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.2	2.6	0.0	0.0	0.0	0.0	0.1	0.8	1.1	0.6	0.6	0.7	1.7	1.1	1.2	0.6	1.1	0.6
SLC24A1	"CSNB1D, HsT17412, KIAA0702, NCKX, NCKX1, RODX"	ENSG00000074621	"Solute carrier family 24 member 1"	O60721	15	65611366-65660995	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"retina: 91.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039370	Enhanced		Approved	Microtubules				Microtubules	Microtubules	"HPA039370: AB_10960279"	"unprognostic (9.47e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.66e-3)"	"unprognostic (6.39e-3)"	"unprognostic (4.64e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.91e-2)"	"prognostic favourable (2.33e-6)"	"unprognostic (8.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.96e-2)"	6.2	5.3	4.5	7.7	5.0	2.6	9.3	7.0	3.4	8.9	5.0	5.6	7.5	3.7	10.6	12.2	4.2	9.0	6.2	4.1	4.7	4.1	7.9	4.7	12.0	6.0	5.3	2.6	9.7	6.6	6.5	6.1	8.9	4.0	6.0	4.1	91.1	6.4	8.3	3.8	8.5	4.5	5.0	6.8	7.8	4.2	10.8	3.2	6.9	9.0	4.6	4.8	6.0	5.3	3.8	2.6	4.7	1.5	2.3	1.8	0.4	1.5	3.1	3.4	3.1	5.1	8.7	4.2	4.0	4.3	3.9	2.6	1.4	6.8	2.2	13.3	3.8	4.4	4.1	4.3	2.3	2.2	2.9	4.7	2.4	6.9	7.4	3.1	6.5	7.3	6.3	2.2	13.2	6.7	5.0	7.4	6.3	6.5	2.0	2.9	4.4	1.2	2.1	1.1	1.4	6.0	6.2	1.6	2.4	1.1	3.0	8.2	6.3	4.3	9.6	4.0	4.1	1.5	2.7	3.0	5.4	2.5	4.2	6.7	3.4	4.7	1.5	2.1	1.4	1.3	1.8	1.4	1.5	1.2	1.1	3.8	1.1	1.5	1.7	2.3	0.6	2.6	0.3	0.4	4.5	5.0	7.0	3.4	4.7	4.1	5.3	2.6	4.0	3.2
SLC6A13	GAT2	ENSG00000010379	"Solute carrier family 6 member 13"	Q9NSD5	12	220621-262873	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"kidney: 77.6;retina: 95.9"	"Cell line enriched"	"Detected in some"	7	"RPTEC TERT1: 10.1"	"Cancer enriched"	"Detected in some"	18	"renal cancer: 32.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036449, HPA052726"			Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol				Mitochondria	Mitochondria	"HPA036449: AB_2675130, HPA052726: AB_2681927"	"unprognostic (8.45e-3)"	"unprognostic (4.20e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.64e-5)"	"unprognostic (1.13e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.21e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.91e-1)"	0.6	0.5	3.0	0.4	5.8	0.5	0.5	2.1	5.8	0.5	0.5	2.5	0.0	1.8	0.5	0.9	0.4	4.2	0.5	1.0	3.1	2.4	77.6	13.2	0.9	0.5	3.4	4.1	0.5	0.4	0.4	1.0	0.5	4.8	0.5	0.5	95.9	0.5	0.5	0.6	0.6	0.8	0.4	5.7	0.5	0.5	1.1	2.1	0.0	4.9	0.0	0.5	0.5	0.0	0.4	0.0	0.0	0.0	0.6	0.9	0.3	0.0	0.0	0.1	0.3	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.6	0.0	0.0	0.0	1.3	0.2	0.1	0.0	0.0	0.0	0.4	0.4	0.5	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.1	10.1	0.1	0.1	0.0	0.1	0.0	0.9	0.0	0.0	0.3	0.2	1.0	0.0	0.4	1.4	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.3	3.0	5.8	2.1	5.8	3.1	2.4	3.4	4.1	4.8	2.1
STRA6	FLJ12541	ENSG00000137868	"Stimulated by retinoic acid 6"	Q9BX79	15	74179466-74212267	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"cervix, uterine: 22.7;placenta: 88.6;retina: 42.8"	"Cell line enhanced"	"Detected in some"		"A549: 16.2;CAPAN-2: 46.0;SH-SY5Y: 28.6;WM-115: 69.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA040839	Approved									"HPA040839: AB_10794881"	"unprognostic (1.20e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.09e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.67e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.89e-1)"	"unprognostic (7.91e-13)"	"unprognostic (2.90e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.91e-1)"	0.2	1.6	0.2	0.5	0.3	0.0	1.1	0.2	0.5	22.7	0.1	0.3	1.6	0.0	6.9	2.8	1.0	5.0	0.7	0.3	0.4	0.2	7.3	0.0	0.3	1.1	0.1	0.3	0.6	0.2	0.0	5.3	88.6	0.7	5.0	0.0	42.8	0.6	2.6	0.1	0.4	0.2	0.3	1.5	0.3	0.1	2.8	0.1	0.9	0.2	1.4	1.9	1.8	2.3	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.2	16.2	0.9	0.0	0.0	0.0	2.7	0.5	0.1	0.0	0.0	5.6	46.0	0.0	11.1	0.0	1.6	0.9	0.0	0.0	0.0	0.0	1.4	0.6	1.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.9	0.2	1.4	0.0	0.2	0.0	0.0	0.0	1.5	8.7	28.6	0.0	1.6	0.0	0.1	0.0	0.0	0.1	3.8	0.3	0.7	0.0	0.1	0.0	0.3	0.0	69.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.4	0.4	0.2	0.1	0.3	0.7	0.1
ABCA4	"ABCR, ARMD2, CORD3, FFM, RP19, STGD, STGD1"	ENSG00000198691	"ATP binding cassette subfamily A member 4"	P78363	1	93992835-94121132	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"retina: 142.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.0;EFO-21: 11.2;HeLa: 3.5;SK-BR-3: 4.2"	"Cancer enhanced"	"Detected in many"		"lung cancer: 3.1"	"Region enriched"	"Detected in some"	13	"pons and medulla: 25.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA078826	Enhanced									"HPA078826: "	"unprognostic (1.25e-1)"	"unprognostic (3.93e-1)"	"unprognostic (3.29e-2)"	"unprognostic (7.17e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.38e-2)"	"prognostic favourable (2.45e-4)"	"unprognostic (3.77e-2)"	"unprognostic (5.25e-1)"	"unprognostic (3.70e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.17e-9)"	"unprognostic (1.61e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.47e-1)"	"prognostic unfavourable (2.72e-4)"	0.7	0.0	0.3	0.2	0.4	0.0	1.1	0.2	0.9	0.7	0.2	3.2	0.2	3.7	0.2	12.9	0.2	0.6	0.2	0.2	2.0	0.2	6.7	1.2	0.4	0.3	0.3	0.2	0.3	0.2	0.0	0.2	0.8	25.5	0.3	0.0	142.7	0.2	2.1	0.2	3.5	4.2	0.2	0.2	0.2	0.1	2.1	0.2	0.2	0.7	0.2	0.2	0.3	0.2	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	5.0	0.2	0.3	0.0	0.2	0.1	0.0	0.0	11.2	0.5	1.1	0.0	0.0	0.1	0.0	0.0	0.7	3.5	1.2	0.6	0.0	0.0	0.5	0.0	0.5	0.0	1.0	0.0	0.2	0.0	1.4	0.5	0.0	2.0	0.0	0.2	0.4	0.3	0.5	0.5	0.0	0.0	1.0	4.2	0.2	0.4	0.0	0.2	0.3	2.2	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.9	2.0	0.2	0.3	0.2	25.5	0.2
AL391650.1		ENSG00000236782			1	26169516-26171821	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	6	"retina: 18.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 3.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"																		"unprognostic (4.80e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.24e-3)"	"unprognostic (9.79e-2)"	"unprognostic (4.84e-2)"	"unprognostic (4.87e-3)"	"unprognostic (6.44e-4)"	"unprognostic (4.45e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.23e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.26e-1)"	0.1	0.5	0.1	0.1	0.1	0.4	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.2	0.7	0.1	0.1	0.0	0.1	0.4	0.1		0.1	0.1	0.2	0.3	0.1	0.1	1.1	2.4	0.0	0.1	0.1	0.1	0.2	0.0	18.5	0.3	0.1	3.3	0.3	0.5	0.1	0.1	0.1	0.3	0.6	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.6	0.2	0.0	0.9	0.0	1.4	0.0	1.0	0.4	0.7	0.4	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.2	0.9	3.2	0.3	0.0	0.8	0.0	0.0	0.0	1.0	1.8	0.6	0.4	0.7	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	2.2	1.4	0.0	0.2	0.7	0.4	2.5	0.0	1.2	0.9	0.4	0.0	0.5	2.2	0.6	0.2	0.7	1.8	0.6	0.0	0.0	0.1	1.8	1.3	0.3	1.2	0.4	2.2	0.0	1.2	1.3	0.0	0.3	0.0	1.0	0.6	0.1	0.4	0.3	0.6	0.2	0.6	1.4	1.0	0.0	0.0	0.9	0.0	1.0	0.0										
CACNG5		ENSG00000075429	"Calcium voltage-gated channel auxiliary subunit gamma 5"	Q9UF02	17	66835117-66885486	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"brain: 6.5;lymphoid tissue: 3.3;retina: 8.8"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.7;RPMI-8226: 1.5;SH-SY5Y: 3.5;THP-1: 1.5"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"olfactory region: 152.3"	"Low region specificity"	"Detected in all"			HPA050115	Uncertain									"HPA050115: AB_2681022"					"unprognostic (1.85e-3)"					"unprognostic (3.84e-2)"	"unprognostic (1.44e-1)"		"unprognostic (2.46e-6)"	"unprognostic (4.52e-2)"	"unprognostic (1.29e-1)"			0.3	0.3	2.7	0.7	2.6	0.3	0.3	1.7	6.5	0.4	0.7	6.3	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.4	2.1	2.0	1.0	0.3	0.3	3.3	1.1	2.3	0.3	0.7	0.3	0.8	0.3	0.7	0.5	0.5	8.8	0.3	0.3	0.3	0.4	0.7	0.3	1.7	1.3	0.3	0.7	3.8	0.0	0.3	0.0	3.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.5	0.0	0.0	0.4	3.5	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	2.6	1.7	6.5	2.1	2.0	1.1	2.3	0.7	3.8
CLIC6	"CLIC1L, CLIC5"	ENSG00000159212	"Chloride intracellular channel 6"	Q96NY7	21	34669389-34718227	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 63.3;retina: 85.1;stomach 1: 45.1"	"Group enriched"	"Detected in some"	4	"HMC-1: 4.3;NTERA-2: 5.8;T-47d: 11.7;THP-1: 5.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	12	"pons and medulla: 63.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA055123, HPA065285"	Enhanced									"HPA055123: AB_2682704, HPA065285: AB_2685454"	"prognostic favourable (6.11e-5)"	"unprognostic (2.17e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.78e-2)"	"prognostic favourable (3.15e-5)"	"unprognostic (4.90e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.52e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.43e-3)"	7.7	0.0	0.8	3.0	1.7	0.0	5.7	0.6	2.3	8.7	1.8	12.4	0.6	0.9	1.0	5.2	1.2	6.1	4.5	6.3	5.4	1.0	0.9	0.6	6.4	0.4	0.4	0.5	2.3	1.2	0.0	1.3	0.6	63.3	4.0	1.3	85.1	10.9	3.8	1.9	2.3	1.1	1.9	0.6	0.7	45.1	1.1	0.6	2.4	8.2	0.9	1.8	7.5	2.0	0.3	0.1	0.4	0.0	0.2	0.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	1.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.1	0.0	4.3	0.2	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.4	11.7	5.2	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.4	0.0	0.0	0.3	0.2	0.0	0.1	0.1	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.1	0.8	1.7	0.6	2.3	5.4	1.0	0.4	0.5	63.3	0.6
CNGB1	"CNCG2, CNCG3L, CNGB1B, GAR1, GARP, RCNC2, RCNCb, RP45"	ENSG00000070729	"Cyclic nucleotide gated channel beta 1"	Q14028	16	57882340-57971116	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"retina: 79.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.9;RPMI-8226: 3.3;SCLC-21H: 9.4;SiHa: 5.4"	"Cancer enriched"	"Detected in single"	6	"head and neck cancer: 2.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.6"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA039159, HPA060355"			Approved	Vesicles,Cytosol				Cytosol	Cytosol	"HPA039159: AB_10795579, HPA060355: "	"unprognostic (5.52e-3)"	"unprognostic (4.51e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.73e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.56e-4)"	"unprognostic (3.08e-1)"	"unprognostic (9.84e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.14e-4)"	"unprognostic (5.42e-2)"	"unprognostic (1.01e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.57e-2)"	"unprognostic (9.07e-2)"	0.2	7.2	13.1	3.0	3.0	0.7	0.2	0.2	6.3	0.2	1.7	0.0	0.0	0.5	0.2	0.5	0.2	0.4	0.8	0.2	7.1	11.0	0.2	0.2	0.4	0.7	1.3	4.0	0.1	1.5	0.0	0.5	1.2	4.2	0.2	1.2	79.8	0.3	0.4	0.1	0.5	1.8	0.2	0.7	0.2	0.2	1.3	0.0	0.0	0.2	0.0	0.4	0.3	0.2	0.4	0.3	2.6	0.3	0.3	0.4	0.0	0.6	1.2	0.0	0.2	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	2.9	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.6	1.7	0.9	0.0	0.0	0.2	0.0	0.1	0.0	1.7	0.0	0.0	0.4	0.0	0.1	0.6	0.1	0.2	0.2	0.1	0.0	3.3	0.0	1.2	9.4	0.1	5.4	2.7	0.0	0.1	0.1	0.7	0.3	0.4	0.4	0.1	0.2	0.5	0.1	0.1	0.3	0.1	0.6	0.3	0.2	0.2	0.2	0.1	0.2	0.1	0.1	0.0	0.4	0.4	0.2	2.6	0.3	0.3	0.3	0.0	0.0	13.1	3.0	0.2	6.3	7.1	11.0	1.3	4.0	4.2	0.0
FRZB	"FRE, FRITZ, FRP-3, FRZB-1, FRZB-PEN, FRZB1, FZRB, hFIZ, SFRP3, SRFP3"	ENSG00000162998	"Frizzled related protein"	Q92765	2	182833275-182867162	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"retina: 265.8"	"Cell line enhanced"	"Detected in some"		"AF22: 17.3;ASC diff: 8.4;NTERA-2: 7.0;SH-SY5Y: 6.0"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"pons and medulla: 21.7"	"Group enriched"	"Detected in some"	9	"memory B-cell: 3.0;naive B-cell: 1.5"	"Lineage enriched"	"Detected in single"	12	"B-cells: 3.0"	"Region enhanced"	"Detected in many"		"olfactory region: 69.9"	"Low region specificity"	"Detected in all"								"Secreted in other tissues"	27000	27000				"unprognostic (5.39e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.64e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.67e-2)"	"unprognostic (8.58e-2)"	"unprognostic (5.41e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavourable (8.97e-6)"	"unprognostic (3.53e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.04e-2)"	"unprognostic (3.21e-1)"	4.4	1.4	2.8	4.8	5.4	0.0	5.1	2.9	3.5	7.1	5.1	3.3	2.6	4.5	5.5	3.5	3.6	2.8	12.9	8.4	2.8	2.8	5.5	2.2	3.7	4.8	3.6	3.4	4.4	2.4	0.6	11.3	44.3	21.7	4.0	6.6	265.8	5.1	5.4	8.4	4.3	4.7	10.5	2.9	28.2	12.0	4.2	2.3	3.1	5.0	3.1	3.4	3.5	6.2	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	17.3	0.2	8.4	0.2	0.1	0.0	0.8	3.0	2.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.7	0.6	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	7.0	0.0	0.6	0.7	0.0	0.0	0.0	1.1	6.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	5.4	2.9	3.5	2.8	2.8	3.6	3.4	21.7	2.3
KCNJ13	"Kir1.4, Kir7.1, LCA16"	ENSG00000115474	"Potassium voltage-gated channel subfamily J member 13"	O60928	2	232766464-232776568	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 22.9;intestine: 49.5;retina: 70.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.8;CACO-2: 2.7;U-2197: 4.7"	"Cancer enriched"	"Detected in some"	5	"melanoma: 5.9"	"Region enriched"	"Detected in some"	7	"pons and medulla: 22.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"														"unprognostic (4.29e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.69e-1)"	"unprognostic (9.03e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.12e-2)"		"unprognostic (2.26e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.11e-2)"	0.2	0.2	0.5	0.0	0.7	0.1	0.3	0.4	0.9	0.2	10.1	7.0	1.3	4.3	0.2	0.3	0.2	0.1	1.6	0.2	3.2	0.5	1.9	0.3	0.2	0.0	0.4	0.4	0.3	0.4	8.5	0.3	0.0	22.9	0.3	0.0	70.3	0.3	1.6	0.2	1.8	49.5	0.0	0.6	0.2	1.1	0.5	0.1	0.0	3.8	0.0	0.0	0.3	0.3	1.1	0.8	5.4	1.1	1.1	2.7	0.1	0.1	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.5	0.0	0.3	0.2	0.9	0.0	0.0	0.4	0.0	0.6	0.0	0.1	0.0	0.3	1.1	0.2	0.3	0.0	0.1	0.0	4.7	0.4	1.4	0.1	0.8	0.8	0.4	0.0	5.4	1.1	0.9	1.0	0.2	1.2	0.8	1.8	0.7	0.4	1.1	2.1	1.1	0.8	1.1	1.0	0.8	2.7	0.1	0.5	0.7	0.4	0.9	3.2	0.5	0.4	0.4	22.9	0.1
MLANA	MART1	ENSG00000120215	Melan-A	Q16655	9	5890802-5910606	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"retina: 191.5"	"Cell line enriched"	"Detected in single"	384	"SK-MEL-30: 120.4"	"Cancer enriched"	"Detected in single"	556	"melanoma: 277.0"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB000057, HPA048662"	Enhanced									"CAB000057: AB_442107, HPA048662: AB_2680485"	"unprognostic (2.52e-2)"	"unprognostic (6.87e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.53e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.71e-3)"	"unprognostic (3.60e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.01e-2)"	"unprognostic (5.78e-2)"	"unprognostic (9.43e-2)"	0.1	0.1	0.1	0.2	0.1	0.6	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.0	191.5	1.2	0.1	0.2	31.5	0.1	0.1	0.8	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.3	2.1	1.6	3.5	1.2	1.8	1.5	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	120.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	3.5	1.2	0.8	1.4	0.8	1.1	1.4	1.3	1.2	0.4	2.1	1.4	1.5	2.9	1.8	1.1	1.6	0.6	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1
AANAT	SNAT	ENSG00000129673	"Aralkylamine N-acetyltransferase"	Q16613	17	76453351-76470117	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"retina: 27.7;testis: 8.2"	"Cell line enhanced"	"Detected in some"		"A549: 4.5;SCLC-21H: 5.6;U-266/70: 4.5;U-266/84: 4.7;U-698: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA054321			Supported	Cytosol	"Intracellular and membrane"			Cytosol	Cytosol	"HPA054321: AB_2682449"	"unprognostic (7.89e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.61e-1)"	"unprognostic (9.30e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.81e-7)"	"unprognostic (1.04e-1)"	"unprognostic (6.00e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.34e-2)"	0.3	0.2	1.2	3.8	0.8	2.7	0.3	1.3	1.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.8	0.4	1.8	0.3	1.2	1.5	0.3	0.3	0.3	3.3	1.7	0.7	0.4	0.3	0.0	0.9	0.3	1.9	0.3	0.0	27.7	0.3	0.3	1.8	3.3	0.7	0.3	1.2	2.2	0.2	8.2	0.3	0.3	0.8	0.3	0.3	0.9	0.3	1.3	1.3	2.2	0.1	1.8	0.2	0.0	0.9	4.5	0.7	0.5	0.0	0.1	0.5	0.0	0.4	0.3	0.1	0.1	3.2	3.7	0.5	0.0	1.1	0.0	0.0	0.3	0.0	1.1	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	1.9	0.4	0.5	0.1	0.1	1.2	0.4	0.2	0.2	1.9	0.0	0.1	5.6	0.4	0.1	0.2	1.5	2.8	0.7	0.0	0.0	1.8	0.2	0.1	4.5	4.7	6.6	1.2	0.4	0.8	2.0	0.1	2.2	0.2	0.0	0.0	0.6	0.1	0.0	0.0	1.3	0.0	0.2	0.6	1.8	0.0	1.3	0.1	0.0	1.2	0.8	1.3	0.9	1.2	1.5	1.7	0.7	1.9	0.3
ABCG4	WHITE2	ENSG00000172350	"ATP binding cassette subfamily G member 4"	Q9H172	11	119149012-119162653	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 20.7;parathyroid gland: 7.4;retina: 7.5;testis: 7.2"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.6;HAP1: 3.0;U-2 OS: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA057635	Enhanced									"HPA057635: "	"unprognostic (3.26e-2)"	"unprognostic (4.75e-4)"	"unprognostic (6.31e-2)"	"unprognostic (1.83e-3)"	"unprognostic (3.76e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.07e-2)"	"unprognostic (3.29e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.15e-4)"	"unprognostic (2.26e-1)"	"unprognostic (6.48e-3)"	"unprognostic (2.65e-3)"	0.7	1.6	3.9	0.7	5.7	0.3	0.4	20.7	12.8	0.8	0.8	0.8	0.0	0.9	1.1	1.3	1.9	0.6	1.2	2.2	4.9	6.6	0.8	0.5	0.5	0.5	4.7	5.2	0.5	1.2	7.4	0.3	0.7	12.7	0.9	0.7	7.5	0.4	2.0	0.4	1.2	0.7	1.4	1.5	0.5	0.5	7.2	0.5	0.6	1.5	0.0	1.5	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	1.2	5.6	0.8	0.0	0.1	0.2	0.1	0.7	1.5	0.0	0.1	0.0	0.6	0.2	0.5	3.0	0.3	0.7	0.3	1.0	1.0	0.1	0.0	1.9	0.0	1.6	0.5	0.0	1.0	0.0	1.2	0.1	0.1	0.9	0.2	0.4	0.0	2.4	0.6	0.1	0.0	0.1	0.0	0.0	0.5	1.1	1.7	0.2	0.1	0.4	0.0	0.2	0.4	2.9	0.5	0.2	0.3	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	5.7	20.7	12.8	4.9	6.6	4.7	5.2	12.7	0.5
AMMECR1L	MGC4268	ENSG00000144233	"AMMECR1 like"	Q6DCA0	2	127861630-127885922	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"retina: 45.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000590, HPA057234"	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA000590: AB_2666037, HPA057234: AB_2683376"	"unprognostic (1.34e-1)"	"unprognostic (1.29e-3)"	"unprognostic (8.95e-2)"	"prognostic unfavourable (6.10e-4)"	"unprognostic (1.92e-1)"	"unprognostic (9.10e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.06e-3)"	"unprognostic (7.75e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.12e-2)"	"unprognostic (8.91e-2)"	7.8	6.4	5.2	5.2	5.2	5.0	7.1	5.7	5.2	7.6	5.5	5.2	5.2	4.6	8.7	5.2	6.4	6.9	5.9	5.2	5.2	3.3	5.2	7.7	5.6	5.2	5.2	5.2	7.6	8.8	7.6	5.2	7.3	5.2	6.4	5.7	45.9	5.9	5.2	5.2	7.2	5.8	7.5	5.2	6.8	6.1	7.9	5.2	5.2	6.1	5.2	5.4	5.8	7.3	4.2	5.4	9.0	3.7	3.5	6.1	3.2	12.2	8.2	16.9	13.8	16.1	13.1	16.0	14.5	13.2	16.0	14.5	18.2	9.2	11.9	9.7	14.3	12.2	16.4	12.1	17.6	14.1	12.0	15.1	12.2	10.3	19.2	14.9	15.5	14.4	26.5	19.6	26.5	16.7	13.8	12.0	12.8	8.7	13.9	14.5	13.4	15.2	14.6	13.6	6.8	12.7	10.7	11.2	12.6	12.0	18.8	29.1	8.7	10.4	16.6	19.8	18.6	9.2	10.9	10.1	14.8	12.3	9.5	9.6	13.1	1.6	3.2	9.0	4.7	3.7	6.1	3.6	4.5	4.1	4.8	4.2	4.1	3.8	4.3	3.5	3.7	5.4	4.2	3.2	5.2	5.2	5.7	5.2	5.2	3.3	5.2	5.2	5.2	5.2
ANO2	"C12orf3, TMEM16B"	ENSG00000047617	"Anoctamin 2"	Q9NQ90	12	5531869-5946232	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"placenta: 46.9;retina: 30.6;testis: 13.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.4;HUVEC TERT2: 8.3;U-2 OS: 22.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"basophil: 5.1"	"Lineage enriched"	"Detected in single"	51	"granulocytes: 5.1"	"Region enriched"	"Detected in some"	4	"basal ganglia: 20.0"					"HPA036276, HPA057499"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA036276: , HPA057499: AB_2732613"	"unprognostic (6.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.84e-3)"	"unprognostic (3.78e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.10e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.17e-1)"	5.8	0.1	1.0	1.3	2.3	0.0	4.3	1.2	1.3	3.3	1.0	1.6	0.9	0.8	1.8	2.1	0.9	1.9	1.5	3.9	1.9	0.9	1.2	0.9	4.7	0.9	1.6	2.0	0.9	0.9	1.4	0.9	46.9	1.2	1.4	0.7	30.6	0.9	1.6	2.3	0.6	0.9	2.1	1.1	1.9	1.0	13.4	0.9	0.9	1.6	1.3	0.9	1.3	2.3	0.0	0.0	5.1	0.0	0.0	0.0	0.2	2.1	0.0	3.9	0.0	0.0	0.2	1.8	0.0	8.4	0.4	0.9	0.0	0.1	0.1	0.2	0.0	0.3	0.0	0.1	0.6	0.2	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.3	0.0	1.6	0.0	0.8	0.0	0.0	4.0	0.0	1.6	0.0	0.9	0.1	0.1	0.0	0.0	2.0	1.4	0.0	1.1	0.0	0.2	0.0	22.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	1.0	2.3	1.2	1.3	1.9	0.9	1.6	2.0	1.2	0.9
C7orf33		ENSG00000170279	"Chromosome 7 open reading frame 33"	Q8WU49	7	148590565-148615860	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"retina: 3.9;testis: 2.0"	"Cell line enriched"	"Detected in single"	32	"SCLC-21H: 7.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																				"unprognostic (4.09e-1)"			0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	3.9	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CABP4	CSNB2B	ENSG00000175544	"Calcium binding protein 4"	P57796	11	67452406-67460313	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 12.6;lymphoid tissue: 12.3;retina: 26.9"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 21.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	13	"non-classical monocyte: 12.6"	"Lineage enriched"	"Detected in single"	15	"monocytes: 12.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (2.24e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.78e-3)"	"unprognostic (2.91e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.32e-3)"	"unprognostic (2.57e-1)"	"unprognostic (7.10e-4)"	"unprognostic (5.35e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.44e-3)"	2.2	1.0	2.0	0.6	0.8	0.3	2.2	0.4	1.0	2.5	0.8	1.3	3.0	1.1	0.9	3.6	0.6	0.9	1.3	1.7	0.9	0.7	1.1	1.4	2.6	4.9	1.6	1.0	0.4	0.9	0.1	0.3	2.9	1.4	2.3	0.8	26.9	1.5	1.6	3.0	0.8	1.6	0.6	1.2	12.3	2.7	0.5	0.4	0.4	1.6	0.5	0.6	1.0	0.5	0.3	0.5	0.8	12.6	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	4.9	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	3.7	0.1	0.0	0.0	21.6	0.0	0.0	0.1	0.0	0.6	0.0	0.3	1.2	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.6	0.1	0.1	0.2	0.9	0.3	0.1	0.1	0.2	0.5	0.3	0.1	0.1	0.8	0.2	12.6	0.1	0.0	0.1	2.0	0.8	0.4	1.0	0.9	0.7	1.6	1.0	1.4	0.4
CABP5	CaBP3	ENSG00000105507	"Calcium binding protein 5"	Q9NP86	19	48029953-48044053	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"retina: 53.0"	"Cell line enhanced"	"Detected in single"		"HBF TERT88: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 2.2"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043698	Enhanced									"HPA043698: AB_10797147"																		0.0	0.1	0.1	0.0	0.2	2.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.0	0.2	0.2	0.2	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	53.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	1.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.2	0.0	0.4	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.4	9.9	0.1	0.2	0.1	0.3	0.2	0.2	0.0	0.0	0.0	0.0
COL2A1	"AOM, SEDC, STL1"	ENSG00000139219	"Collagen type II alpha 1 chain"	P02458	12	47972965-48004554	"Cancer-related genes, Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"epididymis: 22.7;pituitary gland: 11.0;retina: 8.1;stomach 1: 11.3"	"Cell line enhanced"	"Detected in some"		"AF22: 54.0;HAP1: 33.8;HEK 293: 12.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002214, HPA055753"	Supported		Approved	Nucleoplasm	"Secreted to extracellular matrix"			Nucleoplasm	Nucleoplasm	"CAB002214: AB_563666, HPA055753: AB_2682908"	"unprognostic (7.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.08e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.31e-4)"	"unprognostic (2.64e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.02e-1)"	0.0	0.0	0.1	2.2	0.3	0.0	0.7	0.9	0.9	0.0	0.2	0.3	0.0	0.0	0.3	22.7	0.0	0.0	0.0	0.0	0.5	1.3	0.0	0.0	1.4	0.0	0.0	0.7	1.3	0.0	0.0	11.0	0.4	1.9	2.6	0.4	8.1	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	11.3	2.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	33.8	0.0	0.0	0.0	12.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.9	0.9	0.5	1.3	0.0	0.7	1.9	0.0
COL9A3	"DJ885L7.4.1, EDM3, FLJ90759, IDD, MED"	ENSG00000092758	"Collagen type IX alpha 3 chain"	Q14050	20	62816244-62841159	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 26.4;retina: 37.2;salivary gland: 38.9;thyroid gland: 18.1"	"Group enriched"	"Detected in some"	6	"BEWO: 52.5;Hep G2: 20.7;SK-MEL-30: 17.2;WM-115: 20.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA040125, HPA058323"	Supported		Approved	"Nucleoplasm,Intermediate filaments"	"Secreted to extracellular matrix"			Nucleoplasm	Nucleoplasm	"HPA040125: AB_10805604, HPA058323: AB_2683679"	"unprognostic (1.14e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.21e-3)"	"unprognostic (4.25e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.67e-1)"	2.2	2.0	11.2	2.3	16.3	1.2	1.5	1.5	8.9	1.7	3.4	26.4	1.6	2.3	1.8	1.5	1.6	1.2	1.4	2.1	14.9	9.8	1.4	1.3	1.3	1.4	18.4	8.1	1.6	5.4	1.1	5.3	1.9	12.4	1.7	1.3	37.2	38.9	3.4	1.5	1.8	2.5	1.4	25.0	1.2	1.8	6.4	15.2	0.0	18.1	1.4	1.2	1.3	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.3	52.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	4.8	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	2.4	20.7	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	2.3	0.0	0.9	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	17.2	0.0	1.9	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	16.3	1.5	8.0	14.9	9.8	18.4	8.1	12.4	15.2
FOXC1	"ARA, FKHL7, FREAC3, IGDA, IHG1, IRID1"	ENSG00000054598	"Forkhead box C1"	Q12948	6	1609972-1613897	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"retina: 32.7;salivary gland: 86.6"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 38.9;HEK 293: 37.9;RPTEC TERT1: 15.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 1.4"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040670	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA040670: AB_10673412"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavourable (3.53e-4)"	"unprognostic (3.22e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.33e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.83e-3)"	"unprognostic (3.74e-1)"	7.7	4.4	2.6	1.3	3.4	1.0	9.4	2.3	3.4	6.6	1.4	2.8	3.2	1.2	2.4	3.8	3.8	3.4	9.8	9.5	3.2	2.1	12.9	1.4	3.8	1.6	4.5	2.3	4.8	2.8	2.2	6.5	3.1	6.5	6.0	1.3	32.7	86.6	4.9	3.6	7.1	1.2	2.1	3.9	0.9	1.1	4.6	2.6	2.8	3.7	4.2	2.9	5.7	4.6	0.0	0.0	0.2	0.1	1.4	0.0	0.0	7.2	0.8	0.2	38.9	1.8	2.0	1.2	3.6	4.3	2.3	1.8	2.7	1.5	0.0	4.2	2.1	8.2	3.7	2.7	1.9	2.2	37.9	1.5	2.2	1.3	1.2	0.5	2.5	6.8	3.7	3.1	3.6	3.3	1.0	0.0	0.9	1.5	0.0	0.8	0.1	3.1	0.0	1.6	0.2	15.2	5.5	1.4	3.4	4.5	0.0	2.6	1.1	0.6	0.8	4.9	3.0	2.5	3.8	0.1	0.3	0.0	1.4	1.8	4.4	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.0	0.0	2.6	3.4	2.3	3.4	3.2	2.1	4.5	2.3	6.5	2.6
GNGT2	GNG9	ENSG00000167083	"G protein subunit gamma transducin 2"	O14610	17	49202791-49210574	"Predicted intracellular proteins, RAS pathway related proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	5	"blood: 29.1;lymphoid tissue: 21.1;retina: 46.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 35.6;HDLM-2: 30.6;HUVEC TERT2: 9.2;RH-30: 11.3;TIME: 8.9;U-698: 10.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 29.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"							HPA043381	Enhanced									"HPA043381: AB_2678455"	"unprognostic (9.11e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.99e-2)"	"unprognostic (4.62e-5)"	"unprognostic (1.34e-1)"	"unprognostic (3.20e-3)"	"unprognostic (1.75e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavourable (3.11e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.23e-1)"	2.7	2.1	2.7	9.4	3.7	1.3	1.8	0.7	2.2	2.1	2.3	2.0	0.4	2.6	1.6	1.2	1.8	1.7	3.3	2.4	2.5	1.9	3.0	2.6	6.2	12.2	3.2	0.4	1.7	1.2	0.1	1.4	1.9	2.2	2.2	3.3	46.7	1.6	1.1	0.6	0.6	4.9	2.9	4.5	21.1	1.7	0.8	2.5	6.0	2.5	1.4	16.6	3.6	5.1	2.0	9.7	0.9	29.1	10.6	14.4	5.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.6	0.5	0.0	0.0	35.6	0.3	0.1	0.0	0.0	0.0	2.0	30.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	9.2	0.0	0.2	0.8	0.0	2.7	2.1	0.3	0.0	6.9	11.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.9	0.0	5.7	0.0	0.0	0.1	1.6	10.9	0.1	0.1	0.0	0.0	4.3	0.4	14.4	21.5	12.6	1.9	2.4	10.2	9.7	2.0	1.5	5.9	0.9	10.6	29.1	0.8	1.8	5.4	2.7	3.7	0.7	2.2	2.5	1.9	3.2	0.4	2.2	2.5
GRIK1	"GluK1, GLUR5"	ENSG00000171189	"Glutamate ionotropic receptor kainate type subunit 1"	P39086	21	29536933-29940033	"FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 23.7;brain: 44.2;retina: 12.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.4"	"Group enriched"	"Detected in some"	7	"glioma: 4.5;prostate cancer: 0.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014623	Uncertain									"HPA014623: AB_1850305"	"unprognostic (1.39e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.12e-3)"	"unprognostic (1.25e-1)"	"unprognostic (8.77e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.20e-3)"	"unprognostic (1.47e-8)"	"unprognostic (2.09e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.15e-3)"	0.8	23.7	9.8	0.9	10.2	0.7	4.1	6.6	18.3	1.2	1.2	2.9	0.0	0.7	0.7	4.3	1.2	0.7	0.8	0.6	10.0	13.4	0.6	0.8	0.8	0.9	7.1	7.6	1.1	0.6	0.6	0.3	1.3	44.2	5.3	1.5	12.0	0.7	0.8	0.8	2.1	1.3	0.8	2.6	0.8	0.7	1.4	2.7	0.0	0.7	0.0	0.6	1.0	0.6	0.4	0.3	1.6	1.1	0.2	0.4	0.0	0.2	0.4	0.8	0.3	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.2	0.7	4.4	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.4	1.3	1.0	0.2	0.0	1.0	0.7	0.0	0.0	0.0	0.0	0.0	0.9	1.8	0.0	0.0	0.4	1.0	1.0	0.3	0.2	1.1	0.3	0.0	0.4	0.1	0.3	0.1	1.0	0.1	0.5	1.0	0.4	0.6	0.9	0.2	0.2	0.5	0.9	0.2	0.7	0.7	1.7	0.0	1.1	0.6	0.1	0.8	0.0	0.2	0.1	0.0	0.3	0.4	0.3	0.1	1.6	0.2	0.5	0.1	0.4	0.0	9.8	10.2	6.6	18.3	10.0	13.4	7.1	7.6	44.2	2.7
GSX2	Gsh2	ENSG00000180613	"GS homeobox 2"	Q9BZM3	4	54099523-54102505	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 4.8;retina: 16.7"	"Group enriched"	"Detected in some"	5	"HAP1: 3.0;RPTEC TERT1: 1.8"	"Cancer enriched"	"Detected in single"	15	"glioma: 2.6"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.3"	"Low region specificity"	"Detected in many"																		"unprognostic (4.48e-2)"						"unprognostic (1.05e-1)"				"unprognostic (7.01e-2)"	"unprognostic (1.89e-1)"		0.0	0.0	3.3	0.4	4.8	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.7	0.1	0.0	0.0	0.4	1.0	0.8	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	16.7	0.0	0.0	0.0	1.7	0.3	0.0	0.7	0.2	0.1	2.2	0.5	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.3	4.8	0.0	0.9	0.7	0.7	1.0	0.8	0.5	0.5
HCN1	"BCNG-1, BCNG1, HAC-2"	ENSG00000164588	"Hyperpolarization activated cyclic nucleotide gated potassium channel 1"	O60741	5	45254950-45696498	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 26.4;retina: 16.1"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.6;WM-115: 4.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA019195	Enhanced									"HPA019195: AB_2670094"	"unprognostic (1.30e-1)"		"unprognostic (3.62e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.24e-3)"			"unprognostic (6.82e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.63e-3)"	"unprognostic (4.11e-3)"		"unprognostic (6.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.68e-3)"		1.0	2.8	6.0	1.0	13.0	1.3	1.2	9.8	26.4	0.9	1.0	0.5	0.0	0.9	1.1	0.9	1.1	1.0	1.0	4.6	8.1	4.5	0.9	1.0	1.0	1.0	2.6	11.1	1.1	1.7	0.9	4.0	0.9	9.2	1.0	1.0	16.1	1.0	0.9	3.6	1.6	1.1	0.9	1.2	1.1	1.1	1.2	0.0	0.0	1.1	0.0	0.9	0.9	0.3	0.6	0.2	0.6	0.2	0.3	0.4	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.3	0.1	0.3	1.6	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.2	0.3	4.6	0.5	0.2	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.6	0.2	0.3	0.6	0.3	0.1	0.2	0.0	0.0	6.0	13.0	9.8	26.4	8.1	4.5	2.6	11.1	9.2	0.0
HPDL	"4-HPPD-L, GLOXD1, MGC15668"	ENSG00000186603	"4-hydroxyphenylpyruvate dioxygenase like"	Q96IR7	1	45326905-45328533	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 38.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 46.3;HL-60: 13.1;NB-4: 16.3;SK-BR-3: 29.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	18	"hippocampal formation: 0.7;hypothalamus: 0.9;midbrain: 2.0;pons and medulla: 0.9;thalamus: 0.8"	"HPA031997, HPA057346"			Supported	Mitochondria				Mitochondria	Mitochondria	"HPA031997: AB_10602909, HPA057346: AB_2683415"	"prognostic favourable (1.81e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavourable (1.60e-5)"	"unprognostic (1.02e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-1)"	"prognostic favourable (1.03e-4)"	"unprognostic (1.08e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.43e-1)"	0.9	0.7	2.7	3.1	4.2	3.6	1.0	7.6	3.4	2.0	8.4	2.4	0.0	5.4	1.0	1.3	3.6	1.0	1.8	3.0	2.7	2.4	0.7	0.2	0.8	2.6	2.5	1.8	1.0	0.3	0.2	0.4	5.1	3.1	1.7	7.1	38.4	1.3	0.6	3.3	1.1	4.7	0.9	2.2	2.8	7.8	1.4	0.6	6.4	1.0	4.2	2.3	0.8	1.6	3.1	0.7	0.0	0.3	2.1	1.5	0.8	0.0	0.4	0.1	0.0	0.0	0.1	46.3	0.6	0.0	0.8	0.1	11.5	3.0	2.3	0.1	0.5	2.8	0.0	0.1	0.2	0.0	0.1	0.2	5.0	0.0	0.3	13.1	0.3	0.5	0.1	0.4	0.0	0.9	0.0	2.1	0.1	5.7	8.4	16.3	0.2	0.0	2.5	0.0	7.6	0.1	0.1	9.1	0.6	5.8	29.3	4.5	0.0	2.4	0.4	0.0	0.1	0.4	0.0	0.3	0.1	8.2	0.0	0.0	0.5	0.0	0.3	0.0	0.4	0.1	1.5	3.1	0.7	1.2	0.7	0.3	0.9	0.8	0.0	2.1	0.0	0.0	0.4	0.8	2.7	4.2	7.6	3.4	2.7	2.4	2.5	1.8	3.1	0.6
KIAA1614		ENSG00000135835	KIAA1614	Q5VZ46	1	180913154-180951614	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 58.8;retina: 23.8"	"Cell line enhanced"	"Detected in many"		"RH-30: 12.0;SH-SY5Y: 30.4"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	5	"cerebellum: 58.8"	"Cell type enhanced"	"Detected in some"		"basophil: 4.4"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.4"					"Low region specificity"	"Detected in all"			"HPA028227, HPA061684"	Approved		Approved	"Nuclear membrane,Vesicles"				"Nuclear membrane, Vesicles"	"Nuclear membrane, Vesicles"	"HPA028227: AB_10601765, HPA061684: AB_2684585"	"unprognostic (3.23e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.55e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.61e-5)"	"unprognostic (8.93e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.35e-2)"	4.6	1.5	2.4	1.4	2.6	0.1	2.2	58.8	11.3	4.5	4.6	1.8	0.8	3.0	5.2	1.6	4.6	3.5	3.1	7.5	2.7	1.4	3.0	0.4	3.2	1.1	1.5	3.8	6.3	2.1	0.0	1.3	3.6	3.3	3.5	0.5	23.8	4.6	2.8	2.1	3.0	2.5	4.1	1.4	2.6	2.2	1.2	2.5	0.4	7.6	0.9	0.4	4.3	5.1	0.5	0.5	4.4	0.5	0.5	0.6	0.3	1.1	0.5	0.9	2.0	3.0	7.3	3.2	2.2	2.6	1.1	0.6	1.0	1.1	0.5	2.1	2.7	2.1	0.2	0.0	0.3	0.6	0.9	1.6	0.4	1.4	4.1	1.0	1.1	3.5	0.1	0.1	0.0	1.5	1.3	0.7	0.9	0.9	1.3	0.4	2.2	0.3	0.7	12.0	1.6	1.7	1.0	8.3	30.4	0.6	0.8	4.8	0.8	1.4	3.4	2.3	1.7	2.7	0.8	1.5	2.0	1.0	0.3	0.8	1.5	4.4	0.5	1.2	0.3	0.3	0.4	0.5	0.3	0.3	0.5	0.4	0.6	0.4	0.7	0.5	0.1	0.5	0.2	0.3	2.4	2.6	58.8	11.3	2.7	1.4	1.5	3.8	3.3	2.5
LHX2	"hLhx2, LH-2"	ENSG00000106689	"LIM homeobox 2"	P50458	9	124001670-124033301	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 44.7;retina: 17.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 15.8;HAP1: 15.7;HeLa: 10.9;NTERA-2: 19.6;U-138 MG: 10.3"	"Group enriched"	"Detected in many"	5	"cervical cancer: 3.2;glioma: 10.7;melanoma: 3.5"	"Group enriched"	"Detected in many"	6	"amygdala: 30.7;basal ganglia: 20.5;cerebral cortex: 26.6;hippocampal formation: 23.6;olfactory region: 16.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 41.7;basal ganglia: 25.3;cerebral cortex: 46.8;hippocampal formation: 47.4;olfactory region: 19.7"	"Group enriched"	"Detected in many"	6	"amygdala: 55.6;basal ganglia: 46.4;cerebral cortex: 70.9;hippocampal formation: 73.5;olfactory region: 35.5"	HPA000838		Supported	Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA000838: AB_2666109"	"unprognostic (3.60e-3)"	"prognostic favourable (9.52e-4)"	"unprognostic (3.52e-1)"	"unprognostic (9.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (6.37e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.59e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.32e-2)"	"unprognostic (4.66e-15)"	"unprognostic (1.72e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.77e-1)"	0.9	1.0	30.7	1.1	20.5	0.9	1.1	0.0	44.7	0.8	0.9	4.7	0.0	1.0	0.8	0.8	0.8	0.8	1.0	0.8	23.6	2.4	0.8	6.1	0.9	1.1	1.5	16.1	1.1	0.8	0.8	4.6	5.1	0.0	0.8	1.1	17.0	1.1	0.8	0.8	2.2	0.9	0.8	0.2	0.9	0.9	4.0	4.2	0.0	0.8	0.0	1.1	0.9	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	4.9	0.1	15.8	0.0	0.2	1.6	0.4	0.2	1.2	0.1	4.9	0.0	0.1	2.1	0.9	0.1	15.7	0.0	0.6	0.0	3.4	0.0	10.9	0.2	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	7.9	0.0	0.1	19.6	4.6	4.2	0.0	0.0	0.0	0.0	6.4	0.0	4.0	0.0	0.0	5.6	2.0	0.0	10.3	0.4	2.9	0.7	0.2	3.2	0.0	0.6	2.2	1.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	30.7	20.5	0.0	26.6	23.6	2.4	1.5	16.1	0.0	4.2
LHX4	Gsh4	ENSG00000121454	"LIM homeobox 4"	Q969G2	1	180230286-180278982	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	5	"retina: 21.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 14.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055705			Approved	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA055705: AB_2682892"	"unprognostic (2.83e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.86e-2)"	"unprognostic (9.38e-2)"	"unprognostic (5.76e-5)"	"unprognostic (9.39e-4)"	"unprognostic (1.47e-1)"	"unprognostic (2.39e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.77e-3)"	"unprognostic (2.72e-3)"	"unprognostic (4.07e-8)"	"unprognostic (3.63e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.44e-3)"	"unprognostic (7.83e-3)"	0.8	1.4	0.8	2.3	0.8	1.5	0.9	4.3	1.4	0.9	1.2	0.8	0.8	2.5	1.3	0.8	1.2	1.3	1.2	0.8	0.8	0.4	4.6	0.8	1.0	2.2	0.8	0.8	2.2	2.5	0.0	2.4	2.8	2.1	1.2	1.1	21.0	1.4	0.8	1.3	3.4	2.4	0.8	1.4	2.2	1.4	3.6	0.8	0.8	1.9	0.8	0.8	1.3	1.5	0.6	0.1	0.6	0.7	0.2	0.7	0.0	1.4	6.0	1.5	3.2	0.0	0.0	14.3	1.6	0.4	0.4	0.1	1.1	2.6	1.5	0.4	0.0	2.5	2.8	0.0	0.7	0.8	2.3	1.0	5.7	0.6	0.0	1.6	1.8	0.0	0.0	0.0	0.0	0.0	1.7	0.6	0.0	3.0	0.9	3.0	1.3	0.3	1.0	3.8	0.6	0.0	1.2	1.5	1.3	1.7	1.3	0.5	3.4	0.3	1.9	1.4	2.6	1.5	1.0	1.1	0.4	1.3	0.5	1.2	1.5	0.0	0.7	0.0	0.6	0.2	0.4	0.6	0.3	0.4	0.0	0.5	0.6	0.3	0.6	0.2	0.5	0.1	0.7	0.0	0.8	0.8	4.3	0.8	0.8	0.4	0.8	0.8	2.1	0.8
LHX9		ENSG00000143355	"LIM homeobox 9"	Q9NQ69	1	197911902-197935478	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"ovary: 22.1;retina: 24.3;testis: 17.5"	"Cell line enriched"	"Detected in some"	10	"fHDF/TERT166: 77.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"hippocampal formation: 6.9;midbrain: 20.7;thalamus: 13.3"	"Group enriched"	"Detected in many"	5	"midbrain: 38.1;pons and medulla: 11.9;thalamus: 24.4"	HPA009695	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA009695: AB_1079251"	"unprognostic (8.05e-2)"	"unprognostic (1.18e-1)"		"unprognostic (1.38e-4)"	"unprognostic (1.43e-1)"	"unprognostic (5.68e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.26e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.62e-3)"	"unprognostic (6.35e-3)"	"unprognostic (1.42e-1)"		"unprognostic (1.88e-1)"	0.3	0.2	1.7	0.1	1.0	0.1	0.1	0.1	0.5	1.1	0.3	0.7	0.4	0.2	0.8	4.1	0.1	0.4	0.2	1.5	0.7	2.6	0.1	1.2	2.7	0.1	0.8	0.0	22.1	0.1	0.1	1.4	0.1	3.1	0.1	0.2	24.3	0.1	0.2	0.9	0.1	0.2	0.1	0.5	0.1	0.1	17.5	0.5	0.0	0.1	0.0	0.1	0.1	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	1.2	2.1	0.1	0.0	0.0	0.0	0.0	77.1	0.0	1.9	0.0	0.6	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	2.3	2.3	0.8	0.0	0.0	0.0	1.8	0.0	0.7	0.4	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	1.0	0.1	0.5	0.7	2.6	0.8	0.0	3.1	0.5
LMO1	"RBTN1, RHOM1, TTG1"	ENSG00000166407	"LIM domain only 1"	P25800	11	8224304-8268716	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"retina: 29.4;skeletal muscle: 29.1"	"Cell line enhanced"	"Detected in some"		"HeLa: 21.2;SCLC-21H: 8.3;SH-SY5Y: 25.4;SiHa: 5.1"	"Cancer enriched"	"Detected in many"	6	"glioma: 6.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (3.74e-3)"	"unprognostic (1.45e-1)"		"unprognostic (4.75e-6)"	"unprognostic (9.34e-2)"	"unprognostic (2.37e-1)"		"unprognostic (1.98e-1)"	"unprognostic (7.06e-3)"	"unprognostic (8.09e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.05e-2)"	"unprognostic (4.36e-12)"	"unprognostic (1.76e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.13e-2)"	0.3	1.7	2.5	0.3	2.1	0.2	0.6	0.4	3.0	0.2	0.2	1.5	0.1	0.4	0.3	2.1	0.6	0.3	0.2	0.5	2.3	5.9	1.0	0.2	0.2	0.2	3.5	0.6	0.2	1.6	0.2	2.1	0.3	2.1	0.3	0.2	29.4	0.2	0.2	29.1	6.4	0.3	0.5	1.2	0.6	0.6	1.6	2.0	0.1	0.2	0.1	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.9	0.0	21.2	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	8.3	25.4	5.1	2.9	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.1	0.4	3.0	2.3	5.9	3.5	0.6	2.1	2.0
LRIT2	"AC022389.4, LRRC22"	ENSG00000204033	"Leucine rich repeat, Ig-like and transmembrane domains 2"	A6NDA9	10	84220495-84225589	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"retina: 25.4;skin 1: 8.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"basal ganglia: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA037788	Enhanced									"HPA037788: AB_10672393"			"unprognostic (3.12e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.99e-1)"	"unprognostic (9.44e-2)"				"unprognostic (2.36e-1)"			"unprognostic (1.76e-2)"		"unprognostic (2.41e-1)"			0.1	0.2	0.2	0.1	3.4	0.0	0.1	0.1	2.2	0.1	1.6	0.1	0.1	0.0	0.1	0.1	0.4	0.0	0.1	0.1	0.3	0.3	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	25.4	0.1	0.1	0.1	8.5	0.7	0.1	0.1	0.3	0.0	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.4	0.1	0.5	0.3	0.3	0.3	0.1	0.1	0.1
LRTM1	HT017	ENSG00000144771	"Leucine rich repeats and transmembrane domains 1"	Q9HBL6	3	54918237-54967088	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"lymphoid tissue: 12.2;retina: 18.8;skeletal muscle: 22.5;tongue: 15.3"	"Cell line enhanced"	"Detected in some"		"HEL: 4.2"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.5"	"Region enriched"	"Detected in single"	7	"pons and medulla: 2.9"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"																		"unprognostic (2.28e-1)"	"unprognostic (1.58e-2)"								"unprognostic (9.56e-2)"	"unprognostic (2.16e-1)"		"unprognostic (1.87e-3)"	0.3	0.1	0.3	0.0	0.3	0.0	0.3	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.3	3.6	0.1	0.4	0.1	0.3	0.2	0.1	0.2	0.1	0.0	0.3	0.0	0.1	0.1	0.3	0.1	0.4	2.9	1.2	0.0	18.8	2.1	0.4	22.5	0.1	0.3	0.0	1.0	12.2	0.1	0.3	0.0	0.0	0.1	15.3	0.5	0.1	0.1	0.7	1.0	2.3	1.9	0.7	0.9	0.5	0.5	0.3	1.7	0.2	0.2	0.0	1.7	0.0	0.5	0.9	1.6	0.3	1.3	0.0	0.8	0.8	1.0	0.4	1.5	0.5	1.0	0.2	4.2	1.1	0.9	0.2	0.4	1.1	1.8	0.4	0.7	0.2	0.1	0.1	1.6	0.3	0.1	0.4	2.3	1.5	0.5	0.1	0.3	1.3	0.2	0.7	0.4	0.7	0.5	2.2	0.3	1.2	0.3	0.0	0.7	0.9	0.7	0.1	0.0	1.0	0.1	0.4	0.6	0.9	2.3	0.5	0.6	0.7	0.6	0.9	0.7	0.6	0.3	1.0	0.3	0.8	0.6	1.5	0.7	1.9	0.6	0.7	0.5	0.3	0.3	0.1	0.2	0.3	0.2	0.3	0.0	2.9	0.0
NYX	"CLRP, CSNB1, CSNB1A, CSNB4"	ENSG00000188937	Nyctalopin	Q9GZU5	X	41447434-41475710	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"retina: 13.9"	"Group enriched"	"Detected in some"	7	"HDLM-2: 7.2;NTERA-2: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"									"unprognostic (3.27e-2)"	"unprognostic (6.72e-2)"				"unprognostic (4.21e-2)"	"unprognostic (4.10e-4)"			"unprognostic (1.83e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.80e-1)"			0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.0	13.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.7	0.0	0.0	0.1	0.0	0.3	0.0
PCP2	"GPSM4, MGC41903"	ENSG00000174788	"Purkinje cell protein 2"	Q8IVA1	19	7631611-7633748	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 45.5;retina: 20.2;testis: 80.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 8.9;Karpas-707: 4.5;NB-4: 18.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	14	"cerebellum: 45.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in some"	43	"cerebellum: 2422.3"	"Region enriched"	"Detected in single"	19	"cerebellum: 135.0"	HPA057428			Approved	"Nuclear speckles,Vesicles"				"Nuclear speckles"	"Nuclear speckles"	"HPA057428: AB_2683436"	"prognostic favourable (7.93e-4)"	"unprognostic (6.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.79e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.88e-5)"	"unprognostic (1.11e-1)"	"unprognostic (6.23e-2)"	"unprognostic (9.15e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.70e-2)"	"prognostic favourable (2.76e-5)"	0.5	0.4	0.5	0.5	0.5	1.9	3.3	45.5	0.6	1.0	0.5	0.5	0.5	0.6	0.5	2.0	0.5	1.3	1.2	0.5	0.5	0.0	2.5	1.0	1.2	1.4	0.5	0.5	0.5	1.6	0.3	0.5	0.5	3.2	2.0	0.0	20.2	10.6	1.0	0.5	4.2	0.5	0.5	1.9	1.1	0.9	80.7	0.5	0.5	1.9	0.5	0.6	0.5	0.5	1.0	1.7	2.6	0.3	0.7	1.2	5.2	1.8	0.4	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.7	1.6	0.7	1.1	0.0	1.3	0.0	0.2	0.0	0.8	0.6	2.7	2.5	0.1	0.0	0.3	8.9	0.0	0.6	0.0	0.0	0.0	0.2	4.5	0.0	0.3	0.3	18.0	0.4	0.0	0.8	0.2	0.7	0.9	0.1	0.1	0.0	1.4	1.5	0.0	3.9	3.3	0.2	0.0	0.6	0.4	0.1	1.6	0.6	0.2	0.0	2.1	0.0	0.0	0.3	0.0	0.9	0.1	1.2	0.4	0.5	0.5	0.5	1.0	0.8	1.0	2.6	0.7	0.0	1.7	0.2	5.2	0.5	0.5	45.5	0.6	0.5	0.0	0.5	0.5	3.2	0.5
PDE6G	"PDEG, RP57"	ENSG00000185527	"Phosphodiesterase 6G"	P18545	17	81650459-81663112	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 260.3"	"Cell line enhanced"	"Detected in some"		"Hep G2: 6.4;NB-4: 6.8;NTERA-2: 11.8;REH: 13.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basophil: 29.7;NK-cell: 57.8"	"Group enriched"	"Detected in all"	5	"granulocytes: 29.7;NK-cells: 57.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045118	Supported		Uncertain	Vesicles				Vesicles	Vesicles	"HPA045118: AB_2732517"	"unprognostic (6.16e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.85e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.94e-2)"	"unprognostic (5.71e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.14e-1)"	0.9	1.3	0.4	2.9	0.5	4.7	0.7	0.5	0.6	0.4	0.8	0.5	0.4	0.0	0.4	0.5	0.6	0.3	1.6	0.5	0.5	0.7	3.8	2.6	2.0	13.8	0.6	0.5	0.5	0.4	0.0	0.5	8.6	0.5	0.5	0.5	260.3	0.5	0.4	0.6	0.8	2.8	0.4	0.8	17.9	0.7	2.2	0.5	2.5	0.6	0.4	4.6	2.1	0.4	1.3	8.6	29.7	7.7	57.8	2.4	3.7	0.2	0.3	0.5	0.0	0.3	0.0	0.0	0.3	1.2	1.2	1.3	0.1	0.8	0.6	0.2	0.7	0.1	0.2	0.2	2.9	0.2	0.0	0.9	0.1	6.4	1.0	0.1	0.2	0.0	0.2	1.2	0.0	3.3	0.1	0.3	1.3	0.8	0.1	6.8	11.8	0.4	13.7	0.1	2.1	0.0	0.0	0.1	0.3	0.0	0.3	0.5	0.1	0.8	1.3	0.4	0.1	0.2	0.3	0.1	0.6	1.0	1.6	2.7	0.2	29.7	5.1	8.6	1.2	7.7	0.4	0.8	0.3	0.6	8.6	1.3	0.7	2.4	0.7	57.8	4.2	0.8	0.0	3.7	0.4	0.5	0.5	0.6	0.5	0.7	0.6	0.5	0.5	0.5
PLD5	FLJ40773	ENSG00000180287	"Phospholipase D family member 5"	Q8N7P1	1	242082986-242524696	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 54.8;retina: 37.7"	"Cell line enhanced"	"Detected in some"		"A549: 3.9;AF22: 13.7;HDLM-2: 6.8;SH-SY5Y: 3.8;U-2 OS: 4.7"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Region enriched"	"Detected in all"	4	"cerebellum: 54.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028389, HPA050367"			Approved	Vesicles,Mitochondria,Cytosol				Mitochondria	Mitochondria	"HPA028389: AB_10602145, HPA050367: AB_2681105"	"unprognostic (5.20e-2)"	"unprognostic (1.05e-1)"		"unprognostic (9.14e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.32e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.16e-5)"	"unprognostic (2.79e-2)"	"unprognostic (4.46e-1)"	"unprognostic (3.44e-3)"	"unprognostic (2.18e-1)"	1.1	5.4	5.0	0.4	3.7	0.4	1.6	54.8	7.6	2.2	0.8	7.7	0.0	0.4	3.5	0.9	1.6	1.8	0.8	0.8	4.4	4.6	1.5	0.5	0.8	3.3	5.4	2.5	6.6	3.1	1.4	7.2	1.5	12.7	2.7	0.6	37.7	2.2	9.3	0.8	0.6	0.5	2.9	6.0	2.2	0.8	4.2	6.2	0.0	1.0	0.0	1.5	0.4	1.0	0.4	0.2	1.0	0.2	0.3	0.4	0.0	0.0	3.9	13.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.2	0.6	0.0	6.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.6	0.0	0.0	0.5	2.6	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.0	0.2	0.3	0.3	0.2	0.3	0.2	0.3	0.3	0.1	0.4	0.3	0.4	1.0	0.3	0.2	0.2	0.2	0.0	5.0	3.7	54.8	5.5	4.4	4.6	5.4	2.5	12.7	6.2
PMEL	"D12S53E, gp100, Pmel17, SI, SIL, SILV"	ENSG00000185664	"Premelanosome protein"	P40967	12	55954105-55973317	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 230.1"	"Cell line enriched"	"Detected in some"	66	"SK-MEL-30: 431.8"	"Cancer enriched"	"Detected in many"	500	"melanoma: 2481.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA031649	Enhanced		Supported	"Endoplasmic reticulum,Golgi apparatus"	"Intracellular and membrane"	14000000	14000000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA031649: AB_2673976"	"unprognostic (4.63e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.90e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.46e-3)"	"unprognostic (6.44e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.12e-2)"	"unprognostic (3.98e-1)"	"prognostic favourable (3.70e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.04e-1)"	0.9	0.1	0.4	0.4	0.5	0.4	3.4	0.4	0.5	38.2	1.0	0.4	0.5	0.4	11.8	0.4	0.4	0.2	0.6	0.5	0.4	0.0	0.6	1.8	0.7	1.9	0.4	0.4	1.6	0.6	0.9	0.4	0.9	0.4	0.5	0.2	230.1	1.1	0.4	0.6	46.8	0.6	1.3	0.8	0.4	0.2	1.5	0.4	0.4	0.4	0.6	0.6	0.5	0.8	1.3	2.3	2.1	1.4	0.2	1.9	0.6	0.7	0.0	0.2	0.0	4.4	0.0	6.5	0.0	0.0	0.1	0.1	0.6	0.3	0.1	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	431.8	0.2	0.4	0.0	0.0	0.3	0.0	0.4	0.1	0.5	0.1	0.0	0.1	0.0	0.0	1.4	0.7	0.3	0.0	1.9	1.3	0.5	0.4	0.0	0.9	1.1	0.1	2.1	0.2	0.4	2.3	0.4	0.6	0.4	0.5	0.4	0.5	0.4	0.0	0.4	0.4	0.4	0.4
RDH8	"PRRDH, SDR28C2"	ENSG00000080511	"Retinol dehydrogenase 8 (all-trans)"		19	10013249-10022279	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	5	"retina: 29.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.8;SK-MEL-30: 3.4"	"Group enriched"	"Detected in some"	8	"melanoma: 2.2;stomach cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"unprognostic (4.12e-1)"		"unprognostic (2.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.98e-3)"		"unprognostic (4.58e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.45e-1)"			"unprognostic (1.02e-1)"	"unprognostic (3.86e-1)"		"unprognostic (2.63e-1)"	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	2.8	0.8	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ROM1	"ROM, TSPAN23"	ENSG00000149489	"Retinal outer segment membrane protein 1"	Q03395	11	62611722-62615120	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 108.1"	"Cell line enhanced"	"Detected in many"		"HSkMC: 17.8;U-266/84: 18.7"	"Cancer enriched"	"Detected in all"	6	"glioma: 14.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 5.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA028910	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA028910: AB_2672824"	"unprognostic (1.54e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.05e-1)"	"prognostic favourable (2.20e-4)"	"unprognostic (2.20e-1)"	"unprognostic (9.87e-2)"	"unprognostic (7.65e-3)"	"unprognostic (3.50e-2)"	"prognostic unfavourable (2.85e-6)"	"unprognostic (2.61e-1)"	"unprognostic (4.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.24e-2)"	9.4	4.6	16.3	2.3	15.0	0.9	3.6	5.7	18.8	4.9	3.1	5.1	3.3	2.0	3.8	5.7	4.7	7.4	5.2	2.7	14.7	9.2	2.4	3.2	3.0	2.3	18.1	4.7	13.2	3.2	4.8	2.1	1.6	8.7	3.8	3.0	108.1	2.5	5.9	2.2	3.7	1.7	6.3	21.6	2.5	2.4	3.7	7.7	0.7	3.0	2.2	2.6	3.1	9.2	1.1	0.8	0.8	1.2	5.6	3.2	1.4	2.1	1.2	2.2	4.6	3.2	15.6	0.4	1.4	2.5	3.1	2.0	0.6	3.6	2.0	10.0	8.1	2.7	1.0	2.8	0.8	3.6	1.8	1.8	5.3	2.5	9.2	0.7	0.6	17.8	4.1	3.1	6.4	4.7	2.6	4.6	6.2	5.3	1.1	1.5	0.5	3.2	1.1	1.8	12.7	3.4	1.2	2.3	3.3	3.5	4.0	1.6	5.6	0.9	5.4	5.1	1.9	5.9	1.6	2.0	18.7	1.6	9.5	2.1	1.0	0.0	1.2	0.8	0.9	0.3	2.4	0.7	3.2	0.8	0.6	1.1	1.5	1.8	0.4	5.6	1.1	0.8	0.9	1.4	16.3	15.0	5.7	8.4	14.7	9.2	18.1	4.7	8.7	7.7
RTBDN	FLJ36353	ENSG00000132026	Retbindin	Q9BSG5	19	12825478-12835428	"Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 17.3;pituitary gland: 25.8;retina: 57.0"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 8.0;SH-SY5Y: 5.3;U-266/84: 20.6;U-87 MG: 4.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 1.7;neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"							"Not detected"	"Not detected"			HPA052511			Approved	"Endoplasmic reticulum"	"Secreted in other tissues"			"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA052511: AB_2797243"	"unprognostic (4.55e-4)"	"unprognostic (3.94e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.54e-4)"	"unprognostic (3.33e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.55e-1)"	"unprognostic (6.48e-2)"	"unprognostic (7.04e-3)"	"unprognostic (7.66e-9)"	"unprognostic (3.55e-2)"	"unprognostic (1.00e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.24e-2)"	0.3	6.9	10.2	0.5	3.4	0.9	0.3	2.7	17.3	0.2	0.9	0.4	0.0	1.0	0.3	1.5	0.3	0.3	0.4	0.3	7.3	5.1	0.2	0.4	0.5	0.4	2.8	2.8	0.3	2.5	0.2	25.8	0.3	4.0	0.4	0.9	57.0	0.3	0.3	0.3	0.5	1.0	0.6	1.0	0.4	2.5	3.5	0.0	7.0	0.4	0.0	0.4	0.3	0.0	0.3	0.2	1.8	0.2	0.4	0.2	0.0	0.9	0.1	0.1	0.6	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.3	0.1	0.8	0.9	0.0	0.2	0.3	0.0	0.0	0.1	0.1	0.0	0.4	0.8	0.0	0.1	2.3	0.0	0.0	0.4	0.2	0.0	1.2	2.6	0.0	0.1	0.0	0.0	0.9	1.1	0.7	0.1	1.0	0.0	0.0	8.0	5.3	0.1	0.1	0.4	2.7	0.7	0.0	0.8	1.0	0.7	0.1	1.2	20.6	3.9	4.7	0.0	0.0	1.7	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.2	0.2	1.8	0.4	0.2	0.2	0.1	0.0	10.2	3.4	2.7	8.6	7.3	5.1	2.8	2.8	4.0	0.0
SCRT2	ZNF898B	ENSG00000215397	"Scratch family transcriptional repressor 2"	Q9NQ03	20	661596-676179	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 17.9;retina: 6.1"	"Group enriched"	"Detected in some"	5	"Karpas-707: 3.9;NTERA-2: 3.6;RPMI-8226: 7.9;SCLC-21H: 3.8;SH-SY5Y: 4.2"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.0"	"Group enriched"	"Detected in many"	4	"cerebellum: 8.8;cerebral cortex: 17.9"	"Cell type enriched"	"Detected in single"	25	"neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA067697			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA067697: AB_2685890"					"unprognostic (9.71e-2)"					"unprognostic (2.03e-1)"	"unprognostic (6.97e-2)"			"unprognostic (9.70e-2)"	"unprognostic (1.70e-1)"			0.3	0.3	0.7	0.3	0.7	0.3	0.3	8.8	17.9	0.3	0.3	0.6	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.7	0.6	0.3	0.3	0.3	0.3	1.9	0.0	0.3	1.3	0.3	0.0	0.4	3.2	0.3	0.3	6.1	0.3	0.3	0.3	0.3	0.3	0.3	1.1	0.6	0.3	0.7	0.0	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	7.9	0.0	0.0	3.8	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.7	0.7	8.8	17.9	0.7	0.6	1.9	0.0	3.2	0.0
SFRP5	SARP3	ENSG00000120057	"Secreted frizzled related protein 5"	Q5T4F7	10	97766751-97771952	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"gallbladder: 34.9;heart muscle: 27.1;intestine: 17.8;pancreas: 70.4;retina: 67.6"	"Cell line enhanced"	"Detected in some"		"A549: 3.3;CACO-2: 15.9;RPMI-8226: 5.7;SCLC-21H: 2.6"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 30.4"	"Group enriched"	"Detected in some"	5	"hypothalamus: 1.8;midbrain: 4.5;pons and medulla: 5.6"	"Cell type enriched"	"Detected in some"	5	"naive CD8 T-cell: 7.4"	"Lineage enriched"	"Detected in many"	5	"T-cells: 7.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"								"Secreted in other tissues"						"unprognostic (2.63e-4)"	"unprognostic (3.03e-3)"	"unprognostic (6.74e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.51e-9)"	"unprognostic (1.67e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.62e-1)"	0.9	5.1	0.0	1.3	0.8	0.4	0.6	0.5	0.4	1.8	10.9	1.1	9.1	14.7	1.1	2.8	4.3	0.6	34.9	27.1	0.7	1.8	0.2	3.2	1.9	0.4	4.5	0.1	0.3	70.4	0.2	0.1	0.2	5.6	1.9	0.5	67.6	9.2	2.4	0.4	0.9	17.8	1.0	1.9	0.3	3.4	0.4	0.3	0.0	0.2	1.6	0.3	1.3	1.4	0.0	1.5	0.0	0.0	0.0	7.4	0.5	0.0	3.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.7	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	5.7	0.0	0.0	2.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	7.4	0.0	0.0	0.0	1.5	0.0	0.5	0.0	0.8	0.5	0.3	0.7	1.8	4.5	0.1	5.6	0.3
SLC24A5	"JSX, OCA6"	ENSG00000188467	"Solute carrier family 24 member 5"	Q71RS6	15	48120972-48142672	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"retina: 71.9"	"Cell line enriched"	"Detected in single"	733	"SK-MEL-30: 73.2"	"Cancer enriched"	"Detected in single"	162	"melanoma: 8.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"hippocampal formation: 3.3;pons and medulla: 4.4;thalamus: 1.7"	"Low region specificity"	"Detected in all"																		"unprognostic (3.47e-2)"				"unprognostic (1.80e-1)"	"unprognostic (1.35e-1)"			"unprognostic (1.92e-3)"					0.1	0.1	0.5	0.1	0.6	0.1	0.6	1.5	0.5	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.2	0.1	0.4	0.1	0.5	1.0	0.3	0.1	0.2	0.1	1.7	0.1	0.1	0.1	0.1	1.5	0.1	0.4	0.1	0.1	71.9	0.2	0.1	0.1	15.4	0.7	0.1	0.6	0.1	0.1	3.0	0.4	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.6	1.5	0.5	0.5	1.0	1.7	0.1	0.4	0.4
SLC4A5	NBC4	ENSG00000188687	"Solute carrier family 4 member 5"	Q9BY07	2	74216242-74343414	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 109.1"	"Cell line enhanced"	"Detected in many"		"U-266/70: 14.2"	"Cancer enriched"	"Detected in single"	11	"thyroid cancer: 3.3"	"Group enriched"	"Detected in many"	5	"cerebellum: 3.4;pons and medulla: 9.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA036621	Uncertain									"HPA036621: AB_10696779"	"unprognostic (1.30e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.83e-4)"	"unprognostic (3.38e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.56e-3)"	"unprognostic (5.37e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.55e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.72e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.06e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.27e-4)"	1.2	0.4	1.0	0.8	0.8	1.6	1.1	3.4	1.2	0.7	0.8	2.5	0.6	0.3	0.9	1.7	0.6	1.4	0.8	0.7	1.2	1.0	0.7	3.2	1.7	1.0	1.0	0.6	1.3	0.9	1.5	2.3	0.6	9.0	0.9	0.3	109.1	1.3	0.8	1.1	3.7	0.7	0.9	1.6	0.7	0.5	16.1	0.7	1.0	21.4	0.6	0.7	0.9	0.9	2.5	5.8	6.1	0.9	1.7	2.5	0.6	0.4	0.8	1.4	1.4	1.5	2.5	1.8	0.4	1.3	0.8	1.2	0.4	1.0	2.1	0.4	0.0	0.1	1.5	0.2	0.3	1.8	0.9	3.2	1.4	0.8	0.2	1.1	2.3	0.7	1.9	0.1	0.3	0.5	0.7	2.3	0.3	5.1	0.5	2.2	1.1	0.3	1.1	1.3	0.0	0.3	1.0	1.0	2.0	0.5	1.7	2.3	1.6	2.2	0.0	1.5	2.4	1.5	0.5	14.2	2.0	1.6	0.9	1.2	0.3	6.1	0.9	0.9	1.5	0.8	1.0	1.8	2.3	2.0	0.6	2.5	2.1	2.5	4.2	1.7	0.3	5.8	2.4	0.6	1.0	0.8	3.4	1.2	1.2	1.0	1.0	0.6	9.0	0.7
SLC6A20	"XT3, Xtrp3"	ENSG00000163817	"Solute carrier family 6 member 20"	Q9NP91	3	45755450-45796535	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"gallbladder: 14.3;intestine: 25.5;retina: 51.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 5.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 6.1"	"Cell type enhanced"	"Detected in some"		"neutrophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA029873	Uncertain									"HPA029873: "	"unprognostic (1.57e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.26e-2)"	"unprognostic (4.33e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.46e-1)"	"prognostic favourable (1.55e-5)"	"unprognostic (2.87e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.09e-2)"	0.3	0.1	0.3	0.6	0.8	0.5	0.7	1.5	2.2	2.4	11.2	3.0	0.4	22.3	1.3	1.7	0.1	0.4	14.3	0.1	0.5	0.4	3.3	0.2	1.9	0.2	1.0	1.7	0.1	5.1	0.0	2.0	0.1	6.1	1.0	0.2	51.3	1.3	0.1	0.9	0.6	25.5	0.3	1.5	0.1	4.7	0.4	0.3	0.0	0.1	0.4	0.1	0.2	0.3	0.8	0.7	2.6	0.2	0.5	0.4	0.1	0.4	0.7	0.7	0.7	0.2	0.1	0.8	0.3	0.0	0.1	0.1	2.7	2.4	0.4	1.9	0.0	5.2	0.2	0.0	0.3	0.2	0.3	2.2	2.0	0.4	0.0	0.1	0.4	0.1	1.1	0.0	0.1	0.0	0.3	0.8	0.0	0.6	0.8	0.5	2.4	0.5	0.8	0.2	0.6	0.4	0.6	0.6	0.8	2.6	0.4	0.1	0.5	0.3	0.1	0.9	0.7	0.7	0.5	1.4	0.5	0.2	0.4	0.5	0.2	1.0	0.2	0.2	0.3	0.1	0.3	0.2	0.2	0.2	0.1	0.8	0.4	0.3	2.6	0.5	0.1	0.7	0.1	0.1	0.3	0.8	1.5	2.2	0.5	0.4	1.0	1.7	6.1	0.3
SMIM36		ENSG00000261873	"Small integral membrane protein 36"		17	55448433-55511444	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Tissue enriched"	"Detected in some"	5	"retina: 29.3"	"Cell line enhanced"	"Detected in some"		"TIME: 1.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"																															"unprognostic (2.07e-1)"				0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	29.3	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.2	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.8	2.9	0.8	1.2	0.7	0.6	0.1	0.5	0.2	0.2	0.0	0.0	0.8	1.1	0.0	0.0	0.0	0.0	0.5	0.2	0.2	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.3	1.0	0.8	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.4	0.3	0.1	0.4	0.2	0.0	0.0	0.0	0.8	0.5	0.7	0.6	0.1	0.0	0.6	0.0	1.3	0.5	0.4	0.5	0.3	0.4	0.2	0.5	0.4	0.7	0.2	2.9	0.8	0.8	0.6	0.6	0.5	0.5	0.5	0.5	0.3	1.4	0.6	0.7	2.4	1.2	0.7	0.8	0.5	0.6										
TMEM72	"bA285G1.3, C10orf127, KSP37"	ENSG00000187783	"Transmembrane protein 72"	A0PK05	10	44911200-44937002	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"kidney: 46.5;retina: 17.1"	"Group enriched"	"Detected in some"	118	"RPMI-8226: 25.5;U-937: 15.9"	"Cancer enriched"	"Detected in some"	8	"renal cancer: 8.7"	"Group enriched"	"Detected in some"	6	"hippocampal formation: 1.2;pons and medulla: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA039894, HPA062907"	Enhanced									"HPA039894: AB_10795261, HPA062907: AB_2684900"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.08e-1)"		"unprognostic (4.57e-2)"	"unprognostic (3.24e-2)"		"unprognostic (8.58e-2)"	"unprognostic (5.45e-2)"		"prognostic favourable (1.01e-4)"	"unprognostic (4.99e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.22e-1)"		0.1	0.0	0.1	0.9	0.2	0.1	0.0	0.3	0.2	0.0	4.2	1.3	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.1	1.2	0.3	46.5	0.1	0.0	0.0	0.4	0.0	0.0	5.7	0.1	0.3	0.0	4.9	0.0	4.9	17.1	2.7	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.2	1.9	0.0	0.4	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	25.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.2	1.2	0.3	0.4	0.0	4.9	0.0
TYRP1	"b-PROTEIN, CAS2, CATB, GP75, OCA3, TRP, TYRP"	ENSG00000107165	"Tyrosinase related protein 1"	P17643	9	12685439-12710290	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"retina: 277.3"	"Cell line enriched"	"Detected in some"	52	"SK-MEL-30: 173.5"	"Cancer enriched"	"Detected in some"	262	"melanoma: 313.2"	"Region enriched"	"Detected in some"	5	"pons and medulla: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"olfactory region: 5.6;thalamus: 2.0"	"Low region specificity"	"Detected in all"			"HPA000937, CAB002520"	Enhanced		Supported	Vesicles		16000	16000	Vesicles	Vesicles	"CAB002520: AB_564153, HPA000937: AB_1080437"	"unprognostic (7.48e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.28e-1)"	"unprognostic (3.16e-3)"	"unprognostic (8.10e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.25e-3)"	"unprognostic (4.46e-1)"	"unprognostic (8.71e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.68e-6)"	"unprognostic (1.27e-1)"	"unprognostic (5.99e-2)"		"unprognostic (1.95e-2)"	0.2	0.0	0.2	0.2	0.3	0.0	1.7	0.2	1.0	0.2	0.5	1.3	0.2	1.6	0.2	0.3	3.6	0.2	1.4	21.5	0.9	0.1	5.7	0.2	2.1	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.2	5.0	0.2	1.8	277.3	1.1	0.2	1.3	51.1	1.4	0.4	1.1	0.2	0.6	0.5	0.2	0.2	0.2	0.9	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	173.5	2.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	1.0	0.9	0.1	0.2	0.3	5.0	0.2
USH2A	"RP39, USH2"	ENSG00000042781	Usherin	O75445	1	215622894-216423396	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"liver: 13.7;retina: 36.6"	"Group enriched"	"Detected in some"	4	"AF22: 1.5;SCLC-21H: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"						"unprognostic (3.92e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.97e-2)"	"unprognostic (5.38e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.04e-1)"	"unprognostic (6.62e-4)"	"unprognostic (1.00e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.07e-3)"	"unprognostic (3.15e-2)"	"unprognostic (3.28e-11)"	"unprognostic (2.02e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.09e-4)"	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.4	0.7	0.0	0.1	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.4	0.1	0.2	0.3	13.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	5.1	0.1	0.5	0.0	0.0	36.6	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	1.4	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.3	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.4	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.7	0.1	0.2	0.1	0.0	0.5	0.0
BEST2	"FLJ20132, VMD2L1"	ENSG00000039987	"Bestrophin 2"	Q8NFU1	19	12751702-12758458	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 25.2;retina: 28.7;skin 1: 11.7"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 3.5"	HPA046229	Approved									"HPA046229: AB_10966140"	"unprognostic (3.19e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.02e-3)"		"unprognostic (2.77e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.46e-3)"	"unprognostic (9.18e-6)"	"unprognostic (3.45e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.64e-5)"	0.2	0.1	0.2	4.1	0.2	1.8	0.3	0.2	1.3	0.4	25.2	0.2	0.2	0.0	0.2	0.7	0.2	0.2	0.3	0.2	0.2	0.1	0.2	0.2	0.2	2.2	0.2	0.2	0.4	0.2	0.4	0.2	0.2	0.2	0.2	12.8	28.7	0.6	0.2	0.2	11.7	11.5	0.5	0.2	0.2	0.1	0.3	0.2	0.2	0.4	1.5	5.2	0.2	1.0	3.1	2.7	2.2	0.8	1.7	2.1	1.2	0.9	0.7	2.3	3.5	0.0	0.4	1.6	1.0	0.0	0.5	0.7	2.6	3.6	2.9	0.9	1.2	1.8	0.0	0.5	0.6	3.3	1.5	2.4	3.2	0.9	0.4	1.1	5.1	0.5	0.3	0.4	0.3	0.3	0.6	1.5	0.5	3.0	0.8	1.9	3.0	2.6	0.4	1.3	0.5	1.0	1.2	1.9	1.9	1.5	0.7	0.6	1.8	0.9	2.6	0.9	1.0	1.6	2.1	0.9	1.3	1.1	1.3	2.7	1.8	1.7	0.5	0.4	1.4	0.8	1.1	2.2	1.0	0.8	0.2	3.1	2.1	2.1	2.2	1.7	0.5	2.7	0.7	1.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
BHLHE23	"bA305P22.3, Beta4, BHLHB4, bHLHe23"	ENSG00000125533	"Basic helix-loop-helix family member e23"	Q8NDY6	20	63005927-63007035	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 1.0;lymphoid tissue: 4.1;retina: 1.3;testis: 1.8"	"Cell line enriched"	"Detected in single"	23	"MOLT-4: 16.5"	"Cancer enriched"	"Detected in single"	11	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 3.0"	HPA030575	Uncertain									"HPA030575: AB_10601459"															"unprognostic (1.74e-1)"			0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.8	0.0	4.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.7	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CDHR1	"CORD15, KIAA1775, PCDH21, RP65"	ENSG00000148600	"Cadherin related family member 1"	Q96JP9	10	84194635-84219621	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 31.2;intestine: 22.6;retina: 42.5;skin 1: 86.8"	"Cell line enhanced"	"Detected in some"		"HAP1: 10.3;HEK 293: 5.3;HEL: 6.2;K-562: 4.4;NTERA-2: 4.5;RPTEC TERT1: 16.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 13.8"	"Region enhanced"	"Detected in many"		"basal ganglia: 31.2"	"Cell type enriched"	"Detected in single"	11	"NK-cell: 10.5"	"Lineage enriched"	"Detected in single"	11	"NK-cells: 10.5"	"Region enriched"	"Detected in some"	21	"olfactory region: 408.8"	"Low region specificity"	"Detected in all"			HPA036819	Enhanced				"Intracellular and membrane"					"HPA036819: AB_10671750"	"unprognostic (8.91e-4)"	"unprognostic (5.60e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.03e-2)"	"unprognostic (6.40e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.67e-1)"	"unprognostic (6.69e-4)"	"unprognostic (1.90e-1)"	"unprognostic (5.51e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.56e-3)"	"unprognostic (5.07e-2)"	0.3	1.2	1.9	0.7	31.2	0.5	2.3	0.9	7.7	2.8	12.3	2.2	0.0	0.3	0.6	2.2	4.8	0.6	0.5	0.9	3.4	2.1	0.5	0.5	0.4	0.7	1.5	3.1	0.8	0.4	0.3	1.5	0.4	9.3	0.9	22.6	42.5	1.0	2.2	0.7	86.8	5.3	0.9	1.2	3.0	0.4	0.4	3.0	2.4	0.4	3.3	0.9	0.4	1.5	0.0	0.0	0.0	0.0	10.5	0.9	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	10.3	2.0	0.0	0.0	5.3	6.2	0.0	0.0	0.2	0.0	0.2	0.0	2.2	0.0	0.7	0.0	4.4	0.0	0.0	0.0	0.0	1.5	4.5	0.0	0.0	0.0	1.3	16.8	0.0	3.5	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.1	1.9	31.2	0.9	7.7	3.4	2.1	1.5	3.1	9.3	3.0
CHRNB4		ENSG00000117971	"Cholinergic receptor nicotinic beta 4 subunit"	P30926	15	78624119-78727754	"FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"adrenal gland: 6.6;lymphoid tissue: 18.5;retina: 10.6;testis: 10.7"	"Group enriched"	"Detected in some"	16	"SCLC-21H: 20.2;SH-SY5Y: 26.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.0"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"olfactory region: 6.5;pons and medulla: 1.4;thalamus: 4.6"	"Not detected"	"Not detected"			HPA059484			Approved	"Endoplasmic reticulum,Cell Junctions"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA059484: "	"unprognostic (4.74e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.26e-2)"	"unprognostic (8.77e-5)"	"unprognostic (8.15e-2)"	"unprognostic (6.43e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.45e-4)"	"unprognostic (7.00e-3)"	"unprognostic (2.58e-1)"	"unprognostic (8.50e-2)"	"unprognostic (7.76e-2)"	0.2	6.6	2.7	3.9	0.8	0.7	0.2	0.5	0.4	0.6	2.3	0.2	0.0	0.2	0.8	0.7	1.4	0.1	0.1	0.8	1.0	0.3	0.5	0.1	0.1	2.9	0.2	0.0	0.3	0.2	0.0	1.6	0.0	1.3	0.2	1.1	10.6	2.2	2.4	0.6	0.3	1.0	0.9	1.0	1.0	0.8	10.7	0.1	18.5	0.4	0.3	1.1	0.5	0.5	1.5	0.4	1.4	0.8	1.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	20.2	26.2	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.4	0.8	0.3	0.5	0.2	0.6	0.9	0.5	0.6	0.2	1.5	0.8	0.8	1.4	1.0	0.4	0.4	0.3	0.0	2.7	0.8	0.5	0.4	1.0	0.3	0.2	0.0	1.3	0.1
CLRN1	"RP61, USH3, USH3A"	ENSG00000163646	"Clarin 1"	P58418	3	150926163-150972999	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"adrenal gland: 11.2;retina: 16.2"	"Cell line enriched"	"Detected in single"	32	"NTERA-2: 8.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.8"	"Low lineage specificity"	"Detected in single"											HPA054636	Uncertain									"HPA054636: AB_2682551"	"unprognostic (1.00e-3)"				"unprognostic (1.26e-1)"					"unprognostic (5.54e-1)"					"unprognostic (9.68e-2)"			0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.1	0.0	1.6	0.0	2.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.8	0.7	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	8.7	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.1	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRYBA4		ENSG00000196431	"Crystallin beta A4"	P53673	22	26621964-26630672	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 2.2;epididymis: 6.0;retina: 2.0;testis: 4.1"	"Cell line enriched"	"Detected in some"	4	"HEL: 12.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.2"	"Not detected"	"Not detected"							HPA071178	Supported									"HPA071178: AB_2686354"	"unprognostic (6.69e-2)"	"unprognostic (3.94e-3)"	"unprognostic (5.61e-5)"	"unprognostic (1.74e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.71e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.85e-1)"	"unprognostic (9.05e-6)"	"unprognostic (2.86e-1)"	"unprognostic (1.20e-6)"	"unprognostic (1.87e-2)"	"unprognostic (7.23e-2)"	"unprognostic (7.71e-2)"	"unprognostic (3.70e-1)"	0.1	0.0	0.5	0.3	0.5	0.4	0.1	0.1	0.5	0.2	0.5	0.1	0.1	0.8	0.1	6.0	0.1	0.0	0.1	0.1	0.2	0.4	0.1	0.3	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	2.0	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.8	0.1	4.1	0.1	0.1	0.1	0.1	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.5	0.1	0.5	0.2	0.4	0.3	0.1	0.1	0.1
FRMPD2	"MGC35285, PDZD5C, PDZK5C"	ENSG00000170324	"FERM and PDZ domain containing 2"	Q68DX3	10	48153088-48274870	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 14.2;epididymis: 7.9;fallopian tube: 11.1;heart muscle: 6.3;retina: 11.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 6.6;HBEC3-KT: 2.8;Hep G2: 1.5;SCLC-21H: 2.8;SK-BR-3: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 7.6"												"unprognostic (1.53e-1)"	"unprognostic (3.08e-1)"		"unprognostic (7.88e-4)"	"unprognostic (7.59e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.54e-3)"		"unprognostic (1.85e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.25e-12)"	"unprognostic (3.48e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.43e-5)"	0.4	0.4	5.6	0.4	12.0	0.4	2.1	7.3	4.1	1.4	0.6	12.7	0.0	0.4	0.9	7.9	0.4	11.1	0.4	6.3	6.4	4.0	1.1	0.4	1.5	0.4	3.1	1.3	0.8	0.7	0.4	0.5	0.7	14.2	1.8	1.0	11.4	0.5	0.6	0.4	0.4	0.5	0.4	2.4	0.4	0.4	1.5	6.5	0.0	2.3	0.0	0.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	2.8	0.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	12.0	7.3	1.7	6.4	4.0	3.1	1.3	14.2	6.5
GNAT2	ACHM4	ENSG00000134183	"G protein subunit alpha transducin 2"	P19087	1	109603267-109619929	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"retina: 27.6"	"Cell line enhanced"	"Detected in some"		"HAP1: 5.4;U-698: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"eosinophil: 3.0"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"																															0.1	0.4	0.1	0.1	0.3	0.0	0.4	0.2	0.3	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.4	0.6	0.2	0.2	0.2	0.1	2.5	0.5	0.3	0.1	0.1	0.1	0.4	0.4	0.8	1.2	0.3	0.2	0.5	27.6	0.4	0.3	0.1	0.1	0.6	0.2	0.1	0.4	0.1	6.4	0.1	0.1	0.2	0.1	0.4	0.3	0.1	0.2	0.3	3.0	0.4	0.0	0.3	0.0	0.8	0.2	0.3	0.9	0.4	0.3	0.0	0.5	0.3	0.5	0.1	2.2	0.8	2.4	2.1	0.1	0.2	5.4	0.1	0.9	0.0	0.1	0.1	0.5	0.9	0.0	2.2	0.3	1.1	0.7	1.3	1.0	1.4	1.3	1.5	0.8	1.7	0.7	0.2	1.0	0.5	0.7	0.0	1.1	0.6	0.6	1.7	0.0	1.8	0.5	2.9	0.4	0.0	0.0	0.4	0.6	1.0	0.5	2.6	1.6	3.8	0.7	0.4	0.5	0.0	0.0	3.0	0.0	0.4	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.3	0.0	0.0	0.1	0.3	0.2	0.3	0.2	0.2	0.1	0.1	0.3	0.1
GPR143	OA1	ENSG00000101850	"G protein-coupled receptor 143"	P51810	X	9725346-9786297	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"retina: 51.5"	"Cell line enriched"	"Detected in some"	7	"SK-MEL-30: 57.3"	"Cancer enriched"	"Detected in all"	9	"melanoma: 84.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"basophil: 5.0"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 5.0"	"Not detected"	"Not detected"							HPA003648	Enhanced									"HPA003648: AB_2667028"	"unprognostic (4.60e-2)"	"prognostic favourable (8.73e-4)"	"unprognostic (7.43e-3)"	"unprognostic (5.41e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.64e-3)"	"unprognostic (3.78e-1)"	"unprognostic (5.89e-2)"	"unprognostic (8.18e-2)"	"unprognostic (8.40e-2)"	"prognostic favourable (2.45e-5)"	"unprognostic (2.75e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.59e-2)"	0.8	1.3	4.2	0.0	7.6	0.0	2.1	1.5	4.5	2.0	1.6	3.0	3.6	0.6	3.9	7.0	2.8	3.7	1.1	0.4	3.4	3.7	6.6	2.0	1.2	0.4	5.7	3.1	4.5	2.1	3.0	2.0	7.9	6.3	3.4	1.8	51.5	4.1	6.3	0.2	11.5	0.5	1.2	4.3	0.2	0.9	1.0	2.2	1.0	4.2	1.0	1.8	1.8	1.1	0.5	0.1	5.0	0.3	0.1	0.3	0.0	0.6	0.1	1.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.1	0.2	0.9	0.0	1.3	0.0	0.6	0.0	0.0	2.5	0.0	0.0	0.0	4.3	0.0	0.0	4.1	0.0	0.0	0.0	0.0	8.3	1.1	0.3	0.0	0.1	0.0	57.3	0.7	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.0	0.3	0.2	0.3	0.1	0.1	0.4	0.1	0.1	0.1	0.5	0.1	0.2	0.8	0.1	0.1	0.0	0.0	0.0	4.2	7.6	1.5	4.5	3.4	3.7	5.7	3.1	6.3	2.2
GUCA1C	GCAP3	ENSG00000138472	"Guanylate cyclase activator 1C"	O95843	3	108907792-108953895	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"heart muscle: 10.2;pancreas: 31.0;retina: 15.7"	"Cell line enriched"	"Detected in single"	84	"RPTEC TERT1: 17.6"	"Cancer enriched"	"Detected in single"	7	"pancreatic cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA041597	Uncertain		Approved	"Focal adhesion sites"				"Focal adhesion sites"	"Focal adhesion sites"	"HPA041597: AB_10795501"						"unprognostic (7.56e-2)"					"unprognostic (6.56e-2)"							0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.7	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.7	31.0	0.0	0.2	0.0	0.5	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.7	0.0	0.0	0.0	0.0	0.0	2.8	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.7	0.0	0.7	0.0	0.5	0.0
GUCY2D	"CORD6, CYGD, GUC1A4, GUC2D, LCA, LCA1, retGC, RETGC-1, ROS-GC1"	ENSG00000132518	"Guanylate cyclase 2D, retinal"	Q02846	17	8002594-8020339	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 10.6;retina: 33.3"	"Cell line enriched"	"Detected in single"	7	"HMC-1: 5.3"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	31	"plasmacytoid DC: 10.6"	"Lineage enriched"	"Detected in single"	53	"dendritic cells: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (3.57e-4)"	"unprognostic (5.05e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.75e-5)"	"unprognostic (5.94e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.26e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.44e-1)"	"unprognostic (7.59e-5)"	"unprognostic (1.05e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.07e-1)"	0.1	0.0	0.1	0.3	0.1	0.5	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.5	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	1.3	0.3	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.4	0.0	33.3	0.4	0.1	0.1	0.4	0.1	0.1	0.1	0.6	0.1	5.0	0.1	0.2	0.1	0.1	0.9	0.1	0.2	0.0	10.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	5.3	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.2	0.3	0.1	0.1	0.1
IMPG2	"IPM200, RP56"	ENSG00000081148	"Interphotoreceptor matrix proteoglycan 2"	Q9BZV3	3	101222546-101320560	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"retina: 72.1"	"Low cell line specificity"	"Detected in some"			"Cancer enriched"	"Detected in single"	12	"ovarian cancer: 2.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA008779, HPA015907"	Enhanced									"HPA008779: AB_2668138, HPA015907: AB_2669323"	"unprognostic (2.00e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.28e-1)"	"unprognostic (4.80e-5)"	"unprognostic (6.66e-4)"	"unprognostic (1.85e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.59e-2)"	"unprognostic (7.51e-3)"	"unprognostic (1.28e-1)"	"unprognostic (4.50e-9)"	"unprognostic (7.12e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.81e-2)"	"unprognostic (6.08e-2)"	0.2	0.3	0.2	0.4	0.4	0.2	0.2	0.2	0.2	0.2	0.3	0.3	0.1	0.1	0.3	0.3	0.1	16.5	0.2	0.3	0.3	0.6	0.3	0.1	0.1	0.4	0.5	0.1	0.4	0.2	0.1	0.4	0.1	0.4	0.2	0.2	72.1	0.2	0.1	0.2	0.2	0.4	0.3	0.2	0.6	0.5	0.2	0.1	0.1	0.2	0.1	0.2	0.2	0.1	0.6	0.1	1.0	0.1	1.1	0.3	0.0	0.1	0.0	1.1	1.3	0.4	1.0	0.1	0.1	0.2	0.3	0.5	0.0	0.1	0.1	1.0	0.1	0.0	0.3	0.1	1.1	0.3	0.3	0.5	0.4	0.1	0.1	0.3	1.9	1.3	0.7	0.2	0.0	1.7	0.0	1.2	0.9	0.1	0.2	0.2	0.0	0.3	0.2	0.0	0.1	0.7	0.3	1.6	0.2	0.0	0.0	0.1	0.2	0.4	1.4	1.2	0.6	0.4	0.7	0.6	1.0	0.2	0.0	0.0	1.2	0.6	0.1	0.3	0.3	0.1	0.1	0.2	0.2	0.1	0.0	0.6	0.2	0.3	1.0	1.1	0.1	0.1	0.1	0.0	0.2	0.4	0.2	0.2	0.3	0.6	0.5	0.1	0.4	0.1
NEUROG1	"AKA, bHLHa6, Math4C, NEUROD3, ngn1"	ENSG00000181965	"Neurogenin 1"	Q92886	5	135534282-135535949	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"brain: 2.1;retina: 7.7;testis: 2.3"	"Group enriched"	"Detected in some"	9	"AF22: 1.2;SCLC-21H: 1.1;THP-1: 2.4"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 1.1"	"Region enhanced"	"Detected in single"		"midbrain: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																												"unprognostic (3.04e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.3	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	2.1	0.0	0.4	0.0
OPN1SW	"BCP, BOP, CBT"	ENSG00000128617	"Opsin 1, short wave sensitive"	P03999	7	128772491-128775790	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 11.4;retina: 23.9"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 36.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA013562, HPA014083"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytokinetic bridge,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA013562: AB_2668850, HPA014083: AB_2668938"	"unprognostic (2.88e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavourable (8.50e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.79e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavourable (2.26e-8)"	"prognostic unfavourable (5.98e-8)"	"unprognostic (2.53e-1)"	"unprognostic (8.99e-2)"	"prognostic unfavourable (9.33e-4)"	0.9	1.8	0.7	3.7	0.9	1.7	0.7	1.0	2.3	0.7	2.2	0.7	0.7	0.5	2.6	0.7	2.4	0.8	4.2	11.4	0.7	0.8	0.7	0.7	0.9	1.0	0.7	1.3	0.7	0.7	0.0	0.7	0.7	0.7	1.4	0.0	23.9	1.1	0.7	1.9	0.9	0.9	0.7	0.7	1.1	1.4	1.1	0.7	0.7	2.3	0.7	0.7	4.3	0.7	0.5	1.2	0.6	1.4	0.0	1.4	0.3	1.6	2.2	5.1	1.7	0.0	0.0	1.5	9.6	0.0	0.0	0.0	5.0	2.0	2.5	1.4	0.0	1.4	0.0	0.0	0.0	0.3	3.6	1.5	3.0	2.5	0.0	1.9	1.5	0.0	0.0	0.0	0.0	0.0	2.2	0.6	1.0	0.7	2.0	3.5	4.6	2.9	1.0	5.3	2.9	0.0	0.6	0.7	6.8	2.3	5.2	4.3	0.5	1.9	4.0	9.8	1.0	7.6	8.6	2.0	2.1	1.5	36.9	4.5	9.1	0.0	0.3	0.6	1.4	1.4	0.9	0.2	0.8	1.0	1.2	0.5	0.3	0.9	0.0	0.0	1.0	0.7	0.4	0.3	0.7	0.9	1.0	0.9	0.7	0.8	0.7	1.3	0.7	0.7
PDE6C	"ACHM5, COD4, PDEA2"	ENSG00000095464	"Phosphodiesterase 6C"	P51160	10	93612588-93666010	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"retina: 12.8"	"Cell line enhanced"	"Detected in some"		"Hep G2: 2.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"cerebellum: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (1.39e-3)"	"unprognostic (7.41e-3)"	"unprognostic (2.61e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.17e-2)"	"unprognostic (5.23e-3)"	"unprognostic (2.46e-3)"	"unprognostic (2.81e-3)"	"unprognostic (9.68e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.96e-3)"	"unprognostic (2.19e-7)"	"unprognostic (1.19e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.80e-3)"	0.4	0.6	0.3	0.4	0.4	1.3	0.4	3.0	0.7	0.8	0.3	0.3	0.3	0.4	0.5	0.3	0.3	0.5	0.3	0.3	0.3	0.2	0.3	0.5	0.5	1.0	0.3	0.3	1.0	0.3	0.0	0.8	0.3	0.3	0.7	0.0	12.8	0.8	0.3	3.1	3.1	0.7	0.3	0.3	0.9	0.6	0.7	0.3	0.3	0.6	0.3	0.3	0.4	0.7	0.2	0.1	0.2	0.2	0.3	0.6	0.0	0.2	0.7	0.4	1.4	0.0	0.1	1.0	0.8	0.0	0.0	0.0	0.7	1.0	0.6	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.6	0.5	1.4	2.4	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.2	1.0	1.5	0.8	0.4	0.6	0.0	0.1	0.0	0.2	1.2	0.1	0.2	0.0	0.1	0.5	0.3	0.2	0.0	0.4	0.0	0.2	0.7	0.6	0.6	0.5	0.4	0.2	0.0	0.2	0.0	0.5	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.6	0.5	0.2	0.3	0.2	0.1	0.0	0.0	0.3	0.4	3.0	0.3	0.3	0.2	0.3	0.3	0.3	0.3
PLCD4		ENSG00000115556	"Phospholipase C delta 4"	Q9BRC7	2	218607765-218637184	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"retina: 23.0;skeletal muscle: 62.5;smooth muscle: 33.1"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 21.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009914, HPA038139, HPA038140"	Enhanced		Approved	"Nuclear membrane,Plasma membrane,Cytosol"				Cytosol	Cytosol	"CAB009914: AB_2252306, HPA038139: AB_2675855, HPA038140: AB_2675856"	"unprognostic (2.11e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.65e-5)"	"unprognostic (7.77e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.06e-3)"	"unprognostic (2.86e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.87e-3)"	"unprognostic (7.54e-5)"	"unprognostic (3.28e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.32e-2)"	"unprognostic (8.46e-3)"	"unprognostic (3.09e-1)"	1.1	2.5	1.5	1.0	1.6	0.5	1.0	0.9	2.4	0.6	6.4	0.3	3.8	0.9	0.8	1.1	3.7	0.6	0.9	0.9	1.0	1.5	3.9	0.5	0.7	0.7	1.6	1.0	0.7	0.4	1.4	4.7	0.6	2.6	6.4	1.5	23.0	1.4	0.6	62.5	0.8	1.4	33.1	1.1	0.5	3.5	3.9	0.5	0.0	1.4	6.8	0.5	9.6	5.3	0.9	1.2	0.3	0.4	0.9	0.9	1.0	0.6	1.5	2.1	0.4	0.2	1.4	1.2	1.2	2.6	0.4	1.4	2.4	0.3	1.4	1.8	0.4	1.0	0.0	1.5	0.3	0.5	1.8	1.2	3.5	1.9	0.2	1.2	0.6	3.0	0.1	1.9	0.5	2.7	1.0	1.1	2.2	1.8	0.4	1.2	0.7	3.4	0.9	0.8	0.5	4.3	3.0	2.3	21.1	1.0	0.8	0.3	2.5	0.5	6.0	1.5	1.2	0.7	0.7	0.5	0.8	0.9	4.6	0.3	1.6	0.0	0.4	0.0	0.5	0.0	0.1	0.0	0.3	0.9	0.3	0.9	0.7	0.8	0.3	0.9	0.0	1.2	0.7	1.0	1.5	1.6	0.9	2.4	1.0	1.5	1.6	1.0	2.6	0.5
PRCD	RP36	ENSG00000214140	"Photoreceptor disc component"	Q00LT1	17	76527586-76553578	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"retina: 61.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 3.4;ASC TERT1: 3.2;BEWO: 3.6;Hep G2: 4.9;HHSteC: 3.2;HSkMC: 4.1;SH-SY5Y: 3.2"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in some"	12	"cerebellum: 14.8"	"Group enriched"	"Detected in some"	6	"memory B-cell: 1.0;naive B-cell: 1.8;NK-cell: 1.6"	"Group enriched"	"Detected in many"	7	"B-cells: 1.8;NK-cells: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Intracellular and membrane"						"unprognostic (2.37e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.83e-3)"	"unprognostic (3.74e-1)"	"unprognostic (1.31e-4)"	"unprognostic (6.56e-2)"	"unprognostic (4.07e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.19e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.94e-3)"	"unprognostic (1.39e-2)"	1.6	2.2	0.7	0.7	0.7	0.0	1.5	14.8	1.1	1.2	0.7	0.7	0.7	0.7	1.5	3.5	0.7	1.1	1.5	2.0	0.7	0.5	0.7	0.7	1.1	1.4	0.7	0.7	1.3	0.8	4.1	0.7	1.4	1.2	1.1	0.0	61.1	2.3	1.2	1.2	1.5	0.7	0.7	1.0	2.3	0.4	0.7	0.7	0.7	1.0	1.0	0.7	1.7	1.9	1.8	0.0	0.2	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	3.4	3.2	3.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.3	0.0	4.9	3.2	0.0	0.0	4.1	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.2	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	1.8	0.0	0.1	0.2	1.6	0.0	0.0	0.0	0.0	0.7	0.7	14.8	1.1	0.7	0.5	0.7	0.7	1.2	0.7
PRX	KIAA1620	ENSG00000105227	Periaxin	Q9BXM0	19	40393768-40413366	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 42.1;lung: 31.7;retina: 20.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"midbrain: 42.1"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	21	"midbrain: 24.7"	HPA001868	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"				"Golgi apparatus, Vesicles, Plasma membrane"	"Golgi apparatus, Vesicles, Plasma membrane"	"HPA001868: AB_2172440"	"unprognostic (1.29e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.54e-2)"	"unprognostic (5.82e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.03e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.97e-2)"	3.4	4.4	4.8	1.0	4.1	1.1	2.7	2.2	5.4	3.0	2.3	1.8	2.8	1.2	3.8	2.0	2.2	3.2	2.4	2.9	4.0	2.2	4.3	0.6	31.7	1.3	42.1	3.7	7.5	5.4	7.3	1.1	6.0	10.3	3.2	0.8	20.6	3.9	4.4	5.4	2.2	1.5	3.3	11.0	1.7	2.4	1.6	3.6	0.0	7.2	6.7	0.9	3.1	2.0	0.3	0.4	0.0	0.3	0.1	1.2	0.2	2.4	2.7	3.3	4.2	2.7	7.0	4.1	2.0	2.3	2.9	2.1	2.3	2.7	0.8	2.6	1.9	1.3	1.1	0.9	1.0	1.2	1.4	0.5	0.9	0.7	3.2	0.2	3.6	4.9	4.9	1.9	1.6	1.5	3.0	0.8	1.5	3.2	1.1	0.8	0.7	2.5	4.8	2.7	2.4	0.5	1.3	0.3	1.5	3.9	3.3	3.0	4.9	1.2	2.2	5.9	4.6	2.3	1.2	8.4	7.3	1.1	1.8	1.3	1.3	0.0	0.3	0.0	0.6	0.2	0.2	0.0	0.4	0.6	0.0	0.3	0.3	1.2	0.0	0.1	0.0	0.4	0.3	0.2	4.8	4.1	2.2	5.4	4.0	2.2	42.1	3.7	10.3	3.6
RXRG	NR2B3	ENSG00000143171	"Retinoid X receptor gamma"	P48443	1	165400917-165445355	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 14.9;pituitary gland: 29.8;retina: 13.5;skeletal muscle: 44.8"	"Cell line enriched"	"Detected in some"	7	"SK-MEL-30: 28.3"	"Group enriched"	"Detected in many"	13	"melanoma: 25.7;thyroid cancer: 34.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"basal ganglia: 89.8"	"Low region specificity"	"Detected in all"			"CAB002615, HPA012933"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"CAB002615: , HPA012933: AB_2732406"	"unprognostic (2.29e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.29e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.95e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.18e-1)"	"prognostic favourable (9.40e-5)"	"unprognostic (5.03e-2)"	1.9	3.9	5.4	1.0	14.9	0.6	1.0	0.3	5.9	4.0	2.5	5.3	0.6	1.3	1.8	1.3	1.7	3.6	1.2	5.8	7.5	8.9	0.7	0.8	3.4	0.8	4.1	4.3	1.7	2.7	0.8	29.8	1.3	14.1	1.1	2.7	13.5	1.9	2.1	44.8	2.9	2.0	1.8	8.9	1.0	1.1	1.5	5.4	0.0	1.1	2.5	0.6	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	14.9	0.3	5.9	7.5	8.9	4.1	4.3	14.1	5.4
SERINC4	FLJ40363	ENSG00000184716	"Serine incorporator 4"	A6NH21	15	43794162-43800221	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"retina: 24.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.2;RT4: 1.4;SCLC-21H: 3.1;U-138 MG: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																															0.0	0.0	0.5	0.0	0.6	0.2	0.1	0.6	0.4	0.0	0.4	0.3	0.0	0.7	0.7	0.0	0.2	0.2	0.0	0.1	0.3	0.3	0.4	0.0	0.4	0.2	0.8	0.0	0.3	0.0	0.0	0.1	0.2	1.8	0.3	0.3	24.5	0.1	0.1	0.2	0.0	0.3	0.0	0.8	0.0	0.1	5.8	0.0	0.0	0.2	0.0	0.2	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.1	0.0	0.0	1.4	3.1	0.0	0.0	0.8	0.0	0.7	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.6	0.3	0.3	0.3	0.8	0.0	1.8	0.0
SLC35G1	"C10orf60, FLJ33990, TMEM20"	ENSG00000176273	"Solute carrier family 35 member G1"	Q2M3R5	10	93893973-93956062	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 73.5;retina: 24.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 2.6;T-cells: 3.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"														"unprognostic (1.94e-2)"	"unprognostic (1.90e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.90e-4)"	"unprognostic (8.89e-2)"	"unprognostic (9.01e-3)"	"unprognostic (1.15e-2)"	"unprognostic (9.47e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.29e-3)"	"unprognostic (3.28e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.30e-1)"	1.4	1.7	0.7	2.7	1.9	0.5	1.1	1.2	1.4	1.0	29.0	0.8	0.7	52.2	1.9	0.9	2.2	1.1	1.1	2.4	0.8	0.6	0.8	5.1	1.1	1.5	0.6	1.0	1.9	11.6	1.0	3.7	0.9	4.5	1.1	4.7	24.6	2.1	0.9	1.3	2.2	73.5	1.9	0.7	1.4	3.3	4.4	0.4	1.5	2.1	1.6	1.0	1.4	1.5	0.6	0.3	2.6	0.4	0.0	3.8	1.0	7.8	7.6	3.5	4.4	1.1	3.2	5.2	7.2	8.3	6.2	8.3	5.9	5.8	5.0	3.0	4.4	13.7	7.8	2.5	10.3	6.5	9.1	4.1	4.7	4.6	1.9	7.8	8.1	3.2	2.6	5.3	3.1	2.7	3.8	3.1	4.2	2.6	3.9	1.4	4.8	9.6	0.0	6.0	2.0	3.1	7.0	4.5	4.2	9.5	4.5	5.6	5.0	2.2	3.7	5.3	9.0	9.1	7.0	3.5	3.4	1.8	3.4	0.0	3.7	0.0	0.4	2.6	0.4	0.4	1.6	0.4	3.0	1.8	0.3	0.6	3.2	2.0	0.2	0.0	0.0	0.3	3.8	1.0	0.7	1.9	1.2	1.4	0.8	0.6	0.6	1.0	4.5	0.4
SLCO1C1	"OATP-F, OATP1, OATP1C1, SLC21A14"	ENSG00000139155	"Solute carrier organic anion transporter family member 1C1"	Q9NYB5	12	20695355-20753386	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"brain: 32.4;retina: 15.3"	"Cell line enriched"	"Detected in single"	13	"HeLa: 9.3"	"Cancer enriched"	"Detected in single"	17	"glioma: 4.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"														"unprognostic (1.15e-1)"	"unprognostic (8.18e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.64e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.32e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.37e-4)"	"unprognostic (1.56e-3)"	"unprognostic (1.51e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.76e-2)"	3.5	1.2	11.6	1.0	16.2	0.9	1.2	1.1	32.4	0.9	1.4	6.2	0.0	1.1	0.9	1.3	1.2	0.9	2.1	1.5	10.4	2.8	1.1	0.9	1.2	1.2	6.5	8.0	0.9	1.0	1.5	5.5	1.0	20.3	1.0	1.3	15.3	1.1	1.0	0.9	1.2	1.6	1.2	4.9	0.9	1.0	3.3	8.1	0.0	1.7	0.2	1.4	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	16.2	1.1	11.5	10.4	2.8	6.5	8.0	20.3	8.1
TECTB		ENSG00000119913	"Tectorin beta"	Q96PL2	10	112283400-112305035	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"retina: 15.8"	"Group enriched"	"Detected in some"	7	"Hep G2: 7.2;U-2197: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted in other tissues"								"unprognostic (3.14e-2)"		"unprognostic (2.84e-2)"		"unprognostic (9.75e-3)"				"unprognostic (1.65e-1)"	"unprognostic (1.32e-2)"		"unprognostic (5.54e-2)"	"unprognostic (2.80e-2)"	"unprognostic (8.10e-2)"		0.1	0.0	0.8	0.1	1.3	0.0	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.1	0.1	3.5	0.1	0.0	0.1	0.1	0.4	0.2	0.1	2.4	0.1	0.1	0.9	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.0	15.8	0.1	0.1	0.1	0.0	0.3	0.1	0.5	0.1	0.0	0.2	0.1	0.1	1.4	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.1	0.3	0.4	0.2	0.9	0.1	0.1	0.1
UBE2QL1	FLJ25076	ENSG00000215218	"Ubiquitin conjugating enzyme E2 Q family like 1"	A1L167	5	6448623-6494909	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"brain: 28.1;heart muscle: 11.3;retina: 8.2;seminal vesicle: 8.6;skeletal muscle: 21.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 17.8;PC-3: 14.9;SCLC-21H: 13.9;U-266/70: 33.3;U-266/84: 29.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057414			Supported	"Nucleoplasm,Plasma membrane"				Nucleoplasm	Nucleoplasm	"HPA057414: "	"unprognostic (1.45e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.08e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.10e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.15e-3)"	"unprognostic (8.41e-2)"	"prognostic favourable (6.81e-8)"	"unprognostic (3.18e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.41e-2)"	0.6	2.3	8.6	0.8	4.2	0.3	0.9	20.7	28.1	1.0	1.8	1.0	0.5	0.7	1.4	1.8	1.0	0.5	0.8	11.3	12.6	8.2	2.6	1.1	0.4	0.7	5.2	4.6	3.6	0.8	0.3	1.3	0.3	8.7	3.1	0.8	8.2	1.0	8.6	21.3	2.4	1.0	1.3	1.4	0.4	2.2	0.9	0.0	0.0	1.9	2.0	0.5	0.5	0.9	0.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.8	0.0	3.0	0.0	0.0	0.2	14.9	0.1	0.0	6.6	0.0	0.0	13.9	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	33.3	29.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	4.2	20.7	19.4	12.6	8.2	5.2	4.6	8.7	0.0
UNC119	"HRG4, POC7, POC7A"	ENSG00000109103	"Unc-119 lipid binding chaperone"	Q13432	17	28546707-28552668	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"retina: 197.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA041912	Enhanced									"HPA041912: AB_10795267"	"unprognostic (8.93e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.14e-3)"	"unprognostic (4.95e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.64e-2)"	"prognostic unfavourable (2.38e-4)"	"unprognostic (2.76e-3)"	"prognostic favourable (8.09e-5)"	"unprognostic (2.65e-1)"	"unprognostic (8.08e-3)"	"unprognostic (5.51e-3)"	"unprognostic (1.87e-1)"	"prognostic unfavourable (9.82e-4)"	"unprognostic (1.71e-3)"	10.0	12.3	15.0	15.1	16.1	34.8	10.3	16.3	21.6	10.1	8.2	6.8	9.1	8.1	9.3	12.9	11.5	9.5	10.2	9.8	15.4	19.8	14.3	20.7	9.0	18.1	13.3	10.1	10.6	13.5	10.5	12.5	8.3	13.3	12.1	7.6	197.8	17.3	15.0	4.4	15.3	10.2	9.5	6.5	23.7	7.7	22.9	6.4	11.4	12.1	5.7	19.7	11.4	10.3	9.1	22.4	32.3	47.9	4.3	4.9	7.4	12.0	15.2	15.3	21.3	16.2	15.9	7.5	10.0	13.7	18.2	17.2	21.2	4.1	9.9	10.9	15.3	20.1	12.9	14.9	9.8	18.4	24.1	6.9	7.4	6.4	11.1	10.1	21.6	14.5	20.5	13.1	6.5	14.6	7.0	8.2	11.1	19.0	10.0	10.2	14.9	11.1	16.0	25.1	4.3	13.8	13.5	6.0	21.1	14.4	23.5	14.9	18.5	17.6	11.0	10.5	20.1	16.9	9.7	9.5	9.7	2.1	17.3	16.4	9.6	5.2	11.5	28.2	2.2	27.9	2.3	6.8	4.3	3.5	20.0	9.1	4.9	3.4	32.3	4.3	47.9	22.4	3.7	7.4	15.0	16.1	16.3	21.6	15.4	19.8	13.3	10.1	13.3	6.4
VSX1	"PPCD, PPCD1, PPD"	ENSG00000100987	"Visual system homeobox 1"	Q9NZR4	20	25070885-25082365	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"brain: 17.0;retina: 20.7"	"Cell line enriched"	"Detected in some"	6	"Karpas-707: 9.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"cerebellum: 17.0"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (1.93e-1)"	"unprognostic (6.63e-2)"		"unprognostic (9.68e-3)"	"unprognostic (4.33e-2)"		"unprognostic (2.27e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.01e-1)"	"unprognostic (8.64e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.31e-9)"	"unprognostic (1.53e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.07e-4)"	"unprognostic (2.38e-1)"	0.4	3.0	2.3	0.4	1.6	1.6	0.4	17.0	2.8	0.4	0.4	0.4	0.4	0.1	1.0	0.4	0.4	0.4	0.4	0.5	1.9	2.1	0.4	0.4	0.4	0.4	2.1	0.4	4.6	1.2	1.1	2.7	0.4	0.5	0.5	0.1	20.7	0.4	1.0	1.0	0.6	0.5	0.4	1.5	0.4	0.3	0.7	0.4	0.4	0.7	0.4	0.4	0.4	0.4	1.0	1.5	2.4	0.3	1.3	0.6	0.1	0.1	1.5	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.1	0.4	0.3	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	9.8	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.2	0.5	0.1	0.0	0.3	0.0	0.8	0.3	0.1	0.3	0.0	0.1	0.0	0.3	0.0	0.3	0.9	0.1	0.1	2.4	0.3	0.3	0.6	0.3	0.5	0.7	0.4	0.3	0.0	1.0	0.4	0.5	2.1	1.3	0.2	1.5	0.1	0.1	2.3	1.6	17.0	1.4	1.9	2.1	2.1	0.4	0.5	0.4
ABCB5	"ABCB5alpha, ABCB5beta, EST422562"	ENSG00000004846	"ATP binding cassette subfamily B member 5"	Q2M3G0	7	20615207-20777038	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"epididymis: 33.4;retina: 43.3"	"Cell line enriched"	"Detected in some"	6	"SK-MEL-30: 31.8"	"Cancer enriched"	"Detected in some"	9	"melanoma: 5.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"olfactory region: 1.3"												"unprognostic (3.82e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.23e-2)"	"unprognostic (5.26e-3)"	"unprognostic (3.56e-3)"	"unprognostic (9.30e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.70e-2)"	10.6	0.1	0.0	0.4	0.0	0.3	8.6	0.0	0.1	4.4	3.8	0.0	5.3	0.1	1.8	33.4	0.3	0.4	2.8	0.9	0.0	0.0	0.3	0.1	0.2	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.4	0.1	2.9	0.6	43.3	0.3	0.4	1.0	2.1	0.9	1.5	0.3	0.1	0.7	2.6	0.0	0.0	0.1	0.2	0.1	1.8	1.6	0.7	0.5	2.3	0.5	0.5	0.3	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	4.3	5.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	31.8	0.0	0.1	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.5	0.4	0.2	0.2	0.1	0.4	0.3	0.2	0.1	0.7	0.2	0.3	0.8	0.5	0.2	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
ABHD12B	"BEM46L3, C14orf29"	ENSG00000131969	"Abhydrolase domain containing 12B"	Q7Z5M8	14	50872160-50904970	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 10.0;retina: 10.0;skin 1: 21.6"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.4;Hep G2: 1.5;NB-4: 2.5;NTERA-2: 1.7;RH-30: 2.1;SH-SY5Y: 1.4;T-47d: 1.4;THP-1: 2.0"	"Cancer enriched"	"Detected in many"	5	"testis cancer: 7.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"eosinophil: 2.3;neutrophil: 5.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 5.4"	"Region enriched"	"Detected in single"	5	"thalamus: 2.3"	"Low region specificity"	"Detected in many"			HPA002873	Uncertain		Uncertain	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA002873: AB_2220573"	"unprognostic (6.61e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.99e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.31e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.70e-3)"	"unprognostic (3.16e-2)"	"unprognostic (9.62e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.68e-1)"	1.1	0.2	2.4	0.4	10.0	2.4	2.8	0.3	5.2	0.2	1.5	5.4	0.3	0.2	0.8	0.4	0.7	2.0	0.4	0.5	1.4	1.2	0.6	0.2	0.8	0.4	2.2	2.7	0.3	1.1	1.3	0.3	0.4	2.2	0.3	2.4	10.0	0.2	0.2	0.2	21.6	0.3	0.2	0.7	0.2	0.2	1.2	3.9	0.0	0.4	0.0	0.3	0.2	0.2	0.0	0.1	5.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.5	0.5	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	1.7	0.0	0.0	2.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.9	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.4	0.0	0.1	0.0	0.0	0.0	2.4	10.0	0.3	5.2	1.4	1.2	2.2	2.7	2.2	3.9
AC008878.1		ENSG00000267952			19	7507052-7519622	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"retina: 19.5;skeletal muscle: 21.3"	"Cell line enhanced"	"Detected in many"		"AF22: 10.9;ASC diff: 12.3;fHDF/TERT166: 13.1;HBF TERT88: 6.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"NK-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"NK-cells: 1.2"																													"unprognostic (4.56e-1)"							"unprognostic (8.56e-2)"	2.1	2.0	3.1	1.2	6.3	1.6	3.5	4.9	6.8	0.4	1.9	0.9	1.2	0.4	2.6	0.4	2.5	2.2	2.0	1.5	2.2	1.8	5.4	1.5	1.9	0.6	3.9	1.0	1.7	0.4	0.4	0.6	0.9	3.3	0.8	1.7	19.5	0.7	0.6	21.3	0.9	1.7	0.7	7.1	2.4	1.2	1.0	2.5	0.0	2.0	0.0	0.4	0.9	2.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	10.9	1.2	12.3	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	1.1	2.5	6.9	0.2	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.3	4.4	0.0	0.0	2.9	0.6	0.2	0.0	0.2	0.0	2.6	3.9	1.8	4.0	0.0	0.0	3.3	1.2	1.1	0.0	0.6	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.1	6.3	4.9	5.2	2.2	1.8	3.9	1.0	3.3	2.5
ADAMTSL1	"ADAMTSR1, C9orf94, FLJ35283"	ENSG00000178031	"ADAMTS like 1"	Q8N6G6	9	17906563-18910950	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 50.7;retina: 39.3"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 34.6;HSkMC: 17.6;hTEC/SVTERT24-B: 18.1;LHCN-M2: 17.8;TIME: 57.0;U-138 MG: 27.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA057437, HPA074973"	Uncertain		Approved	Vesicles	"Secreted in other tissues"	74000000	74000000	Vesicles	Vesicles	"HPA057437: AB_2683440, HPA074973: "	"unprognostic (4.64e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.95e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.52e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.01e-4)"	"unprognostic (3.66e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.41e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.50e-2)"	6.3	7.6	0.5	5.9	0.8	0.0	4.4	3.9	1.5	14.3	5.2	0.6	6.5	1.6	50.7	12.0	9.0	5.2	4.4	2.9	1.6	1.0	3.4	1.0	1.9	2.2	0.4	1.2	4.9	1.3	0.1	3.9	0.8	0.9	8.4	4.6	39.3	3.1	5.6	0.5	2.0	2.7	13.3	0.7	0.9	5.0	2.3	0.0	0.0	2.0	1.7	1.5	2.8	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.3	0.0	5.0	34.6	0.0	1.0	4.4	4.1	9.3	0.0	0.0	0.0	0.0	12.1	0.0	1.8	0.2	12.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	17.6	0.0	18.1	0.0	7.6	0.0	0.0	17.8	0.0	0.0	0.0	1.6	0.1	0.0	2.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.0	27.8	0.7	0.7	4.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	3.9	1.5	1.6	1.0	0.4	1.2	0.9	0.0
ADTRP	"AIG1L, C6orf105, dJ413H6.1"	ENSG00000111863	"Androgen dependent TFPI regulating protein"	Q96IZ2	6	11712054-11807046	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 48.3;intestine: 61.2;retina: 38.0;seminal vesicle: 48.0"	"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 10.3;HUVEC TERT2: 35.2;RPMI-8226: 13.3;TIME: 19.0;U-138 MG: 12.7;U-266/84: 14.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"pons and medulla: 12.4"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 10.5;T-reg: 9.8"	"Lineage enriched"	"Detected in many"	7	"T-cells: 10.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048113	Uncertain		Uncertain	Nucleoli				Nucleoli	Nucleoli	"HPA048113: AB_2680268"	"unprognostic (6.82e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.14e-3)"	"unprognostic (3.04e-3)"	"unprognostic (1.41e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.90e-1)"	"prognostic unfavourable (1.13e-5)"	"unprognostic (2.61e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.26e-1)"	0.8	0.4	0.6	10.6	0.8	0.0	0.9	0.3	2.1	0.4	21.8	1.5	48.3	22.4	0.4	4.0	0.9	0.5	0.3	0.5	1.2	0.4	3.8	1.0	3.9	2.0	0.4	1.1	0.4	0.6	0.8	0.3	0.3	12.4	1.7	16.2	38.0	0.7	48.0	0.4	12.7	61.2	0.5	0.4	1.0	11.4	14.1	0.1	0.8	0.7	0.6	3.2	2.7	0.5	0.2	0.2	1.4	0.3	0.1	10.5	1.5	1.6	0.0	0.0	0.0	0.2	0.3	0.0	0.5	0.3	0.4	0.3	1.5	0.8	0.0	0.7	0.3	0.7	0.0	4.7	0.6	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.1	0.0	8.7	3.5	10.3	35.2	8.5	0.0	1.2	0.0	0.0	0.2	0.1	2.4	0.0	0.1	13.3	0.7	0.1	0.0	0.1	0.6	0.0	0.3	0.0	0.3	19.0	12.7	0.9	0.3	1.0	0.5	14.9	0.0	2.6	0.5	0.1	1.4	0.1	0.0	0.0	0.3	2.3	0.2	2.8	0.2	0.1	0.1	10.5	0.8	0.2	0.1	0.2	0.2	9.8	1.5	0.6	0.8	0.3	2.1	1.2	0.4	0.4	1.1	12.4	0.1
AL121758.1		ENSG00000270299			20	646626-675800	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"brain: 19.1;retina: 6.0"	"Cell line enhanced"	"Detected in many"		"HEL: 6.5;Hep G2: 14.8;Karpas-707: 8.7;SK-BR-3: 9.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"cerebral cortex: 19.1"	"Group enriched"	"Detected in some"	6	"naive CD8 T-cell: 1.0;neutrophil: 2.0;non-classical monocyte: 2.1"	"Group enriched"	"Detected in many"	14	"granulocytes: 2.0;monocytes: 2.1;T-cells: 1.0"																				"unprognostic (2.38e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.37e-2)"	"unprognostic (7.42e-3)"	"unprognostic (4.14e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.87e-3)"	"unprognostic (5.93e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.42e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.03e-2)"	0.3	2.4	0.9	0.0	0.8	0.3	0.3	3.6	19.1	0.3	0.3	0.8	0.0	0.0	2.9	0.0	2.3	0.3	0.9	4.7	1.0	0.9	0.3	0.4	0.4	0.3	0.7	0.0	0.3	0.4	0.0	0.5	0.4	3.3	0.4	0.0	6.0	2.2	0.0	0.7	0.7	0.4	0.0	0.8	0.5	0.6	2.6	0.2	0.0	0.3	0.0	0.0	0.3	0.3	0.0	0.1	2.0	2.1	0.0	1.0	0.0	0.3	4.4	0.0	1.9	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.6	0.4	0.7	0.3	0.0	0.0	0.0	0.8	0.0	0.5	0.1	6.5	0.9	14.8	0.0	1.2	3.4	0.0	0.0	0.7	0.0	0.0	0.4	8.7	0.0	0.0	0.0	0.0	3.2	0.2	0.0	2.1	2.8	0.0	0.5	1.0	2.5	1.5	9.1	1.6	1.1	2.7	5.3	0.9	1.2	0.0	1.5	0.5	4.2	0.3	0.4	0.1	4.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	2.0	0.0	2.1	0.0	0.0	0.0	0.9	0.8	3.6	19.1	1.0	0.9	0.7	0.0	3.3	0.2
ALKAL2	"AUGA, FAM150B"	ENSG00000189292	"ALK and LTK ligand 2"	Q6UX46	2	279558-288851	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 70.8;retina: 81.0"	"Cell line enriched"	"Detected in some"	21	"AF22: 55.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"						"unprognostic (1.39e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.03e-3)"	"unprognostic (2.88e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.35e-1)"	"unprognostic (9.29e-3)"	"unprognostic (5.19e-2)"	"unprognostic (3.68e-1)"	5.7	70.8	1.6	1.2	4.9	0.1	6.7	0.4	1.2	4.5	2.7	2.2	3.3	1.2	8.2	8.6	2.2	6.8	7.4	1.4	1.3	1.1	36.8	1.8	8.6	6.9	0.4	1.0	24.7	30.3	1.3	3.0	3.9	2.4	1.8	2.3	81.0	2.0	2.9	1.1	4.9	2.6	3.7	3.0	2.9	3.4	22.2	0.6	0.9	2.5	1.4	1.4	2.9	1.8	1.3	0.9	0.0	0.6	1.0	1.9	0.5	0.0	0.0	55.5	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.4	0.6	1.1	1.3	0.9	0.8	0.1	0.5	1.9	0.9	0.0	1.0	0.0	0.9	1.5	0.5	1.6	4.9	0.4	1.2	1.3	1.1	0.4	1.0	2.4	0.6
ALX1	CART1	ENSG00000180318	"ALX homeobox 1"	Q15699	12	85280107-85301784	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 13.9"	"Cell line enhanced"	"Detected in some"		"HAP1: 6.8;HEK 293: 15.2;HUVEC TERT2: 11.1;SK-MEL-30: 18.3;THP-1: 12.0;WM-115: 9.7"	"Cancer enriched"	"Detected in some"	10	"melanoma: 16.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001598, HPA018905"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus"				"Nuclear bodies"	"Nuclear bodies"	"HPA001598: AB_1078400, HPA018905: AB_1844783"	"unprognostic (4.92e-3)"	"unprognostic (8.09e-2)"		"unprognostic (1.09e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.24e-2)"		"unprognostic (2.05e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.55e-5)"		"unprognostic (8.97e-2)"		"unprognostic (1.43e-1)"	1.9	0.0	0.1	0.0	0.2	0.0	4.8	0.0	0.2	5.4	0.1	0.0	0.8	0.0	5.4	8.5	0.1	4.7	0.0	0.1	0.2	0.2	8.3	0.0	0.1	0.0	0.2	0.0	3.6	0.1	0.0	1.6	0.1	0.0	1.6	0.0	13.9	3.8	2.0	0.4	3.3	0.1	1.1	0.0	0.0	0.1	1.5	0.0	0.0	0.2	4.0	0.0	2.4	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.5	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	6.8	0.3	0.0	0.0	15.2	0.0	2.6	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	5.6	0.0	0.0	0.0	1.8	3.9	0.0	0.0	18.3	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.2	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0
ALX3	FND	ENSG00000156150	"ALX homeobox 3"	O95076	1	110059994-110070700	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"retina: 19.3"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	7	"olfactory region: 14.8"	"Low region specificity"	"Detected in single"			HPA074290			Approved	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA074290: "	"unprognostic (4.28e-1)"				"unprognostic (4.41e-2)"			"unprognostic (2.91e-1)"		"unprognostic (2.48e-2)"					"unprognostic (1.31e-1)"			0.5	1.8	1.2	1.0	2.7	0.8	2.6	0.9	4.1	0.7	0.4	1.2	0.3	1.6	2.7	0.9	2.6	2.6	1.7	0.7	1.3	1.5	0.8	0.4	1.0	2.3	0.5	1.9	3.1	1.0	0.2	5.3	0.7	0.5	0.8	0.0	19.3	2.0	0.3	2.8	8.0	2.7	0.3	0.4	2.4	0.8	1.8	0.6	0.3	2.1	1.8	0.3	1.4	2.4	0.4	0.0	1.4	0.1	0.0	2.0	0.2	3.3	1.7	4.2	6.2	0.0	0.0	7.9	8.3	11.0	0.0	0.0	3.3	1.5	1.8	3.4	0.1	5.0	0.0	0.0	0.0	4.4	6.1	1.0	3.8	2.0	0.0	1.9	0.8	0.0	0.0	0.0	0.0	0.0	2.8	0.5	0.0	3.8	1.3	1.6	4.4	4.7	3.0	5.3	1.5	0.0	4.4	5.2	7.3	3.8	5.9	5.6	2.7	3.2	3.3	5.0	4.3	6.3	2.1	3.2	1.2	1.9	5.3	4.7	3.4	0.8	0.1	1.4	0.1	0.0	0.3	0.2	1.1	0.4	0.0	0.4	0.1	2.0	0.0	0.0	0.1	0.0	0.1	0.2	1.2	2.7	0.9	4.1	1.3	1.5	0.5	1.9	0.5	0.6
ALX4	"FPP, KIAA1788, PFM, PFM2"	ENSG00000052850	"ALX homeobox 4"	Q9H161	11	44260444-44310166	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 10.5;retina: 14.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.3;BJ: 4.4;HAP1: 6.2;HEK 293: 6.3;HEL: 8.7;K-562: 4.0;SiHa: 9.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"olfactory region: 11.1"	"Region enriched"	"Detected in single"	35	"olfactory region: 27.7"	HPA001903			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA001903: AB_2666495"	"unprognostic (7.56e-5)"	"unprognostic (1.69e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.74e-1)"	"unprognostic (7.24e-3)"	"unprognostic (2.63e-4)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.33e-4)"	"unprognostic (5.13e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.34e-6)"	"unprognostic (3.62e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.02e-3)"	"unprognostic (2.03e-1)"	1.6	0.1	0.6	0.0	1.6	0.0	10.5	0.7	1.6	2.0	0.1	1.4	0.0	0.0	2.4	2.4	0.5	0.8	0.3	0.9	1.3	0.7	0.3	0.0	0.5	0.0	0.4	2.2	0.2	0.1	0.2	0.3	0.0	0.3	2.0	0.0	14.4	5.6	0.1	3.1	2.8	0.0	1.1	0.2	0.1	0.1	2.5	0.5	0.0	0.4	4.2	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	5.3	0.0	0.0	0.0	4.4	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.2	0.0	0.0	1.3	6.3	8.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.6	0.7	1.6	1.3	0.7	0.4	2.2	0.3	0.5
ARMC9	"ARM, FLJ12584, KIAA1868, KU-MEL-1"	ENSG00000135931	"Armadillo repeat containing 9"	Q7Z3E5	2	231198546-231374837	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 37.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 69.1;SK-MEL-30: 56.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 6.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019041, HPA026671"	Approved									"HPA019041: AB_1845035, HPA026671: AB_1845036"	"unprognostic (2.90e-1)"	"unprognostic (2.86e-1)"	"unprognostic (5.35e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.57e-2)"	"unprognostic (7.20e-4)"	"unprognostic (1.58e-2)"	"unprognostic (4.85e-2)"	"unprognostic (7.17e-3)"	"unprognostic (4.14e-1)"	"unprognostic (9.15e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.30e-2)"	"unprognostic (4.19e-2)"	"unprognostic (5.57e-2)"	"prognostic unfavourable (7.66e-5)"	2.5	15.4	8.4	5.9	12.2	1.6	3.6	5.8	11.8	5.6	13.3	3.6	4.6	2.0	27.3	6.5	6.4	9.5	8.2	2.9	5.1	6.7	5.9	1.6	7.5	1.7	3.8	6.5	11.5	5.9	14.9	17.0	5.9	9.1	6.2	5.7	37.1	3.5	7.6	1.6	2.5	6.8	23.9	2.4	1.5	10.7	11.0	2.5	2.3	8.3	1.1	2.2	8.9	4.0	1.4	0.7	1.7	0.3	6.0	0.8	0.6	5.1	3.0	5.3	3.9	4.2	6.3	2.2	5.8	69.1	7.3	9.7	0.8	2.6	0.6	2.8	18.2	3.1	6.2	6.1	6.4	0.4	3.8	0.4	3.6	2.8	10.6	1.2	1.3	16.6	2.4	9.7	3.7	5.4	1.1	0.1	11.5	7.4	1.5	1.7	11.1	3.2	2.0	4.6	0.0	8.0	1.7	4.0	8.2	2.3	6.4	56.1	2.4	1.3	5.6	4.8	2.8	2.9	2.7	6.7	1.7	0.3	8.7	0.2	4.7	1.6	0.3	0.4	0.4	0.2	0.2	1.4	0.5	0.8	0.6	0.9	0.5	0.8	1.7	6.0	0.2	0.7	0.1	0.6	8.4	12.2	5.8	11.8	5.1	6.7	3.8	6.5	9.1	2.5
ATP6V1C2	"ATP6C2, VMA5"	ENSG00000143882	"ATPase H+ transporting V1 subunit C2"	Q8NEY4	2	10721649-10785110	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 49.3;placenta: 39.0;retina: 54.4;salivary gland: 41.8"	"Group enriched"	"Detected in some"	8	"BEWO: 39.7;SK-BR-3: 14.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA034734, HPA067305"	Approved		Uncertain	Mitochondria				Mitochondria	Mitochondria	"HPA034734: AB_2674305, HPA067305: AB_2732763"	"unprognostic (2.29e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.55e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.03e-3)"	"unprognostic (8.53e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.73e-2)"	"prognostic unfavourable (1.12e-11)"	"unprognostic (6.17e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.27e-2)"	1.4	0.9	0.4	0.4	0.5	1.1	2.4	0.5	0.8	21.2	0.8	0.6	49.3	0.1	2.1	30.5	6.9	0.8	0.8	0.7	0.8	0.3	13.2	2.0	0.8	0.5	0.4	0.4	0.9	1.1	0.1	8.9	39.0	0.5	1.8	0.7	54.4	41.8	15.1	0.4	36.7	0.7	0.4	0.6	1.3	0.6	0.8	0.4	0.9	1.4	6.0	3.5	0.5	7.2	1.1	0.8	0.6	1.7	0.9	2.2	1.1	0.3	0.4	1.2	1.4	0.0	0.0	39.7	0.5	0.0	0.0	0.0	0.7	1.0	1.0	0.8	0.0	0.6	0.6	0.0	0.0	0.5	1.5	0.5	0.6	1.4	0.0	0.9	0.5	0.0	0.1	0.0	0.0	0.0	0.4	1.9	0.0	1.2	0.3	1.5	1.0	0.4	0.8	0.7	3.2	0.0	0.9	1.0	1.3	0.3	14.2	0.4	1.4	2.1	0.2	0.5	1.0	0.5	0.5	3.4	1.0	0.6	0.6	0.8	0.4	0.3	0.8	0.6	2.2	1.7	1.3	1.1	1.0	1.7	0.5	0.9	1.0	0.5	0.0	0.9	0.8	0.8	0.9	1.1	0.4	0.5	0.5	0.8	0.8	0.3	0.4	0.4	0.5	0.4
BIRC7	"KIAP, ML-IAP, mliap, RNF50"	ENSG00000101197	"Baculoviral IAP repeat containing 7"	Q96CA5	20	63235883-63240507	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 14.4;placenta: 13.6;retina: 21.1"	"Cell line enriched"	"Detected in some"	4	"SK-MEL-30: 62.2"	"Cancer enriched"	"Detected in many"	10	"melanoma: 73.7"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	9	"T-cells: 2.0"	"Not detected"	"Not detected"							"HPA047850, HPA061283"			Enhanced	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	Nucleoplasm	"HPA047850: AB_2680181, HPA061283: "	"unprognostic (3.60e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.24e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.82e-3)"	"unprognostic (1.22e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.84e-2)"	1.6	1.3	1.0	0.7	1.0	0.3	0.7	0.1	2.2	3.0	1.3	0.5	0.1	0.4	0.8	14.4	0.3	0.3	0.5	2.8	0.9	1.1	2.6	0.8	2.3	2.2	4.9	1.0	0.2	0.1	0.1	0.6	13.6	1.5	0.4	0.3	21.1	0.8	0.1	0.1	4.9	0.3	0.2	4.3	1.6	0.3	0.4	0.3	0.3	0.3	1.0	0.5	0.4	1.8	0.0	0.0	0.0	0.2	0.0	2.0	0.1	0.1	1.4	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	2.1	0.4	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.0	0.0	0.0	0.2	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	62.2	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	1.0	0.1	2.2	0.9	1.1	4.9	1.0	1.5	0.3
BMP4	BMP2B	ENSG00000125378	"Bone morphogenetic protein 4"	P12644	14	53949736-53958761	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 72.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 26.0;CAPAN-2: 65.2;EFO-21: 21.7;Hep G2: 69.4;U-2 OS: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"classical monocyte: 1.8;intermediate monocyte: 2.9;memory CD4 T-cell: 2.5;naive CD4 T-cell: 3.3;naive CD8 T-cell: 1.1;non-classical monocyte: 4.3"	"Group enriched"	"Detected in many"	12	"monocytes: 4.3;T-cells: 3.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006863, HPA066235"	Enhanced				"Secreted to blood"					"CAB006863: , HPA066235: AB_2685641"	"unprognostic (1.30e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.20e-3)"	"unprognostic (3.39e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.45e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.45e-3)"	"unprognostic (7.06e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.24e-1)"	7.9	7.8	1.2	3.6	2.0	0.0	10.3	8.1	3.1	8.6	11.7	3.6	3.5	7.8	5.9	2.7	6.0	5.4	9.9	8.3	2.1	0.8	6.1	2.8	8.2	3.4	2.4	2.6	12.0	2.1	0.0	4.1	21.4	11.9	18.0	14.5	72.4	6.4	9.4	7.3	9.4	11.0	11.0	3.7	2.7	11.9	2.4	2.6	1.6	7.3	4.5	4.0	13.0	22.5	0.0	0.3	0.0	4.3	0.0	3.3	0.9	3.3	8.7	0.4	0.4	0.1	0.0	0.1	1.7	7.4	4.4	3.4	26.0	65.2	0.0	21.7	0.0	15.9	1.8	0.2	2.4	0.8	1.3	0.0	1.7	69.4	4.4	0.0	0.2	0.0	0.6	2.1	0.1	13.0	0.0	0.0	2.1	1.5	1.1	0.0	3.0	0.7	0.0	2.3	0.0	6.2	0.2	0.0	0.0	0.0	0.2	0.2	8.5	0.3	0.6	0.1	20.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.9	0.0	1.8	0.0	0.3	2.9	0.0	0.0	2.5	0.5	0.3	0.0	3.3	1.1	0.0	0.0	4.3	0.1	0.0	0.9	1.2	2.0	8.1	3.1	2.1	0.8	2.4	2.6	11.9	2.6
BMP5		ENSG00000112175	"Bone morphogenetic protein 5"	P22003	6	55753645-55875564	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 42.7;prostate: 29.4;retina: 21.2"	"Group enriched"	"Detected in some"	11	"AF22: 22.1;U-2 OS: 17.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"pons and medulla: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"						"unprognostic (2.84e-4)"		"unprognostic (9.07e-4)"	"unprognostic (3.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.39e-3)"		"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.76e-2)"	"unprognostic (4.43e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.76e-2)"	2.1	0.6	0.2	3.3	0.2	0.1	1.5	0.7	0.7	0.2	4.3	0.0	0.0	5.0	0.1	0.2	1.9	0.2	1.5	3.4	0.3	0.2	1.6	1.9	14.3	0.2	2.0	1.4	0.2	1.2	0.1	5.0	42.7	5.2	29.4	4.7	21.2	1.7	0.0	7.0	0.2	10.2	5.5	3.6	0.1	1.9	0.2	0.0	0.0	1.5	5.0	0.1	11.8	1.3	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.7	0.7	0.3	0.2	2.0	1.4	5.2	0.0
BMP7	OP-1	ENSG00000101144	"Bone morphogenetic protein 7"	P18075	20	57168748-57266629	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 37.0;thyroid gland: 44.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 41.5;MCF7: 48.0;RPMI-8226: 18.4;SK-BR-3: 31.3;U-698: 56.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"basophil: 2.4"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA057757			Approved	Nucleoplasm,Nucleoli,Vesicles	"Secreted to blood"			Vesicles	Vesicles	"HPA057757: AB_2683518"	"unprognostic (1.67e-1)"	"unprognostic (9.72e-3)"	"unprognostic (9.67e-2)"	"prognostic unfavourable (2.91e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.78e-2)"	"unprognostic (4.63e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.82e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.59e-1)"	1.5	7.2	16.8	2.4	17.5	0.7	2.1	3.8	19.7	9.2	2.3	23.6	6.0	2.7	1.9	17.7	17.2	10.0	1.2	8.5	13.9	9.9	4.5	0.7	1.8	1.6	14.3	11.2	0.8	1.0	0.8	1.9	24.4	12.2	5.0	2.4	37.0	2.6	10.3	1.0	15.5	2.4	1.0	13.8	1.3	4.1	1.4	13.4	1.8	44.3	5.7	4.9	7.8	7.0	0.1	0.1	2.4	0.0	0.0	0.1	0.0	0.0	0.1	5.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	1.6	41.5	10.6	0.0	12.0	1.2	0.0	0.0	0.1	4.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	48.0	0.0	0.0	3.0	0.0	0.0	0.0	18.4	0.0	0.0	0.1	4.5	1.3	31.3	0.1	0.2	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	56.7	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	16.8	17.5	3.8	12.5	13.9	9.9	14.3	11.2	12.2	13.4
C1QTNF5	"CTRP5, DKFZp586B0621, LORD"	ENSG00000223953	"C1q and TNF related 5"	Q9BXJ0	11	119338939-119340940	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 30.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 9.4;fHDF/TERT166: 7.4;HHSteC: 19.0;HUVEC TERT2: 28.0;TIME: 25.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"CAB025607, HPA038604"	Uncertain				"Secreted to blood"	1600000	1600000			"CAB025607: , HPA038604: AB_2676110"																		13.6	3.2	3.7	4.3	4.0	0.0	6.4	3.1	7.1	6.4	6.1	7.9	1.5	5.5	7.1	8.3	3.7	3.8	19.0	10.2	3.9	3.6	7.3	3.2	8.9	3.6	8.1	2.3	6.2	3.1	1.2	4.2	5.0	9.6	4.3	2.7	30.5	3.2	3.2	4.2	3.1	5.8	10.9	5.4	5.7	4.3	3.1	5.2	0.0	4.1	4.6	1.1	8.1	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	9.4	2.6	0.1	2.3	0.1	0.3	1.4	0.0	0.0	0.0	1.0	7.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	19.0	0.0	0.0	4.5	0.0	0.1	0.0	28.0	0.0	0.0	1.4	0.0	0.0	0.0	0.4	0.0	0.0	2.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.5	0.0	0.0	25.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.7	4.0	3.1	3.2	3.9	3.6	8.1	2.3	9.6	5.2
C5orf67		ENSG00000225940	"Chromosome 5 open reading frame 67"	F2Z3F1	5	56511567-56606232	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 17.9;kidney: 9.3;retina: 16.3"	"Group enriched"	"Detected in some"	7	"CACO-2: 3.1;EFO-21: 9.1;U-266/70: 10.2"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.9"	"Region enriched"	"Detected in some"	5	"pons and medulla: 6.1"	"Cell type enhanced"	"Detected in some"		"neutrophil: 3.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;granulocytes: 3.3;monocytes: 1.9"																				"unprognostic (7.28e-2)"	"unprognostic (1.41e-1)"		"unprognostic (2.55e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.12e-3)"	"unprognostic (6.58e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.69e-2)"		"unprognostic (1.35e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.62e-2)"		0.4	0.0	0.2	0.2	1.2	0.4	1.0	0.2	0.2	0.4	0.8	0.4	0.2	1.5	0.6	17.9	0.4	0.4	0.2	0.2	0.6	0.2	9.3	0.2	0.4	0.6	0.7	0.2	0.2	0.2	0.0	0.2	0.2	6.1	0.2	0.0	16.3	1.1	0.2	0.2	0.8	1.6	0.2	0.2	1.5	0.1	0.2	0.2	0.2	2.1	0.2	0.2	0.2	0.2	0.1	1.5	3.3	1.9	0.0	0.4	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.3	0.0	9.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.1	0.0	0.0	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.5	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.6	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.0	3.3	0.0	1.9	1.5	0.4	0.1	0.2	1.2	0.2	0.2	0.6	0.2	0.7	0.2	6.1	0.2
CA14		ENSG00000118298	"Carbonic anhydrase 14"	Q9ULX7	1	150257159-150265078	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.9;retina: 29.4;seminal vesicle: 16.5;skeletal muscle: 24.1"	"Group enriched"	"Detected in some"	18	"AF22: 28.0;AN3-CA: 16.6;NTERA-2: 21.8;SK-MEL-30: 55.8"	"Group enriched"	"Detected in many"	7	"glioma: 4.9;melanoma: 23.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008482	Approved		Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA008482: AB_1078395"	"unprognostic (3.06e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.25e-2)"	"prognostic favourable (8.47e-4)"	"unprognostic (7.28e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.89e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.80e-2)"	0.1	0.3	4.6	0.2	5.2	0.9	0.3	1.4	6.8	0.1	1.7	10.8	0.1	0.3	0.1	0.5	1.6	1.3	0.7	4.4	6.4	4.1	0.3	6.3	0.2	0.2	11.3	3.2	1.4	0.3	0.8	0.1	0.3	4.4	3.2	0.7	29.4	0.6	16.5	24.1	3.7	0.6	0.5	20.9	0.3	0.8	0.5	2.7	0.1	0.9	0.1	0.1	0.2	0.1	2.8	2.2	2.1	2.0	0.2	1.6	0.2	0.2	0.0	28.0	16.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	21.8	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.1	55.8	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	1.2	0.1	0.1	0.1	0.0	0.0	0.9	1.3	1.6	2.0	0.6	2.0	1.0	1.2	0.2	2.8	1.2	1.3	2.1	0.2	0.5	2.2	0.0	0.2	4.6	5.2	1.4	4.7	6.4	4.1	11.3	3.2	4.4	2.7
CCL26	"eotaxin-3, IMAC, MIP-4a, MIP-4alpha, SCYA26, TSC-1"	ENSG00000006606	"C-C motif chemokine ligand 26"	Q9Y258	7	75769533-75789896	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"ovary: 16.6;retina: 50.2"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 10.4;PC-3: 29.6;U-2 OS: 8.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 14.0"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	27	"intermediate monocyte: 2.7"	"Lineage enriched"	"Detected in single"	27	"monocytes: 2.7"					"Not detected"	"Not detected"								"Secreted to blood"						"unprognostic (1.14e-1)"	"unprognostic (4.17e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.18e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.02e-1)"	"unprognostic (8.71e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.05e-11)"	"unprognostic (2.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.73e-1)"	"unprognostic (6.29e-3)"	1.7	2.9	0.4	0.5	0.6	0.0	1.4	0.4	0.9	2.8	0.8	0.9	1.0	0.4	0.8	2.3	1.1	1.9	1.3	3.3	0.6	0.0	1.5	0.4	1.2	4.1	1.2	0.4	16.6	0.4	5.9	13.6	0.4	3.3	1.3	8.7	50.2	1.0	0.4	0.4	1.4	0.7	1.6	0.8	0.4	0.6	1.5	0.6	0.8	0.8	0.8	0.9	1.0	3.2	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	6.7	0.0	0.0	0.7	0.9	0.0	0.3	3.1	2.7	5.7	0.3	1.9	0.0	4.6	2.6	1.2	0.1	0.0	3.8	0.0	0.6	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.3	10.4	0.1	0.0	5.1	0.0	2.0	0.7	0.0	0.0	6.4	29.6	0.0	0.6	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.2	5.0	8.4	2.7	1.7	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.4	0.9	0.6	0.0	1.2	0.4	3.3	0.6
CDH23	"CDHR23, DFNB12, USH1D"	ENSG00000107736	"Cadherin related 23"	Q9H251	10	71396934-71815947	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 28.9"	"Group enriched"	"Detected in some"	4	"RT4: 16.1;SCLC-21H: 6.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 14.4;non-classical monocyte: 19.9"	"Lineage enhanced"	"Detected in many"		"monocytes: 19.9"									HPA017232	Approved					14000	14000			"HPA017232: AB_1845903"	"unprognostic (6.76e-2)"	"unprognostic (2.86e-3)"	"unprognostic (3.82e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.07e-1)"	"unprognostic (5.52e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.88e-1)"	"unprognostic (6.44e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.05e-1)"	"unprognostic (9.23e-3)"	"unprognostic (2.14e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.70e-2)"	"prognostic favourable (3.40e-4)"	11.9	3.6	4.9	2.7	6.1	2.6	4.2	12.8	4.7	3.7	1.7	6.5	1.6	1.6	8.4	4.7	2.1	5.7	3.1	3.0	3.4	4.1	0.7	10.3	6.1	2.2	5.6	2.6	25.1	12.1	22.6	0.9	0.9	27.4	5.9	1.8	28.9	1.6	1.3	3.4	2.1	2.0	3.1	3.5	5.1	1.5	6.8	6.2	5.0	1.5	2.0	2.0	4.8	4.0	0.0	5.7	3.2	19.9	0.0	0.4	1.4	0.0	0.9	1.0	1.6	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.4	0.1	0.2	0.1	0.0	0.6	1.7	0.0	0.0	0.1	1.7	1.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	1.9	0.0	1.4	0.0	0.1	0.0	16.1	6.7	1.4	0.9	0.2	0.2	0.2	2.7	0.0	0.0	1.4	0.0	0.0	0.8	0.1	0.2	1.9	1.2	0.0	0.0	3.3	2.9	0.1	14.4	0.3	0.0	0.1	0.0	2.7	0.0	0.1	0.4	3.2	0.0	19.9	5.7	0.0	1.4	4.9	6.1	12.8	4.7	3.4	4.1	5.6	2.6	27.4	6.2
CDH3	"CDHP, PCAD"	ENSG00000062038	"Cadherin 3"	P22223	16	68636189-68722616	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 44.0;retina: 40.5"	"Cell line enhanced"	"Detected in some"		"A-431: 24.4;HaCaT: 67.7;HBEC3-KT: 32.6;hTCEpi: 26.1;hTERT-HME1: 19.9;RPTEC TERT1: 29.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	10	"pons and medulla: 16.0"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"HPA001767, CAB002487"	Enhanced		Supported	"Plasma membrane,Cell Junctions"				"Plasma membrane"	"Plasma membrane"	"CAB002487: AB_563446, HPA001767: AB_1078376"	"unprognostic (1.55e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.38e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.85e-2)"	"prognostic unfavourable (8.53e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.45e-2)"	"prognostic unfavourable (8.43e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.41e-5)"	"unprognostic (2.11e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.33e-3)"	"unprognostic (8.56e-2)"	2.2	0.1	1.0	2.5	1.2	0.0	8.7	1.5	1.1	10.5	1.0	2.2	3.0	0.3	9.4	10.3	23.5	8.9	1.4	0.4	1.1	0.8	8.3	0.2	3.6	2.1	0.6	0.4	32.6	0.4	0.5	3.6	6.4	16.0	11.7	0.5	40.5	9.3	4.4	0.1	21.2	0.4	4.1	1.5	10.0	0.7	2.2	0.1	44.0	2.0	26.1	20.1	2.5	6.7	0.9	0.6	1.4	0.5	0.6	0.8	0.2	24.4	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	14.6	9.1	0.0	0.1	0.0	67.7	0.6	32.6	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	26.1	0.0	19.9	0.0	0.0	0.0	0.0	12.7	0.0	0.0	1.2	2.0	0.0	0.0	0.0	29.3	11.0	0.1	0.0	0.2	0.0	11.5	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.5	0.2	0.4	0.2	0.3	0.6	0.5	0.4	0.1	0.9	0.6	0.8	1.4	0.6	0.2	0.6	0.2	0.2	1.0	1.2	1.5	1.1	1.1	0.8	0.6	0.4	16.0	0.1
CFAP161	"C15orf26, FLJ38615"	ENSG00000156206	"Cilia and flagella associated protein 161"	Q6P656	15	81007033-81149175	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.0;fallopian tube: 22.4;retina: 14.9;testis: 18.2"	"Group enriched"	"Detected in some"	5	"HEL: 41.4;K-562: 13.9"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.4"	"Region enhanced"	"Detected in many"		"pons and medulla: 18.0"	"Cell type enhanced"	"Detected in single"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA076975	Supported									"HPA076975: "	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.07e-2)"	"prognostic favourable (3.05e-4)"	"unprognostic (1.57e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.29e-3)"	"unprognostic (8.93e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.24e-2)"	"unprognostic (6.22e-2)"	0.8	0.4	2.3	0.4	5.2	0.9	0.6	0.4	1.1	1.5	0.4	6.8	0.2	0.2	1.1	5.4	0.4	22.4	0.5	1.1	3.3	3.3	0.5	0.5	4.0	0.3	0.6	1.1	4.2	2.7	0.2	9.9	2.1	18.0	0.4	0.3	14.9	0.5	0.5	0.5	0.9	0.4	0.6	0.8	0.9	0.5	18.2	1.5	0.0	1.0	0.0	0.6	0.5	0.2	0.0	0.3	2.3	0.4	0.0	0.7	7.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	41.4	0.0	0.1	0.0	0.0	5.6	0.0	0.0	0.1	0.5	0.8	13.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.7	0.0	0.0	0.5	0.4	0.0	0.2	0.4	0.0	0.0	0.2	0.7	0.3	0.0	0.0	0.1	2.3	0.0	0.1	0.1	0.0	7.3	2.3	5.2	0.4	1.1	3.3	3.3	0.6	1.1	18.0	1.5
CHRM3		ENSG00000133019	"Cholinergic receptor muscarinic 3"	P20309	1	239386565-239915452	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 39.8"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 9.9;SH-SY5Y: 31.8;U-266/70: 13.2;U-266/84: 9.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 8.7"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.3"	"Group enriched"	"Detected in many"	18	"monocytes: 1.2;T-cells: 2.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA024106, HPA048036"	Approved		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA024106: AB_1854211, HPA048036: AB_2680238"	"unprognostic (1.63e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.11e-3)"	"unprognostic (3.48e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.30e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.29e-2)"	"unprognostic (6.44e-2)"	"unprognostic (5.34e-4)"	"unprognostic (3.04e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.88e-2)"	0.8	0.0	2.1	1.4	1.8	0.0	0.8	0.8	8.7	0.8	5.9	0.8	0.8	0.8	1.4	0.8	6.6	0.3	0.8	0.8	2.5	1.8	0.8	0.8	1.5	0.8	0.8	1.1	4.3	8.7	0.2	0.8	0.8	0.8	3.8	2.2	39.8	13.7	2.5	0.8	0.7	1.2	3.3	0.8	1.0	4.8	1.7	0.8	1.3	1.3	0.8	1.6	7.1	0.8	0.0	0.0	0.0	1.2	0.0	2.3	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.5	0.3	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	3.4	0.3	2.3	1.6	0.0	2.2	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	5.5	0.5	0.8	0.0	0.0	2.8	5.0	0.0	0.7	9.9	0.4	0.5	0.0	31.8	0.0	0.1	0.1	1.1	0.0	0.0	1.3	0.5	0.1	0.3	13.2	9.4	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	1.2	0.7	0.0	0.5	0.4	0.0	0.0	2.3	0.7	0.0	0.0	0.7	0.0	0.5	0.2	2.1	1.8	0.8	8.7	2.5	1.8	0.8	1.1	0.8	0.8
CHRNA6		ENSG00000147434	"Cholinergic receptor nicotinic alpha 6 subunit"	Q15825	8	42752620-42796392	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 8.3;retina: 5.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.8;HDLM-2: 4.9;HMC-1: 2.4;RPMI-8226: 1.9;U-698: 6.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"T-reg: 3.4"	"Lineage enriched"	"Detected in single"	8	"T-cells: 3.4"	"Group enriched"	"Detected in some"	7	"midbrain: 24.1;thalamus: 7.0"	"Region enriched"	"Detected in all"	6	"midbrain: 93.1"												"unprognostic (1.91e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.25e-2)"	"unprognostic (5.23e-2)"	"unprognostic (7.60e-4)"	"unprognostic (4.99e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.73e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.27e-3)"	"unprognostic (3.66e-2)"	0.1	2.2	0.6	0.6	0.6	0.0	0.9	8.3	3.8	1.2	0.1	1.7	1.4	0.0	0.9	0.0	0.1	1.7	0.2	0.1	0.8	1.6	1.1	0.1	0.4	0.7	4.3	1.7	0.6	0.3	0.0	0.5	0.2	3.6	0.1	0.1	5.1	1.3	1.5	0.1	0.1	0.2	0.0	0.8	0.2	0.1	1.3	0.0	2.0	0.8	0.0	2.8	0.2	0.1	0.4	0.1	0.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	1.3	0.0	0.0	0.3	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.2	0.1	2.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.5	0.0	1.0	0.0	0.1	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.6	0.6	8.3	3.8	0.8	1.6	4.3	1.7	3.6	0.0
CLUL1		ENSG00000079101	"Clusterin like 1"	Q15846	18	596988-650334	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 45.2"	"Cell line enhanced"	"Detected in many"		"Hep G2: 24.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			"CAB025264, HPA075240"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted in other tissues"			"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB025264: , HPA075240: AB_2732286"	"unprognostic (1.75e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.81e-3)"	"unprognostic (3.00e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.97e-3)"	"unprognostic (8.38e-3)"	"unprognostic (3.76e-2)"	"unprognostic (4.85e-3)"	"unprognostic (4.96e-3)"	"unprognostic (6.36e-4)"	"unprognostic (1.32e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.37e-2)"	0.5	1.4	5.0	0.5	3.8	4.3	3.1	4.5	6.6	2.1	1.0	1.4	1.0	0.6	1.9	0.7	1.6	2.4	2.5	0.4	5.9	6.4	7.5	0.7	1.8	0.8	4.9	2.0	7.4	1.6	2.5	6.1	0.7	5.1	12.0	0.0	45.2	3.1	1.6	0.1	0.8	1.7	0.4	5.3	0.1	3.9	3.4	2.8	0.3	9.4	0.1	0.4	2.1	0.3	1.0	1.3	2.1	0.3	0.1	2.0	0.5	2.5	3.9	7.4	5.0	0.0	0.0	4.4	2.8	0.2	0.0	0.0	3.0	1.5	3.1	0.7	0.0	1.1	0.0	0.4	0.0	2.5	6.8	5.2	2.1	24.3	0.0	1.7	1.0	0.2	0.0	0.0	0.0	0.3	7.2	9.0	0.0	0.8	3.0	5.5	0.5	1.7	6.2	3.5	10.8	0.8	0.7	6.5	4.5	2.9	1.8	2.2	2.4	0.7	0.6	3.0	4.3	2.1	1.4	5.1	8.9	6.4	2.4	3.3	2.5	0.9	0.3	0.2	0.2	0.0	0.1	1.0	0.4	0.2	0.5	0.1	0.1	0.8	2.1	0.1	0.0	1.3	2.0	0.5	5.0	3.8	4.5	5.7	5.9	6.4	4.9	2.0	5.1	2.8
COL10A1		ENSG00000123500	"Collagen type X alpha 1 chain"	Q03692	6	116118923-116158747	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 12.2;retina: 32.7"	"Cell line enriched"	"Detected in some"	6	"hTEC/SVTERT24-B: 29.4"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 51.9"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.7"	"Region enhanced"	"Detected in single"		"amygdala: 1.0"	"Low region specificity"	"Detected in all"			HPA053268			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	21000	21000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA053268: "	"unprognostic (3.83e-2)"	"unprognostic (6.81e-2)"	"unprognostic (7.20e-2)"	"unprognostic (7.45e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.37e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.38e-11)"	"unprognostic (2.16e-3)"	"unprognostic (7.22e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.06e-3)"	0.9	0.1	0.4	0.8	0.7	0.1	0.3	0.3	1.4	1.4	0.3	0.9	0.3	0.0	0.6	0.3	0.5	0.0	12.2	0.3	0.6	0.2	0.8	0.7	3.5	0.4	0.3	0.6	5.4	4.2	0.5	0.9	0.3	3.2	2.6	0.0	32.7	6.5	0.9	0.3	0.7	0.3	0.5	0.3	2.9	0.2	0.5	0.3	0.8	1.4	0.3	2.0	0.3	0.3	0.6	0.3	2.7	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	2.1	0.3	4.5	0.0	0.0	0.1	0.0	0.7	0.5	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	29.4	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.2	0.0	0.0	4.8	0.1	0.3	0.3	0.0	0.0	0.1	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.3	2.7	0.0	0.0	0.0	0.0	0.3	0.4	0.7	0.3	1.4	0.6	0.2	0.3	0.6	3.2	0.3
COL25A1		ENSG00000188517	"Collagen type XXV alpha 1 chain"	Q9BXS0	4	108808725-109302752	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 17.4;retina: 22.1;testis: 23.6"	"Cell line enriched"	"Detected in some"	8	"HeLa: 30.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA029107			Approved	"Endoplasmic reticulum,Vesicles,Cytosol"				"Vesicles, Cytosol"	"Vesicles, Cytosol"	"HPA029107: "	"unprognostic (1.77e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.87e-5)"	"unprognostic (2.43e-2)"	"unprognostic (3.20e-1)"	"unprognostic (7.62e-3)"	"unprognostic (6.86e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.30e-3)"	"unprognostic (2.82e-3)"	"unprognostic (9.75e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.96e-1)"	9.0	0.8	6.7	0.2	4.4	0.0	5.1	0.8	3.4	1.6	0.9	0.4	0.9	4.0	2.1	3.5	0.8	1.4	3.1	2.0	4.7	2.1	2.9	3.2	0.9	0.1	0.8	0.0	1.6	0.9	3.9	17.4	0.4	2.5	0.9	0.4	22.1	6.7	1.4	1.4	1.1	3.1	1.5	0.9	1.0	0.9	23.6	1.5	0.0	3.7	0.1	0.0	1.6	3.4	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	3.8	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.4	0.0	1.9	0.0	0.1	0.0	2.3	4.1	30.8	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.0	0.0	0.8	0.2	3.9	0.0	0.5	0.0	1.1	0.1	0.0	2.1	0.0	0.0	0.0	0.8	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	4.4	0.8	3.4	4.7	2.1	0.8	0.0	2.5	1.5
COL8A2	"FECD, FECD1, PPCD, PPCD2"	ENSG00000171812	"Collagen type VIII alpha 2 chain"	P25067	1	36095236-36125220	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 39.4"	"Cell line enhanced"	"Detected in some"		"BJ: 6.6;fHDF/TERT166: 4.9;HHSteC: 16.8;THP-1: 5.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"classical monocyte: 1.0;intermediate monocyte: 1.2;myeloid DC: 2.8;plasmacytoid DC: 2.4"	"Group enriched"	"Detected in many"	15	"dendritic cells: 2.8;monocytes: 1.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA049788	Uncertain		Uncertain	"Golgi apparatus"	"Secreted to extracellular matrix"			"Golgi apparatus"	"Golgi apparatus"	"HPA049788: AB_2680882"	"unprognostic (9.98e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.51e-2)"	"unprognostic (8.41e-3)"	"unprognostic (8.76e-2)"	"prognostic favourable (9.44e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (7.26e-4)"	"unprognostic (3.50e-2)"	"unprognostic (3.01e-1)"	"prognostic unfavourable (9.35e-5)"	"unprognostic (1.08e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.16e-3)"	4.4	1.2	1.7	8.1	3.4	0.3	7.2	6.0	1.3	9.6	4.8	4.5	1.0	1.4	5.2	3.1	6.4	3.4	6.3	11.1	1.7	1.4	1.1	0.4	4.8	2.9	3.8	0.9	4.2	1.8	0.1	3.7	13.7	7.6	5.5	2.1	39.4	6.5	13.4	1.4	4.6	1.8	16.3	4.8	7.5	9.6	1.9	2.5	1.9	7.7	4.7	3.5	10.1	5.5	0.0	2.8	0.1	1.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.6	1.2	0.1	6.6	2.0	1.8	1.0	0.2	0.1	0.0	1.0	4.9	0.3	0.0	0.1	1.4	0.0	0.0	0.0	0.1	0.1	16.8	0.0	0.0	2.0	0.2	0.8	0.1	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.4	0.0	0.5	0.1	0.1	0.0	0.6	0.6	0.6	0.0	0.3	0.0	5.3	0.1	2.7	0.4	0.5	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.1	0.0	0.2	2.4	0.0	0.2	1.7	3.4	6.0	1.3	1.7	1.4	3.8	0.9	7.6	2.5
COL9A1		ENSG00000112280	"Collagen type IX alpha 1 chain"	P20849	6	70215061-70303083	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 29.6;retina: 52.6"	"Group enriched"	"Detected in some"	6	"AF22: 23.2;NTERA-2: 7.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA074749	Enhanced				"Secreted to extracellular matrix"					"HPA074749: AB_2732266"	"unprognostic (2.18e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.48e-3)"	"unprognostic (5.72e-2)"	"unprognostic (5.32e-4)"	"unprognostic (3.24e-3)"	"unprognostic (8.79e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.68e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.62e-2)"	0.7	0.6	8.5	0.7	7.5	0.5	0.6	3.6	4.7	0.6	1.1	7.2	0.0	1.8	1.1	0.8	0.8	0.7	1.1	5.6	8.4	9.4	1.1	0.5	0.6	0.6	10.3	1.7	0.6	0.5	0.9	3.3	0.6	5.6	29.6	1.4	52.6	3.0	1.1	0.6	0.6	2.0	0.9	5.3	0.6	2.6	4.1	6.9	0.0	1.0	0.2	0.7	0.7	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	7.5	3.6	4.7	8.4	9.4	10.3	1.7	5.6	6.9
COL9A2	"EDM2, MED"	ENSG00000049089	"Collagen type IX alpha 2 chain"	Q14055	1	40300487-40317813	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.3;pituitary gland: 32.1;retina: 40.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 34.6;HMC-1: 33.4;THP-1: 37.4"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 68.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 6.4;myeloid DC: 2.7"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.7;granulocytes: 6.4"	"Low region specificity"	"Detected in all"							"HPA056316, HPA075286"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"			Vesicles	Vesicles	"HPA056316: AB_2683099, HPA075286: AB_2732288"	"unprognostic (1.42e-2)"	"unprognostic (3.54e-2)"	"unprognostic (8.94e-2)"	"prognostic unfavourable (5.13e-4)"	"unprognostic (4.46e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.06e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.16e-3)"	"unprognostic (4.28e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.71e-2)"	0.7	2.3	17.2	2.6	19.5	7.6	3.1	2.3	12.1	10.0	3.6	32.0	17.4	4.6	3.9	1.5	0.7	3.7	6.5	1.0	20.8	14.5	4.3	0.6	2.8	4.2	29.8	10.5	0.6	1.7	28.3	32.1	0.9	16.3	8.8	2.6	40.8	13.7	21.3	0.3	2.0	3.3	1.3	35.3	3.2	12.8	0.8	19.7	0.2	4.3	0.9	2.5	4.0	0.5	0.7	2.7	6.4	0.7	0.4	0.3	0.1	4.2	0.1	0.6	0.3	0.9	0.5	2.9	0.0	0.0	0.2	0.5	0.1	2.4	1.2	3.7	0.1	0.7	0.0	0.0	0.1	34.6	0.5	0.7	0.3	9.7	0.6	0.3	33.4	1.8	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.9	0.4	0.7	0.8	0.4	0.8	0.0	2.4	0.0	5.1	0.5	0.8	0.0	4.3	0.4	5.4	37.4	0.0	0.0	4.4	0.0	0.1	0.5	0.0	1.1	0.3	4.4	0.2	0.0	0.2	6.4	0.0	0.5	0.0	0.5	0.2	0.0	2.7	0.7	0.1	0.0	1.1	0.4	0.7	0.3	0.3	0.1	17.2	19.5	2.3	10.8	20.8	14.5	29.8	10.5	16.3	19.7
CPA6	CPAH	ENSG00000165078	"Carboxypeptidase A6"	Q8N4T0	8	67422038-67746385	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 16.2;prostate: 10.6;retina: 13.0"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.0;CACO-2: 6.2;EFO-21: 3.5;Hep G2: 9.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	10	"olfactory region: 15.5"	"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"						"unprognostic (2.85e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.23e-2)"	"unprognostic (6.99e-2)"	"unprognostic (3.57e-4)"	"unprognostic (9.61e-5)"	"unprognostic (1.75e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.41e-2)"	0.2	0.1	0.1	9.8	0.1	0.2	0.2	0.1	0.1	9.4	16.2	0.7	0.8	0.2	8.3	1.7	3.7	0.2	0.3	0.1	0.2	0.1	0.3	0.1	0.7	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.3	0.3	10.6	7.2	13.0	0.1	0.7	0.1	0.2	1.3	3.4	0.7	0.3	0.5	1.3	0.0	0.0	0.2	1.5	0.6	4.1	5.5	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.0	6.2	0.0	0.0	3.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.0	0.3	0.0
CPAMD8	"K-CAP, KIAA1283, VIP"	ENSG00000160111	"C3 and PZP like, alpha-2-macroglobulin domain containing 8"	Q8IZJ3	19	16892947-17026815	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 19.3;retina: 23.7;seminal vesicle: 30.5"	"Group enriched"	"Detected in some"	7	"BEWO: 14.4;EFO-21: 9.3;T-47d: 25.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.5"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in single"			"HPA031327, HPA031328, HPA031329, HPA031330"	Uncertain		Uncertain	"Focal adhesion sites"	"Secreted to blood"	180000	180000	"Focal adhesion sites"	"Focal adhesion sites"	"HPA031327: AB_2673829, HPA031328: AB_2673830, HPA031329: , HPA031330: AB_10603788"	"unprognostic (4.71e-3)"	"unprognostic (1.07e-2)"	"unprognostic (4.20e-2)"	"unprognostic (2.76e-2)"	"unprognostic (4.32e-2)"	"unprognostic (4.06e-3)"	"unprognostic (7.85e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.24e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.08e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.80e-2)"	3.1	1.3	1.0	0.4	2.3	0.2	3.6	0.6	2.3	5.3	0.4	2.9	6.5	0.2	1.5	8.2	0.6	0.6	0.4	7.0	1.2	1.3	8.9	0.5	11.5	1.5	4.9	0.4	0.6	0.4	3.5	2.0	3.1	5.1	19.3	0.0	23.7	1.1	30.5	1.7	0.4	0.4	0.4	5.6	1.1	0.1	0.9	2.8	0.9	11.6	1.4	0.4	1.2	1.4	0.2	0.0	0.6	1.5	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	14.4	0.0	0.1	0.0	0.0	0.0	0.0	0.3	9.3	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	2.2	0.5	0.0	1.4	0.0	0.1	0.3	1.9	0.0	0.0	0.0	0.4	0.0	25.2	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.6	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	2.3	0.6	2.3	1.2	1.3	4.9	0.4	5.1	2.8
CPLX3	CPX-III	ENSG00000213578	"Complexin 3"	Q8WVH0	15	74826547-74831802	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 20.8;lymphoid tissue: 31.8;prostate: 56.4;retina: 32.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.5;Karpas-707: 4.8;SK-BR-3: 2.7;U-266/84: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			CAB079003		Supported								"CAB079003: "																		0.4	2.5	6.4	0.5	7.4	0.4	0.4	20.8	19.6	0.5	0.5	3.3	0.0	0.4	0.4	0.5	0.5	0.4	0.4	13.4	6.4	0.8	0.4	0.4	0.4	0.5	0.6	7.9	0.4	0.4	0.4	1.7	0.4	8.2	56.4	0.4	32.8	9.8	0.4	0.4	0.5	0.6	0.4	1.0	31.8	4.6	2.2	1.2	0.0	0.4	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.5	0.0	0.0	0.1	0.2	0.1	0.0	5.5	0.1	0.0	0.2	0.1	0.0	0.0	1.9	0.1	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.2	0.2	0.0	0.0	0.0	4.8	0.0	0.1	0.0	0.9	0.1	0.3	0.2	0.0	0.4	0.0	0.1	2.1	0.1	0.0	2.7	1.1	1.6	0.0	0.0	0.1	0.1	0.5	0.0	1.3	3.1	2.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	7.4	20.8	19.6	6.4	0.8	0.6	7.9	8.2	1.2
CRABP1	"CRABP, CRABP-I, CRABPI, RBP5"	ENSG00000166426	"Cellular retinoic acid binding protein 1"	P29762	15	78340324-78348230	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.1;retina: 73.2;thyroid gland: 80.6"	"Group enriched"	"Detected in some"	8	"AF22: 143.3;NTERA-2: 42.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 117.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"myeloid DC: 1.2"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 1.2"	"Group enriched"	"Detected in many"	5	"amygdala: 6.6;basal ganglia: 20.9;hypothalamus: 15.5;olfactory region: 15.7;pons and medulla: 7.8"	"Low region specificity"	"Detected in some"			HPA017203	Enhanced	Supported								"HPA017203: AB_1846512"	"unprognostic (1.23e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (4.72e-4)"	"unprognostic (2.01e-1)"	"unprognostic (4.35e-2)"		"unprognostic (1.05e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.45e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.79e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.69e-1)"	0.7	1.3	6.3	1.8	25.6	0.6	24.8	2.8	12.4	1.2	1.9	3.3	0.3	0.9	1.5	1.9	0.7	0.5	1.2	0.7	1.1	21.9	4.2	0.5	0.8	0.6	16.9	4.5	0.7	0.7	0.5	6.3	7.0	40.1	1.0	1.3	73.2	0.6	24.8	0.5	12.3	2.3	1.3	7.3	21.1	1.9	0.6	2.4	0.4	80.6	2.4	1.0	0.7	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	143.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.1	0.0	0.9	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	7.6	0.0	42.9	0.1	0.0	0.0	0.0	0.0	0.2	12.0	8.1	0.0	0.0	0.0	0.2	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	25.6	2.8	12.4	1.1	21.9	16.9	4.5	40.1	2.4
CRTAC1	"ASPIC1, CEP-68, FLJ10320"	ENSG00000095713	"Cartilage acidic protein 1"	Q9NQ79	10	97865000-98030828	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 34.0;lung: 42.1;retina: 31.6;seminal vesicle: 31.1"	"Cell line enhanced"	"Detected in some"		"HeLa: 3.5;HUVEC TERT2: 8.7;SCLC-21H: 5.8;SK-MEL-30: 9.6;TIME: 11.7"	"Cancer enhanced"	"Detected in many"		"melanoma: 43.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA008175	Enhanced				"Secreted to extracellular matrix"	360000000	360000000			"HPA008175: AB_1847254"	"unprognostic (2.55e-1)"	"unprognostic (6.41e-3)"	"unprognostic (4.90e-3)"	"prognostic unfavourable (5.01e-6)"	"unprognostic (2.54e-1)"	"unprognostic (6.96e-3)"	"unprognostic (9.30e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.01e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.69e-1)"	"prognostic favourable (1.85e-4)"	"unprognostic (6.70e-4)"	"unprognostic (1.05e-2)"	"unprognostic (3.29e-3)"	"prognostic favourable (1.51e-4)"	4.5	1.4	6.2	1.6	7.2	0.8	2.0	7.2	27.3	3.9	6.0	3.8	4.5	1.2	1.2	4.8	7.9	34.0	1.1	6.2	5.5	7.0	3.1	1.1	42.1	1.1	9.2	5.8	2.2	1.8	1.4	3.2	0.8	27.5	3.3	1.1	31.6	3.4	31.1	1.4	2.9	1.2	3.6	6.8	0.8	1.0	4.0	2.7	0.0	4.4	0.7	1.0	25.5	2.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.3	0.7	0.0	3.5	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.2	0.0	0.2	5.8	1.3	0.7	0.0	9.6	0.1	0.0	11.7	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	7.2	7.2	18.7	5.5	7.0	9.2	5.8	27.5	2.7
DAPL1		ENSG00000163331	"Death associated protein like 1"	A0PJW8	2	158795317-158862781	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 53.5;esophagus: 75.6;retina: 63.9;skin 1: 61.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 3.6;hTCEpi: 21.6;SCLC-21H: 5.5;U-87 MG: 7.9"	"Group enriched"	"Detected in all"	7	"cervical cancer: 16.2;head and neck cancer: 14.5;lung cancer: 19.7;ovarian cancer: 62.5;thyroid cancer: 30.1"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"							"HPA046937, HPA058635"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Microtubules"				"Nucleoplasm, Nuclear bodies, Microtubules"	"Nucleoplasm, Nuclear bodies, Microtubules"	"HPA046937: AB_2679870, HPA058635: AB_2732625"	"unprognostic (3.95e-5)"	"prognostic favourable (8.43e-4)"	"unprognostic (2.05e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.63e-2)"		"unprognostic (8.59e-2)"	"unprognostic (5.24e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.44e-3)"	"unprognostic (4.09e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.30e-3)"	0.3	14.7	1.4	0.4	1.3	0.0	7.4	0.4	1.0	11.7	1.0	0.8	1.6	0.0	2.1	53.5	75.6	21.1	0.6	0.2	1.5	3.6	1.3	0.2	0.8	0.4	2.8	0.3	3.8	5.7	0.0	5.6	0.2	1.5	2.3	0.0	63.9	6.8	0.4	0.2	61.3	0.5	1.1	0.4	0.2	0.2	2.1	0.8	0.8	21.5	37.3	16.9	2.0	21.1	1.4	4.0	2.9	2.6	2.8	1.3	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.1	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.2	21.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.8	0.0	0.0	0.3	5.5	0.0	0.0	0.0	0.6	0.6	1.1	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	7.9	0.0	0.0	2.9	2.6	1.6	0.5	1.9	1.0	1.2	0.8	0.4	1.0	1.4	0.4	0.5	2.2	2.8	0.6	4.0	1.3	0.5	1.4	1.3	0.4	1.0	1.5	3.6	2.8	0.3	1.5	0.8
DUXB		ENSG00000282757	"Double homeobox B"		16	75693929-75701459	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"bone marrow: 1.3;retina: 1.8;testis: 1.2;thyroid gland: 1.4"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.1;MCF7: 1.8;NTERA-2: 1.0"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0		0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.1	1.2	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
EDN3	ET3	ENSG00000124205	"Endothelin 3"	P14138	20	59300427-59325992	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 35.8;retina: 86.8;salivary gland: 37.0;vagina: 37.8"	"Cell line enriched"	"Detected in single"	5	"SH-SY5Y: 3.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	17	"memory CD4 T-cell: 2.1;T-reg: 1.2"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.1"	"Low region specificity"	"Detected in all"												"Secreted to blood"						"unprognostic (4.64e-3)"	"unprognostic (7.87e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.88e-3)"	"prognostic favourable (1.73e-4)"	"unprognostic (1.58e-1)"		"unprognostic (1.78e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.69e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.08e-2)"	"unprognostic (4.48e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.40e-2)"		0.0	1.2	1.1	0.7	2.5	0.0	3.7	0.8	3.3	22.7	21.7	2.1	0.2	20.7	2.6	3.2	9.2	0.0	1.3	0.0	2.3	1.6	0.2	0.0	0.2	0.0	1.8	1.7	0.6	5.1	0.0	20.8	0.2	3.2	3.2	8.9	86.8	37.0	0.4	0.6	0.8	35.8	1.3	1.7	3.6	0.8	1.1	0.4	0.1	33.2	1.3	0.6	0.2	37.8	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	1.1	2.5	0.8	3.3	2.3	1.6	1.8	1.7	3.2	0.4
EFR3B	"FLJ37871, KIAA0953"	ENSG00000084710	"EFR3 homolog B"	Q9Y2G0	2	25042130-25159137	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.5;retina: 21.1;skeletal muscle: 25.1"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.9;BEWO: 10.4;SH-SY5Y: 9.3;SK-BR-3: 15.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038089, HPA071831"	Uncertain		Supported	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA038089: AB_10672618, HPA071831: "	"unprognostic (9.31e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.24e-3)"	"unprognostic (3.82e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.32e-2)"	"unprognostic (4.49e-6)"	"unprognostic (4.83e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.55e-1)"	1.9	3.2	13.1	1.7	22.9	1.3	1.3	15.5	30.5	1.4	1.7	9.4	0.0	1.4	1.8	8.4	1.3	1.8	1.5	6.9	11.4	8.7	1.4	1.1	4.4	1.3	8.7	13.5	1.4	1.3	2.4	4.1	3.2	29.9	1.5	1.8	21.1	1.1	2.0	25.1	1.7	1.3	2.6	7.8	4.3	2.2	3.5	9.0	0.0	4.5	0.2	1.1	1.4	0.7	1.0	0.6	4.4	0.5	1.0	0.7	0.1	0.1	7.0	8.2	8.9	0.5	0.1	10.4	0.8	0.2	0.4	0.1	5.6	0.3	0.1	0.5	1.2	0.5	6.5	0.0	0.1	1.3	1.6	1.3	0.3	0.5	0.0	0.1	0.7	0.1	0.0	2.0	0.1	0.2	0.1	0.4	0.2	0.8	0.2	0.4	1.6	5.6	0.6	7.9	0.2	0.1	0.2	3.5	9.3	1.0	15.6	5.0	0.8	0.1	0.5	0.5	2.4	3.6	1.7	0.6	0.7	0.1	6.4	0.1	1.7	4.4	0.4	1.1	0.7	0.3	0.5	0.6	0.4	0.6	0.3	1.0	0.4	0.7	1.7	1.0	0.5	0.6	0.2	0.1	13.1	22.9	15.5	22.7	11.4	8.7	8.7	13.5	29.9	9.0
ERICH5	"C8orf47, FLJ39553"	ENSG00000177459	"Glutamate rich 5"	Q6P6B1	8	98064311-98093610	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 27.9;retina: 26.7"	"Cell line enhanced"	"Detected in some"		"A549: 6.8;EFO-21: 5.2;HAP1: 6.3;HEK 293: 9.1;RPTEC TERT1: 6.1;RT4: 15.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 23.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	9	"myeloid DC: 5.3"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA025070, HPA025293, HPA027233"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Golgi apparatus"	"HPA025070: AB_1845778, HPA025293: AB_1845779, HPA027233: AB_1845780"	"unprognostic (2.88e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.96e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.66e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.73e-1)"	"prognostic favourable (3.76e-4)"	"unprognostic (4.36e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.17e-2)"	"prognostic favourable (9.38e-4)"	0.5	0.2	2.3	0.2	6.7	0.0	0.8	0.4	2.2	2.0	3.3	0.1	3.6	4.3	1.1	0.6	0.7	8.8	13.1	5.4	0.7	2.6	8.7	8.1	1.7	0.7	1.0	2.2	1.6	27.9	0.6	1.7	4.1	1.9	2.2	3.0	26.7	1.3	1.9	0.1	0.6	1.3	0.4	1.0	0.2	9.5	3.4	0.5	0.3	0.6	0.0	0.5	3.1	0.5	0.0	5.3	0.0	0.0	0.0	0.5	0.0	0.0	6.8	0.0	0.0	0.1	0.0	4.0	3.6	1.3	1.9	1.4	0.1	2.0	0.0	5.2	0.9	0.3	6.3	0.1	2.3	0.0	9.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.8	1.4	2.7	0.0	0.0	0.1	6.1	15.9	3.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.3	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.3	6.7	0.4	2.2	0.7	2.6	1.0	2.2	1.9	0.5
ESRRB	"DFNB35, ERR2, ERRb, ERRbeta, ESRL2, NR3B2"	ENSG00000119715	"Estrogen related receptor beta"	O95718	14	76310712-76501837	"Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 14.5;retina: 50.2"	"Cell line enhanced"	"Detected in some"		"HMC-1: 2.7;K-562: 9.5;U-266/70: 4.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (1.12e-1)"	"unprognostic (1.34e-2)"	"unprognostic (6.28e-2)"	"unprognostic (3.92e-5)"	"unprognostic (5.18e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.12e-4)"	"unprognostic (4.40e-2)"	0.2	0.1	0.3	0.0	1.0	0.0	0.6	0.3	0.6	0.1	0.0	0.8	0.3	0.0	0.1	0.4	0.1	0.1	0.0	7.8	0.3	0.4	14.5	0.1	0.1	0.9	0.5	0.4	0.0	0.2	0.0	0.3	0.1	1.3	0.2	0.0	50.2	0.1	0.4	9.5	0.0	0.1	0.0	0.5	1.2	5.1	2.0	0.2	0.0	0.0	1.2	0.1	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.5	1.5	0.5	0.0	0.1	0.0	0.6	2.7	0.0	0.0	0.0	0.0	0.0	9.5	0.4	0.0	1.3	0.0	0.3	0.6	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.0	0.1	0.5	4.8	1.4	0.0	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	1.0	0.3	0.6	0.3	0.4	0.5	0.4	1.3	0.2
F2RL2	PAR3	ENSG00000164220	"Coagulation factor II thrombin receptor like 2"	O00254	5	76615482-76623434	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"retina: 34.2"	"Cell line enhanced"	"Detected in some"		"BJ: 12.5;BJ hTERT+: 21.6;BJ hTERT+ SV40 Large T+ RasG12V: 12.4;HBF TERT88: 13.9;HEL: 29.1;hTEC/SVTERT24-B: 14.2;U-138 MG: 22.3;WM-115: 27.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"basophil: 10.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 10.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (1.35e-3)"	"unprognostic (5.71e-3)"	"prognostic favourable (4.69e-4)"	"unprognostic (6.71e-2)"	"unprognostic (4.16e-3)"	"unprognostic (3.56e-2)"	"unprognostic (9.71e-2)"	"unprognostic (8.49e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.24e-8)"	"unprognostic (7.64e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.73e-2)"	0.7	0.7	0.4	2.7	1.3	0.3	6.1	0.1	0.8	2.3	6.7	0.5	0.0	2.5	5.9	0.5	5.9	0.6	11.4	2.6	0.9	3.8	1.0	5.1	1.1	0.1	4.7	0.7	0.3	4.2	0.2	1.5	0.4	7.0	0.9	2.9	34.2	7.4	0.2	0.3	4.6	6.3	6.3	1.1	0.5	2.9	0.4	0.1	4.1	0.6	10.2	3.1	2.1	0.8	0.3	1.6	10.2	0.7	1.8	1.2	0.1	0.0	0.8	0.0	0.0	0.9	5.1	0.0	12.5	21.6	3.4	12.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	13.9	0.0	0.0	29.1	0.2	0.1	1.9	0.0	0.0	2.7	0.0	14.2	0.0	1.1	0.0	0.0	1.2	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3	6.7	0.9	0.1	1.0	0.0	0.0	2.6	0.0	27.8	10.2	0.7	0.2	1.2	0.3	1.0	0.1	1.1	0.6	0.2	0.3	0.5	1.2	1.4	1.8	0.2	1.6	1.2	0.1	0.4	1.3	0.1	0.8	0.9	3.8	4.7	0.7	7.0	0.1
FAM57B	DKFZP434I2117	ENSG00000149926	"Family with sequence similarity 57 member B"	Q71RH2	16	30024427-30052978	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.4;retina: 20.8;testis: 51.7"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 8.0;SCLC-21H: 43.0;SH-SY5Y: 16.3"	"Cancer enriched"	"Detected in some"	5	"glioma: 2.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (9.31e-2)"	"unprognostic (9.72e-4)"	"unprognostic (7.78e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.06e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.40e-11)"	"unprognostic (1.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.09e-3)"	1.2	3.8	12.0	1.4	14.2	2.6	1.5	36.4	35.7	1.1	1.3	1.7	0.0	1.5	1.2	1.1	1.5	1.3	1.2	1.2	11.8	7.9	1.2	1.2	1.2	1.6	7.6	9.5	1.2	1.3	1.2	10.4	1.2	29.4	1.3	1.3	20.8	1.4	1.2	13.9	1.5	1.3	1.2	3.9	1.2	1.4	51.7	2.8	0.0	1.2	1.8	1.4	1.3	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.8	0.3	1.6	0.7	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	1.1	0.5	0.0	0.0	0.3	0.1	0.0	0.4	1.2	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.1	0.3	1.3	0.3	8.0	0.4	3.4	0.6	0.5	0.0	0.0	43.0	16.3	0.1	0.1	0.0	0.1	0.0	0.0	0.1	1.1	0.2	0.1	4.2	0.1	0.1	0.8	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	12.0	14.2	36.4	35.7	11.8	7.9	7.6	9.5	29.4	2.8
FLRT2		ENSG00000185070	"Fibronectin leucine rich transmembrane protein 2"	O43155	14	85530144-85654426	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 34.8;retina: 50.6"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 26.6;HUVEC TERT2: 16.7;TIME: 23.6;U-138 MG: 26.0;U-2197: 18.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Intracellular and membrane"	18000	18000				"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.13e-3)"	"unprognostic (4.59e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.75e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.59e-1)"	"unprognostic (5.34e-2)"	"unprognostic (8.02e-6)"	"unprognostic (1.98e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.50e-5)"	10.5	5.1	6.5	4.6	13.2	0.4	3.9	0.8	16.1	12.2	3.8	1.6	2.3	1.2	6.7	4.3	3.9	7.4	9.5	6.6	4.7	3.6	2.1	1.5	2.6	6.5	3.7	5.8	31.7	34.8	1.4	2.6	1.5	1.4	5.8	3.5	50.6	2.2	3.9	6.7	6.4	2.3	7.3	4.2	5.9	2.6	9.2	0.8	0.0	6.5	2.2	2.9	6.9	12.3	0.6	0.3	2.3	0.2	0.4	0.3	0.0	0.0	0.1	3.8	0.0	3.5	6.5	0.0	4.1	2.7	3.9	3.7	0.0	0.0	0.0	0.0	12.1	0.8	5.8	7.9	9.7	0.0	3.3	0.0	2.2	0.0	11.3	0.8	0.0	3.6	4.6	3.2	26.6	16.7	0.0	0.0	9.4	0.0	0.0	0.0	1.8	0.1	0.0	4.7	0.0	0.0	0.0	0.9	0.0	0.9	0.0	1.4	0.0	0.0	23.6	26.0	4.4	18.7	7.4	0.0	0.0	0.0	8.2	0.0	2.5	2.3	0.2	2.0	0.2	0.1	0.1	0.3	0.2	0.2	0.0	0.6	0.3	0.3	1.0	0.4	0.2	0.3	0.1	0.0	6.5	13.2	0.8	16.1	4.7	3.6	3.7	5.8	1.4	0.8
FMN1	"DKFZP686C2281, FLJ45135, FMN, LD, MGC125288, MGC125289"	ENSG00000248905	"Formin 1"	Q68DA7	15	32765545-33194733	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 21.9"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 9.3;RH-30: 12.5;SK-MEL-30: 13.0;T-47d: 11.4;U-138 MG: 7.3"	"Cancer enriched"	"Detected in many"	9	"melanoma: 14.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA005465, HPA046786"	Supported		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA005465: AB_1859515, HPA046786: AB_10963545"	"unprognostic (1.57e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-3)"	"unprognostic (3.67e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.53e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.73e-1)"	"unprognostic (4.32e-1)"	"unprognostic (7.61e-2)"	7.0	2.1	3.7	3.9	5.3	2.2	4.9	0.6	12.1	8.9	8.5	1.8	2.6	2.6	2.2	4.8	3.9	5.1	4.0	2.4	3.3	2.0	4.7	1.4	7.7	3.3	5.9	7.3	1.1	2.5	2.6	8.0	5.1	4.6	3.8	6.9	21.9	6.4	2.5	2.2	9.2	4.3	3.7	6.4	3.0	11.7	12.4	4.6	1.8	4.7	1.5	2.0	2.7	6.8	0.6	1.8	2.8	0.7	0.1	0.7	0.1	1.6	1.8	0.3	0.2	0.0	0.2	2.0	2.3	1.8	0.6	1.7	0.2	2.2	0.2	0.8	2.7	1.4	0.0	1.5	1.7	0.0	0.1	1.2	0.3	0.1	0.1	0.0	0.1	0.7	0.0	2.7	0.0	0.0	0.0	9.3	4.1	1.7	0.0	0.0	0.5	0.1	0.2	12.5	2.2	0.8	0.6	0.1	0.3	0.0	1.5	13.0	11.4	0.0	1.6	7.3	1.2	6.6	0.6	0.0	0.0	0.4	3.5	0.0	4.5	2.8	0.7	0.0	0.3	0.0	0.5	0.0	0.7	0.6	1.4	0.6	0.4	0.0	0.1	0.1	0.0	1.8	0.1	0.1	3.7	5.3	0.6	12.1	3.3	2.0	5.9	7.3	4.6	4.6
FOXC2	"FKHL14, MFH-1"	ENSG00000176692	"Forkhead box C2"	Q99958	16	86567251-86569728	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 17.6"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 15.7;HUVEC TERT2: 12.0;LHCN-M2: 19.3;TIME: 21.4;U-138 MG: 11.5;U-2197: 19.3;U-87 MG: 15.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA056302			Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA056302: AB_2683093"	"unprognostic (3.17e-2)"	"unprognostic (1.76e-3)"	"unprognostic (4.87e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.71e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (3.57e-7)"	"unprognostic (1.12e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.84e-4)"	4.8	5.7	1.1	1.6	1.4	0.5	6.4	1.1	3.4	6.2	2.0	2.2	0.1	1.1	1.6	5.3	3.0	3.9	5.6	8.8	1.1	1.1	9.1	0.9	4.9	5.4	4.3	2.6	4.0	1.3	0.6	3.7	0.9	9.9	2.1	1.0	17.6	4.2	2.9	3.2	1.5	0.9	2.1	8.5	0.5	1.1	7.7	0.7	0.0	3.3	1.0	0.9	4.9	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	5.0	0.0	6.4	8.8	5.0	0.9	0.0	0.0	0.0	0.9	0.8	0.0	0.1	2.0	4.4	0.0	0.3	0.0	4.8	0.0	1.7	0.0	0.0	0.8	2.1	15.7	5.0	12.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	21.4	11.5	0.0	19.3	0.0	0.0	0.0	0.0	15.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.4	1.1	3.4	1.1	1.1	4.3	2.6	9.9	0.7
FOXD1	"FKHL8, FREAC4"	ENSG00000251493	"Forkhead box D1"	Q16676	5	73444827-73448527	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"retina: 13.6"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 24.0;U-138 MG: 32.3"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"														"unprognostic (7.06e-4)"	"unprognostic (1.02e-3)"	"unprognostic (3.00e-5)"	"unprognostic (1.48e-4)"	"unprognostic (1.09e-2)"	"prognostic unfavourable (2.73e-4)"	"unprognostic (1.11e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.06e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.61e-10)"	"unprognostic (3.64e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.29e-2)"	"prognostic unfavourable (9.65e-4)"	1.5	6.2	0.9	0.7	3.2	0.3	0.6	0.4	3.2	1.5	0.5	2.8	0.2	0.2	0.3	0.8	6.4	0.4	1.7	0.4	2.1		3.9	0.2	0.6	1.2	5.1	3.0	0.4	0.1	0.2	1.6	4.3	3.9	1.5	0.4	13.6	1.9	0.6	1.0	1.7	1.7	0.9	5.2	0.5	0.5	6.8	1.6	0.0	0.3	5.1	1.8	1.4	2.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	14.2	1.0	0.1	5.5	2.9	2.8	0.5	11.4	5.7	14.1	12.6	0.0	17.9	0.0	0.4	10.9	5.1	1.8	7.1	15.5	4.2	8.0	0.1	0.1	0.0	1.1	0.7	0.0	3.1	4.9	24.0	7.6	0.0	0.1	0.0	14.8	3.5	0.0	0.0	3.4	2.3	3.4	2.6	0.3	5.4	1.2	2.1	0.5	3.6	0.1	0.5	0.4	19.6	0.0	32.3	18.5	9.6	0.1	0.0	0.0	0.0	17.8	0.9	10.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FOXF2	"FKHL6, FREAC2"	ENSG00000137273	"Forkhead box F2"	Q12947	6	1389576-1395603	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 28.5;intestine: 24.0;retina: 58.7"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 39.2;HEK 293: 13.1;U-2197: 16.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.14e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.39e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.89e-3)"	"unprognostic (2.53e-1)"	"unprognostic (4.50e-2)"	"unprognostic (8.76e-2)"	"unprognostic (8.75e-7)"	"unprognostic (1.03e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.29e-2)"	1.4	0.4	3.5	3.4	4.4	0.1	2.2	1.7	3.9	1.3	24.0	2.3	0.0	7.6	0.2	1.2	28.5	0.4	2.0	0.5	2.8	2.4	0.2	0.3	13.6	0.6	3.7	3.2	0.2	0.7	0.8	5.5	11.5	2.2	13.2	12.3	58.7	0.8	1.0	0.6	0.9	15.8	4.8	2.1	0.2	12.6	0.8	1.4	0.0	2.5	2.7	2.4	9.1	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.8	0.6	0.4	1.8	2.9	0.0	8.2	39.2	3.6	1.6	0.1	0.0	0.0	1.8	2.5	6.4	6.8	0.3	1.6	0.0	13.1	0.0	3.1	0.0	3.5	0.0	0.2	0.5	2.8	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.1	0.0	2.0	0.0	2.7	0.0	0.1	0.0	3.3	6.1	16.0	1.4	0.2	0.0	0.0	0.0	2.5	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	4.4	1.7	3.9	2.8	2.4	3.7	3.2	2.2	1.4
FRMPD1	"FRMD2, KIAA0967"	ENSG00000070601	"FERM and PDZ domain containing 1"	Q5SYB0	9	37651000-37746904	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 28.1;testis: 15.3"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 6.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA042934	Uncertain									"HPA042934: AB_10960422"	"unprognostic (6.41e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.48e-3)"	"unprognostic (4.04e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.63e-3)"	"unprognostic (3.94e-2)"	"unprognostic (1.12e-3)"	"unprognostic (7.80e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.91e-2)"	1.0	0.7	3.0	2.9	4.7	4.1	1.4	2.0	5.6	0.5	0.9	2.8	0.2	1.0	1.5	1.0	2.6	1.4	2.5	1.0	3.1	2.7	1.1	1.2	1.1	2.0	4.2	3.8	0.6	1.7	1.3	2.0	0.6	7.2	0.8	0.7	28.1	5.8	0.8	5.7	10.0	1.6	0.5	5.3	0.5	0.8	15.3	4.2	0.0	1.7	0.0	1.5	1.2	0.6	1.8	1.3	5.6	1.3	3.7	1.0	0.4	0.6	0.8	3.0	0.4	0.0	0.0	3.8	1.4	0.1	0.3	0.4	1.5	1.4	0.8	0.5	0.8	2.2	2.3	1.2	0.9	1.0	0.9	0.4	1.7	0.7	0.0	0.0	0.8	1.6	0.0	1.3	0.6	0.0	1.3	0.8	0.5	0.7	0.3	0.5	1.9	1.6	1.5	2.4	0.4	0.1	2.3	6.2	4.3	0.0	4.0	1.9	2.0	0.8	0.0	1.4	1.3	1.3	1.0	1.1	1.6	1.3	1.4	0.8	0.9	5.6	1.3	0.8	0.9	1.1	0.7	0.8	0.7	0.7	0.3	1.8	1.0	0.9	3.4	3.7	1.0	1.3	0.7	0.4	3.0	4.7	2.0	5.6	3.1	2.7	4.2	3.8	7.2	4.2
FSCN2	"RFSN, RP30"	ENSG00000186765	"Fascin actin-bundling protein 2, retinal"	O14926	17	81528396-81537130	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 21.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 5.1;T-47d: 5.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 3.6"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (3.50e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.73e-4)"	"unprognostic (1.08e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.11e-2)"	"unprognostic (6.49e-3)"	"unprognostic (3.49e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.11e-1)"	0.6	0.0	0.6	0.6	0.6	0.1	0.7	1.0	0.8	1.7	0.6	0.6	0.6	0.5	1.7	1.2	0.6	1.1	0.6	0.6	0.6	0.6	0.8	0.6	1.1	0.6	0.6	0.6	1.2	6.8	7.0	1.3	0.9	0.6	0.9	0.2	21.9	4.2	1.1	0.6	1.2	0.6	0.6	0.6	0.6	2.0	0.6	0.6	0.6	6.2	0.6	0.6	0.6	0.6	0.9	0.7	0.0	0.1	0.0	0.6	0.0	1.8	1.2	0.8	1.3	0.4	0.0	1.3	0.8	1.4	0.0	0.2	1.0	1.3	1.4	5.1	1.3	1.4	0.0	0.0	0.0	1.9	1.1	0.0	0.9	0.5	0.7	0.3	0.0	0.4	0.0	0.0	0.2	0.2	0.3	1.3	0.0	2.5	0.0	0.5	0.3	0.3	1.0	0.6	0.5	0.5	0.6	1.5	0.1	0.1	0.1	1.8	5.5	0.0	1.6	1.8	0.4	0.2	0.5	0.1	0.3	0.1	2.1	0.0	0.9	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	1.0	0.8	0.6	0.6	0.6	0.6	0.6	0.6
FYB2	"ARAP, C1orf168, FLJ43208, RP4-758N20.2"	ENSG00000187889	"FYN binding protein 2"	Q5VWT5	1	56718804-56819696	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 15.5;liver: 22.6;retina: 16.7"	"Cell line enriched"	"Detected in single"	18	"T-47d: 10.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"hippocampal formation: 1.6;pons and medulla: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hippocampal formation: 2.3"	"Low region specificity"	"Detected in many"														"unprognostic (6.12e-5)"	"unprognostic (1.78e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.89e-2)"	"unprognostic (9.19e-3)"	"unprognostic (4.77e-3)"		"unprognostic (1.29e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.86e-4)"	"unprognostic (3.84e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.04e-3)"	0.2	0.2	0.2	0.0	0.2	0.0	0.7	0.7	0.7	4.1	0.9	2.0	7.5	0.3	3.7	7.7	0.6	15.5	0.0	3.7	1.6	0.2	10.0	22.6	3.2	0.0	0.2	0.8	4.3	1.2	0.0	12.4	0.2	5.7	2.1	0.5	16.7	3.0	2.1	2.8	0.2	3.0	0.1	0.2	0.2	0.5	2.1	0.0	2.5	0.7	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.7	0.3	1.6	0.2	0.2	0.8	5.7	0.0
GABRR1		ENSG00000146276	"Gamma-aminobutyric acid type A receptor rho1 subunit"	P24046	6	89177501-89231278	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"retina: 12.3;testis: 4.6"	"Group enriched"	"Detected in some"	9	"NTERA-2: 5.1;THP-1: 1.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"amygdala: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																		"unprognostic (5.75e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.90e-2)"	"unprognostic (5.78e-2)"	"unprognostic (4.90e-2)"		"unprognostic (8.32e-3)"	"unprognostic (2.52e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-5)"	"unprognostic (1.18e-1)"	"unprognostic (9.90e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.29e-1)"	0.4	0.0	2.2	0.1	0.1	0.0	0.2	0.3	0.1	0.2	0.3	0.1	0.1	0.1	0.1	0.2	1.0	0.1	0.1	0.1	0.1	0.2	0.4	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.2	1.0	0.3	0.2	0.1	12.3	0.2	0.1	0.7	0.6	0.7	0.1	0.1	0.1	0.0	4.6	0.1	0.1	0.1	0.1	0.2	0.6	0.2	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.1	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.3	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	2.2	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.3	0.1
GAL3ST3	GAL3ST2	ENSG00000175229	"Galactose-3-O-sulfotransferase 3"	Q96A11	11	66041952-66049180	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.4;retina: 14.2;thyroid gland: 28.0"	"Group enriched"	"Detected in some"	5	"NTERA-2: 12.3;SH-SY5Y: 10.0"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 10.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"naive CD8 T-cell: 1.8"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"									"prognostic unfavourable (6.53e-6)"	"unprognostic (1.24e-1)"			"unprognostic (3.30e-1)"		"unprognostic (1.57e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.01e-3)"	"unprognostic (7.26e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.29e-1)"	0.8	0.7	6.3	0.7	15.4	0.7	0.7	7.5	14.5	5.4	0.8	2.4	0.3	0.8	8.0	1.0	0.8	2.5	0.8	5.9	6.1	4.3	4.0	0.7	0.7	0.9	2.9	5.0	0.9	1.5	1.9	3.5	0.7	3.7	2.2	0.7	14.2	0.8	5.9	1.3	1.0	0.8	9.7	1.2	0.7	0.7	2.6	2.0	0.0	28.0	0.0	0.8	0.7	0.2	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	12.3	0.0	0.0	0.0	0.3	0.0	0.0	0.6	10.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	6.3	15.4	7.5	14.5	6.1	4.3	2.9	5.0	3.7	2.0
GDF11	BMP-11	ENSG00000135414	"Growth differentiation factor 11"	O95390	12	55743280-55757278	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 35.4"	"Cell line enhanced"	"Detected in many"		"HMC-1: 53.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060985, HPA069609"	Enhanced		Approved	Vesicles	"Secreted to blood"	270000	270000	Vesicles	Vesicles	"HPA060985: AB_2684403, HPA069609: AB_2686159"	"unprognostic (5.21e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.62e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.23e-2)"	"prognostic favourable (1.08e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.01e-3)"	"unprognostic (9.48e-2)"	4.6	4.9	15.9	5.6	13.9	2.6	1.9	10.7	13.3	10.3	4.5	9.2	6.6	2.7	10.0	3.5	4.0	6.9	7.4	11.4	13.3	12.9	3.2	1.6	3.1	4.1	13.9	7.3	7.5	4.7	4.6	4.6	3.3	9.3	7.7	2.8	35.4	7.0	16.0	1.9	2.1	3.6	7.3	13.1	5.7	3.5	1.7	9.5	5.7	4.6	1.6	2.9	7.5	2.9	2.4	2.3	1.4	1.2	0.8	3.9	0.5	1.9	3.1	13.5	7.6	10.3	7.6	3.4	4.0	3.9	5.1	4.5	10.4	0.8	3.8	5.4	4.2	1.9	10.2	7.2	1.8	7.2	9.2	4.6	5.1	1.5	2.0	3.8	53.0	7.2	0.4	7.5	2.1	6.7	5.1	12.3	6.6	3.6	6.2	3.3	10.8	7.7	9.9	3.7	2.3	3.2	2.6	9.2	5.6	2.5	1.1	1.0	4.3	4.2	4.1	6.3	9.7	4.9	2.9	3.3	1.0	1.9	3.3	3.8	4.4	0.7	0.7	1.4	3.9	0.5	3.6	2.3	2.4	2.5	0.6	2.4	2.2	3.0	1.2	0.8	1.2	2.3	1.7	0.5	15.9	13.9	10.7	10.0	13.3	12.9	13.9	7.3	9.3	9.5
GJD2	"CX36, GJA9"	ENSG00000159248	"Gap junction protein delta 2"	Q9UKL4	15	34751032-34754965	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 13.8;pancreas: 8.7;pituitary gland: 23.9;retina: 9.1"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 2.3;SCLC-21H: 3.0"	"Cancer enriched"	"Detected in single"	32	"pancreatic cancer: 4.2"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"																		"unprognostic (4.30e-2)"						"unprognostic (2.87e-2)"			"unprognostic (1.28e-3)"	"unprognostic (1.15e-1)"			0.3	13.8	1.3	0.3	2.1	0.3	0.2	1.4	4.5	0.4	0.3	0.1	0.0	0.2	0.4	0.2	0.2	0.2	0.3	7.0	1.1	1.6	0.9	0.2	0.3	0.2	0.8	2.8	0.2	8.7	0.2	23.9	0.3	3.4	0.2	0.3	9.1	0.2	0.2	0.3	0.3	0.3	0.3	0.2	0.3	0.4	0.4	0.0	0.0	0.3	0.0	0.3	0.3	0.0	0.5	0.6	2.1	1.1	1.0	0.7	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.8	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.4	0.8	0.5	0.6	0.7	0.5	0.5	0.3	0.5	0.5	0.6	0.6	2.1	1.0	1.1	0.6	0.5	0.4	1.3	2.1	1.4	4.5	1.1	1.6	0.8	2.8	3.4	0.0
GLB1L2		ENSG00000149328	"Galactosidase beta 1 like 2"	Q8IW92	11	134331874-134378341	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 36.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 24.1;HaCaT: 25.3;HMC-1: 14.0;SCLC-21H: 17.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 11.2"	"Cell type enhanced"	"Detected in many"		"gdTCR: 5.8;NK-cell: 5.8"	"Group enriched"	"Detected in many"	23	"NK-cells: 5.8;T-cells: 5.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA054808, HPA059955"	Uncertain		Supported	Nucleoplasm	"Secreted - unknown location"			Nucleoplasm	Nucleoplasm	"HPA054808: AB_2682608, HPA059955: AB_2684178"	"unprognostic (2.63e-2)"	"unprognostic (9.77e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.01e-1)"	0.8	1.2	1.6	4.4	4.2	0.1	4.5	0.3	2.5	6.0	13.5	4.5	8.7	3.6	20.5	6.6	3.0	17.1	15.7	0.8	2.2	2.7	13.8	0.3	4.1	1.3	0.9	1.4	9.5	6.5	22.7	8.6	5.4	11.2	23.5	7.8	36.2	5.2	17.4	0.8	5.9	2.7	5.6	0.7	0.2	5.7	7.0	0.3	1.4	15.0	5.2	2.6	5.1	2.9	0.2	0.0	0.0	0.0	5.8	5.8	0.8	7.4	0.7	4.0	2.2	0.0	0.0	2.7	0.0	0.0	0.0	0.0	6.3	24.1	0.0	8.0	0.0	25.3	12.2	0.2	0.0	0.0	11.5	0.0	3.2	0.3	1.1	0.0	14.0	0.1	0.3	0.0	0.0	0.0	12.1	0.0	0.0	7.2	2.0	1.4	2.3	8.8	0.0	0.0	0.7	6.8	5.2	17.2	6.4	5.5	6.9	0.0	8.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	1.5	0.0	0.0	0.0	5.8	0.0	2.3	0.0	1.3	2.3	0.0	0.2	1.6	2.6	0.0	5.8	0.0	0.0	0.0	0.8	1.6	4.2	0.3	2.5	2.2	2.7	0.9	1.4	11.2	0.3
GPR179	"CSNB1E, GPR158L1"	ENSG00000277399	"G protein-coupled receptor 179"		17	38325530-38343847	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"brain: 3.0;retina: 7.5"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.0;U-266/84: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA017885	Uncertain									"HPA017885: AB_2279357"	"unprognostic (1.65e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.24e-4)"	"unprognostic (8.89e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.34e-2)"	"unprognostic (6.57e-3)"	"unprognostic (5.31e-2)"	"unprognostic (5.09e-10)"	"unprognostic (6.18e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.41e-4)"	0.2	0.6	1.6	0.0	3.0	0.0	0.2	0.8	1.9	0.1	0.1	0.2	0.0	0.3	0.2	1.0	0.0	0.2	0.0	0.0	0.5		0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.4	0.3	0.0	7.5	0.6	0.3	1.5	0.0	0.3	0.1	0.6	0.0	0.5	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	1.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0										
GPR61	BALGR	ENSG00000156097	"G protein-coupled receptor 61"	Q9BZJ8	1	109539872-109548406	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 10.6;pituitary gland: 6.3;retina: 6.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.1;U-266/70: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 1.1;naive CD8 T-cell: 1.0"	"Group enriched"	"Detected in many"	11	"granulocytes: 1.1;T-cells: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007326, HPA026088"	Approved									"HPA007326: AB_1849308, HPA026088: AB_10602323"	"unprognostic (1.70e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.70e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.63e-3)"	"unprognostic (2.94e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.46e-4)"	"unprognostic (3.27e-1)"	"unprognostic (4.08e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.72e-2)"	"unprognostic (3.85e-2)"	0.5	4.0	4.9	0.7	8.2	0.7	0.5	6.4	10.6	0.5	0.6	0.2	0.0	0.8	0.8	0.6	0.7	0.5	0.7	0.9	5.4	3.9	0.6	0.6	0.5	0.8	1.7	8.3	0.6	0.5	0.5	6.3	0.6	4.9	0.6	0.5	6.3	0.7	0.5	2.3	0.8	1.0	0.5	1.2	0.6	0.6	1.7	1.2	0.0	3.6	0.0	0.5	0.7	0.3	0.0	0.0	1.1	0.0	0.0	1.0	0.0	0.4	0.5	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.4	0.2	0.3	0.2	0.2	0.3	0.3	0.0	0.0	0.1	0.6	0.1	0.2	0.0	0.1	0.1	0.0	0.2	0.2	0.4	0.5	0.0	2.4	0.4	0.2	0.0	0.3	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.0	0.1	0.0	0.0	0.0	0.1	0.0	4.9	8.2	6.4	10.6	5.4	3.9	1.7	8.3	4.9	1.2
GRP		ENSG00000134443	"Gastrin releasing peptide"	P07492	18	59220168-59230774	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 15.6;pituitary gland: 13.2;retina: 22.5"	"Group enriched"	"Detected in some"	12	"BJ hTERT+: 8.4;fHDF/TERT166: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 12.7;hippocampal formation: 34.7;midbrain: 24.8"						"Secreted to blood"						"unprognostic (3.91e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.30e-3)"	"unprognostic (3.21e-2)"	"unprognostic (7.86e-3)"	"unprognostic (3.01e-3)"		"unprognostic (1.14e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.86e-4)"	"unprognostic (2.65e-4)"	"unprognostic (9.94e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.16e-2)"	0.7	0.7	3.6	0.5	0.7	0.2	5.2	0.5	3.7	0.5	2.3	1.3	0.0	0.4	0.9	0.9	0.6	0.3	1.3	0.2	11.7	5.6	0.3	0.2	15.6	0.2	4.9	0.7	0.2	4.7	4.7	13.2	0.2	10.5	1.9	0.4	22.5	0.2	0.5	0.2	0.4	0.7	2.3	1.6	0.3	12.7	3.0	0.1	0.1	11.2	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.3	0.0	0.0	0.0	0.7	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.7	0.5	3.7	11.7	5.6	4.9	0.7	10.5	0.1
HMX1	"H6, NKX5-3"	ENSG00000215612	"H6 family homeobox 1"	Q9NP08	4	8846076-8871817	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.0;retina: 17.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 11.8;EFO-21: 7.0;HEK 293: 12.8;SH-SY5Y: 4.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (6.11e-2)"				"unprognostic (1.63e-2)"	"unprognostic (2.97e-1)"				"unprognostic (6.35e-2)"		"unprognostic (7.94e-2)"		"unprognostic (9.36e-2)"	"unprognostic (1.97e-1)"			0.5	1.0	3.9	0.4	3.6	0.3	0.3	0.8	5.0	0.3	0.3	1.1	0.0	0.8	0.3	0.3	0.3	0.3	0.3	0.3	3.1	3.5	0.3	0.3	0.3	0.3	3.6	0.1	0.3	0.3	0.3	0.4	0.3	2.7	0.3	0.4	17.4	0.5	0.3	0.5	0.6	0.3	0.3	1.8	0.3	0.4	3.5	1.6	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	3.6	0.8	2.8	3.1	3.5	3.6	0.1	2.7	1.6
IFITM10		ENSG00000244242	"Interferon induced transmembrane protein 10"	A6NMD0	11	1732410-1750591	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 31.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.9;MCF7: 5.5;SH-SY5Y: 13.2;U-87 MG: 7.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.89e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.22e-6)"	"unprognostic (6.49e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.66e-1)"	"unprognostic (4.09e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.68e-3)"	"unprognostic (2.49e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.76e-2)"	1.9	13.3	0.7	1.0	2.2	4.3	0.9	1.4	2.0	0.7	0.8	4.3	2.2	1.2	0.7	1.0	0.8	0.7	3.0	0.6	1.0	0.7	1.8	6.6	2.1	0.7	7.4	0.2	0.8	0.6	0.5	0.4	1.0	4.1	2.7	0.6	31.4	6.7	4.8	1.2	2.0	1.0	1.0	8.2	2.2	0.6	1.6	2.7	0.0	0.5	10.8	1.6	2.6	3.4	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.2	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	13.2	0.0	0.0	2.0	1.4	0.0	0.0	0.5	0.0	0.0	0.2	0.3	0.8	0.0	7.9	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.2	1.4	2.0	1.0	0.7	7.4	0.2	4.1	2.7
INPP5K	SKIP	ENSG00000132376	"Inositol polyphosphate-5-phosphatase K"	Q9BT40	17	1494571-1516888	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 114.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (7.47e-2)"	"prognostic favourable (3.91e-4)"	"unprognostic (8.91e-2)"	"prognostic favourable (2.33e-5)"	"unprognostic (3.25e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.77e-2)"	"prognostic favourable (1.47e-6)"	"unprognostic (4.71e-2)"	"unprognostic (9.35e-3)"	"unprognostic (3.01e-2)"	"unprognostic (7.20e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.04e-1)"	27.9	10.5	12.7	13.8	13.5	25.9	37.0	14.9	17.7	13.4	13.4	14.9	9.8	9.1	12.8	12.2	12.0	10.4	12.9	17.5	12.8	12.6	11.6	10.5	20.8	14.3	12.8	12.0	14.3	18.9	12.0	10.8	15.9	21.2	13.5	11.4	114.9	12.9	12.2	26.4	22.3	13.9	10.9	10.7	16.2	12.8	20.8	11.3	22.1	27.3	13.8	16.4	12.5	14.1	12.1	16.5	36.4	27.0	17.0	30.8	24.6	9.4	13.1	5.4	10.3	14.0	7.8	8.0	7.9	13.4	9.0	11.5	8.1	5.6	8.4	15.2	12.1	12.4	12.8	5.1	9.3	21.8	21.6	5.2	10.0	3.2	17.7	4.9	10.2	9.2	13.7	9.0	8.9	14.3	5.7	15.2	5.9	6.7	14.9	4.0	2.3	8.9	11.5	4.2	8.0	7.3	5.8	4.2	10.8	6.2	12.2	14.1	10.3	4.0	10.1	7.9	8.1	11.4	10.2	8.0	13.4	4.5	8.9	5.1	9.9	36.4	19.9	31.9	22.2	18.7	18.2	12.1	20.7	22.4	16.5	11.3	17.7	18.9	33.3	17.0	27.0	11.9	30.8	24.6	12.7	13.5	14.9	17.7	12.8	12.6	12.8	12.0	21.2	11.3
KALRN	"ARHGEF24, DUET, duo, HAPIP, Hs.8004, Kalirin, TRAD"	ENSG00000160145	"Kalirin RhoGEF kinase"	O60229	3	124080023-124726325	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.2;retina: 31.2"	"Cell line enhanced"	"Detected in many"		"CACO-2: 32.1;HEL: 19.6;SH-SY5Y: 9.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.3"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.3"	"Low region specificity"	"Detected in many"							"HPA011913, CAB026456"	Approved		Approved	Nucleoplasm,Cytosol		110000	110000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB026456: , HPA011913: "	"unprognostic (2.54e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.12e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.41e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.26e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.81e-3)"	5.5	4.3	12.7	2.4	14.1	0.6	4.2	1.8	35.2	4.0	3.8	3.7	0.5	2.7	5.6	2.3	9.6	4.2	3.1	12.1	17.6	3.9	2.6	7.3	2.9	1.1	4.1	15.8	2.3	11.9	2.5	14.4	6.8	9.4	3.1	2.1	31.2	2.2	5.4	23.5	1.5	7.2	6.4	3.6	8.0	11.5	2.2	2.4	0.0	5.3	6.7	3.1	2.9	4.1	0.1	0.0	0.9	0.0	0.1	4.3	1.2	0.3	0.6	3.6	0.7	0.5	0.1	4.6	1.4	0.8	1.4	0.6	32.1	2.5	0.1	0.4	3.6	0.2	0.8	0.0	1.1	0.0	0.3	19.6	0.3	4.9	0.0	0.0	0.0	0.2	0.0	0.3	0.0	1.6	4.5	0.1	0.4	2.3	0.0	0.0	2.0	3.1	1.0	1.6	0.0	0.1	0.3	1.2	9.2	0.4	0.3	0.3	0.7	0.1	8.1	4.1	1.6	0.6	0.6	0.0	0.3	0.0	0.5	0.0	1.8	0.1	0.0	0.0	0.1	0.0	0.0	0.1	1.8	0.3	0.0	0.0	2.4	0.7	0.9	0.1	0.0	0.0	4.3	1.2	12.7	14.1	1.8	35.2	17.6	3.9	4.1	15.8	9.4	2.4
KAZALD1	"FKSG28, FKSG40"	ENSG00000107821	"Kazal type serine peptidase inhibitor domain 1"	Q96I82	10	101061841-101068131	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.6;prostate: 24.0;retina: 22.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 22.3;T-47d: 28.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	13	"memory B-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA011800	Uncertain				"Secreted to extracellular matrix"					"HPA011800: AB_1852082"	"unprognostic (3.34e-1)"	"unprognostic (8.86e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.43e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.68e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.44e-3)"	"unprognostic (6.35e-2)"	"prognostic unfavourable (5.10e-4)"	"unprognostic (2.11e-1)"	2.6	0.6	0.8	3.2	0.5	0.1	2.6	0.3	1.0	10.3	2.3	0.4	2.9	3.3	5.2	10.6	1.6	2.0	3.0	7.7	1.0	0.4	1.9	0.4	2.4	2.8	0.6	0.3	1.9	1.1	1.6	3.6	1.1	1.5	24.0	2.0	22.5	8.3	3.0	4.8	1.7	3.7	5.6	0.5	20.6	8.7	1.8	0.3	0.6	2.5	5.7	2.3	3.0	3.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.2	1.7	22.3	1.9	6.7	1.7	4.1	4.7	1.1	1.0	4.9	1.8	0.2	2.4	4.1	0.4	1.5	0.0	0.2	2.6	0.8	0.3	4.9	4.7	0.4	0.3	2.0	0.9	0.3	0.1	0.8	0.1	0.6	2.4	0.7	3.7	0.1	1.4	0.5	9.1	9.5	8.3	0.3	0.4	1.1	0.3	1.0	0.5	0.7	1.3	28.5	0.6	0.1	0.6	1.9	0.3	1.1	0.7	2.1	2.0	1.0	2.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.3	1.0	1.0	0.4	0.6	0.3	1.5	0.3
KCNB1	Kv2.1	ENSG00000158445	"Potassium voltage-gated channel subfamily B member 1"	Q14721	20	49293394-49484297	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.9;retina: 22.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 3.5;CACO-2: 5.0;hTCEpi: 3.1;U-2 OS: 4.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB001979, HPA042434"	Enhanced									"CAB001979: , HPA042434: AB_2677996"	"unprognostic (4.51e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.54e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.09e-2)"	"unprognostic (6.22e-2)"	"unprognostic (5.31e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.07e-3)"	"unprognostic (8.17e-2)"	"unprognostic (9.35e-2)"	"unprognostic (5.25e-4)"	16.9	3.6	11.4	1.3	14.6	0.8	2.4	8.1	25.9	2.3	5.1	1.8	0.7	1.2	6.8	2.3	3.9	9.0	1.9	1.9	6.6	5.3	1.3	3.5	1.2	0.8	3.3	12.5	1.2	1.2	0.9	2.5	1.0	2.5	4.8	1.9	22.4	1.7	6.5	6.2	1.1	1.8	9.6	1.2	1.2	3.9	1.5	2.4	0.0	1.0	0.1	0.8	4.0	0.9	0.4	0.3	1.2	0.2	0.3	0.7	0.0	0.0	0.1	0.8	0.0	3.5	0.3	0.1	0.0	0.4	0.4	0.0	5.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.1	0.2	0.0	0.1	0.0	0.0	2.5	0.0	0.6	3.1	0.0	0.1	0.0	0.0	1.9	1.1	0.3	0.0	2.3	0.1	0.9	0.0	0.9	0.0	0.0	0.0	2.3	1.8	1.6	2.3	0.0	1.6	0.0	0.0	2.2	4.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.2	0.0	0.1	0.1	0.3	0.2	0.0	0.4	0.7	0.2	1.2	0.3	0.1	0.3	0.1	0.0	11.4	14.6	8.1	25.9	6.6	5.3	3.3	12.5	2.5	2.4
KCNG4	Kv6.4	ENSG00000168418	"Potassium voltage-gated channel modifier subfamily G member 4"	Q8TDN1	16	84218667-84239750	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"retina: 8.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 101.5"	"Low region specificity"	"Detected in many"																		"unprognostic (3.54e-1)"									"unprognostic (6.67e-2)"				0.7	2.8	2.6	0.2	1.8	1.8	0.1	0.7	3.5	0.0	0.1	1.6	0.0	0.1	0.3	0.8	0.4	0.2	0.3	0.1	2.8	2.0	0.2	0.1	0.1	0.5	2.8	0.0	0.6	0.3	0.0	1.1	0.2	2.3	0.4	0.2	8.8	0.4	0.1	1.0	2.1	0.4	0.1	1.3	0.4	0.4	0.7	1.0	0.0	0.4	0.0	0.1	0.4	0.0	0.9	0.8	2.4	0.6	1.3	0.6	0.2	0.3	0.3	0.9	3.2	0.3	0.3	0.8	0.6	0.0	0.0	0.0	0.6	0.7	0.5	0.4	0.2	0.4	0.0	0.0	0.2	0.2	0.7	0.5	1.1	1.0	0.2	0.1	0.3	0.1	0.0	0.1	0.3	0.1	0.6	1.4	0.0	0.8	0.3	1.0	0.8	0.8	0.3	0.8	0.1	0.0	0.8	0.8	0.6	0.7	0.4	1.8	0.6	0.3	0.5	0.5	0.4	0.9	0.4	0.6	0.3	0.4	0.7	0.5	0.6	2.4	0.6	0.6	0.4	0.3	0.3	0.4	0.4	0.3	0.2	0.9	0.4	0.6	2.1	1.3	0.3	0.8	0.4	0.2	2.6	1.8	0.7	3.5	2.8	2.0	2.8	0.0	2.3	1.0
KCNH5	"eag2, H-EAG2, Kv10.2"	ENSG00000140015	"Potassium voltage-gated channel subfamily H member 5"	Q8NCM2	14	62699454-63102037	"Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 4.6;brain: 9.2;retina: 5.7"	"Group enriched"	"Detected in some"	5	"HeLa: 9.9;RT4: 13.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030487, HPA072351"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol				Centrosome	Centrosome	"HPA030487: AB_10609995, HPA072351: "		"unprognostic (1.16e-1)"		"unprognostic (7.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.23e-2)"		"unprognostic (2.70e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.76e-2)"	"unprognostic (8.45e-2)"		"unprognostic (2.66e-1)"	"unprognostic (1.70e-3)"		"unprognostic (3.11e-1)"	0.9	4.6	1.7	0.5	3.6	0.3	0.4	0.2	9.2	0.3	0.4	0.4	0.0	0.3	0.4	0.5	0.3	0.3	0.3	0.3	1.3	3.0	0.4	0.3	0.3	0.3	1.2	4.2	0.3	0.3	0.3	1.5	1.2	6.5	0.7	0.3	5.7	0.3	0.3	0.3	0.3	0.3	0.3	1.6	0.3	0.3	1.7	0.0	0.0	0.3	0.0	0.3	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	13.1	0.1	0.0	1.7	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.6	0.2	9.2	1.3	3.0	1.2	4.2	6.5	0.0
KCNH6	"erg2, HERG2, Kv11.2"	ENSG00000173826	"Potassium voltage-gated channel subfamily H member 6"	Q9H252	17	63523334-63548977	"Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 8.7;kidney: 15.4;pituitary gland: 7.6;retina: 7.6"	"Group enriched"	"Detected in some"	6	"SCLC-21H: 8.5;SH-SY5Y: 3.3"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 5.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"olfactory region: 4.7"	HPA061704	Approved									"HPA061704: "	"unprognostic (8.00e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.46e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.98e-5)"	"unprognostic (3.39e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.66e-1)"	"unprognostic (8.05e-2)"	"unprognostic (9.15e-2)"	0.0	0.2	0.3	0.7	1.1	0.3	0.0	0.1	1.2	0.0	4.2	0.0	0.0	3.9	0.0	0.5	0.0	0.3	0.1	0.6	0.3	2.8	15.4	0.0	0.9	0.1	1.1	0.5	0.1	2.4	0.1	7.6	0.6	1.0	6.2	0.4	7.6	0.1	0.0	0.2	0.3	8.7	0.0	0.7	0.1	1.7	1.4	0.3	0.3	0.1	0.0	0.0	0.1	0.0	0.8	0.4	1.7	0.5	0.7	0.5	0.4	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.2	0.7	0.2	0.1	0.1	0.0	0.0	0.3	8.5	3.3	0.0	0.2	0.1	0.3	0.2	0.0	0.3	1.0	0.2	0.1	0.2	0.1	0.2	0.1	0.1	0.2	1.2	0.5	0.4	0.4	0.3	0.1	0.6	0.2	0.2	0.2	0.8	0.5	0.4	1.7	0.7	0.3	0.4	0.2	0.4	0.3	1.1	0.1	1.2	0.3	2.8	1.1	0.5	1.0	0.3
KCNJ14	"IRK4, Kir2.4"	ENSG00000182324	"Potassium voltage-gated channel subfamily J member 14"	Q9UNX9	19	48455509-48466980	"Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 22.9"	"Cell line enhanced"	"Detected in many"		"NB-4: 12.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA071765			Approved	Nucleoli				Nucleoli	Nucleoli	"HPA071765: AB_2686444"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.33e-5)"	"unprognostic (5.77e-2)"	"unprognostic (9.41e-2)"	"unprognostic (5.26e-2)"	"unprognostic (7.05e-4)"	"unprognostic (7.83e-4)"	"unprognostic (1.26e-1)"	"unprognostic (6.48e-2)"	"unprognostic (4.43e-3)"	"unprognostic (4.92e-2)"	"unprognostic (5.02e-6)"	"unprognostic (1.47e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.82e-3)"	"unprognostic (4.41e-2)"	1.0	0.4	1.1	0.9	6.1	4.9	1.8	2.3	2.2	0.9	0.9	0.9	0.9	0.6	0.9	1.8	1.5	1.1	1.0	0.9	1.4	1.3	0.9	0.9	0.9	1.2	1.2	0.9	1.3	1.4	1.0	1.0	1.4	1.4	1.5	0.7	22.9	0.9	0.9	3.3	4.9	0.9	0.9	0.9	0.9	0.6	2.8	0.9	0.9	1.6	0.9	0.9	0.9	1.1	1.5	0.8	3.5	0.8	0.6	1.0	0.2	1.6	3.8	0.8	2.5	1.7	1.6	2.5	0.6	0.3	0.8	1.2	3.8	2.2	1.8	0.8	0.6	5.3	1.2	0.6	2.0	1.3	2.0	1.1	2.1	1.0	0.9	1.5	3.1	1.5	2.8	1.9	2.2	0.5	1.8	1.9	0.5	2.3	0.6	12.2	1.4	2.1	2.5	1.5	0.4	0.6	4.5	1.4	1.7	1.7	2.5	1.3	1.7	1.3	1.0	2.7	3.5	2.6	3.0	2.0	3.0	1.3	0.7	3.9	2.8	3.5	0.8	0.6	0.6	0.6	0.5	1.2	0.7	1.0	0.4	1.5	0.8	1.0	2.9	0.6	0.3	0.8	0.6	0.2	1.1	6.1	2.3	2.0	1.4	1.3	1.2	0.9	1.4	0.9
KCNK17	"K2p17.1, TALK-2, TALK2, TASK-4, TASK4"	ENSG00000124780	"Potassium two pore domain channel subfamily K member 17"	Q96T54	6	39299001-39314553	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 29.1;retina: 20.0"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 41.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	34	"plasmacytoid DC: 29.1"	"Lineage enriched"	"Detected in single"	34	"dendritic cells: 29.1"					"Not detected"	"Not detected"			HPA043892	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA043892: AB_10962838"	"unprognostic (5.33e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.95e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.77e-11)"	"unprognostic (5.89e-2)"	"unprognostic (5.36e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.86e-3)"	0.7	0.4	0.3	0.6	1.1	1.4	3.3	0.3	0.8	0.7	1.3	0.8	1.9	3.0	1.9	0.5	1.0	1.3	6.5	7.9	0.6	0.6	0.3	4.6	10.4	0.9	2.6	0.8	0.4	6.1	0.4	2.7	6.3	1.9	1.1	0.6	20.0	2.9	1.0	0.2	0.1	1.7	1.5	0.6	1.1	5.4	0.6	0.1	3.4	9.3	2.6	2.4	0.9	0.5	0.0	29.1	0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	41.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	29.1	0.0	0.1	0.3	1.1	0.3	0.8	0.6	0.6	2.6	0.8	1.9	0.1
KCNQ4	"DFNA2, Kv7.4"	ENSG00000117013	"Potassium voltage-gated channel subfamily Q member 4"	P56696	1	40783814-40840452	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"pancreas: 40.1;retina: 23.0"	"Cell line enhanced"	"Detected in some"		"HAP1: 3.9;HEK 293: 5.8;K-562: 5.8;MCF7: 3.4;REH: 3.0;THP-1: 3.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA018305	Uncertain									"HPA018305: "	"unprognostic (1.42e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.43e-3)"	"unprognostic (4.59e-3)"	"unprognostic (8.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.86e-2)"	"unprognostic (4.34e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.40e-2)"	"unprognostic (5.18e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.44e-2)"	2.5	0.9	1.1	1.5	2.9	0.4	1.3	3.8	3.6	2.5	9.1	0.9	1.5	1.5	5.8	0.9	3.5	4.6	2.8	2.1	1.6	0.7	0.4	0.4	1.4	0.4	1.4	2.1	1.6	40.1	0.5	0.6	2.1	1.3	3.3	1.7	23.0	5.4	5.3	5.9	1.1	2.3	7.5	2.0	0.4	2.9	1.2	1.4	0.5	0.6	0.9	0.4	5.3	2.5	0.0	0.5	0.0	0.0	0.0	0.4	0.4	0.1	0.2	0.3	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.3	1.6	0.3	0.6	0.0	0.0	3.9	0.0	0.0	0.1	5.8	1.9	0.3	0.0	0.4	0.4	0.2	0.5	0.0	0.0	0.0	0.0	5.8	0.1	0.0	3.4	0.7	0.0	0.4	0.1	3.0	0.0	0.0	0.6	0.0	2.6	0.5	0.0	1.5	0.6	0.3	3.4	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.4	1.1	2.9	3.8	3.6	1.6	0.7	1.4	2.1	1.3	1.4
KRT12	K12	ENSG00000187242	"Keratin 12"	Q99456	17	40861303-40867210	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 3.3;retina: 3.6;skin 1: 1.9"	"Cell line enriched"	"Detected in single"	6	"HeLa: 3.7"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA055217, HPA055835"	Enhanced									"HPA055217: AB_2682742, HPA055835: AB_2682935"	"unprognostic (1.89e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.82e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.74e-2)"	"unprognostic (5.52e-2)"	"unprognostic (9.41e-3)"	"unprognostic (3.49e-1)"	"unprognostic (1.73e-1)"		"unprognostic (3.94e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.60e-4)"	"unprognostic (6.31e-3)"	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.9	0.1	3.3	0.1	0.1	1.3	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.0	3.6	0.1	0.1	0.1	1.9	3.3	0.1	0.1	0.1	0.4	0.7	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	3.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.9	0.1	0.0	0.1	0.1	0.1	0.1
LMX1B	NPS1	ENSG00000136944	"LIM homeobox transcription factor 1 beta"	O60663	9	126614443-126701032	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 16.5;salivary gland: 35.3"	"Cell line enhanced"	"Detected in some"		"HEK 293: 4.7;MCF7: 17.7;T-47d: 10.9"	"Cancer enriched"	"Detected in some"	14	"breast cancer: 12.9"	"Region enriched"	"Detected in single"	4	"pons and medulla: 2.9"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"pons and medulla: 2.4"	"Region enhanced"	"Detected in some"		"midbrain: 7.9"	HPA073716			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA073716: AB_2686630"	"unprognostic (4.17e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.53e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.50e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.63e-5)"	"unprognostic (1.69e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-6)"	"unprognostic (1.13e-2)"	1.3	0.1	0.0	0.1	0.0	0.1	7.5	0.0	0.1	0.1	0.5	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.3	1.9	0.1	0.2	1.4	0.0	0.1	0.0	0.6	0.0	0.1	0.8	0.0	0.6	0.0	2.9	0.1	0.0	16.5	35.3	0.0	0.4	1.5	0.2	0.0	2.4	0.0	0.1	3.1	0.0	0.0	0.9	0.1	0.0	0.2	0.1	0.6	0.4	1.2	0.3	0.9	0.5	0.0	2.5	1.2	0.4	3.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.3	1.3	0.0	0.5	0.0	1.2	3.9	0.0	0.0	0.0	4.7	0.0	0.0	0.4	0.0	0.0	2.4	0.0	0.5	0.0	2.1	0.0	0.0	0.0	0.0	17.7	0.0	0.0	0.0	0.2	0.0	3.3	0.0	0.0	0.3	0.0	1.6	0.4	0.1	0.4	10.9	0.2	0.0	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.3	0.3	0.3	0.1	0.2	0.3	0.3	0.2	0.1	0.6	0.5	0.4	1.2	0.9	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.0	2.9	0.0
LRIT3	"CSNB1F, FIGLER4, FLJ44691"	ENSG00000183423	"Leucine rich repeat, Ig-like and transmembrane domains 3"	Q3SXY7	4	109848202-109872315	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 17.1"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA013454	Enhanced		Approved	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Mitochondria, Cytosol"	"Nucleoplasm, Mitochondria, Cytosol"	"HPA013454: AB_1853277"	"unprognostic (5.41e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.67e-3)"	"unprognostic (1.54e-1)"	"unprognostic (5.25e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.49e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.34e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.14e-2)"	0.6	0.6	0.7	0.6	1.2	0.4	1.7	2.0	1.3	1.2	0.6	0.6	0.6	0.3	0.7	1.8	0.6	1.0	0.6	0.6	0.8	0.7	4.4	0.7	0.6	0.6	0.6	0.6	0.6	0.7	0.7	0.6	0.6	0.6	0.9	0.5	17.1	0.8	0.6	1.6	3.2	0.6	0.6	0.6	0.8	0.2	1.3	0.6	0.6	0.8	0.6	0.6	0.6	0.6	0.1	0.3	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.8	0.0	0.4	0.1	0.1	0.0	0.0	0.2	0.2	0.3	0.0	0.6	0.6	0.0	0.1	1.3	0.1	0.2	0.3	1.6	0.3	0.4	0.2	0.1	1.3	0.0	0.0	2.0	0.1	0.3	0.1	0.3	0.6	0.0	0.0	0.9	1.0	0.2	0.2	0.6	0.0	0.2	1.0	0.3	0.5	0.0	0.0	0.4	0.0	0.1	1.2	0.0	0.3	0.3	0.6	0.3	0.6	1.0	0.0	0.3	0.9	0.3	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.9	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.7	1.2	2.0	1.3	0.8	0.7	0.6	0.6	0.6	0.6
MAK	"dJ417M14.2, RP62"	ENSG00000111837	"Male germ cell associated kinase"	P20794	6	10762723-10838555	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 38.1;testis: 19.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	7	"pons and medulla: 10.6"	"Cell type enriched"	"Detected in single"	13	"neutrophil: 11.7"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 11.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"														"unprognostic (1.23e-3)"	"unprognostic (8.77e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.97e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.13e-3)"	"unprognostic (6.73e-2)"	"unprognostic (6.59e-5)"	"unprognostic (1.55e-1)"	"unprognostic (8.40e-2)"	"unprognostic (7.71e-3)"	"unprognostic (4.59e-2)"	0.6	0.3	0.7	0.7	1.5	1.4	0.7	0.4	0.4	0.8	0.2	3.5	0.3	0.2	0.6	2.9	0.3	8.6	1.0	0.3	1.1	1.2	0.3	0.2	1.8	3.7	0.2	0.1	2.2	0.5	9.3	3.6	0.2	10.6	0.5	0.0	38.1	0.5	0.4	0.2	1.1	0.4	0.1	0.7	1.4	0.5	19.3	0.7	0.0	0.6	0.4	0.2	0.2	1.2	0.6	0.4	11.7	0.8	0.3	0.7	0.1	3.0	0.9	1.8	1.8	0.1	0.0	1.7	0.0	0.2	1.0	1.0	1.3	1.7	0.9	0.7	0.0	0.5	0.6	0.3	0.4	4.7	1.9	0.7	0.7	1.2	0.0	3.2	2.9	0.1	0.0	0.2	0.3	0.0	1.6	0.6	0.1	0.4	0.4	1.9	0.8	0.4	0.6	0.8	0.3	0.1	0.4	1.9	0.9	0.1	0.5	0.1	1.1	0.3	0.2	0.7	1.1	0.2	1.1	0.5	0.1	0.4	0.5	0.6	1.0	0.5	0.8	0.9	0.4	0.5	0.4	0.2	0.4	0.3	0.4	0.6	0.4	0.7	11.7	0.3	0.8	0.4	0.1	0.1	0.7	1.5	0.4	0.4	1.1	1.2	0.2	0.1	10.6	0.7
MGARP	"C4orf49, CESP-1, HUMMR, OSAP"	ENSG00000137463	"Mitochondria localized glutamic acid rich protein"	Q8TDB4	4	139266163-139280338	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 88.9;retina: 30.7"	"Cell line enhanced"	"Detected in some"		"BJ: 10.5;fHDF/TERT166: 15.6;HHSteC: 12.7;HUVEC TERT2: 31.7"	"Cancer enhanced"	"Detected in some"		"renal cancer: 4.1"	"Group enriched"	"Detected in many"	4	"basal ganglia: 4.5;cerebellum: 8.0"	"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.7;naive CD4 T-cell: 1.6"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in single"			HPA015994	Enhanced		Supported	Mitochondria				Mitochondria	Mitochondria	"HPA015994: AB_2630370"	"unprognostic (2.68e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.02e-3)"	"unprognostic (2.90e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.36e-1)"	3.2	88.9	1.0	0.5	4.5	0.4	1.2	8.0	1.2	3.6	1.0	2.1	1.1	0.4	2.6	3.0	0.5	0.8	1.3	6.1	0.8	1.4	1.0	0.4	0.5	0.6	1.0	0.0	20.1	0.5	0.4	15.3	0.5	1.5	2.0	0.5	30.7	0.4	2.0	0.6	0.5	0.4	2.3	0.7	0.6	0.4	5.9	0.5	0.0	0.5	0.0	0.5	2.1	1.0	0.5	0.0	0.0	0.3	0.5	1.7	0.3	0.0	0.5	0.3	0.2	0.8	0.4	0.0	10.5	0.0	1.5	0.0	0.0	0.1	0.0	0.1	15.6	0.2	2.2	0.0	0.9	0.0	1.0	0.0	0.0	0.1	12.7	0.1	0.1	3.8	0.3	1.7	0.1	31.7	0.2	0.2	2.6	0.0	0.4	0.2	0.6	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.6	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.4	0.3	0.2	4.4	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	1.7	0.4	0.0	0.3	1.6	0.7	0.0	0.5	0.2	0.0	0.3	0.3	1.0	4.5	8.0	1.2	0.8	1.4	1.0	0.0	1.5	0.5
MIP	"AQP0, LIM1, MP26"	ENSG00000135517	"Major intrinsic protein of lens fiber"	P30301	12	56449502-56469166	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"liver: 2.9;retina: 2.1;testis: 3.3"	"Cell line enhanced"	"Detected in some"		"HEL: 2.7;SK-BR-3: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014940	Supported									"HPA014940: AB_2669122"	"unprognostic (6.48e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.14e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.51e-5)"	"unprognostic (4.56e-3)"	"unprognostic (6.75e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.82e-2)"	0.2	0.4	0.4	0.2	0.5	0.1	0.2	0.3	0.7	0.2	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.0	0.2	0.4	0.5	0.8	0.2	2.9	0.2	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.3	2.1	0.2	0.2	0.2	0.1	0.2	0.2	0.6	0.2	0.0	3.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	1.1	1.3	1.0	1.4	0.3	0.6	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.6	0.1	0.0	0.3	0.8	0.0	0.2	0.9	0.1	0.1	0.2	0.2	0.0	0.0	0.6	0.3	2.7	0.2	0.0	0.1	0.8	1.8	0.1	0.0	0.3	0.1	0.0	0.3	1.7	0.4	0.4	0.0	0.9	0.6	0.6	0.0	0.1	0.7	0.3	0.4	1.5	0.5	0.9	2.5	0.7	0.5	1.8	0.2	0.4	0.3	0.0	0.0	0.1	0.2	0.9	0.0	0.8	0.3	1.0	1.4	0.1	0.6	0.8	0.3	0.7	0.6	0.2	0.0	1.1	0.2	0.4	0.6	0.3	0.3	1.3	0.5	0.0	0.4	0.5	0.3	0.5	0.5	0.8	0.4	0.2	0.2	0.2
MPZ	"CMT1, CMT1B, CMT2I, CMT2J, HMSNIB"	ENSG00000158887	"Myelin protein zero"	P25189	1	161304735-161309972	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 118.7;retina: 60.6"	"Cell line enriched"	"Detected in some"	5	"WM-115: 66.6"	"Cancer enriched"	"Detected in many"	11	"melanoma: 83.9"	"Region enriched"	"Detected in many"	4	"midbrain: 118.7"	"Group enriched"	"Detected in some"	6	"eosinophil: 1.9;neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.9"	"Group enriched"	"Detected in some"	5	"olfactory region: 3.6;pons and medulla: 1.4"	"Region enriched"	"Detected in single"	57	"midbrain: 262.7"	HPA068925	Enhanced									"HPA068925: AB_2732123"	"unprognostic (6.77e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.88e-3)"	"unprognostic (1.51e-1)"	"unprognostic (6.62e-8)"	"unprognostic (6.75e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.66e-1)"	"unprognostic (8.32e-2)"	14.3	12.6	2.2	3.4	2.9	1.3	4.7	6.0	2.2	4.5	6.1	2.6	9.9	2.6	1.7	7.5	8.7	1.5	4.3	7.2	2.4	4.3	3.2	7.9	3.1	1.3	118.7	0.7	1.9	2.2	0.5	7.4	0.8	28.4	7.3	5.0	60.6	6.4	15.6	4.2	2.3	6.3	5.6	40.9	6.8	2.1	2.7	0.8	0.2	2.8	26.3	3.0	9.3	3.3	0.1	0.0	1.9	0.2	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.9	0.4	0.1	0.1	0.1	0.0	0.5	0.0	0.0	0.7	0.5	0.1	0.0	0.6	0.2	0.0	0.3	0.0	0.3	0.1	12.3	0.4	1.4	1.2	1.4	0.0	2.0	0.1	0.9	3.1	0.0	1.4	0.0	0.2	2.4	0.5	0.0	0.1	0.0	0.4	0.1	0.0	0.6	0.1	0.0	0.0	6.3	0.0	3.0	0.9	0.1	0.1	0.8	0.0	0.3	0.3	0.3	1.6	5.6	66.6	0.0	0.2	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.2	0.1	2.2	2.9	6.0	2.2	2.4	4.3	118.7	0.7	28.4	0.8
MSI1		ENSG00000135097	"Musashi RNA binding protein 1"	O43347	12	120341330-120369180	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 27.3;skeletal muscle: 23.2"	"Cell line enhanced"	"Detected in some"		"AF22: 42.9;HAP1: 19.6;NTERA-2: 22.3;SCLC-21H: 31.8;SH-SY5Y: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA074923, HPA075573"	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA074923: , HPA075573: "	"unprognostic (1.21e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.89e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.75e-2)"	"prognostic favourable (5.99e-4)"	"unprognostic (3.66e-1)"	"unprognostic (1.46e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.19e-1)"	0.8	6.8	8.7	0.6	7.4	0.4	1.2	3.9	14.2	1.9	1.5	8.6	2.2	7.8	4.3	2.7	1.5	3.1	1.4	4.0	11.3	5.9	0.7	1.0	1.0	0.6	4.7	6.1	2.9	7.3	1.3	12.8	1.4	4.6	4.5	1.5	27.3	1.3	2.5	23.2	0.5	5.2	2.2	4.7	0.7	3.1	12.5	5.4	0.0	1.3	0.0	0.4	0.9	0.9	0.1	0.4	0.6	0.2	0.2	0.3	0.0	0.0	0.5	42.9	10.8	0.0	0.0	5.4	0.0	0.0	0.2	0.5	7.5	0.2	0.0	0.6	0.0	0.1	19.6	0.0	0.1	0.2	4.4	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.5	0.0	0.1	22.3	0.2	0.1	0.0	0.1	0.0	0.0	31.8	15.5	0.0	0.3	0.3	6.6	0.0	0.0	0.1	5.9	0.0	0.0	0.5	0.1	0.0	0.1	0.1	0.4	0.3	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.3	0.1	0.6	0.2	0.2	0.4	0.1	0.0	8.7	7.4	3.9	7.2	11.3	5.9	4.7	6.1	4.6	5.4
MTMR8	FLJ20126	ENSG00000102043	"Myotubularin related protein 8"	Q96EF0	X	64268081-64395431	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 16.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 7.0;Karpas-707: 5.0;NTERA-2: 6.5;U-2197: 5.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"														"unprognostic (1.73e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.22e-2)"	"unprognostic (8.20e-2)"	2.8	2.6	1.2	3.1	2.2	1.9	2.2	6.1	2.0	4.2	4.0	2.5	4.1	1.7	6.0	2.9	3.8	8.1	2.0	1.8	1.5	1.7	3.2	1.4	2.1	3.0	2.4	0.7	6.6	2.5	2.7	6.8	0.5	2.0	3.4	4.9	16.4	2.8	6.5	1.5	2.1	5.3	6.7	2.4	4.3	4.1	1.3	3.0	5.5	2.4	1.6	6.1	4.9	3.1	3.2	0.2	0.7	1.4	0.8	4.0	1.6	0.0	1.4	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	1.5	7.0	1.0	0.0	0.0	3.9	0.8	1.7	0.0	1.6	2.2	0.3	0.0	0.0	4.8	3.0	0.0	1.0	0.1	0.3	0.0	5.0	5.0	0.0	0.3	2.5	0.8	6.5	0.6	3.9	0.0	1.7	0.4	1.1	0.0	0.7	0.0	0.1	0.0	1.3	2.5	0.0	0.0	1.7	5.7	0.0	0.0	0.5	4.3	0.0	0.0	0.0	0.4	0.4	0.1	3.2	1.2	3.1	3.0	3.3	2.0	0.2	3.2	4.0	3.5	0.7	0.8	1.4	0.2	1.7	1.6	1.2	2.2	6.1	2.0	1.5	1.7	2.4	0.7	2.0	3.0
MYO3B		ENSG00000071909	"Myosin IIIB"	Q8WXR4	2	170178145-170655171	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 20.0;parathyroid gland: 12.6;retina: 21.6"	"Group enriched"	"Detected in some"	10	"HDLM-2: 11.0;HEL: 10.1;RT4: 11.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"gdTCR: 1.4;naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.4"	"Region enriched"	"Detected in single"	5	"basal ganglia: 4.7"	"Not detected"	"Not detected"			HPA045483	Approved									"HPA045483: AB_2679344"	"unprognostic (1.65e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.07e-2)"	"unprognostic (2.61e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.12e-1)"	"unprognostic (7.99e-3)"	"unprognostic (2.59e-1)"	"unprognostic (4.25e-5)"	"unprognostic (2.34e-1)"	"unprognostic (8.12e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.07e-1)"	0.2	0.2	0.3	0.0	0.3	0.0	0.2	0.2	0.3	0.6	0.2	0.0	4.6	0.0	0.3	20.0	0.3	0.5	0.0	0.3	0.3	0.5	8.5	0.2	0.3	0.5	0.3	0.3	0.4	2.2	12.6	1.0	0.0	0.3	0.3	0.0	21.6	1.4	1.1	0.2	0.5	0.2	0.5	0.2	0.3	0.2	4.2	0.0	0.0	2.2	0.0	0.8	4.4	0.3	0.1	0.3	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	11.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.5	0.3	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.2	0.3	0.3	0.5	0.3	0.3	0.3	0.0
MYO7A	"DFNA11, DFNB2, NSRD2, USH1B"	ENSG00000137474	"Myosin VIIA"	Q13402	11	77128264-77215241	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 26.3;retina: 30.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 11.3;CACO-2: 6.9;RH-30: 15.6;RPMI-8226: 10.2;SK-BR-3: 8.5;U-937: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"classical monocyte: 5.6;intermediate monocyte: 4.0;NK-cell: 1.4"	"Group enriched"	"Detected in many"	10	"monocytes: 5.6;NK-cells: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA028918, CAB034059"	Uncertain		Approved	Cytosol				Cytosol	Cytosol	"CAB034059: AB_2148626, HPA028918: AB_10603022"	"unprognostic (1.14e-3)"	"unprognostic (2.58e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.66e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.65e-2)"	"unprognostic (6.81e-2)"	"prognostic unfavourable (3.07e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.03e-2)"	5.8	26.3	3.6	3.7	5.6	1.1	5.0	0.7	3.0	1.3	1.7	3.5	0.9	2.2	1.3	2.9	1.2	2.3	2.8	1.7	4.0	3.8	5.3	14.8	1.6	4.5	5.2	1.7	4.4	3.8	1.2	25.1	16.9	7.2	13.6	1.4	30.9	1.1	0.9	1.0	0.6	2.4	2.4	3.9	11.2	2.0	22.9	4.7	0.5	1.5	0.3	1.1	1.9	4.4	0.0	0.3	0.0	5.6	1.4	0.1	1.8	0.0	1.1	0.1	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	6.9	2.0	0.0	1.6	0.0	0.3	0.0	0.1	0.0	0.0	1.7	0.0	0.3	4.2	0.1	0.0	0.0	0.1	0.0	0.0	0.5	2.9	0.1	0.0	0.0	1.0	0.0	0.0	0.3	0.3	0.0	15.6	10.2	0.0	0.2	2.4	0.7	0.1	8.5	0.1	1.2	1.0	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	5.6	0.0	0.0	4.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	1.8	3.6	5.6	0.7	3.0	4.0	3.8	5.2	1.7	7.2	4.7
MYOC	"GLC1A, JOAG1, TIGR"	ENSG00000034971	Myocilin	Q99972	1	171635417-171652683	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 100.8"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	6	"melanoma: 13.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA027364	Uncertain				"Secreted to extracellular matrix"	12000000	12000000			"HPA027364: AB_10602036"	"unprognostic (2.02e-2)"	"unprognostic (4.65e-2)"		"unprognostic (4.44e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.43e-1)"		"unprognostic (2.33e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.94e-4)"	"unprognostic (5.35e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.24e-1)"	26.9	0.8	0.0	0.5	0.0	0.0	8.4	0.0	0.0	5.4	6.0	0.0	5.3	2.4	8.1	7.6	40.7	7.4	8.3	12.6	0.1	0.0	0.2	0.1	3.7	0.0	0.0	0.0	3.9	2.1	0.2	0.1	0.1	0.2	9.0	2.5	100.8	10.5	4.8	21.7	2.4	2.6	39.4	0.3	0.1	29.9	2.8	0.0	0.6	14.9	28.2	5.0	26.1	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0
MYRIP	"DKFZp586F1018, exophilin-8, MyRIP, SLAC2-C, SLAC2C"	ENSG00000170011	"Myosin VIIA and Rab interacting protein"	Q8NFW9	3	39808914-40260321	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.0;retina: 36.3"	"Cell line enhanced"	"Detected in some"		"HAP1: 4.4;HUVEC TERT2: 16.6;REH: 3.9;SCLC-21H: 3.5;SH-SY5Y: 10.3;T-47d: 4.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006433			Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"				"Nucleoplasm, Nucleoli fibrillar center, Golgi apparatus"	"Nucleoplasm, Nucleoli fibrillar center, Golgi apparatus"	"HPA006433: AB_10603023"	"unprognostic (1.87e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.66e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.34e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.91e-1)"	"prognostic favourable (3.96e-8)"	"unprognostic (7.12e-2)"	"unprognostic (2.40e-1)"	"unprognostic (8.92e-2)"	"unprognostic (6.16e-2)"	4.8	2.0	31.0	2.2	7.8	0.5	3.4	23.7	19.4	9.0	4.2	3.9	1.3	2.9	6.0	3.8	2.4	3.3	4.3	2.8	13.9	9.6	2.7	16.7	1.7	2.6	8.5	11.0	5.3	13.1	2.1	8.4	0.6	10.8	3.4	4.4	36.3	16.0	1.8	2.7	1.8	2.8	3.9	5.5	10.2	7.7	1.7	4.2	0.0	2.1	1.6	2.9	2.8	2.7	0.8	0.1	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.3	0.2	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.0	0.0	0.0	0.0	16.6	0.0	0.1	0.2	0.1	0.0	0.0	1.1	0.1	3.9	0.0	0.0	0.4	2.1	3.5	10.3	0.0	0.0	0.0	4.1	0.0	1.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.0	31.0	7.8	23.7	18.4	13.9	9.6	8.5	11.0	10.8	4.2
NDNF	"C4orf31, FLJ23191"	ENSG00000173376	"Neuron derived neurotrophic factor"	Q8TB73	4	121035613-121073021	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 91.6;retina: 41.0"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 22.7;U-266/70: 10.1;U-266/84: 38.7"	"Cancer enhanced"	"Detected in many"		"lung cancer: 12.6"	"Region enriched"	"Detected in many"	4	"pons and medulla: 7.6"	"Cell type enriched"	"Detected in single"	11	"naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.0"	"Group enriched"	"Detected in many"	4	"basal ganglia: 11.4;olfactory region: 41.7"	"Low region specificity"	"Detected in all"			HPA048881			Supported	Vesicles	"Secreted in other tissues"			Vesicles	Vesicles	"HPA048881: "	"unprognostic (2.84e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.94e-1)"	"unprognostic (6.26e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.65e-4)"	"unprognostic (2.18e-3)"	"unprognostic (6.27e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavourable (3.26e-4)"	"unprognostic (2.38e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.18e-4)"	"unprognostic (1.74e-1)"	3.8	1.3	1.2	0.4	1.0	0.0	14.2	0.6	1.5	7.2	3.5	1.2	1.7	1.3	3.1	2.2	5.7	10.0	6.9	4.9	1.2	1.5	12.5	0.5	91.6	0.1	1.8	1.2	21.3	0.6	0.4	8.2	28.0	7.6	26.1	4.0	41.0	2.1	2.2	7.5	1.8	3.9	2.6	5.5	0.4	2.2	8.0	0.8	7.0	1.6	9.0	1.4	8.9	11.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	5.1	0.0	6.8	5.6	0.1	0.1	0.2	0.1	0.2	0.7	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.5	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	6.8	0.4	0.0	0.0	0.0	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	5.6	0.0	0.1	0.2	10.1	38.7	0.0	1.9	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.0	0.6	1.5	1.2	1.5	1.8	1.2	7.6	0.8
NOG	"SYM1, SYNS1"	ENSG00000183691	Noggin	Q13253	17	56593699-56595590	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 32.8;placenta: 37.1;retina: 18.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 49.8;LHCN-M2: 15.1;NB-4: 11.0;PC-3: 15.1;U-2 OS: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"naive CD4 T-cell: 32.8;naive CD8 T-cell: 15.1"	"Lineage enriched"	"Detected in single"	81	"T-cells: 32.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061318	Approved				"Secreted to blood"					"HPA061318: AB_2684478"	"unprognostic (1.49e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.49e-5)"	"prognostic favourable (6.66e-4)"	"unprognostic (4.69e-2)"	"unprognostic (5.23e-3)"		"unprognostic (1.26e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavourable (6.86e-5)"	"unprognostic (2.88e-1)"	"unprognostic (1.14e-6)"	"unprognostic (8.39e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.00e-1)"	"unprognostic (1.65e-1)"	0.9	0.3	4.9	2.0	7.2	0.7	0.5	0.9	8.3	5.5	0.6	1.8	0.4	0.5	0.8	6.3	0.4	0.4	0.3	0.4	3.8	3.1	0.8	0.4	1.0	3.3	1.9	2.7	0.3	0.5	0.3	0.8	37.1	1.1	1.4	0.4	18.6	0.4	2.9	3.6	0.4	0.7	0.5	0.8	1.5	0.8	1.6	1.8	1.7	0.3	0.0	1.1	0.9	3.1	0.0	0.1	0.4	0.1	0.2	32.8	1.7	2.4	0.0	0.1	0.0	0.1	0.0	0.0	1.2	1.4	0.5	0.5	0.1	0.4	0.0	49.8	0.6	0.2	0.8	0.1	1.3	0.0	0.9	0.0	1.9	0.0	0.0	0.3	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	15.1	0.0	0.4	11.0	1.0	15.1	6.5	4.6	0.0	1.1	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.2	0.3	0.9	15.5	0.1	1.0	0.0	0.0	0.1	0.0	1.2	0.0	0.3	0.0	0.1	0.2	0.1	0.1	0.0	1.9	0.2	0.0	0.0	32.8	15.1	0.4	0.2	0.1	0.1	1.3	1.7	4.9	7.2	0.9	2.5	3.8	3.1	1.9	2.7	1.1	1.8
NPPC	CNP	ENSG00000163273	"Natriuretic peptide C"	P23582	2	231921820-231926403	"Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 34.2;retina: 24.7"	"Cell line enhanced"	"Detected in some"		"HEK 293: 7.7;NTERA-2: 3.6;SCLC-21H: 5.1;SK-MEL-30: 22.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.7"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.7"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"pons and medulla: 33.4"	HPA035362	Uncertain				"Secreted to blood"					"HPA035362: AB_10671103"	"unprognostic (9.70e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.06e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.22e-3)"	"unprognostic (9.81e-3)"	"unprognostic (9.16e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.91e-1)"	1.4	0.9	4.1	6.3	4.4	4.5	1.4	5.4	12.0	3.0	5.0	2.9	0.7	0.9	1.6	34.2	7.3	1.8	0.6	3.9	6.9	6.3	0.9	0.5	0.8	4.5	2.8	2.2	1.8	0.5	0.5	3.8	1.1	12.4	13.1	1.3	24.7	4.4	2.0	2.4	0.8	1.6	2.2	13.3	1.7	4.3	1.0	0.9	13.7	2.1	9.3	6.0	0.5	0.6	0.0	1.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	3.6	0.0	0.9	0.0	0.0	0.0	0.0	5.1	0.3	0.2	0.2	22.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	4.1	4.4	5.4	12.0	6.9	6.3	2.8	2.2	12.4	0.9
NPSR1	"GPR154, GPRA, PGR14"	ENSG00000187258	"Neuropeptide S receptor 1"	Q6W5P4	7	34658239-34878332	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 3.5;retina: 9.1;stomach 1: 3.7"	"Group enriched"	"Detected in some"	5	"HAP1: 4.6;SCLC-21H: 2.5"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 2.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"midbrain: 9.6"													"unprognostic (3.56e-1)"	"unprognostic (9.34e-2)"	"unprognostic (7.55e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.00e-2)"		"unprognostic (9.35e-2)"			"unprognostic (6.34e-3)"			"unprognostic (2.85e-1)"	"unprognostic (1.36e-2)"		"unprognostic (2.08e-2)"	0.0	0.2	0.5	1.0	0.1	0.0	0.0	3.5	1.0	0.1	0.9	1.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.6	3.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.2	1.1	0.0	0.6	9.1	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	3.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.6	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	3.5	1.0	0.6	3.2	0.6	0.0	1.1	0.0
NRN1L	"MRCC2446, UNQ2446"	ENSG00000188038	"Neuritin 1 like"	Q496H8	16	67884805-67888855	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 20.9"	"Cell line enriched"	"Detected in some"	5	"BEWO: 26.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041761	Uncertain				"Secreted - unknown location"					"HPA041761: AB_10961155"										"unprognostic (2.79e-2)"				"unprognostic (3.32e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.99e-2)"	"unprognostic (4.85e-1)"	1.9	2.1	3.4	1.9	11.6	7.2	1.8	8.5	5.1	2.0	1.7	6.3	0.4	3.1	2.2	0.9	1.5	2.5	1.7	4.8	5.9	5.3	1.6	1.8	4.4	4.4	5.7	3.1	4.9	2.6	3.6	6.5	1.6	6.4	2.6	1.4	20.9	4.4	2.0	4.5	6.8	2.6	1.6	3.5	4.3	2.2	2.6	6.1	0.4	2.4	1.5	1.5	3.9	1.9	1.6	0.5	2.1	1.9	0.8	3.8	0.9	0.1	0.4	0.6	0.7	0.3	0.8	26.7	0.4	0.0	0.3	0.2	0.0	0.4	0.3	0.5	0.1	0.3	0.0	0.2	0.2	0.3	0.6	0.2	1.1	1.5	0.6	0.1	1.1	0.5	0.9	0.0	0.0	0.0	0.7	0.6	0.2	1.3	0.5	3.3	5.0	0.3	1.3	0.0	0.5	0.2	0.3	0.8	0.3	0.4	0.4	0.4	0.9	1.1	0.5	0.3	0.2	0.0	0.0	0.2	0.3	0.7	0.1	0.3	0.1	0.0	1.9	0.0	3.8	1.1	2.0	1.6	2.3	1.2	0.5	1.3	2.0	1.1	2.1	0.8	1.3	0.4	1.3	0.9	3.4	11.6	8.5	5.1	5.9	5.3	5.7	3.1	6.4	6.1
OC90	PLA2L	ENSG00000253117	"Otoconin 90"	Q02509	8	132024220-132059380	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 1.5;lymphoid tissue: 1.1;placenta: 1.3;retina: 2.9"	"Cell line enriched"	"Detected in single"	46	"SK-MEL-30: 4.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"														"unprognostic (1.92e-1)"						"unprognostic (2.93e-1)"			0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.4	0.2	0.7	1.5	0.0	0.0	0.0
OCA2	"BEY, BEY1, BEY2, D15S12, EYCL, EYCL2, EYCL3, P"	ENSG00000104044	"OCA2 melanosomal transmembrane protein"	Q04671	15	27754875-28099358	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 37.9;skin 1: 12.3"	"Group enriched"	"Detected in some"	6	"SH-SY5Y: 5.8;SK-MEL-30: 22.2"	"Cancer enriched"	"Detected in many"	17	"melanoma: 19.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA036402			Approved	"Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA036402: "	"unprognostic (6.07e-3)"	"unprognostic (1.97e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.82e-2)"	"unprognostic (4.60e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.47e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.20e-6)"	"unprognostic (2.61e-1)"	"unprognostic (4.21e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.28e-2)"	0.4	0.1	0.9	1.3	4.8	0.0	0.3	0.2	2.9	2.4	0.3	3.6	0.2	0.0	0.4	1.7	2.9	1.6	0.5	0.2	1.3	3.6	0.4	0.4	1.2	3.1	0.3	0.4	0.4	0.2	0.0	1.0	2.9	9.5	0.9	0.2	37.9	1.9	2.7	0.4	12.3	0.2	0.2	0.2	2.0	0.1	2.6	0.2	0.3	7.0	0.5	1.5	0.8	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.2	0.0	0.0	0.5	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.5	0.0	0.0	0.1	5.8	0.0	0.0	22.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	4.8	0.2	2.9	1.3	3.6	0.3	0.4	9.5	0.2
OR51E2	PSGR	ENSG00000167332	"Olfactory receptor family 51 subfamily E member 2"	Q9H255	11	4680171-4697854	"Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"prostate: 42.1;retina: 14.6"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.2;BJ hTERT+: 3.4"	"Cancer enriched"	"Detected in some"	274	"prostate cancer: 217.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"														"unprognostic (1.98e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.09e-3)"	"unprognostic (1.57e-2)"	"unprognostic (8.00e-4)"	"unprognostic (3.61e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.61e-1)"	"unprognostic (5.04e-5)"	"unprognostic (3.34e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.29e-1)"	0.7	0.2	0.2	5.0	0.2	0.1	1.7	0.1	0.5	0.6	8.2	0.0	0.5	0.2	1.6	1.3	0.6	0.6	0.3	1.1	0.2	0.2	0.4	0.1	0.1	0.0	0.2	0.0	1.1	0.2	0.1	0.2	5.1	0.4	42.1	2.2	14.6	0.2	2.4	0.5	0.3	0.9	2.0	0.2	0.1	0.5	0.7	0.0	0.0	0.2	0.4	0.0	1.6	0.3	1.6	0.9	2.2	0.6	0.8	1.2	0.4	0.1	0.0	0.1	0.1	0.7	6.2	0.3	0.0	3.4	0.0	0.2	0.2	0.3	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.1	1.2	1.2	0.3	0.0	0.0	0.3	0.4	0.1	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.5	0.1	0.1	0.4	0.0	0.3	0.1	0.2	0.2	0.2	0.2	0.1	0.2	0.1	0.0	0.5	0.4	0.7	0.3	0.0	0.5	0.0	0.1	0.4	0.0	0.0	1.5	0.6	0.5	1.2	0.5	0.8	0.8	0.8	0.6	0.3	1.6	0.8	1.1	2.2	0.8	0.5	0.9	0.4	0.4	0.2	0.2	0.1	0.5	0.2	0.2	0.2	0.0	0.4	0.0
OSBP2	"KIAA1664, ORP-4, ORP4, OSBPL1"	ENSG00000184792	"Oxysterol binding protein 2"	Q969R2	22	30693782-30907824	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.1;retina: 45.7"	"Cell line enhanced"	"Detected in many"		"HEL: 15.2;HeLa: 54.7;hTERT-HME1: 14.6;SiHa: 14.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021514	Uncertain		Approved	Cytosol				Cytosol	Cytosol	"HPA021514: AB_1854813"	"unprognostic (2.89e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.94e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-5)"	"unprognostic (3.01e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.31e-1)"	"prognostic favourable (3.79e-6)"	"unprognostic (9.00e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.53e-2)"	1.0	8.5	5.7	2.3	11.6	36.1	1.2	17.0	14.4	1.4	1.6	8.5	1.3	6.3	1.9	13.0	3.3	2.0	2.7	10.0	7.7	5.6	2.1	0.7	1.8	1.9	7.1	6.2	1.7	4.9	8.8	14.1	4.0	7.3	2.2	1.7	45.7	2.5	2.4	2.3	4.6	4.6	1.2	6.4	3.4	3.2	19.6	5.5	0.0	2.9	0.3	1.3	4.3	2.2	1.9	1.6	2.5	3.1	2.7	3.2	6.2	2.6	5.7	0.5	2.5	0.3	2.2	0.6	0.5	1.2	1.8	1.8	5.1	1.4	4.5	2.2	0.7	1.5	2.3	0.2	1.3	2.4	0.7	15.2	54.7	0.9	0.3	0.1	0.9	0.1	6.3	4.5	14.6	4.5	9.5	0.2	4.1	2.8	0.4	1.6	1.4	5.2	1.3	0.2	0.2	0.2	0.9	6.4	2.6	14.6	1.5	0.1	1.8	0.8	3.2	1.3	6.9	1.2	2.5	1.2	1.6	0.8	5.1	0.0	1.0	0.6	1.8	1.1	1.5	3.1	3.1	1.7	2.9	1.4	1.6	1.9	3.0	3.2	2.5	2.7	2.3	0.7	1.9	6.2	5.7	11.6	17.0	14.4	7.7	5.6	7.1	6.2	7.3	5.5
OTX1		ENSG00000115507	"Orthodenticle homeobox 1"	P32242	2	63050057-63057836	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 11.3;retina: 18.9;salivary gland: 19.6;skin 1: 14.3"	"Cell line enriched"	"Detected in many"	9	"THP-1: 33.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	113	"neutrophil: 11.3"	"Lineage enriched"	"Detected in single"	113	"granulocytes: 11.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB012341, HPA052122"	Uncertain		Uncertain	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"	"Nuclear speckles, Cytosol"	"CAB012341: AB_2157155, HPA052122: AB_2681736"	"unprognostic (2.25e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.36e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.67e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.71e-1)"	"unprognostic (0.00e+0)"	"unprognostic (4.64e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.80e-4)"	"unprognostic (3.67e-3)"	0.5	0.4	8.2	0.4	4.3	0.4	1.1	0.2	7.2	0.4	0.4	5.8	0.0	0.6	0.4	0.4	1.4	0.5	0.5	0.4	9.0	1.4	0.4	0.5	0.8	0.4	2.0	3.4	0.6	0.6	0.4	0.1	0.4	0.1	2.3	0.4	18.9	19.6	0.4	0.4	14.3	0.4	0.4	0.1	0.6	1.0	0.9	4.4	0.0	0.4	4.4	5.6	0.6	0.2	0.0	0.0	11.3	0.0	0.0	0.0	0.0	1.4	0.8	2.7	1.6	0.0	0.1	3.8	0.0	0.2	0.2	0.2	2.8	1.4	0.1	0.5	0.0	1.9	1.8	1.2	0.3	0.6	1.6	1.7	1.4	3.1	0.0	1.2	1.3	0.0	0.5	0.0	0.5	0.0	1.5	0.0	0.1	1.3	1.6	2.9	0.0	1.0	1.4	2.3	0.4	0.7	0.5	0.3	0.3	1.1	0.1	0.9	0.6	33.9	0.1	0.6	1.1	0.0	0.5	1.0	0.7	2.5	0.2	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	8.2	4.3	0.2	7.2	9.0	1.4	2.0	3.4	0.1	4.4
PAX3	"HUP2, WS1"	ENSG00000135903	"Paired box 3"	P23760	2	222199888-222298996	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 19.1;retina: 39.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 7.5;BJ hTERT+ SV40 Large T+ RasG12V: 8.9;HBF TERT88: 6.6;RH-30: 12.9;SK-MEL-30: 22.7"	"Cancer enriched"	"Detected in some"	24	"melanoma: 20.3"	"Group enriched"	"Detected in some"	6	"cerebellum: 19.1;pons and medulla: 7.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"cerebellum: 3.9;midbrain: 1.6;pons and medulla: 1.4"	"Group enriched"	"Detected in many"	5	"cerebellum: 10.0;midbrain: 11.7;pons and medulla: 3.5"	"HPA063659, HPA069000"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA063659: AB_2685080, HPA069000: AB_2686067"	"unprognostic (2.57e-2)"				"unprognostic (1.48e-2)"	"unprognostic (1.27e-2)"		"unprognostic (1.65e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.70e-1)"		"unprognostic (6.18e-2)"		"unprognostic (1.41e-1)"	"unprognostic (2.26e-1)"		"unprognostic (9.70e-2)"	0.8	0.1	0.0	0.1	0.8	0.1	2.9	19.1	0.2	0.3	0.1	0.1	0.3	0.1	0.2	0.1	0.1	0.1	0.1	0.3	0.0	0.2	0.1	0.1	0.1	0.2	2.2	0.0	0.1	0.2	0.1	0.0	0.1	7.8	0.4	0.1	39.6	7.9	0.2	8.6	7.9	0.1	0.1	4.2	0.1	0.2	2.9	0.8	0.0	0.1	3.9	0.5	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	5.1	5.1	7.5	8.9	0.0	0.5	0.0	0.0	3.4	0.0	0.0	0.0	6.6	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	5.3	0.1	0.0	0.0	12.9	0.0	0.0	0.0	1.3	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	2.8	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.8	19.1	0.1	0.0	0.2	2.2	0.0	7.8	0.8
PAX6	"AN, AN2, D11S812E, WAGR"	ENSG00000007372	"Paired box 6"	P26367	11	31784779-31818062	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 78.3;retina: 29.4"	"Cell line enhanced"	"Detected in some"		"AF22: 11.6;AN3-CA: 15.0;HEK 293: 14.1;HeLa: 11.0;U-251 MG: 12.3"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Region enriched"	"Detected in all"	5	"cerebellum: 78.3"	"Cell type enhanced"	"Detected in some"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"cerebellum: 61.0;olfactory region: 41.2"	"Low region specificity"	"Detected in all"			"HPA030775, CAB034143"	Enhanced	Supported	Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB034143: AB_1127044, HPA030775: AB_10601243"	"unprognostic (2.89e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.42e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.91e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.42e-3)"	0.8	2.0	12.6	0.8	10.4	1.1	1.0	78.3	23.5	0.8	1.1	9.3	0.0	3.5	0.8	1.8	0.8	0.8	0.8	0.8	16.0	3.7	0.9	0.9	0.7	0.9	3.9	9.1	0.8	15.8	0.8	4.6	0.8	10.8	0.8	1.4	29.4	0.8	0.9	1.9	1.6	2.0	0.8	16.1	0.8	19.4	2.8	9.8	0.0	0.8	0.0	1.0	1.1	0.3	0.2	0.2	1.6	0.4	0.4	0.5	0.1	0.0	0.2	11.6	15.0	3.7	5.0	4.5	0.0	0.0	0.1	0.0	0.9	2.7	0.1	4.8	1.6	0.3	1.3	0.0	0.2	0.0	14.1	6.6	11.0	6.2	0.0	0.3	0.0	0.0	0.5	0.1	0.3	0.0	5.3	0.0	0.2	0.0	2.7	0.4	0.2	7.6	0.0	5.5	0.1	0.6	0.4	0.5	0.0	0.3	0.1	0.0	3.4	0.0	0.0	3.9	0.3	0.0	12.3	0.0	0.1	0.0	6.2	0.0	0.0	1.6	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.2	0.2	0.2	0.3	1.0	0.4	0.4	0.2	0.1	0.1	12.6	10.4	78.3	12.2	16.0	3.7	3.9	9.1	10.8	9.8
PCDH15	"CDHR15, DFNB23, USH1F"	ENSG00000150275	"Protocadherin related 15"	Q96QU1	10	53802771-55627942	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 27.4;retina: 25.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.1;HUVEC TERT2: 1.7;U-2 OS: 2.7;U-266/70: 8.1"	"Cancer enriched"	"Detected in single"	9	"glioma: 0.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA074437		Supported			"Intracellular and membrane"					"HPA074437: "	"unprognostic (1.38e-1)"	"unprognostic (3.39e-1)"		"unprognostic (8.15e-5)"	"unprognostic (3.07e-3)"	"unprognostic (2.79e-1)"		"unprognostic (9.15e-4)"	"unprognostic (2.02e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.12e-3)"		"unprognostic (1.31e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-1)"	"unprognostic (7.66e-3)"	0.7	27.4	9.7	0.9	7.4	0.6	0.5	4.3	10.9	0.7	0.7	5.6	0.0	0.8	0.6	1.1	0.6	0.6	0.6	0.9	10.5	5.8	11.0	0.5	3.7	1.8	6.0	3.2	0.5	0.5	0.4	6.9	0.7	8.7	0.7	0.5	25.1	0.6	0.5	0.4	0.5	0.8	0.5	5.7	1.3	0.9	4.4	7.9	0.0	0.6	0.0	1.2	1.5	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.6	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	1.7	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.1	0.0	0.0	1.5	2.7	0.0	0.0	8.1	0.8	0.0	1.2	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.7	7.4	4.3	7.1	10.5	5.8	6.0	3.2	8.7	7.9
PDE6B	"CSNB3, CSNBAD2, PDEB, rd1, RP40"	ENSG00000133256	"Phosphodiesterase 6B"	P35913	4	625584-670782	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.2;retina: 64.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 8.0;MOLT-4: 20.5;REH: 11.1;SCLC-21H: 14.0;SH-SY5Y: 8.2;U-266/84: 15.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA054148, HPA059929"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"HPA054148: AB_2682401, HPA059929: AB_2684166"	"unprognostic (2.43e-2)"	"unprognostic (1.33e-4)"	"unprognostic (2.45e-4)"	"unprognostic (7.18e-3)"	"unprognostic (1.88e-2)"	"unprognostic (5.04e-3)"	"unprognostic (7.32e-3)"	"prognostic favourable (5.34e-4)"	"unprognostic (9.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.85e-1)"	1.6	1.9	12.1	4.6	19.1	6.7	3.8	2.3	13.2	2.3	1.3	30.2	1.5	0.8	2.5	3.9	1.4	9.6	3.2	5.2	18.1	10.2	4.6	0.7	4.2	12.0	29.6	9.8	2.6	1.4	9.1	3.2	2.6	14.5	2.5	1.0	64.2	3.5	2.9	0.7	1.8	2.2	2.1	20.2	8.7	2.5	3.6	22.4	4.3	11.4	0.2	8.3	4.1	1.1	16.5	14.1	11.2	5.8	10.2	13.1	7.1	0.0	0.2	0.8	0.4	0.2	0.3	0.2	0.0	0.0	0.5	1.4	0.0	0.1	0.2	8.0	0.2	0.1	1.7	0.4	0.0	0.1	0.0	0.6	0.2	0.0	4.1	0.1	0.3	0.5	0.1	2.4	0.0	0.7	0.1	0.6	0.0	0.2	20.5	0.2	6.5	0.2	11.1	0.2	0.4	1.4	0.9	14.0	8.2	0.0	0.3	0.1	0.4	0.0	0.2	0.1	0.8	0.1	0.3	5.4	15.2	0.2	0.2	0.2	0.1	11.2	4.2	0.6	11.5	5.8	10.5	10.0	7.7	7.9	6.6	16.5	12.2	13.1	1.1	10.2	5.6	14.1	11.4	7.1	12.1	19.1	2.3	10.0	18.1	10.2	29.6	9.8	14.5	22.4
PI16	"CD364, dJ90K10.5, MGC45378, MSMBBP"	ENSG00000164530	"Peptidase inhibitor 16"	Q6UXB8	6	36948263-36964837	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 87.2"	"Group enriched"	"Detected in some"	4	"Daudi: 9.0;fHDF/TERT166: 8.3"	"Cancer enhanced"	"Detected in many"		"glioma: 15.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 29.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 29.9"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"midbrain: 6.0"	HPA076574	Approved				"Secreted to blood"	3600000000	3600000000			"HPA076574: AB_2732314"	"unprognostic (6.24e-3)"	"unprognostic (6.00e-3)"	"unprognostic (7.34e-2)"	"unprognostic (9.53e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.06e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.25e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.59e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.76e-2)"	22.2	1.7	2.9	1.4	8.8	0.3	27.9	0.7	4.5	62.7	4.5	21.4	22.5	0.8	11.1	27.0	10.5	5.3	17.4	43.1	4.6	3.5	0.8	0.5	3.7	1.1	9.0	3.9	2.8	2.5	0.6	3.3	1.2	9.3	15.0	3.4	87.2	4.0	14.2	5.5	19.8	2.0	55.5	13.7	0.8	8.5	8.3	9.3	0.1	8.3	8.7	4.8	32.7	49.8	0.7	0.2	0.2	0.0	5.7	29.9	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	9.0	0.5	8.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.9	0.3	9.8	2.9	0.0	0.7	3.4	1.0	0.2	5.7	0.0	0.2	29.9	1.7	2.9	8.8	0.7	4.5	4.6	3.5	9.0	3.9	9.3	9.3
PITX2	"ARP1, Brx1, IGDS, IHG2, IRID2, Otlx2, RGS, RIEG, RIEG1, RS"	ENSG00000164093	"Paired like homeodomain 2"	Q99697	4	110617423-110642123	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 30.4;retina: 53.5;skeletal muscle: 28.8"	"Cell line enhanced"	"Detected in many"		"CACO-2: 17.7;HEK 293: 7.8;LHCN-M2: 18.2;RH-30: 15.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"hypothalamus: 2.1;midbrain: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 9.8"	"Region enhanced"	"Detected in single"		"hypothalamus: 5.1"	"HPA050074, HPA062728"			Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA050074: AB_2681005, HPA062728: AB_2684851"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.29e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.14e-2)"	"unprognostic (9.61e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.11e-15)"	"unprognostic (6.97e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.98e-2)"	"unprognostic (9.91e-2)"	0.6	0.1	0.0	18.6	0.0	0.1	0.3	0.0	0.1	1.1	3.0	0.0	0.3	0.1	0.1	1.3	2.7	0.2	1.1	3.5	0.0	2.1	0.3	0.1	0.1	0.1	1.1	0.0	0.1	0.5	0.1	12.5	30.4	0.0	8.3	0.3	53.5	9.3	0.2	28.8	0.9	3.4	15.9	0.0	0.1	0.5	0.3	0.0	0.0	0.1	16.8	0.4	19.4	5.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	1.8	0.0	0.7	1.8	1.5	2.9	0.6	0.3	2.0	1.5	17.7	0.0	0.0	3.8	3.6	0.3	0.1	0.0	1.1	0.0	7.8	0.0	1.4	0.0	6.6	0.0	3.7	2.0	0.1	0.3	0.0	0.0	0.4	0.0	18.2	0.5	1.9	0.0	0.3	0.3	0.0	15.3	0.0	0.3	2.4	0.0	0.0	1.4	2.4	0.2	0.1	0.0	0.0	2.4	5.8	0.0	2.9	0.0	0.1	0.7	1.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.1	0.0	0.0	0.0
PLA2G5		ENSG00000127472	"Phospholipase A2 group V"	P39877	1	20028179-20091190	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 48.3;retina: 58.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.4;HaCaT: 1.0;hTEC/SVTERT24-B: 1.5;U-138 MG: 3.1;U-2197: 6.6"	"Group enriched"	"Detected in many"	5	"glioma: 13.0;prostate cancer: 3.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	23	"plasmacytoid DC: 2.3"	"Lineage enriched"	"Detected in single"	23	"dendritic cells: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053361	Approved				"Secreted - unknown location"					"HPA053361: AB_2682127"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.01e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.70e-3)"	"unprognostic (6.00e-5)"	"unprognostic (2.87e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.97e-3)"	2.6	0.5	2.8	2.0	6.7	0.2	1.9	1.9	5.2	0.3	10.5	2.1	2.5	1.2	0.5	2.1	5.7	1.9	3.0	48.3	2.6	2.4	0.2	1.8	3.2	1.0	6.1	2.0	17.3	1.2	0.2	0.1	8.3	6.8	6.9	3.2	58.3	1.0	10.3	0.4	0.4	1.0	19.3	1.0	0.8	2.3	3.3	1.3	0.0	0.7	0.0	1.7	7.3	2.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	3.1	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	2.8	6.7	1.9	5.2	2.6	2.4	6.1	2.0	6.8	1.3
PLCB4		ENSG00000101333	"Phospholipase C beta 4"	Q15147	20	9068763-9481242	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.9;retina: 40.2;salivary gland: 39.8"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 38.0;hTERT-HME1: 18.6;LHCN-M2: 30.6;RPTEC TERT1: 39.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.5"	"Group enriched"	"Detected in all"	4	"cerebellum: 44.9;pons and medulla: 11.9"	"Cell type enriched"	"Detected in single"	20	"plasmacytoid DC: 6.6"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 6.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007951	Approved		Approved	Nucleoplasm,Microtubules				Microtubules	Microtubules	"HPA007951: AB_2667944"	"unprognostic (3.88e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.19e-2)"	"prognostic favourable (2.11e-4)"	"unprognostic (1.44e-2)"	"unprognostic (9.72e-3)"	"unprognostic (3.32e-3)"	"unprognostic (2.57e-2)"	"unprognostic (7.75e-2)"	"unprognostic (4.23e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.64e-3)"	"unprognostic (7.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.45e-2)"	5.5	5.0	2.1	4.5	4.6	0.2	5.6	44.9	5.2	6.0	13.1	2.7	2.4	1.6	12.3	16.2	6.9	10.9	6.2	12.4	2.3	6.6	2.3	0.9	4.4	1.0	4.0	3.3	2.9	1.3	0.5	15.1	4.4	11.9	6.9	12.6	40.2	39.8	7.1	2.5	4.3	3.1	12.3	3.1	1.1	9.7	2.1	2.4	4.3	21.9	4.4	2.0	7.1	8.8	0.0	6.6	0.0	0.0	0.3	0.0	0.0	0.0	6.1	3.0	0.0	0.0	0.1	0.0	13.3	3.8	4.0	2.5	1.1	0.9	0.0	0.2	38.0	0.0	0.9	2.9	6.0	0.0	1.8	1.6	2.2	0.0	0.5	0.0	0.0	0.9	1.2	5.1	18.6	0.0	1.5	0.1	30.6	1.9	0.0	0.0	3.2	3.8	0.0	0.0	0.2	39.1	2.8	10.2	7.0	0.0	9.2	5.6	7.8	0.0	0.1	4.3	0.3	0.4	5.2	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	6.6	0.0	0.0	2.1	4.6	44.9	5.2	2.3	6.6	4.0	3.3	11.9	2.4
PLCE1	"KIAA1516, NPHS3, PLCE"	ENSG00000138193	"Phospholipase C epsilon 1"	Q9P212	10	94030812-94332823	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 44.6"	"Cell line enhanced"	"Detected in many"		"RT4: 18.7;U-2 OS: 11.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015597, HPA015598"	Enhanced		Supported	Cytosol				Cytosol	Cytosol	"HPA015597: AB_1855321, HPA015598: AB_1855322"	"unprognostic (4.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.73e-2)"	"unprognostic (4.76e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.56e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.54e-2)"	"unprognostic (4.30e-2)"	3.2	2.4	4.1	9.1	5.5	0.0	2.2	1.8	7.9	9.2	13.8	3.1	1.6	5.0	11.4	4.6	4.5	4.2	3.8	12.8	4.1	2.6	6.3	0.7	7.2	0.4	2.4	6.8	3.2	12.8	0.1	5.2	3.1	6.4	3.3	12.6	44.6	2.1	7.7	4.3	0.7	4.6	5.8	2.4	5.8	8.7	1.7	2.3	0.0	15.1	7.3	1.1	7.9	5.4	3.2	1.2	0.8	0.9	1.1	2.3	0.5	6.0	8.3	1.8	1.0	1.0	5.9	2.3	3.7	1.0	0.8	1.2	5.4	1.5	0.7	1.9	3.0	2.6	4.2	1.0	1.3	0.4	2.1	0.4	4.6	0.5	0.1	0.8	0.3	2.4	0.0	2.2	0.0	0.0	0.4	0.3	7.2	0.2	0.7	0.8	0.6	8.7	0.1	5.7	0.2	0.2	18.7	0.8	1.5	4.4	6.0	0.5	5.1	0.5	0.6	3.9	11.2	2.3	4.9	0.5	0.2	0.3	3.1	1.0	3.5	0.4	0.5	0.1	1.5	0.9	1.3	2.6	1.6	1.1	0.6	3.2	2.3	1.8	0.8	1.1	0.8	1.2	0.6	0.5	4.1	5.5	1.8	7.9	4.1	2.6	2.4	6.8	6.4	2.3
PLCH2	"KIAA0450, PLC-eta2, PLCeta2, PLCL4, RP3-395M20.1"	ENSG00000149527	"Phospholipase C eta 2"	O75038	1	2425980-2505530	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.0;retina: 28.6;skin 1: 36.6"	"Group enriched"	"Detected in some"	4	"HBEC3-KT: 49.5;hTCEpi: 23.3;hTERT-HME1: 13.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"NK-cells: 2.9;T-cells: 2.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA072705	Enhanced									"HPA072705: AB_2732211"	"unprognostic (2.06e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.09e-3)"	"unprognostic (3.84e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.59e-2)"	"unprognostic (7.39e-2)"	"unprognostic (7.70e-2)"	"unprognostic (7.58e-2)"	"unprognostic (9.28e-2)"	"unprognostic (2.26e-1)"	"unprognostic (5.95e-2)"	"unprognostic (6.61e-3)"	"unprognostic (8.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.64e-2)"	"unprognostic (5.80e-2)"	0.5	1.2	6.4	2.9	9.1	1.4	3.1	32.0	25.1	3.2	0.9	1.6	0.5	1.6	0.3	1.7	9.7	2.5	2.4	0.3	20.2	2.7	0.8	0.8	1.2	4.0	2.6	8.4	0.2	1.7	0.1	3.0	0.4	2.6	6.7	0.7	28.6	8.6	4.9	0.2	36.6	2.0	0.2	6.4	4.0	1.7	0.8	2.0	0.2	1.2	0.2	4.9	8.3	6.4	0.3	0.1	0.0	0.0	2.9	2.4	0.9	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	6.9	0.0	49.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	13.9	0.0	0.0	1.2	0.1	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	2.7	5.6	1.5	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.9	0.3	1.5	1.4	0.0	0.3	1.1	0.7	0.0	2.9	0.0	0.1	2.1	0.9	6.4	9.1	32.0	25.1	20.2	2.7	2.6	8.4	2.6	2.0
PLXNC1	"CD232, VESPR"	ENSG00000136040	"Plexin C1"	O60486	12	94148723-94307675	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 43.5;retina: 40.6"	"Cell line enhanced"	"Detected in many"		"HAP1: 14.9;SK-MEL-30: 18.5;U-266/70: 29.4;U-266/84: 30.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 24.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 14.2;monocytes: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026155, HPA066899"	Uncertain		Approved	Mitochondria		82000	82000	Mitochondria	Mitochondria	"CAB026155: , HPA066899: AB_2685743"	"unprognostic (1.49e-1)"	"unprognostic (4.01e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.24e-2)"	"unprognostic (4.67e-3)"	"unprognostic (2.80e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.02e-2)"	"unprognostic (5.33e-3)"	"unprognostic (3.19e-2)"	"unprognostic (6.85e-3)"	"unprognostic (5.48e-2)"	6.6	7.5	7.1	16.1	6.9	12.6	3.9	16.8	8.6	8.0	5.1	3.1	0.8	3.1	7.3	2.2	4.9	4.3	8.3	4.1	6.3	15.2	3.2	2.0	15.2	43.5	4.5	7.7	13.0	2.3	0.5	6.3	7.5	5.2	4.3	5.4	40.6	3.7	3.7	2.9	6.6	5.0	5.7	4.9	28.6	3.4	12.1	3.3	8.6	3.3	2.7	10.2	9.6	6.5	2.4	2.5	14.2	6.7	0.9	1.7	1.5	0.4	0.2	1.2	0.2	0.7	0.5	0.1	0.6	0.8	0.8	2.3	4.0	0.0	9.5	0.0	0.9	0.0	14.9	0.6	0.5	6.6	0.3	0.5	0.2	2.7	8.3	1.9	3.3	8.2	0.0	0.9	0.4	0.0	0.2	11.7	0.2	0.1	0.4	1.0	2.5	0.5	1.5	0.4	5.2	0.0	0.7	1.0	0.7	0.1	0.1	18.5	0.0	1.6	0.3	0.2	1.1	0.1	0.3	29.4	30.6	0.6	0.1	5.2	0.6	0.0	3.0	12.2	1.4	5.2	1.6	2.4	1.6	1.7	2.5	1.4	1.4	1.5	14.2	0.9	6.7	0.9	1.0	1.5	7.1	6.9	16.8	8.6	6.3	15.2	4.5	7.7	5.2	3.3
PROM1	"AC133, CD133, CORD12, MCDR2, PROML1, RP41, STGD4"	ENSG00000007062	"Prominin 1"	O43490	4	15963076-16084378	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 52.4;salivary gland: 71.0"	"Cell line enhanced"	"Detected in some"		"AF22: 13.5;CACO-2: 25.1;CAPAN-2: 10.7;EFO-21: 24.5;NTERA-2: 36.4;RPTEC TERT1: 33.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA004922, CAB011525, HPA031053"	Enhanced									"CAB011525: AB_470302, HPA004922: AB_1846238, HPA031053: AB_2673713"	"unprognostic (6.33e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.21e-2)"	"unprognostic (9.06e-2)"	"prognostic favourable (2.56e-5)"	"unprognostic (2.16e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.17e-1)"	0.5	0.5	2.5	11.5	2.2	1.3	11.2	1.0	2.2	20.1	13.8	2.3	1.6	5.2	4.7	3.1	1.8	1.9	12.6	2.7	3.1	2.1	30.2	1.6	3.6	0.1	2.3	0.6	1.6	10.7	0.0	1.8	12.7	2.1	1.6	7.4	52.4	71.0	2.9	0.7	1.1	13.5	1.7	1.8	0.6	10.9	5.0	0.9	0.3	1.7	3.8	10.2	3.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	1.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	10.7	0.3	24.5	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	36.4	0.0	0.9	0.0	0.0	33.7	0.0	4.2	1.4	0.0	0.8	1.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.5	2.2	1.0	2.2	3.1	2.1	2.3	0.6	2.1	0.9
PRSS56		ENSG00000237412	"Serine protease 56"	P0CW18	2	232520463-232525716	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.4;retina: 8.6;skeletal muscle: 16.2"	"Cell line enriched"	"Detected in single"	5	"Daudi: 4.6"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 4.7"	"Region enhanced"	"Detected in many"		"hypothalamus: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"basal ganglia: 1.6;olfactory region: 5.2"	"Region enhanced"	"Detected in many"		"olfactory region: 32.6"														"unprognostic (3.26e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.73e-3)"			"unprognostic (2.28e-1)"	"unprognostic (7.15e-2)"				"unprognostic (4.64e-2)"	"unprognostic (1.20e-1)"			0.1	0.1	0.3	0.1	1.8	0.1	0.1	0.1	1.0	0.1	0.1	0.1	0.1	0.1	0.1	1.1	0.1	0.1	0.1	0.1	0.2	4.4	0.1	0.1	0.1	0.1	2.2	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.2	0.1	8.6	0.1	0.1	16.2	0.1	0.1	0.1	0.8	0.2	0.1	2.6	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.8	0.1	1.0	0.2	4.4	2.2	0.1	0.1	0.1
PRTG	"FLJ25756, IGDCC5"	ENSG00000166450	Protogenin	Q2VWP7	15	55611546-55743090	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 16.5;thyroid gland: 23.9"	"Cell line enriched"	"Detected in many"	6	"AF22: 57.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	18	"non-classical monocyte: 1.7"	"Lineage enriched"	"Detected in single"	18	"monocytes: 1.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA032138			Approved	"Vesicles,Plasma membrane,Cytosol"				Cytosol	Cytosol	"HPA032138: AB_10669675"	"unprognostic (2.80e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.96e-4)"	"unprognostic (1.82e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.32e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.42e-6)"	"unprognostic (8.81e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.70e-1)"	1.3	2.2	1.5	1.1	1.8	0.6	2.4	1.2	2.2	4.7	1.4	3.6	1.1	0.7	11.0	4.6	0.7	2.4	1.0	1.3	1.6	1.6	2.6	0.6	5.0	0.6	3.0	2.0	4.5	0.6	6.4	2.7	6.5	4.3	1.4	0.9	16.5	0.9	1.4	3.9	0.6	0.9	2.9	3.5	0.5	1.5	6.5	2.3	0.0	23.9	0.8	0.9	1.2	1.6	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.5	1.2	57.4	1.2	0.0	0.0	5.8	0.4	1.7	1.4	2.1	9.6	0.3	0.0	2.4	0.0	0.0	0.2	0.1	2.0	0.0	3.0	0.4	0.4	3.6	0.4	0.4	0.0	0.2	0.0	0.6	1.0	1.0	1.0	0.0	0.8	0.8	0.0	0.0	2.3	1.4	0.0	9.1	0.0	1.1	0.1	0.7	3.3	0.5	0.7	3.1	0.2	0.1	0.1	0.8	0.6	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.5	1.8	1.2	2.2	1.6	1.6	3.0	2.0	4.3	2.3
PTGDS	"L-PGDS, PGDS"	ENSG00000107317	"Prostaglandin D2 synthase"	P41222	9	136975092-136981742	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 286.6;retina: 331.2"	"Group enriched"	"Detected in some"	6	"HHSteC: 103.8;HSkMC: 50.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	27	"plasmacytoid DC: 140.9"	"Lineage enriched"	"Detected in many"	27	"dendritic cells: 140.9"									"HPA004938, CAB009916"	Approved				"Secreted to blood"	4300000000	4300000000			"CAB009916: AB_2174617, HPA004938: AB_1855745"	"unprognostic (2.79e-2)"	"unprognostic (3.96e-3)"	"unprognostic (9.70e-2)"	"unprognostic (5.71e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (1.19e-7)"	"unprognostic (8.49e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.21e-2)"	34.1	27.9	138.1	37.5	159.8	2.5	11.3	61.5	154.6	260.4	10.5	192.5	23.0	6.4	22.5	130.0	26.0	72.4	65.8	286.6	121.0	85.2	22.3	6.0	39.7	114.8	170.8	130.6	7.0	20.0	1.8	20.6	38.5	118.8	78.5	4.2	331.2	18.8	149.8	17.0	19.7	11.2	18.6	188.0	50.1	13.5	218.5	103.2	3.3	3.4	4.3	51.1	49.5	75.8	0.0	140.9	0.2	0.1	0.3	5.2	1.0	0.0	0.0	0.0	0.0	1.0	3.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	4.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	103.8	0.0	0.2	50.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.1	13.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	5.2	0.1	0.3	0.0	0.4	0.6	0.1	0.0	0.1	1.1	0.2	0.3	0.0	140.9	0.1	1.0	138.1	159.8	61.5	154.6	121.0	85.2	170.8	130.6	118.8	103.2
RAB38	NY-MEL-1	ENSG00000123892	"RAB38, member RAS oncogene family"	P57729	11	88113242-88175467	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 35.5;tongue: 38.1"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 18.9;hTCEpi: 68.0;hTERT-HME1: 60.6;SK-MEL-30: 36.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 73.8"	"Region enriched"	"Detected in single"	5	"pons and medulla: 3.2"	"Group enriched"	"Detected in many"	5	"NK-cell: 15.3;plasmacytoid DC: 4.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 4.2;NK-cells: 15.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA071701			Uncertain	"Nuclear bodies,Mitochondria"				"Nuclear bodies, Mitochondria"	"Nuclear bodies, Mitochondria"	"HPA071701: "	"unprognostic (2.85e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.36e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.96e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.44e-1)"	"unprognostic (9.34e-2)"	"unprognostic (1.00e-2)"	"unprognostic (8.23e-2)"	"prognostic favourable (8.26e-4)"	"unprognostic (3.82e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-2)"	1.8	15.6	0.4	1.2	0.4	0.4	4.6	0.3	0.6	10.8	1.6	1.2	2.8	1.0	7.0	8.7	29.9	2.8	8.2	1.7	0.6	0.5	2.6	0.8	5.3	0.4	0.5	0.2	3.0	2.3	0.9	4.6	7.7	3.2	4.0	0.4	35.5	4.9	5.2	0.5	24.9	2.4	2.7	0.7	1.3	0.9	5.3	0.1	1.6	6.6	38.1	21.0	4.2	13.3	0.0	4.2	0.5	1.3	15.3	1.8	0.6	2.2	0.3	0.0	0.1	0.0	0.5	0.1	1.4	5.7	2.3	4.2	1.0	1.0	0.1	1.4	1.5	15.6	1.2	18.9	3.1	0.2	1.1	11.4	1.5	0.0	0.2	0.1	0.1	0.5	68.0	0.3	60.6	2.7	0.0	0.2	0.0	0.0	0.1	3.8	1.8	0.0	0.1	0.0	0.1	4.4	8.7	0.4	0.2	0.0	0.0	36.6	3.4	1.0	1.5	0.0	1.0	0.0	0.2	0.3	1.4	0.0	0.3	0.4	0.2	0.0	0.6	0.1	1.6	0.6	0.9	0.0	0.5	1.8	1.5	0.0	0.1	0.9	0.5	15.3	1.3	4.2	0.9	0.6	0.4	0.4	0.3	0.6	0.6	0.5	0.5	0.2	3.2	0.1
RARB	"HAP, NR1B2, RRB2"	ENSG00000077092	"Retinoic acid receptor beta"	P10826	3	25174332-25597932	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"retina: 39.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 9.9;HEK 293: 11.2;HUVEC TERT2: 9.3;WM-115: 25.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 22.6"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in many"	9	"basal ganglia: 97.9"	"Low region specificity"	"Detected in all"			"CAB002617, HPA004174"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB002617: , HPA004174: AB_1079744"	"unprognostic (2.04e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.86e-1)"	"prognostic favourable (3.43e-5)"	"unprognostic (9.24e-3)"	"unprognostic (2.28e-1)"	"unprognostic (9.99e-2)"	"unprognostic (6.56e-3)"	3.9	7.1	2.4	2.3	22.6	0.0	6.8	1.5	9.1	13.4	6.0	2.2	6.8	1.7	14.4	7.5	8.1	6.2	5.3	13.6	2.6	2.2	17.5	6.2	5.6	5.6	2.0	3.7	12.2	1.5	12.8	18.9	13.9	3.2	13.0	2.3	39.1	13.7	11.8	2.5	1.4	2.4	14.7	4.6	7.7	4.8	1.7	4.8	0.0	10.0	2.9	4.6	12.1	10.2	1.0	0.4	0.1	0.6	0.1	0.8	0.0	0.0	1.3	0.8	4.5	9.9	2.6	0.0	1.1	0.5	0.0	0.4	0.2	0.0	0.1	0.1	1.7	0.2	0.0	0.1	0.0	0.0	11.2	0.1	0.1	0.7	0.2	0.1	0.1	5.2	0.0	0.0	0.0	9.3	0.1	3.9	0.1	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.4	5.9	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.1	1.5	4.8	0.1	0.0	0.0	4.0	0.1	25.6	0.0	0.6	0.0	0.8	0.1	0.3	0.3	0.5	0.5	0.4	1.0	0.6	0.8	0.1	0.1	0.1	0.4	0.0	0.0	2.4	22.6	1.5	9.1	2.6	2.2	2.0	3.7	3.2	4.8
RBP1	"CRABP-I, CRBP, CRBP1, CRBPI, RBPC"	ENSG00000114115	"Retinol binding protein 1"	P09455	3	139517434-139539829	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 161.0;pancreas: 107.4;retina: 85.3"	"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 134.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"basal ganglia: 56.8"	"HPA007338, CAB018603, CAB019276"	Enhanced		Approved	Nucleoplasm,Cytosol				Cytosol	Cytosol	"CAB018603: AB_2060572, CAB019276: , HPA007338: AB_2667814"	"unprognostic (9.62e-3)"	"unprognostic (7.67e-2)"	"unprognostic (9.53e-3)"	"unprognostic (5.17e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.27e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.74e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.28e-3)"	1.9	43.1	6.5	3.3	11.3	0.1	7.5	5.1	7.8	7.8	3.2	11.5	8.4	4.5	26.8	11.3	3.3	58.4	42.7	7.5	7.7	8.1	3.7	20.1	4.9	6.5	10.4	4.9	161.0	107.4	4.3	26.2	20.6	31.5	9.8	2.1	85.3	4.7	6.4	1.8	2.9	4.8	17.5	8.7	4.7	2.8	12.9	4.3	0.9	3.3	2.6	2.0	7.7	7.2	0.5	0.5	2.1	0.9	0.7	0.4	0.2	1.2	0.3	1.1	26.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.0	0.0	8.6	0.0	0.0	6.0	0.1	0.0	0.0	0.7	0.0	0.4	11.0	25.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	2.9	0.0	0.0	5.1	0.0	0.0	0.0	3.1	134.2	5.5	0.0	0.0	0.5	0.1	0.0	0.0	19.6	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	1.2	0.9	0.8	0.4	0.8	0.1	0.4	0.2	0.1	0.0	0.5	0.3	0.2	2.1	0.7	0.5	0.5	0.1	0.2	6.5	11.3	5.1	7.8	7.7	8.1	10.4	4.9	31.5	4.3
RDH10	SDR16C4	ENSG00000121039	"Retinol dehydrogenase 10"	Q8IZV5	8	73294612-73325281	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 134.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 46.6;BJ: 33.4;CACO-2: 29.8;HDLM-2: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 4.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 4.4;T-cells: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049199			Supported	"Lipid droplets"				"Lipid droplets"	"Lipid droplets"	"HPA049199: AB_2680673"	"unprognostic (1.78e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.86e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.80e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.18e-3)"	"unprognostic (8.88e-3)"	"unprognostic (1.13e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.98e-3)"	"unprognostic (6.23e-2)"	18.3	3.2	2.7	9.5	3.3	0.7	11.8	1.7	2.8	8.2	18.7	2.9	10.0	13.6	5.9	5.8	9.4	4.4	21.9	9.6	2.3	2.4	19.6	37.5	8.7	4.8	4.1	1.7	4.9	14.8	3.7	17.9	20.9	8.7	12.4	6.4	134.3	22.6	5.7	3.4	4.4	34.1	14.0	6.9	5.6	15.3	8.0	2.1	2.0	3.5	7.3	6.5	12.8	6.5	0.6	0.7	4.4	0.6	0.2	2.3	0.5	4.1	12.1	1.3	5.6	46.6	3.4	12.4	33.4	5.4	1.3	2.2	29.8	12.0	2.9	4.4	18.6	11.1	6.1	4.8	2.7	33.5	15.3	5.2	12.0	9.1	1.8	2.4	5.7	2.0	6.2	5.2	4.9	4.9	5.9	4.3	2.2	1.8	2.5	1.0	1.6	5.9	2.2	1.4	1.7	9.0	6.0	0.8	1.0	2.8	20.8	1.7	4.1	1.3	7.4	2.0	3.4	9.1	2.5	2.8	2.9	2.4	1.6	2.2	4.6	4.4	0.6	1.1	1.2	0.3	0.7	0.6	1.3	1.4	0.7	0.1	2.3	1.2	0.8	0.2	0.5	0.2	0.7	0.5	2.7	3.3	1.7	1.8	2.3	2.4	4.1	1.7	8.7	2.1
RDH5	"HSD17B9, RDH1, SDR9C5"	ENSG00000135437	"Retinol dehydrogenase 5"	Q92781	12	55720367-55724705	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 39.4;retina: 127.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 19.5;ASC TERT1: 16.8;hTEC/SVTERT24-B: 10.2;LHCN-M2: 10.1;U-87 MG: 18.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063345			Approved	Vesicles	"Intracellular and membrane"			Vesicles	Vesicles	"HPA063345: AB_2684992"	"unprognostic (1.04e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.26e-3)"	"unprognostic (7.63e-2)"	"unprognostic (8.79e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.12e-3)"	"unprognostic (3.27e-2)"	39.4	0.7	0.6	2.8	0.8	0.2	14.9	0.5	0.8	1.0	7.6	1.0	1.5	8.6	1.9	4.5	2.4	2.2	4.8	3.9	1.0	0.5	3.7	27.2	0.7	1.6	0.8	0.8	1.4	1.5	0.0	0.6	0.4	1.5	1.8	1.9	127.9	3.2	1.0	3.1	1.0	9.4	8.8	1.1	0.9	2.7	0.9	1.0	0.3	1.1	2.6	0.7	2.0	2.5	0.4	2.3	2.1	0.9	1.5	2.6	0.4	0.4	0.9	0.5	0.3	19.5	16.8	0.4	2.5	2.8	0.5	1.0	0.3	5.2	0.6	0.4	1.4	0.2	0.2	0.0	0.4	0.6	0.8	0.1	1.1	1.3	0.5	0.0	0.2	7.2	0.6	10.2	0.0	0.2	0.1	0.9	10.1	0.4	0.2	0.1	0.2	1.5	0.3	0.3	0.3	0.1	0.5	0.2	0.7	0.1	0.3	2.3	0.4	0.4	0.3	1.0	1.0	0.7	0.6	0.8	0.3	0.1	18.1	0.2	0.2	0.3	0.6	2.1	0.4	0.9	0.2	0.4	1.2	2.6	1.2	0.3	1.0	0.4	0.9	1.5	0.9	2.3	0.2	0.4	0.6	0.8	0.5	0.8	1.0	0.5	0.8	0.8	1.5	1.0
RGS9BP	"FLJ45744, PERRS, R9AP, RGS9"	ENSG00000186326	"Regulator of G protein signaling 9 binding protein"	Q6ZS82	19	32675407-32678300	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 38.3;skeletal muscle: 15.8"	"Cell line enhanced"	"Detected in some"		"HEL: 10.4;HMC-1: 2.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	6	"pons and medulla: 6.8"	"Cell type enhanced"	"Detected in some"		"gdTCR: 1.4;memory CD8 T-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049791	Enhanced		Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA049791: AB_2680884"	"unprognostic (2.82e-2)"	"unprognostic (6.99e-3)"	"unprognostic (2.44e-3)"	"unprognostic (1.20e-7)"	"unprognostic (1.49e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.80e-1)"	"unprognostic (6.71e-2)"	"unprognostic (6.74e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.29e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.34e-2)"	0.4	0.5	0.8	0.3	1.1	0.3	0.4	0.2	0.7	0.3	0.4	1.4	0.2	0.4	0.3	0.6	1.1	0.4	0.3	6.7	1.0	0.8	0.9	0.3	0.9	0.3	1.1	0.3	0.3	0.4	0.4	0.6	0.4	6.8	1.3	0.3	38.3	0.5	0.6	15.8	0.6	0.3	7.4	1.3	0.4	0.4	0.9	0.9	0.1	0.4	4.3	0.3	2.3	1.0	0.0	0.3	0.0	0.9	0.5	1.5	0.0	0.2	0.2	0.0	0.9	0.5	0.2	0.5	0.0	0.5	0.3	0.2	0.2	0.3	0.4	0.5	0.1	0.0	1.8	0.1	0.1	0.5	0.2	10.4	0.3	0.0	0.2	0.3	2.8	0.0	0.5	0.0	0.4	0.0	0.9	1.5	0.2	0.4	0.0	1.7	0.0	2.0	0.1	0.4	0.2	0.0	0.1	0.3	0.1	0.0	1.1	0.1	1.0	0.5	0.0	0.5	0.7	0.2	0.3	0.6	0.7	0.1	0.3	0.6	0.8	0.0	0.3	0.0	1.4	0.9	0.0	0.0	0.2	1.5	0.3	0.0	0.0	0.4	0.0	0.5	0.3	0.0	0.0	0.0	0.8	1.1	0.2	0.7	1.0	0.8	1.1	0.3	6.8	0.9
SAPCD1	"C6orf26, NG23"	ENSG00000228727	"Suppressor APC domain containing 1"	Q5SSQ6	6	31762799-31764851	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"retina: 8.8;skin 1: 14.7"	"Cell line enhanced"	"Detected in some"		"HeLa: 7.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA071699			Approved	"Vesicles,Cell Junctions"				Vesicles	Vesicles	"HPA071699: AB_2686433"	"unprognostic (9.25e-4)"	"unprognostic (1.32e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.28e-1)"	"unprognostic (9.34e-2)"	"unprognostic (8.02e-4)"	"unprognostic (1.63e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.15e-10)"	"unprognostic (2.65e-2)"	"unprognostic (4.45e-1)"	"unprognostic (3.57e-1)"	"unprognostic (7.98e-5)"	0.8	0.3	0.7	1.6	1.0	4.8	1.8	0.7	1.3	2.0	1.0	1.3	0.7	0.2	1.2	0.8	0.7	1.8	2.5	0.7	0.7	0.8	3.2	0.9	1.4	2.5	1.9	0.7	1.6	0.7	0.2	2.9	3.3	3.9	2.6	1.1	8.8	0.7	1.6	0.7	14.7	1.5	0.7	3.1	2.1	0.8	1.2	0.7	0.7	0.7	0.7	0.7	0.8	0.7	0.0	0.5	0.2	0.1	0.0	0.7	0.0	0.5	0.0	0.0	0.5	0.4	0.8	0.8	0.5	0.2	0.2	0.0	2.9	1.0	0.8	0.1	0.2	1.7	0.0	0.8	0.1	0.0	3.2	3.9	7.7	1.1	0.2	0.4	0.1	0.2	0.0	1.2	1.4	0.5	0.5	1.2	0.0	3.9	2.9	2.4	0.0	0.9	0.4	0.9	0.0	0.6	0.7	1.2	0.6	0.3	0.7	0.5	0.3	0.0	0.3	0.1	3.1	0.0	0.3	2.2	2.1	2.0	0.2	2.8	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.7	1.0	0.7	1.3	0.7	0.8	1.9	0.7	3.9	0.7
SCUBE1		ENSG00000159307	"Signal peptide, CUB domain and EGF like domain containing 1"	Q8IWY4	22	43197283-43343388	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 35.8;retina: 48.1"	"Group enriched"	"Detected in some"	4	"HMC-1: 32.1;THP-1: 12.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003190	Approved				"Secreted to blood"	130000	130000			"HPA003190: AB_1079882"	"unprognostic (5.29e-2)"	"unprognostic (7.15e-6)"	"unprognostic (6.03e-3)"	"unprognostic (8.33e-2)"	"unprognostic (3.65e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.87e-3)"	3.3	5.3	0.4	1.1	2.0	0.1	3.5	0.3	2.3	1.3	5.5	0.9	1.3	5.9	1.3	0.7	14.8	1.2	0.8	1.0	0.5	0.7	3.4	4.6	7.5	0.1	3.4	1.9	35.8	0.4	0.3	3.8	3.5	1.9	6.4	2.0	48.1	5.3	0.5	8.0	0.6	7.6	1.0	3.5	6.9	7.3	8.5	0.1	0.0	3.1	0.5	0.1	4.2	6.3	0.3	0.3	2.4	0.3	0.5	0.3	0.1	0.0	0.0	1.4	5.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.1	0.1	32.1	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.8	0.0	0.1	0.0	0.0	12.7	0.0	0.2	0.1	0.3	0.0	1.4	2.5	0.0	0.3	0.0	0.1	2.4	0.2	0.3	0.2	0.3	0.3	0.3	0.3	0.2	0.1	0.3	0.3	0.3	1.0	0.5	0.3	0.3	0.2	0.1	0.4	2.0	0.3	2.3	0.5	0.7	3.4	1.9	1.9	0.1
SERPINF1	"EPC-1, PEDF, PIG35"	ENSG00000132386	"Serpin family F member 1"	P36955	17	1761959-1777574	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 360.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 121.4;ASC TERT1: 94.8;Hep G2: 55.4;HHSteC: 40.6;HSkMC: 128.9"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	8	"pons and medulla: 105.5"	"Cell type enriched"	"Detected in some"	18	"plasmacytoid DC: 143.3"	"Lineage enriched"	"Detected in many"	119	"dendritic cells: 143.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005825	Uncertain				"Secreted to blood"	85000000000	85000000000			"HPA005825: AB_1079921"	"unprognostic (3.85e-1)"	"prognostic favourable (5.49e-4)"	"unprognostic (9.44e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.33e-1)"	"unprognostic (7.88e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.18e-2)"	"prognostic unfavourable (1.40e-8)"	"unprognostic (2.11e-3)"	"unprognostic (2.82e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.25e-3)"	70.0	7.5	2.3	15.1	4.5	1.1	61.6	0.7	13.9	84.1	16.4	20.8	14.8	5.0	48.9	71.9	24.3	75.3	66.8	50.3	11.6	1.9	6.9	190.1	20.1	30.6	1.9	5.9	68.1	54.7	0.6	11.0	38.6	105.5	53.2	6.5	360.1	17.8	14.2	51.4	21.5	15.7	27.6	2.4	21.2	17.8	86.3	1.4	6.0	27.4	38.5	14.6	32.1	37.9	0.8	143.3	0.1	1.2	0.1	0.5	1.3	0.0	0.4	0.2	0.2	121.4	94.8	2.0	5.6	4.7	0.0	0.0	0.9	0.0	0.2	0.2	6.7	0.3	8.0	0.4	0.0	0.0	4.3	0.1	0.0	55.4	40.6	0.1	0.1	128.9	0.7	0.1	0.1	0.0	11.4	0.0	5.9	0.0	0.7	0.6	3.2	0.1	0.3	22.3	0.1	0.0	0.6	0.1	4.1	0.0	0.0	5.7	0.7	17.1	0.2	0.0	1.8	1.4	0.1	0.0	0.2	2.9	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.4	0.0	0.8	0.0	0.1	7.9	0.4	0.2	0.5	0.1	0.1	0.0	143.3	0.0	1.3	2.3	4.5	0.7	13.9	11.6	1.9	1.9	5.9	105.5	1.4
SFRP4	"FRP-4, frpHE, FRZB-2"	ENSG00000106483	"Secreted frizzled related protein 4"	Q6FHJ7	7	37905932-38025695	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 144.9;endometrium 1: 100.7;retina: 123.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 13.8;HSkMC: 5.4;U-937: 5.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA009712, HPA050585"	Enhanced				"Secreted in female reproductive system"	1500000	1500000			"HPA009712: AB_1856778, HPA050585: AB_2681183"	"unprognostic (5.93e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (1.36e-5)"	"unprognostic (7.37e-3)"	"unprognostic (1.61e-1)"	"unprognostic (4.35e-3)"	"unprognostic (1.89e-3)"	4.6	2.3	0.5	0.9	0.9	0.0	12.5	0.3	0.4	144.9	0.8	1.7	5.4	0.0	100.7	11.5	3.2	35.1	2.5	5.5	0.4	0.4	1.2	0.2	3.9	0.8	0.8	0.7	42.7	1.4	0.1	4.0	0.4	1.3	4.9	0.2	123.0	2.3	7.1	1.4	0.3	0.5	14.5	3.3	4.1	0.5	5.8	0.3	0.4	3.3	2.5	0.5	8.8	14.8	0.4	0.8	0.4	0.6	0.1	0.1	0.0	0.0	2.5	2.8	0.0	13.8	0.6	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.1	2.9	0.1	0.0	0.3	0.3	0.0	0.0	0.2	0.2	2.0	0.1	0.4	0.0	5.4	0.7	0.6	0.0	0.2	0.0	0.3	0.2	0.4	0.0	1.6	0.1	0.0	0.2	1.7	0.0	0.1	0.2	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.9	0.0	1.2	1.6	0.2	0.5	0.1	0.2	0.3	5.2	0.9	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.1	0.0	0.8	0.0	0.0	0.5	0.9	0.3	0.4	0.4	0.4	0.8	0.7	1.3	0.3
SLC2A12	"GLUT12, GLUT8"	ENSG00000146411	"Solute carrier family 2 member 12"	Q8TD20	6	133988697-134052636	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 46.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 7.6;CAPAN-2: 10.4;HaCaT: 7.9;HEK 293: 6.5;U-2 OS: 11.3"	"Cancer enriched"	"Detected in many"	6	"prostate cancer: 18.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.3;myeloid DC: 1.0"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.0;monocytes: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA031593, HPA031594"	Approved		Supported	"Plasma membrane,Cell Junctions"				"Plasma membrane"	"Plasma membrane"	"HPA031593: AB_10600810, HPA031594: AB_2673948"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.69e-2)"	"unprognostic (5.55e-3)"	"unprognostic (2.18e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.08e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.33e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.55e-3)"	0.9	1.2	5.2	0.4	6.7	0.1	1.5	14.6	5.5	4.8	3.0	7.1	4.9	8.1	9.7	2.6	7.0	3.4	3.0	11.4	6.5	2.8	6.7	7.9	3.4	0.2	3.4	5.2	1.5	1.3	1.2	2.5	1.9	19.7	27.0	1.4	46.6	5.2	11.2	4.2	3.9	11.9	14.8	1.6	0.3	14.4	0.5	3.3	0.6	0.6	1.9	2.7	6.7	2.0	0.0	1.0	0.0	1.3	0.0	0.1	0.1	3.0	1.0	2.6	0.0	2.0	1.1	0.2	1.8	7.6	1.0	4.2	0.0	10.4	0.4	1.6	0.1	7.9	0.0	0.8	1.5	0.0	6.5	0.0	0.9	0.1	0.3	0.0	0.0	1.5	0.7	0.8	0.2	0.6	0.6	0.9	0.2	0.9	0.1	0.1	2.3	0.7	0.0	1.3	2.8	2.3	1.0	0.3	0.8	0.1	2.4	0.0	0.1	0.0	0.1	0.2	11.3	0.2	1.0	3.9	3.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.1	5.2	6.7	14.6	5.5	6.5	2.8	3.4	5.2	19.7	3.3
SLC35D3	FRCL1	ENSG00000182747	"Solute carrier family 35 member D3"	Q5M8T2	6	136922264-136925639	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.9;retina: 16.4"	"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 18.3"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 3.3"	"Group enriched"	"Detected in some"	4	"basal ganglia: 9.9;hypothalamus: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 26.6;olfactory region: 10.4"	"Region enriched"	"Detected in some"	6	"basal ganglia: 24.4"	"HPA030431, HPA067497"	Uncertain		Approved	"Centriolar satellite"				"Centriolar satellite"	"Centriolar satellite"	"HPA030431: AB_10601716, HPA067497: AB_2685854"	"unprognostic (6.56e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.84e-2)"		"unprognostic (2.48e-1)"		"unprognostic (9.94e-2)"	"unprognostic (7.36e-2)"	"unprognostic (4.65e-2)"		"unprognostic (1.37e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.03e-1)"	0.1	4.9	0.0	0.4	9.9	1.2	0.1	0.0	0.4	2.0	0.4	0.4	0.0	0.7	0.1	0.0	0.6	0.1	0.1	0.4	0.0	4.8	4.0	0.0	2.1	0.0	1.7	0.0	0.8	1.2	0.0	0.0	0.1	0.5	4.3	0.6	16.4	0.2	0.1	0.0	0.2	1.3	0.3	0.0	0.2	3.2	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	4.2	18.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	9.9	0.0	0.4	0.0	4.8	1.7	0.0	0.5	0.2
SLC4A2	"AE2, BND3L, EPB3L1, HKB3, NBND3"	ENSG00000164889	"Solute carrier family 4 member 2"	P04920	7	151057210-151076527	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 94.2;retina: 100.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"pons and medulla: 73.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA019339	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Cytosol"				"Nuclear speckles, Plasma membrane"	"Nuclear speckles, Plasma membrane"	"HPA019339: AB_1844825"	"unprognostic (1.19e-1)"	"unprognostic (3.33e-3)"	"unprognostic (8.12e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (9.04e-6)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.21e-1)"	"prognostic favourable (1.26e-4)"	"unprognostic (4.67e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.36e-2)"	9.9	13.5	4.7	10.4	7.4	6.7	10.5	3.0	8.6	12.4	18.6	29.0	6.0	12.1	16.2	6.3	7.7	10.8	14.1	11.9	10.1	3.8	35.5	94.2	12.3	7.2	10.4	4.8	12.6	34.1	30.6	5.3	31.4	73.3	10.5	4.0	100.7	11.9	8.3	8.7	9.5	26.0	10.7	10.4	10.1	27.1	6.5	8.5	8.8	9.7	7.0	5.9	11.7	10.6	2.5	5.6	2.1	4.2	0.5	2.7	1.9	15.6	51.8	10.2	21.0	10.2	6.0	23.3	19.0	10.3	15.6	13.5	29.5	25.1	9.4	41.8	9.0	15.4	10.4	9.2	2.9	27.1	15.5	12.3	25.2	15.0	16.7	6.3	39.8	8.7	8.1	17.7	4.5	8.7	38.2	8.0	12.0	30.1	18.2	11.0	24.3	19.3	14.4	5.6	11.0	12.7	11.9	8.4	30.6	17.4	32.9	16.2	13.6	12.6	18.6	21.0	10.7	20.6	28.0	8.6	11.6	5.3	32.1	16.0	42.1	0.0	4.2	2.1	2.7	3.9	1.9	2.5	2.1	1.8	2.4	1.0	2.4	2.4	1.0	0.5	2.5	5.6	1.0	1.9	4.7	7.4	3.0	8.6	10.1	3.8	10.4	4.8	73.3	8.5
SLC6A6	TAUT	ENSG00000131389	"Solute carrier family 6 member 6"	P31641	3	14402576-14489349	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 76.4"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 33.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 33.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015028, HPA016488"	Enhanced		Approved	"Cell Junctions,Cytosol"				"Cell Junctions, Cytosol"	"Cell Junctions, Cytosol"	"HPA015028: AB_1857200, HPA016488: AB_1857202"	"unprognostic (8.25e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.63e-2)"	"prognostic favourable (5.22e-5)"	"prognostic unfavourable (5.75e-8)"	"unprognostic (4.14e-2)"	"prognostic unfavourable (8.78e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.81e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.90e-1)"	10.2	25.9	5.7	18.0	16.5	46.4	8.1	11.1	12.2	11.3	9.5	8.7	3.6	8.5	14.5	4.4	7.0	7.0	14.5	23.2	5.6	4.6	16.6	2.3	18.6	12.9	18.0	7.6	31.3	2.8	3.8	9.6	18.0	13.3	5.0	4.1	76.4	15.7	7.7	26.6	16.8	22.2	8.2	11.1	20.3	14.0	4.0	12.6	6.2	10.4	11.3	11.2	8.8	6.1	1.6	1.9	33.2	6.9	0.7	3.9	2.3	4.6	17.1	6.2	4.7	8.0	2.5	12.7	6.9	27.5	8.2	6.1	6.2	7.9	13.4	6.4	10.9	3.7	4.2	5.7	7.4	1.5	5.2	12.7	22.5	9.3	0.2	3.4	27.5	1.3	1.7	7.5	1.9	8.9	7.1	2.7	7.2	4.9	9.7	6.7	9.5	5.0	6.9	7.3	20.9	45.1	9.6	11.4	4.1	5.2	2.8	1.5	10.6	1.9	22.5	10.5	5.6	2.6	5.0	3.0	3.4	4.9	24.5	6.8	32.1	2.5	5.1	5.0	1.3	4.2	0.7	1.6	1.4	1.7	1.9	0.9	0.2	0.3	33.2	0.7	6.9	0.7	3.9	2.3	5.7	16.5	11.1	12.2	5.6	4.6	18.0	7.6	13.3	12.6
SLCO1A2	"OATP, OATP-A, OATP1A2, SLC21A3"	ENSG00000084453	"Solute carrier organic anion transporter family member 1A2"	P46721	12	21264600-21419594	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.9;liver: 11.2;retina: 14.2;salivary gland: 14.5"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 13.7;RPMI-8226: 9.5;U-266/70: 20.5;U-266/84: 8.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA071152			Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA071152: AB_2686350"	"unprognostic (5.43e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.66e-4)"	"unprognostic (2.52e-2)"	"unprognostic (3.20e-1)"		"unprognostic (1.24e-1)"	0.2	0.1	3.3	0.0	3.4	0.0	3.6	3.4	17.9	0.1	0.1	1.9	0.0	0.0	0.1	0.1	0.2	0.3	0.1	0.9	4.1	2.5	1.1	11.2	2.7	0.6	3.0	4.0	0.2	2.3	0.5	0.5	1.2	9.7	0.7	0.0	14.2	14.5	0.0	0.4	0.4	0.2	0.0	2.9	0.4	0.4	1.6	1.4	0.0	0.3	0.0	0.3	0.4	0.1	1.3	0.7	4.3	0.4	1.1	2.3	0.2	2.1	0.5	0.8	0.2	0.0	0.0	2.8	0.0	0.0	0.0	0.0	3.0	1.7	0.1	2.1	0.1	0.2	0.2	0.1	0.4	0.5	0.7	0.0	0.5	1.1	0.0	0.3	0.2	0.0	1.4	0.1	0.1	0.1	3.5	1.4	0.0	2.1	0.3	0.1	13.7	0.1	0.1	0.2	9.5	0.0	2.1	1.9	2.3	0.0	0.2	0.2	2.7	0.7	0.0	0.0	1.4	0.7	0.3	20.5	8.2	0.1	0.2	0.2	0.1	0.6	0.4	0.3	1.4	0.3	2.3	1.3	2.2	1.5	0.1	1.0	2.1	1.6	4.3	1.1	0.1	0.7	1.8	0.2	3.3	3.4	3.4	5.0	4.1	2.5	3.0	4.0	9.7	1.4
SOST	"DAND6, VBCH"	ENSG00000167941	Sclerostin	Q9BQB4	17	43753731-43758788	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 17.1;retina: 7.2"	"Cell line enriched"	"Detected in single"	42	"HaCaT: 10.7"	"Group enriched"	"Detected in some"	8	"head and neck cancer: 1.2;lung cancer: 6.2;urothelial cancer: 2.5"	"Group enriched"	"Detected in some"	6	"basal ganglia: 1.0;cerebral cortex: 3.1"	"Cell type enhanced"	"Detected in single"		"eosinophil: 2.3"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 2.3"	"Group enriched"	"Detected in some"	11	"basal ganglia: 1.7;cerebellum: 1.1"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.1"	CAB025660	Approved				"Secreted to extracellular matrix"					"CAB025660: "	"unprognostic (1.26e-1)"	"unprognostic (4.06e-2)"		"unprognostic (6.57e-2)"	"unprognostic (2.55e-3)"	"unprognostic (3.37e-1)"		"unprognostic (4.67e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.38e-2)"		"unprognostic (1.20e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.56e-1)"		"unprognostic (7.90e-2)"	0.3	0.1	0.1	1.4	1.0	0.1	0.1	0.1	3.1	0.2	0.1	0.0	1.1	0.1	0.1	0.1	0.1	0.1	0.1	2.9	0.1	0.1	17.1	0.1	2.4	0.1	0.1	0.3	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	7.2	1.1	0.4	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.3	0.5	0.1	0.1	0.2	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.1	3.1	0.1	0.1	0.1	0.3	0.2	0.0
SOSTDC1	"DAND7, DKFZp564D206, USAG1"	ENSG00000171243	"Sclerostin domain containing 1"	Q6X4U4	7	16461481-16530580	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 51.1;retina: 74.8;stomach 1: 32.3"	"Cell line enhanced"	"Detected in some"		"AF22: 7.3;EFO-21: 10.9;HEL: 4.1;NTERA-2: 4.2;RPTEC TERT1: 20.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 25.9"	"Region enriched"	"Detected in many"	9	"pons and medulla: 51.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 9.4;hippocampal formation: 20.4;pons and medulla: 15.8;thalamus: 12.8"	"Low region specificity"	"Detected in some"								"Secreted to extracellular matrix"						"unprognostic (2.08e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.17e-3)"	"unprognostic (5.59e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.41e-2)"	"prognostic favourable (8.69e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.62e-1)"	"prognostic favourable (3.22e-5)"	"unprognostic (7.01e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavourable (8.72e-4)"	0.4	0.4	2.0	1.4	1.9	0.0	9.5	0.5	5.8	2.6	5.9	7.0	0.2	6.1	2.5	2.4	2.7	2.7	0.4	3.7	3.5	1.6	12.8	0.2	22.0	0.1	0.7	5.3	0.6	1.1	0.0	2.9	0.0	51.1	1.1	8.4	74.8	12.5	6.4	0.3	13.7	4.8	0.5	1.0	0.2	32.3	1.9	0.0	0.0	4.7	3.1	4.9	1.0	3.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	10.9	0.0	0.2	0.4	0.0	0.0	0.1	2.2	4.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	20.3	0.0	0.0	0.3	0.1	0.0	0.0	0.8	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.0	1.9	0.5	5.8	3.5	1.6	0.7	5.3	51.1	0.0
ST6GALNAC2	"SIAT7, SIAT7B, SIATL1, ST6GalNAII, STHM"	ENSG00000070731	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2"	Q9UJ37	17	76565379-76586956	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 78.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 9.4;HaCaT: 11.5;HBEC3-KT: 10.5;hTCEpi: 29.3;MCF7: 11.3;SK-MEL-30: 38.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"pons and medulla: 19.2"	"Cell type enriched"	"Detected in some"	9	"neutrophil: 23.5"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 23.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA048849	Uncertain				"Intracellular and membrane"					"HPA048849: AB_2680539"	"unprognostic (8.93e-3)"	"unprognostic (5.86e-3)"	"unprognostic (1.67e-2)"	"unprognostic (5.18e-3)"	"unprognostic (3.37e-2)"	"unprognostic (3.79e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.37e-2)"	"unprognostic (5.69e-2)"	"prognostic unfavourable (6.48e-4)"	"unprognostic (1.57e-1)"	"unprognostic (5.17e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.33e-1)"	4.3	1.7	0.6	2.7	1.8	0.4	7.0	0.4	1.3	8.6	7.2	6.0	3.6	0.4	2.6	8.8	17.2	28.3	2.1	4.6	2.1	1.3	10.6	1.3	11.3	1.7	4.0	1.0	5.0	3.6	1.5	2.1	18.3	19.2	6.7	3.4	78.2	6.6	6.1	11.3	27.3	2.5	4.7	3.7	2.0	3.5	17.1	1.3	0.7	17.7	12.4	6.9	8.3	7.6	0.0	0.2	23.5	1.1	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.2	0.0	9.4	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.2	0.6	11.5	0.1	10.5	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	29.3	0.0	3.3	0.0	0.0	0.0	0.1	11.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.1	0.1	0.0	1.3	0.0	38.1	7.5	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	1.1	2.6	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	23.5	0.0	0.1	0.0	0.0	0.1	0.6	1.8	0.4	1.3	2.1	1.3	4.0	1.0	19.2	1.3
STK32A	"MGC22688, YANK1"	ENSG00000169302	"Serine/threonine kinase 32A"	Q8WU08	5	147234963-147387852	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adrenal gland: 19.7;brain: 21.1;retina: 31.9"	"Group enriched"	"Detected in some"	5	"RT4: 9.6;SK-MEL-30: 33.8"	"Cancer enhanced"	"Detected in many"		"melanoma: 11.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040236	Uncertain		Approved	Centrosome				Centrosome	Centrosome	"HPA040236: AB_10795416"	"unprognostic (1.90e-1)"	"unprognostic (4.71e-4)"	"unprognostic (5.32e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.62e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.96e-3)"	"unprognostic (4.85e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.87e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.50e-3)"	"unprognostic (5.53e-5)"	"unprognostic (2.48e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.67e-3)"	2.1	19.7	4.8	1.3	7.1	0.4	2.3	21.1	7.7	1.2	1.8	6.2	0.6	1.2	1.6	5.6	1.0	1.3	4.3	1.6	4.9	12.6	6.3	0.6	2.1	0.5	12.1	2.2	5.1	4.2	0.4	8.5	0.7	20.7	2.1	1.1	31.9	1.2	1.8	0.6	2.9	1.1	1.4	12.4	0.8	1.4	2.1	6.9	0.0	15.7	0.5	0.5	4.1	2.1	0.1	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.1	3.7	9.6	0.9	0.4	0.0	0.1	33.8	0.0	0.0	0.1	0.0	0.6	0.4	0.3	1.1	0.2	0.0	1.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	4.8	7.1	21.1	2.3	4.9	12.6	12.1	2.2	20.7	6.9
STK35	"bA550O8.2, CLIK1"	ENSG00000125834	"Serine/threonine kinase 35"	Q8TDR2	20	2101611-2177038	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 27.8;testis: 37.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026452, HPA051673"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA026452: AB_2671861, HPA051673: AB_2681569"	"unprognostic (2.25e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (9.46e-6)"	"unprognostic (6.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.67e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.99e-2)"	5.3	6.0	10.3	3.6	14.3	4.3	5.1	6.1	13.7	3.7	4.3	3.1	2.5	4.2	4.5	3.5	8.0	5.1	4.3	5.2	5.9	4.8	4.4	5.7	4.2	3.3	4.4	7.6	3.9	5.9	5.3	6.5	3.5	4.0	3.8	5.2	27.8	6.1	4.0	3.5	6.3	4.6	4.9	4.5	4.1	4.1	37.6	4.4	1.7	5.4	6.1	4.5	4.1	3.7	1.8	2.0	3.2	1.4	0.8	2.7	1.2	14.8	12.6	9.9	16.9	4.5	6.2	12.0	6.1	7.5	8.2	8.5	16.6	11.6	10.2	5.0	7.6	22.5	11.6	14.0	9.4	4.0	5.5	9.7	4.4	17.9	5.8	8.7	4.5	5.4	12.3	13.0	11.3	7.7	9.4	8.5	5.3	6.6	10.9	12.4	18.3	8.6	9.5	8.8	6.4	7.4	14.9	16.3	7.9	10.8	19.5	9.7	9.6	8.7	6.5	14.0	9.6	7.0	9.6	7.5	9.6	7.1	7.5	9.5	6.1	0.0	1.2	0.7	1.9	1.0	2.5	1.7	2.7	1.3	2.0	1.8	2.6	2.2	3.2	0.8	1.4	1.7	1.3	1.2	10.3	14.3	6.1	13.7	5.9	4.8	4.4	7.6	4.0	4.4
STRIP2	"FAM40B, FAR11B, KIAA1170"	ENSG00000128578	"Striatin interacting protein 2"	Q9ULQ0	7	129434433-129488399	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.6;retina: 55.6;skeletal muscle: 27.4"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 20.9;U-2197: 23.8;U-87 MG: 21.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 36.6"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019657	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA019657: AB_1848399"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.32e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.80e-3)"	"prognostic unfavourable (6.78e-4)"	"unprognostic (9.05e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.87e-6)"	"prognostic favourable (5.41e-4)"	"unprognostic (4.06e-2)"	"unprognostic (5.34e-2)"	"unprognostic (7.50e-2)"	0.7	2.4	1.9	2.0	36.6	3.7	0.8	7.0	10.0	0.4	0.8	3.0	0.0	0.8	0.8	1.6	1.1	0.4	1.2	10.3	1.5	2.1	5.6	0.6	1.0	2.7	2.2	2.9	0.7	1.3	0.4	4.7	1.3	7.6	1.6	1.4	55.6	1.7	0.5	27.4	1.5	1.0	0.8	1.2	1.5	1.0	13.5	9.4	0.2	0.8	2.1	2.1	0.9	0.3	0.6	0.7	2.5	0.6	0.4	0.9	0.4	7.8	3.4	3.1	4.9	1.2	1.1	13.6	3.2	4.1	5.4	5.3	1.8	4.4	3.3	0.4	1.3	8.8	3.3	2.9	8.3	19.1	2.8	2.5	5.6	1.9	0.8	1.6	13.4	1.3	1.0	9.2	5.8	9.3	10.9	2.1	20.9	0.4	4.1	4.0	3.0	7.0	2.8	5.8	0.7	2.0	2.9	0.7	0.7	7.4	0.6	1.6	0.9	3.9	3.3	3.2	3.1	23.8	9.2	1.9	1.3	4.0	21.2	4.1	4.5	2.5	0.6	0.6	0.9	0.4	0.3	0.3	0.6	0.3	0.2	0.6	0.5	0.4	2.0	0.4	0.5	0.7	0.9	0.4	1.9	36.6	7.0	4.8	1.5	2.1	2.2	2.9	7.6	9.4
TFAP2A	"AP-2, AP2TF, TFAP2"	ENSG00000137203	"Transcription factor AP-2 alpha"	P05549	6	10393186-10419659	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 130.5;retina: 48.1"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 28.3;HDLM-2: 31.6;hTCEpi: 30.5"	"Cancer enhanced"	"Detected in many"		"melanoma: 45.6"	"Region enhanced"	"Detected in single"		"cerebellum: 2.2"	"Cell type enriched"	"Detected in single"	10	"myeloid DC: 1.0"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 1.0"	"Region enhanced"	"Detected in single"		"cerebellum: 4.3"	"Region enhanced"	"Detected in single"		"cerebellum: 8.6"	"CAB000326, HPA028850, HPA056871"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB000326: AB_667767, HPA028850: AB_10600730, HPA056871: AB_2683262"	"unprognostic (5.97e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.62e-5)"	"prognostic unfavourable (1.09e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.40e-11)"	"unprognostic (1.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.72e-4)"	"unprognostic (2.25e-2)"	0.4	0.3	0.3	0.0	0.3	0.0	19.0	2.2	0.5	4.4	0.8	0.0	18.7	0.2	0.5	17.8	18.3	0.4	1.7	0.7	0.3	0.2	6.4	0.2	0.5	0.1	0.2	0.2	0.3	0.3	0.0	0.4	130.5	0.6	5.8	0.2	48.1	19.4	26.7	0.2	36.0	0.4	0.1	0.4	0.2	0.7	1.6	0.0	0.1	0.4	16.6	9.9	2.4	9.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	16.5	6.4	0.0	28.3	0.1	0.0	6.1	12.2	9.4	10.0	9.9	0.6	6.2	0.9	1.6	3.5	17.6	1.5	20.9	9.6	31.6	15.9	0.1	14.9	0.0	0.0	0.4	0.4	0.0	30.5	0.0	22.2	0.0	0.9	0.0	0.1	3.6	0.0	5.1	0.1	7.9	1.8	1.5	0.6	5.7	6.7	4.1	0.1	15.0	26.4	24.0	17.5	0.5	0.0	3.1	0.8	2.1	7.7	0.0	1.5	0.2	1.6	0.5	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	2.2	0.3	0.3	0.2	0.2	0.2	0.6	0.0
THSD7B	KIAA1679	ENSG00000144229	"Thrombospondin type 1 domain containing 7B"	Q9C0I4	2	136765545-137677717	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.2;epididymis: 11.6;retina: 14.9"	"Group enriched"	"Detected in some"	8	"Daudi: 10.1;SCLC-21H: 21.0"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	7	"pons and medulla: 24.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA051416, HPA056745"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA051416: AB_2681477, HPA056745: AB_2683224"	"unprognostic (4.65e-3)"	"unprognostic (2.25e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.50e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.20e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.47e-6)"	"unprognostic (2.42e-3)"	"unprognostic (1.89e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.30e-2)"	4.7	0.3	1.7	0.3	1.6	0.1	2.6	0.7	3.2	0.9	0.5	1.1	0.8	0.3	0.9	11.6	1.6	2.8	0.8	1.4	1.8	3.3	2.7	0.6	0.5	0.2	1.8	1.5	0.4	0.3	1.3	3.0	0.7	24.2	2.1	0.3	14.9	1.2	0.7	0.3	0.2	1.5	2.2	3.2	0.2	0.3	1.1	0.3	0.1	2.1	0.0	0.3	0.8	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	10.1	0.0	0.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.5	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.4	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.6	0.7	3.2	1.8	3.3	1.8	1.5	24.2	0.3
TIMP3	SFD	ENSG00000100234	"TIMP metallopeptidase inhibitor 3"	P35625	22	32801701-32863043	"Cancer-related genes, Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 392.5;retina: 247.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 55.9;BJ: 125.0;BJ hTERT+: 55.2;fHDF/TERT166: 113.6;WM-115: 95.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 2.2"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"						"unprognostic (4.98e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.53e-4)"	"unprognostic (1.67e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.22e-2)"	"unprognostic (8.42e-2)"	"prognostic unfavourable (1.90e-5)"	"unprognostic (3.92e-1)"	"unprognostic (1.95e-1)"	"prognostic favourable (1.50e-4)"	"unprognostic (2.66e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.55e-3)"	"unprognostic (3.11e-2)"	130.4	44.6	8.7	15.8	10.1	0.1	103.3	5.1	12.1	68.3	25.4	13.5	27.8	4.5	65.1	47.4	40.2	51.9	39.9	75.0	10.2	8.5	54.0	14.1	115.4	31.3	11.4	8.7	25.3	11.8	15.6	21.6	392.5	19.1	44.2	12.6	247.1	24.3	55.0	22.7	22.9	16.2	58.3	7.2	35.1	22.9	43.2	7.1	1.2	48.9	29.4	10.1	37.5	38.3	0.4	0.0	0.0	0.0	2.2	0.0	0.0	2.0	0.0	1.8	0.2	55.9	31.5	0.1	125.0	55.2	10.2	12.2	2.1	0.0	0.0	3.0	113.6	1.9	0.3	5.1	14.8	0.0	1.5	15.4	2.6	5.4	22.0	0.0	6.5	5.2	13.1	18.1	1.0	0.0	0.0	0.1	4.7	0.1	0.0	0.5	0.2	0.0	0.0	0.3	0.0	0.2	10.2	1.3	1.8	2.5	0.0	32.8	0.0	0.1	0.0	0.8	2.8	26.6	2.0	0.0	0.0	0.0	25.5	0.0	95.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	8.7	10.1	5.1	12.1	10.2	8.5	11.4	8.7	19.1	7.1
TLX2	"Enx, HOX11L1, NCX, Tlx2"	ENSG00000115297	"T cell leukemia homeobox 2"	O43763	2	74513463-74517147	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 8.0;brain: 4.3;retina: 3.8"	"Cell line enriched"	"Detected in some"	15	"SH-SY5Y: 37.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA040969, HPA062254"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA040969: AB_10794431, HPA062254: AB_2684727"	"unprognostic (7.30e-2)"	"unprognostic (3.03e-4)"	"unprognostic (9.54e-4)"	"unprognostic (2.86e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.69e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.40e-1)"	"unprognostic (3.92e-7)"	"unprognostic (2.51e-1)"	"unprognostic (6.86e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.18e-1)"	0.1	8.0	1.7	1.7	4.0	0.2	0.1	0.8	4.3	0.1	2.7	0.0	0.0	1.9	0.1	0.1	0.5	0.1	0.6	0.1	0.4	0.7	0.1	0.1	0.1	0.5	0.8	0.0	0.1	0.6	0.5	0.0	0.2	3.5	0.1	0.7	3.8	0.1	0.1	0.1	0.4	2.5	0.2	0.3	0.2	0.9	3.3	0.6	2.5	0.1	0.0	0.3	2.1	0.4	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.9	1.8	0.0	0.0	0.0	0.0	0.0	0.8	2.3	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	4.0	0.8	4.3	0.4	0.7	0.8	0.0	3.5	0.6
TMEM215		ENSG00000188133	"Transmembrane protein 215"	Q68D42	9	32783499-32787399	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"endometrium 1: 8.0;retina: 6.5;testis: 17.9"	"Group enriched"	"Detected in some"	6	"NTERA-2: 6.4;SH-SY5Y: 1.9"	"Cancer enriched"	"Detected in single"	14	"thyroid cancer: 4.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA052804, HPA063207"	Uncertain		Supported	"Nucleoplasm,Endoplasmic reticulum,Vesicles"				Nucleoplasm	Nucleoplasm	"HPA052804: AB_2681957, HPA063207: AB_2732697"	"unprognostic (1.31e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.38e-3)"		"unprognostic (2.17e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.83e-2)"		"unprognostic (1.23e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.32e-2)"		0.1	0.0	1.8	0.4	1.5	0.0	0.1	0.1	0.9	1.9	0.0	0.0	0.0	0.0	8.0	0.9	0.1	0.1	0.0	0.9	0.9	1.5	0.0	0.0	0.1	0.0	1.7	0.2	0.7	0.0	0.0	0.1	0.0	0.6	0.1	0.0	6.5	0.1	0.0	0.3	0.1	0.1	0.0	1.0	0.0	0.0	17.9	0.0	0.0	3.0	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.5	0.1	0.8	0.9	1.5	1.7	0.2	0.6	0.0
TMEM244	"bA174C7.4, C6orf191"	ENSG00000203756	"Transmembrane protein 244"	Q5VVB8	6	129831244-129861547	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"pituitary gland: 12.2;retina: 22.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.1;LHCN-M2: 8.2;U-2 OS: 2.9;U-251 MG: 6.2;U-266/70: 6.0;WM-115: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 3.9;T-reg: 4.2"	"Lineage enriched"	"Detected in single"	8	"T-cells: 4.2"					"Not detected"	"Not detected"														"unprognostic (4.65e-1)"	"unprognostic (3.65e-2)"				"unprognostic (1.10e-1)"		"unprognostic (1.54e-1)"			"unprognostic (1.15e-1)"			"unprognostic (2.15e-1)"	"unprognostic (9.57e-2)"			0.3	0.2	2.7	0.4	2.7	0.4	0.4	0.2	5.2	0.4	0.5	1.5	0.0	0.0	0.2	1.6	0.3	0.4	0.3	0.7	2.5	0.7	0.7	0.2	0.6	2.3	4.8	3.3	0.2	0.2	0.0	12.2	0.2	0.9	1.1	0.6	22.7	1.2	0.2	1.0	0.4	0.3	0.0	1.9	0.7	1.1	0.4	2.0	0.0	0.3	0.0	2.5	0.8	0.4	0.5	0.0	0.0	0.0	0.0	4.2	0.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.8	8.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.9	0.9	6.2	6.0	0.0	0.0	1.6	0.0	4.0	0.0	0.0	0.0	2.5	0.0	0.0	0.5	3.9	1.1	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	4.2	0.4	2.7	2.7	0.2	2.7	2.5	0.7	4.8	3.3	0.9	2.0
TMEM56-RWDD3		ENSG00000271092	"TMEM56-RWDD3 readthrough"		1	95117923-95247225	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"liver: 42.6;retina: 25.5"	"Cell line enhanced"	"Detected in many"		"RH-30: 15.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"																						"unprognostic (1.80e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.77e-3)"	"unprognostic (4.35e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.42e-2)"	3.1	3.9	4.6	1.8	5.8	2.8	3.9	7.5	9.2	2.9	3.6	3.3	2.3	4.1	3.2	4.9	2.1	3.1	3.7	14.2	3.8	2.4	2.8	42.6	2.7	3.3	2.5	4.9	3.5	6.2	4.1	6.1	4.5	4.1	3.7	3.9	25.5	3.9	2.2	4.7	4.6	5.8	7.0	2.9	2.3	3.9	3.4	2.8	0.0	4.5	1.6	2.6	3.6	2.9	2.7	1.3	1.1	0.8	0.7	2.4	1.0	7.1	4.3	4.0	5.3	1.7	3.1	4.5	1.4	0.9	2.8	3.2	6.6	3.0	2.6	5.0	1.6	1.8	3.8	1.9	3.0	1.9	2.4	3.2	4.2	1.6	1.5	0.9	1.0	1.9	2.1	2.5	0.7	1.2	5.3	1.7	1.5	2.0	2.2	2.5	2.0	2.2	1.9	15.1	0.4	3.8	7.4	3.9	4.5	5.3	4.2	5.2	3.0	2.4	2.6	3.0	4.1	2.8	3.9	2.4	1.6	1.6	1.4	0.6	2.1	0.6	0.7	1.1	1.3	0.8	0.7	2.7	2.0	0.8	1.3	2.6	2.4	0.9	0.0	0.7	0.7	0.6	1.6	1.0	4.6	5.8	7.5	9.2	3.8	2.4	2.5	4.9	4.1	2.8
TMEM98	DKFZP564K1964	ENSG00000006042	"Transmembrane protein 98"	Q9Y2Y6	17	32927910-32945106	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 96.8"	"Cell line enhanced"	"Detected in many"		"CACO-2: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 7.9"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040473, HPA053385"	Uncertain		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA040473: AB_10794876, HPA053385: AB_2682134"	"unprognostic (1.55e-2)"	"unprognostic (5.15e-2)"	"unprognostic (4.36e-3)"	"unprognostic (7.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.93e-2)"	"prognostic unfavourable (8.14e-4)"	"prognostic favourable (7.10e-4)"	"unprognostic (6.38e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.41e-1)"	"unprognostic (9.18e-3)"	"prognostic favourable (3.85e-4)"	"unprognostic (5.16e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.58e-1)"	15.5	15.9	11.8	7.1	36.8	0.9	13.3	6.5	28.3	21.6	26.1	55.5	5.6	29.7	30.5	23.0	8.2	29.6	27.7	13.5	17.0	9.4	10.8	7.7	17.0	3.1	50.4	18.5	60.2	25.7	6.3	7.4	8.0	40.8	24.7	28.7	96.8	14.8	7.4	2.6	7.1	34.0	19.0	37.1	5.7	29.7	9.7	37.7	0.6	14.2	7.4	3.5	15.6	13.3	0.5	7.9	0.6	0.1	0.2	0.6	0.1	1.5	5.7	24.7	0.0	34.0	30.6	0.2	23.9	32.5	12.7	27.5	57.7	1.7	0.3	0.3	30.0	0.2	15.7	6.3	7.5	5.0	19.3	0.9	0.0	25.6	15.7	0.0	0.3	25.5	6.3	16.0	2.6	32.8	15.7	0.0	34.5	0.0	0.0	0.1	16.4	8.9	0.0	23.2	0.1	2.9	10.2	2.1	34.1	0.5	0.0	18.7	7.7	0.0	26.8	18.2	17.1	0.2	0.0	2.0	0.7	0.0	9.2	0.0	9.7	0.5	0.1	0.1	0.1	0.0	0.3	0.2	0.1	0.6	0.0	0.5	0.1	0.2	0.6	0.2	0.1	7.9	0.1	0.1	11.8	36.8	6.5	28.3	17.0	9.4	50.4	18.5	40.8	37.7
VAT1L	KIAA1576	ENSG00000171724	"Vesicle amine transport 1 like"	Q9HCJ6	16	77788530-77980107	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 57.3;brain: 47.1;retina: 32.1"	"Cell line enhanced"	"Detected in some"		"AF22: 9.2;BJ hTERT+: 27.1;fHDF/TERT166: 14.8;NTERA-2: 31.9;U-87 MG: 33.5"	"Cancer enhanced"	"Detected in many"		"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.1"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044061, CAB046032, HPA061138"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"CAB046032: AB_11126308, HPA044061: AB_10959610, HPA061138: "	"unprognostic (1.49e-2)"	"unprognostic (8.74e-3)"	"unprognostic (8.80e-3)"	"unprognostic (3.39e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.39e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.57e-3)"	"unprognostic (2.46e-1)"	"prognostic unfavourable (3.01e-6)"	"unprognostic (2.50e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.96e-2)"	1.1	57.3	7.9	3.0	41.3	1.2	1.0	28.4	20.1	1.3	3.4	5.7	0.0	2.4	1.8	6.3	2.0	1.4	3.8	12.7	3.8	47.1	5.3	1.4	0.9	1.0	8.4	12.7	0.9	2.1	0.6	1.5	2.0	27.2	0.8	5.2	32.1	0.9	1.0	0.6	0.6	3.1	2.6	15.4	0.7	1.7	2.1	5.8	0.0	2.0	0.0	2.4	1.4	0.4	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	3.2	0.0	0.0	1.1	27.1	0.3	0.2	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	31.9	0.0	0.7	0.0	0.0	0.0	0.0	1.2	1.5	0.0	0.4	0.0	0.0	7.2	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	33.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	41.3	28.4	9.1	3.8	47.1	8.4	12.7	27.2	5.8
VAX2	DRES93	ENSG00000116035	"Ventral anterior homeobox 2"	Q9UIW0	2	70900590-70965373	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.4;retina: 21.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 6.5;MCF7: 7.4;RH-30: 6.4;SCLC-21H: 6.4;SH-SY5Y: 7.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 16.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"basal ganglia: 2.1;hypothalamus: 4.7"	HPA009708			Approved	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA009708: AB_2668261"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.52e-2)"	"unprognostic (7.23e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.16e-1)"	"unprognostic (7.74e-3)"	"unprognostic (6.63e-3)"	"unprognostic (4.65e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.18e-2)"	2.7	2.6	4.4	1.4	1.9	0.4	2.1	16.4	7.9	1.9	0.8	1.1	0.0	0.5	3.6	0.8	1.8	1.1	0.6	1.5	2.5	4.1	0.6	0.3	0.9	0.6	1.4	1.1	2.3	6.9	0.9	2.2	1.2	0.8	2.3	0.6	21.2	4.5	0.6	2.0	1.5	0.5	1.9	1.6	0.4	0.4	0.8	1.0	0.0	0.7	1.2	0.4	1.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	4.9	1.2	6.5	1.8	1.0	3.6	1.2	0.5	0.1	0.0	0.1	0.0	0.0	0.0	2.9	0.3	2.5	0.0	0.2	0.0	4.0	0.0	0.1	2.7	0.8	0.0	0.0	1.8	0.0	0.3	0.0	0.6	0.0	0.0	2.4	7.4	0.0	0.1	2.8	0.1	0.0	6.4	0.0	2.0	1.6	6.4	7.7	5.0	0.0	2.7	2.8	0.2	1.2	3.1	0.7	1.5	1.3	0.0	0.0	0.0	1.5	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	1.9	16.4	2.7	2.5	4.1	1.4	1.1	0.8	1.0
WIF1		ENSG00000156076	"WNT inhibitory factor 1"	Q9Y5W5	12	65050626-65121566	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.2;lung: 67.7;retina: 29.6"	"Cell line enhanced"	"Detected in some"		"HEK 293: 5.2;LHCN-M2: 2.4;NTERA-2: 6.8;SCLC-21H: 1.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 16.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"								"Secreted to extracellular matrix"						"unprognostic (5.96e-3)"	"unprognostic (2.00e-1)"	"unprognostic (4.29e-3)"	"unprognostic (3.26e-3)"	"unprognostic (9.66e-2)"	"unprognostic (1.91e-1)"		"unprognostic (1.26e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.30e-5)"	"unprognostic (3.02e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.24e-3)"	0.9	2.4	23.3	0.8	35.2	0.6	14.2	1.6	20.6	1.6	0.8	1.0	1.9	0.6	5.5	14.5	3.4	1.5	0.6	0.7	10.4	3.9	1.0	0.6	67.7	0.7	1.4	8.2	0.8	0.8	0.6	21.4	0.6	0.4	9.5	0.8	29.6	24.8	2.3	0.6	4.2	1.8	1.2	0.7	0.7	0.9	1.0	3.5	0.0	0.6	3.6	0.6	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.4	0.1	0.0	0.9	6.8	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	35.2	1.6	20.6	10.4	3.9	1.4	8.2	0.4	3.5
WNT2B	"WNT13, XWNT2"	ENSG00000134245	"Wnt family member 2B"	Q93097	1	112466541-112530165	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 66.7"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 6.8;HSkMC: 12.9;TIME: 5.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.4"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047274, HPA066368"			Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"			Vesicles	Vesicles	"HPA047274: AB_2732539, HPA066368: AB_2685664"	"unprognostic (2.08e-3)"	"unprognostic (2.06e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.42e-2)"	"unprognostic (4.90e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.65e-4)"	"unprognostic (5.41e-2)"	"unprognostic (7.64e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.49e-2)"	3.4	1.9	1.7	3.4	4.6	0.2	2.1	2.6	2.9	9.2	12.0	0.8	3.7	3.9	7.5	5.4	7.6	4.4	8.0	3.6	1.6	1.7	1.8	0.5	5.2	0.9	2.0	2.4	28.7	2.0	1.2	1.9	6.0	1.5	7.3	6.8	66.7	1.7	18.3	1.3	13.4	9.1	12.9	3.0	1.2	4.4	16.2	0.8	0.5	1.4	5.6	1.9	10.3	8.5	2.3	1.2	1.7	0.7	0.8	1.2	0.1	0.7	0.4	3.4	0.8	3.4	6.8	0.6	1.4	1.5	0.4	0.6	0.3	0.7	1.8	0.3	1.6	2.1	1.1	0.5	0.3	0.1	0.7	0.2	1.1	0.5	2.9	0.2	0.8	12.9	1.2	0.6	0.2	1.7	0.2	0.3	0.4	0.5	0.1	0.2	0.6	0.5	0.1	0.5	0.0	2.3	0.4	0.5	0.5	1.3	0.2	1.1	0.1	0.4	5.2	0.5	2.0	1.2	0.4	0.2	0.1	0.0	1.4	0.2	1.3	0.9	0.7	1.0	0.9	0.3	0.8	1.4	1.2	1.0	0.3	2.3	0.4	0.7	1.7	0.8	0.5	1.2	0.4	0.1	1.7	4.6	2.6	2.9	1.6	1.7	2.0	2.4	1.5	0.8
ZNF280A	"3'OY11.1, SUHW1, ZNF280, ZNF636"	ENSG00000169548	"Zinc finger protein 280A"	P59817	22	22513736-22520270	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 5.6;epididymis: 5.6;retina: 2.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.0;K-562: 12.7;SK-MEL-30: 3.4"	"Cancer enhanced"	"Detected in some"		"melanoma: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA044475			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA044475: AB_10960420"			"unprognostic (7.53e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.56e-2)"		"unprognostic (3.14e-1)"	"unprognostic (1.78e-2)"	"unprognostic (3.29e-1)"	"unprognostic (4.65e-3)"			"unprognostic (1.58e-1)"	"unprognostic (1.29e-1)"			0.0	5.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.4	0.0	0.0	0.1	5.6	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.5	0.0	1.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	0.0	1.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.7	12.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.5	0.3	0.5	0.2	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0
